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General	Introduction	
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Feeling depressed, down or blue… People use various words to describe negative mood 
states and probably everyone has experienced moments of sad mood in their lives. For 
most people sad mood comes and goes but for some people depressed mood persists 
over several days, weeks, months or years. But depression is more than feeling sad: 
People with depression often have lost interest or pleasure in almost all activities; they 
feel worthless and guilty; have trouble concentrating and taking decisions and often 
have sleeping problems. These and other symptoms of depression cause many problems 
in everyday live, such that people with depression have difficulties in engaging in social 
activities, functioning at work and maintaining healthy relationships. In the worst case 
depression can lead to suicide. Due to these negative consequences, depression is one of 
the leading causes of disability worldwide.  
 This dissertation describes a number of studies that my co-authors and I have 
conducted on underlying neurological and psychological vulnerability factors in (chronic) 
depression and on the stability of psychological vulnerability factors during treatment 
for depression. The theoretical application of a new form of psychotherapy, schema 
therapy, for patients with chronic depression is presented as well as the results of a 
single-case series testing the effects of schema therapy for patients with chronic major 
depressive disorder. Finally, the results of a study on potential mechanisms of change in 
schema therapy for chronic depression are presented. The introduction to this 
dissertation provides a general overview on the classification of major depressive 
disorder and chronic forms of depression, a brief review on the prevalence and negative 
consequences of chronic depression, an overview of current treatment options for 
chronic depression, a summary on the underlying developmental, psychological and 
neurological disturbances underlying chronic depression, and a short overview on the 
key concepts of schema therapy as well as a review of the current evidence base of 
schema therapy. At the end of the introduction the aims and outline of this dissertation 
are summarized. 
Major	Depressive	Disorder	
Major depressive disorder is a common mood disorder characterized by low mood, a 
loss of interest and a number of other emotional, cognitive and physical disturbances 
such as feelings of worthlessness or a loss of appetite (American Psychiatric Association, 
2013). Table 1 provides an overview of the full Diagnostic and Statistical Manual of 
Mental Disorders fifth edition (DSM-V) diagnostic criteria of major depressive disorder. 
The criteria of a major depressive episode are met if five or more of these criteria are 
present, including either the depressed mood or the loss of interest criteria, during a 
period of two weeks nearly every day most of the day.  
 Recent epidemiological studies estimate that the lifetime prevalence for a major 
depressive episode varies between 11.1% in low income countries and 14.6% in high 
income countries (Bromet et al., 2011). Since 1990 depression moved from place four of 
the leading causes of disease burden worldwide to place two, highlighting that 
depression is a major global health problem (Ferrari et al., 2013). Findings from the 
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2010 global burden of disease study have shown that among mental disorders, 
depression, including dysthymia, account for the greatest burden of disease worldwide 
(Whiteford et al., 2013), emphasizing the importance of effective treatments for 
depression.  
 
Table	1. DSM-5 diagnostic criteria of Major Depressive Disorder (see print version). 
 
 Among others, common treatment options for major depressive disorder include 
antidepressant medication, psychotherapy, or the combination of antidepressant 
medication and psychotherapy. A recent meta-analysis found that 62% of patients with 
depression do not meet the criteria for depression anymore after psychotherapy 
(Cuijpers et al., 2014) and comparative outcome studies between different types of 
psychotherapy suggest that there are no differences between different types of 
psychotherapy in treatment effects (Cuijpers, van Straten, Andersson, & van Oppen, 
2008). Comparative outcome studies between psychotherapy and antidepressants 
suggest that antidepressants and psychotherapy are approximately equally effective in 
reducing depressive symptoms following treatment (for a meta-analysis see: Cuijpers et 
al., 2013) but psychotherapy seems to have more positive long-term effects than 
antidepressants (for a meta-analysis see: Imel, Malterer, McKay, & Wampold, 2008). 
Combined treatments are slightly more effective than either intervention alone (for 
meta-analyses see: Cuijpers, Dekker, Hollon, & Andersson, 2009; Cuijpers, van Straten, 
Warmerdam, & Andersson, 2009; Khan, Faucett, Lichtenberg, Kirsch, & Brown, 2012). 
Although the majority of patients improve during treatment some patients with 
depression do not get better in treatment. If symptoms of depression do not improve, 
either with treatment or without treatment, depression can become a chronic condition 
(for a review see: Richards, 2011). 
CHAPTER 1 
A	brief	history	of	the	classification	of	chronic	depression	
The concept of chronic depression as an axis-I disorder was first introduced in the third 
edition of the DSM classification system (American Psychiatric Association, 1980). 
Before that, long lasting forms of depression were seen as characterological disorders 
(for a historical review see: Akiskal, 2001). In general, a depression is considered to be 
chronic when the symptoms of depression are present for two years or longer. The DSM-
III included a separate diagnostic category for patients with long lasting depressive 
symptoms that did not meet all criteria of a depressive disorder, i.e. dysthymic disorder. 
In addition to dysthymic disorder as a separate diagnostic category, the revised DSM-III 
and the DSM-IV included specifiers for a more severe form of chronic depression 
(chronic major depressive disorder) (American Psychiatric Association, 1987, 2005). In 
addition, a recurrent major depressive disorder without full interepisode recovery and a 
major depressive episode superimposed on dysthymic disorder (double depression; 
Keller & Shapiro, 1982) are considered chronic forms of depression and are represented 
in the DSM-IV by course specifiers. Figure 1 provides a graphical overview of these four 
different types of chronic depression. 
 
 
Figure	1. Graphical representation of different types of chronic depression. The dashed line represents an 
euthymic state (i.e. normal mood). Depressed mood is indicated by the area under the dashed line 
whereas elevated mood is indicated by the area above the dashed line. The x-axis represents passing of 
time over 2 years. 
 
10 
GENERAL INTRODUCTION 
 11
These different forms of chronic depression appear not to differ from each other with 
respect to a number of demographic, clinical and psychosocial variables and it has 
therefore been argued that chronic depression should be conceptualized as a single 
disorder (McCullough et al., 2003; McCullough et al., 2000). In line with this, in the most 
recent DSM-5 classification, the different subtypes of chronic depression have been 
consolidated into one single category: persistent depressive disorder. The criteria for a 
persistent depressive disorder are met if a person experiences depressed mood most of 
the day nearly every day for two years in addition to at least two out of six of the 
following criteria: poor appetite or overeating; insomnia or hypersomnia; low energy or 
fatigue; low self-esteem; poor concentration or difficulty making decisions; feelings of 
hopelessness (American Psychiatric Association, 2013). All research that is cited and all 
research that was conducted in this dissertation is based on previous diagnostic 
classification systems and therefore, throughout this dissertation, the more common 
term chronic depression will be used to refer to a depression that is present for two years 
or longer. 
Prevalence	and	consequences	of	chronic	depression	
A relatively large proportion of patients with depression develop a chronic course: 
Findings from the Sequenced Treatment Alternatives to Relieve Depression trial (Rush et 
al., 2004) have shown that among 2876 patients with major depressive disorder 25.3% 
had a current episode that lasted 2 years or longer (Trivedi et al., 2006). Comparable 
prevalence rates of chronic depression among patients with major depression have been 
reported in epidemiological studies: The Netherlands Mental Health Survey and Incidence 
Study found that 20% of the patients with a major depressive episode had not recovered 
within two years (Spijker et al., 2002).  
 Given that, by definition, chronic forms of depression are characterized by longer 
depressive episodes, it is reasonable to assume that chronic forms of depression 
contribute more to the burden of disease than non-chronic forms of depression. In line 
with this argument, it has been shown previously, that economic costs of depression are 
explained by the duration of symptoms, rather than by the severity of symptoms, 
indicating that chronic forms of depression are associated with higher economic burden 
(Fostick, Silberman, Beckman, Spivak, & Amital, 2010). A number of studies have 
compared the negative consequences of depression in patients with and without chronic 
depression. Compared to episodic forms of depression, chronic depression is 
characterized by increased impairments in psychosocial functioning (e.g. Wells, Burnam, 
Rogers, & Hays, 1992), is associated with more suicide attempts and hospitalizations, 
higher service use and increased economic costs (for a review see: Arnow & Constantino, 
2003). Findings from an epidemiological survey study (Netherlands Mental Health 
Survey and Incidence Study) have shown that people with chronic forms of depression 
have lower recovery rates and are more likely to have any depressive disorder after 
three year follow-up compared to people with an non-chronic depression (Rhebergen et 
al., 2009). In the light of the relatively high prevalence of chronic depression and the 
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negative consequences of chronic depression it is critical to obtain a better 
understanding of the underlying vulnerability factors of chronic depression and to 
explore new treatment options. 
Current	treatment	of	chronic	depression	
When discussing the effects of treatments for depression it is crucial to distinguish 
between different terms that can be used to describe treatment effects. Table 2 provides 
common definitions of terms that are often used in depression treatment outcome 
studies and meta-analyses to describe treatment effects. One useful conceptualization in 
this context has been the introduction of the terms “response” “remission” and 
“recovery” to describe treatment effects (Frank et al., 1991). Moreover, in meta-analyses 
treatment effects are often described in terms of effect sizes representing standardized 
improvement on depression severity scales. Given that patients who have reached a 
response or only partial remission are usually still symptomatic and therefore at an 
increased risk of relapse (Paykel, 2008), it has been argued that full remission should be 
the desired treatment outcome in depression (Thase, 2003). 
 
Table	 2.	 Terms commonly used to define treatment effects in treatment outcome studies or meta-
analyses 
Term	 Definition	
Response A percentage change from the initial baseline score (often about 50%) on a depression 
symptom severity measure (Riedel et al., 2010). 
Remission Reaching an absolute cutoff score (usually corresponding to a minimum or total absence of 
symptoms) on a depression symptom severity measure (Riedel et al., 2010) or diagnostic 
interview. In the DSM 5 classification system, partial remission refers to a state in which 
some symptoms of depression are present but the criteria for a depressive episode are not 
met or a state in which no symptoms of depression are present for less than two months. Full 
remission refers to a state in which no significant symptoms of depression are present for a 
period of two months or longer (American Psychiatric Association, 2013). 
Recovery Not meeting diagnostic criteria for depression on a diagnostic interview. 
Effect sizes Standardized improvement on depression severity scales. 
 
 Currents treatments for chronic depression include psychotherapy, antidepressant 
medication or the combination of antidepressant medication and psychotherapy. 
Psychotherapy has been shown to be effective in reducing depressive symptoms in 
patients with chronic depression but the effect sizes are small (for a meta analysis see: 
Cuijpers et al., 2010). More promising results have been reported for the cognitive 
behavioral analysis system of psychotherapy (CBASP), a relatively new type of 
psychotherapy that was specifically developed for chronic depression. In a large 
randomized controlled trial comparing the efficacy of CBASP, antidepressants and their 
combination for patients with chronic depression, it has been shown that up to 48% of 
the patients randomized to CBASP showed a response and 33% of the patients in the 
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CBASP condition reached remission (Keller et al., 2000). In the same trial, remission 
rates following antidepressant medication was 29% (Keller et al., 2000). The most 
positive results have been reported for the combination of psychotherapy and 
medications (for a review see: Pampallona, Bollini, Tibaldi, Kupelnick, & Munizza, 2004; 
Spijker, van Straten, Bockting, Meeuwissen, & van Balkom, 2013). In the previously 
mentioned CBASP trial it has been shown, for example, that up to 73% of patients with 
chronic depression responded to combined treatment (48% remitted), compared to a 48% 
response rate for patients receiving either antidepressants or psychotherapy alone 
(Keller et al., 2000). 
 Although such findings show that current treatments for chronic depression can be 
effective, about half of the patients do not reach remission in treatment, even with 
combined treatments, and are therefore at an elevated risk of subsequent relapses and 
recurrences, illustrating that there is still a lot of room for improvement. Another 
problem with current treatment approaches for chronic depression is that the effects 
are often not enduring. Even if patients with chronic depression reach full remission in 
treatment they might still be at an elevated risk for relapse: Findings from the Sequenced 
Treatment Alternatives to Relieve Depression study have shown that relapse among 
patients who have reached remission was more likely in those with a prior chronic 
course of depression (Rush et al., 2012). Such findings indicate that extensive 
continuation and maintenance treatment for chronic depression is required in order to 
prevent relapses and recurrences. It has been shown, for example, that patients with 
chronic depression who initially responded to treatment experience less recurrence one 
year after treatment if they continued medication compared to pill placebo (Gelenberg 
et al., 2003). 
 Taken together, while current treatment options for chronic depression are 
effective, these effects are rather small and often not maintained when treatment is 
terminated. Moreover, even if patients with chronic depression reach remission they are 
still at an elevated risk for relapse. Therefore, it is important to take a closer look at the 
underlying vulnerability factors that might maintain chronic depression when exploring 
novel treatment options in order to get a better understanding of the requirements of 
potentially effective treatments.  
Developmental	and	psychological	vulnerability	factors	underlying	chronic	
depression	
Are there developmental and psychological factors that distinguish episodic forms of 
depression from chronic depression? In recent years, a number of studies have been 
conducted to determine the underlying risk-factors of chronic depression. One 
developmental risk-factor that has often been associated with chronic depression is 
childhood abuse (Brown, Craig, Harris, Handley, & Harvey, 2007; Wiersma et al., 2009). 
Childhood abuse has been shown to moderate treatment response in chronic depression: 
Patients with chronic depression and a history of childhood abuse are less responsive to 
antidepressants, compared to patients with chronic depression and no history of 
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childhood abuse (Klein et al., 2009). Furthermore, another study found that patients 
with chronic depression and a history of childhood trauma benefit more from 
psychotherapy than pharmacotherapy (Nemeroff et al., 2003).  
 Chronic depression has also been associated with dysfunctional cognitive factors. 
It has been shown, for example, that patients with chronic depression score higher on 
measures of dysfunctional cognitions compared to non-chronically depressed patients 
(Riso et al., 2003).  
 Patients with chronic depression also have an increased comorbidity of axis-I and 
axis-II disorders (for a review see: Riso, Miyatake, & Thase, 2002). There is mixed 
evidence as to whether co-morbid axis-II disorders have a negative impact on treatment 
outcomes in depression. While some studies found that axis-II comorbidity in patients 
with depression has a negative impact on treatment outcome (e.g. Newton-Howes, Tyrer, 
& Johnson, 2006; Newton-Howes et al., 2013), other studies did not find evidence for 
this association (e.g. Maddux et al., 2009). 
 Finally, it has been shown that interpersonal problems predict a chronic course of 
depression (Brown & Moran, 1994) and that patients with chronic depression show 
increased social avoidance compared to patients with episodic depression (Ley et al., 
2011).  
 A more detailed description of the underlying developmental and psychological 
risk-factors to chronic depression is provided in chapter 8. 
Neurological	vulnerability	factors	underlying	depression	
In addition to the developmental and psychological risk-factors, it is important to also 
identify specific brain regions and neural networks that are associated with abnormal 
cognitive processing in chronic depression. Towards this end a number of structural and 
functional neuroimaging studies, primarily in patients with episodic major depressive 
disorder, have been conducted in recent years. These studies have made use of modern 
neuroimaging techniques such as Magnetic Resonance Imaging (MRI) or functional 
(f)MRI to measure differences in brain structures between depressed and non-
depressed individuals as well as metabolic changes as an index of neural activity in these 
brain structures, respectively. (f)MRI is a non-invasive technique that makes use of 
strong magnetic fields to measure brain tissue and the amount of deoxygenated 
hemoglobin in the blood as an indicator of brain activity. Most functional neuroimaging 
studies in depression have focused on cognitive and emotional functions that are 
distorted in depression such as processing of emotional stimuli, reward seeking and 
emotion regulation (for a review see: Kupfer, Frank, & Phillips, 2012). Studies that have 
focused on disturbed emotional processing have shown that compared to healthy 
controls, patients with depression show increased neural activity in subcortical systems 
(e.g. amygdala, insula) and lower responses in prefrontal cortical areas (e.g. dorsolateral 
prefrontal cortex) during processing of negative information (for a meta-analysis see: 
Hamilton et al., 2012). Other studies have focused on identifying the neural correlates of 
distorted cognitive processing in depression, such as an increased processing of 
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negative information with regard to the self (i.e. self-referential processing; Northoff, 
2007). Studies in this area have emphasized the role of cortical midline structures, 
including the medial prefrontal cortex, anterior cingulate cortex, as well as the posterior 
medial cortices during self-referential processing in patients with depression (for 
reviews see: Lemogne, Delaveau, Freton, Guionnet, & Fossati, 2012; Nejad, Fossati, & 
Lemogne, 2013). 
 In most functional neuroimaging studies participants are typically presented with 
emotional stimuli such as fearful faces or emotional words and have to engage in a 
cognitive task as part of the experimental paradigm that is used. Another line of research 
has focused on so called resting state networks to determine the connectivity within 
distinct brain networks in depression (Wang, Hermens, Hickie, & Lagopoulos, 2012). In 
these studies participants are typically instructed to rest and relax while no further task 
instructions are provided. Resting state studies have identified a set of distinct neural 
networks in patients with depression as well as in other mental disorders (for a review 
see: Broyd et al., 2009). Although these studies have led to an increased understanding 
of the underlying neurological dysfunctions in depression, most studies in this area were 
performed in patients with episodic forms of depression and it therefore remains 
unclear if the findings in patients with episodic depression generalize to those with 
chronic depression. 
 Given that patients with chronic depression by definition suffer more long-lasting 
depressive episodes, it is possible that they are also characterized by differential 
neurological processing during task-performance as well as during rest. Greicius and 
colleagues (2007), for example, identified a depressed neural network and found that 
connectivity within this network varied as a function of the length of the current 
depressive episode (i.e. chronicity). In the current dissertation the functional 
connectivity within depressogenic brain networks during rest in patients with chronic 
depression will further be investigated in chapter 3. 
Implications	of	underlying	vulnerability	factors	for	treatment	of	chronic	
depression	
As has been summarized in the previous paragraphs, studies on the underlying risk-
factors of chronic depression have shown that chronic depression is characterized by a 
broad range of underlying psychological and developmental risk-factors. In addition, a 
number of abnormalities in neural processing during performance in cognitive tasks as 
well as distinct brain networks during rest have been identified but most studies in this 
area have been conducted in patients with episodic depression. It is therefore important 
to further study underlining neurological, developmental and psychological risk-factors 
to chronic depression. The identification of developmental and psychological risk-
factors has important implications for the treatment of chronic depression. Treatment 
for chronic depression should take the developmental origins of depression into account 
(adverse childhood events), current problems that might maintain the depression 
(interpersonal factors and dysfunctional cognitions) as well as possible personality 
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pathology that might interfere with the psychotherapeutic process. Given the wide range 
of underlying risk-factors, it seems unlikely that any form of psychotherapy with a 
primary focus on only one of these aspects can achieve positive and enduring effects in 
chronic depression. Instead, more positive results might be achieved with an integrative 
treatment approach to chronic depression that takes all of the underlying risk-factors 
into account. 
Schema	Therapy	–	an	integrative	treatment	approach	to	chronic	depression	
Schema therapy is such an integrative treatment approach combining cognitive-
behavioral, interpersonal, experiential and psychodynamic techniques (Young, Klosko, & 
Weishaar, 2003). Young et al. developed schema therapy as a novel treatment for 
complex and difficult to treat patients, particularly those with chronic depression and 
personality pathology (Young et al., 2003). The underlying model of schema therapy 
assumes that patients with psychological problems are characterized by a distinct set of 
negative core beliefs, so called early maladaptive schemas (EMS). EMS determine the 
way in which people perceive the world, themselves and others and can have a powerful 
impact on sensations, emotions and behavior. According to the schema model, EMS are 
formed early in life and remain stable throughout life if no attempts are made to change 
them. Individuals who experience negative traumatic events early during childhood 
might form a distinct set of strong negative EMS. Later in life these EMS might be 
activated by current stressors or environmental events. For example, a student with a 
strong failure schema might activate the schema in situations in which academic 
performance is assessed. Activation of the failure schema might then go along with 
negative emotions and dysfunctional thoughts about the self which contributes to 
depression. 
 Another key concept in schema theory are schema modes. Schema modes describe 
a set of concurrently activated EMS and coping responses (Young et al., 2003). Unlike 
EMS, schema modes describe the moment-to-moment emotional states of a patient. 
Different psychological disorders are characterized by different set of predominant 
schema modes and patients might switch between different sets of schema modes. While 
a number of studies have assessed EMS in patients with depression (e.g., Riso et al., 2006) 
there is a lack of research on schema modes in depression. In chapter 8 hypothetical 
examples of schema modes in chronically depressed patients are discussed and it is 
explained how therapists can deal with schema modes in schema therapy. 
Schema	Therapy	–	Evidence	Base	
In recent years a number of treatment studies have been conducted to test the effects of 
schema therapy for various axis-I and axis-II disorders (for a review see: Bamelis, Bloo, 
Bernstein, & Arntz, 2012). Schema therapy has been shown to be an effective treatment 
for patients with borderline personality disorder (Dickhaut & Arntz, 2014; Farrell, Shaw, 
& Webber, 2009; Giesen-Bloo et al., 2006; Nadort et al., 2009; Nordahl & Nysaeter, 2005) 
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and cluster-c paranoid, histrionic and narcissistic personality disorders (Bamelis, Evers, 
Spinhoven, & Arntz, 2013). Moreover, schema therapy in a group setting, combined with 
treatment as usual, has been shown to be more effective than treatment as usual alone 
for patients with borderline personality disorder (Farrell et al., 2009). Finally, a 
shortened version of group schema therapy with a stronger focus on cognitive 
techniques and EMS (van Vreeswijk & Broersen, 2006) has been shown to have positive 
effects on general symptomatic distress in mixed clinical groups (van Vreeswijk, 
Spinhoven, Eurelings-Bontekoe, & Broersen, 2012) and in young adults with personality 
disorders and personality disorder features (Renner et al., 2013). Given that patients 
with chronic depression often report a history of childhood abuse and co-morbid axis-II 
disorders, schema therapy might be a valuable treatment option for these patients. 
 Only a few studies to date have tested the effects of schema therapy in patients 
with (chronic) depression. In a randomized clinical trial comparing schema therapy, 
client centered therapy and treatment as usual for patients with predominantly cluster-c 
personality disorders the effects of these treatments on co-morbid depression have been 
investigated as secondary outcomes (Bamelis et al., 2013). The authors found that 
patients randomized to schema therapy had a lower risk of meeting the diagnostic 
criteria for a depressive disorder at the end of the three-year follow up phase compared 
to patients who were randomized to the treatment as usual condition (Bamelis et al., 
2013). Brewin et al. (2009) found large treatment effects of imagery rescripting, a core 
technique in schema therapy, for treating patients with chronic depression. A recent 
randomized clinical trial examined the effects of a relatively short protocol of schema 
therapy vs. cognitive behavioral therapy for patients with (chronic) depression (Carter 
et al., 2013). The authors found that at the end of the 12 months study period 50% of the 
patients in the schema therapy condition and 40% of patients in the cognitive therapy 
condition were in remission. These remission rates did not differ statistically 
significantly, indicating that schema therapy is at least as effective as cognitive therapy 
for patients with depression (Carter et al., 2013), though it should be noted that the 
study was probably underpowered and was terminated before the planned sample sizes 
were reached. Chronicity did not differentially impact treatment outcome, suggesting 
that a relatively short protocol of schema therapy is suitable for patients with episodic 
as well as for patients with chronic depression (Carter et al., 2013). Finally, a single-case 
series of schema therapy in 12 patients with chronic depression found large effects of 
schema therapy on improvements in depressive symptoms and approximately 60% 
remission rates (Malogiannis et al., 2014). Although these initial findings are promising, 
there is a need to further investigate the effects of schema therapy for patients with 
chronic depression: The average number of weekly sessions in the schema therapy 
condition in the study by Carter et al. (2013) was relatively small (18 weekly sessions). 
Given that the effects of psychotherapy for chronic depression increase with the number 
of therapy sessions (Cuijpers et al., 2010), it is important to investigate the effects of a 
more intensive course of schema therapy for patients with chronic depression. 
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Aims	of	the	current	dissertation	
Chronic depression is a complex disorder and current treatments fall short, possibly 
because the underlying developmental and psychological vulnerability remains 
untouched. Therefore, there is a need to further investigate the underlying vulnerability 
to (chronic) depression, the stability of vulnerability factors during treatment and to 
explore novel treatment options for patients with chronic depression. In recent years 
there has been an increased interest in schema therapy as a novel treatment option for 
patients with difficult to treat psychiatric disorders. Most studies so far have focused on 
the effects of schema therapy in patients with personality disorders. More recently 
studies emerged that investigated schema therapy-related concepts in patients with 
depression and initial studies have emerged testing the effects of schema therapy for 
chronic depression. This dissertation builds upon this work and aims to further extend 
the knowledge of underlying risk-factors in (chronic) depression and to explore new 
treatment options for chronic depression. 
 The primary aim of this dissertation was to test the effects of schema therapy for 
chronic depression in a single-case series and to explore underlying mechanisms of 
change in schema therapy for chronic depression. The secondary aim was to examine 
underlying neurological and psychological vulnerability factors to (chronic) depression, 
as well as the stability of psychological vulnerability factors throughout treatment. 
Towards this end, my co-authors and I have conducted a number of studies in patients 
with episodic forms of depression and in patients with chronic depression. The results 
of these studies are presented in this dissertation in three parts: 
 Part I of this dissertation describes the results of two neuroimaging studies in 
patients with chronic major depressive disorder and healthy controls. The overall aim of 
part I was to explore the underlying neuropathology of chronic major depressive 
disorder using fMRI. Specifically, in chapter	2 the neural correlates of self-referential 
processing and its associations with explicit and implicit measures of self-associations 
were explored in patients with chronic major depressive disorder and non-patient 
controls. It was hypothesized that patients with chronic depression would show a 
differential activation pattern in areas of the brain that have previously been associated 
with self-referential processing during the presentation of schema-congruent (negative 
and depression-related negative trait words) vs. schema incongruent (neutral or 
positive trait words) compared to non-patient controls. The study described in chapter	
3 is a neuroimaging study, conducted in the same sample as chapter 2, comparing 
resting state functional connectivity of the default mode network of patients with 
chronic major depressive disorder and healthy controls before and after a sad mood 
induction. It was hypothesized that patients with chronic depression would show 
increased default mode network connectivity following a sad mood challenge. 
 Part II of this dissertation focusses on the stability of underlying vulnerability 
factors of depression during treatment for depression. The overall aim of part II was to 
test if putative underlying vulnerability factors of depression remain stable or improve 
during treatment for depression. More specifically, the study described in chapter	4 
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explored the relation between early maladaptive schemas and depressive symptoms 
and the stability of schemas over a course of outpatient treatment for depression in a 
naturalistic treatment setting. It was hypothesized that schemas describing core themes 
of depression would be related to depressive symptoms and that schemas would remain 
stable over the course of treatment. The aim of chapter	5 was to explore the stability of 
the personality traits extraversion and neuroticism in patients with depression who 
sought treatment and in patients with depression who did not seek treatment during a 
two-year period. In the study described in chapter	 6 the stability of interpersonal 
problems in patients with depression during a course of cognitive therapy was tested. It 
was hypothesized that patients would experience less interpersonal distress following 
cognitive therapy for depression but that the interpersonal style of patients would 
remain stable. The main question that was addressed in chapter	 7 was whether 
psychotherapy for depression has positive effects on psychosocial functioning. To 
explore this question, a meta-analysis of randomized clinical trials testing the effects of 
psychotherapy on psychosocial adjustments was conducted. It was hypothesized that 
psychotherapy for depression would have positive effects on psychosocial functioning 
and that these effects would be positively correlated with the effects of psychotherapy 
on depressive symptom severity. 
 Part III of this dissertation focusses on the application of schema therapy as a novel 
treatment option for patients with chronic depression. The overall aim of part III was to 
describe the rationale of applying schema therapy to chronic depression, to test if 
schema therapy is a potentially effective treatment for chronic depression and to 
explore underlying mechanisms of change in schema therapy for chronic depression. 
More specifically, in chapter	8 the theoretical application and the underlying rationale 
of applying schema therapy to chronic depression is described and a general treatment 
protocol of schema therapy for chronic depression is provided. In the study described in 
chapter	9, the results of a single case-series study testing the effects of schema therapy 
for chronic major depressive disorder are described. It was hypothesized that, 
compared to a non-treatment baseline phase, schema therapy would result in 
improvements in depressive symptoms, global symptomatic distress and improvements 
in overall functioning. In the study described in chapter	 10 the temporal relation 
between depressive symptoms and two potential underlying mechanisms of change in 
schema therapy for chronic depression (the therapeutic alliance and negative core 
beliefs) were explored. The main hypotheses were that change in negative core-beliefs 
would predict subsequent change in depressive symptoms and that session to session 
change in depressive symptoms would be positively related to the therapeutic alliance 
rating of the session. 
 In chapter	11 the results of the current dissertation are integrated and discussed. 
Methodological shortcomings and recommendations for future studies are provided. In 
the valorization	addendum the societal relevance, target groups and the innovative 
aspects of this dissertation are described. 
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Abstract	
Patients with depression tend to process negative information with regard to the self (i.e. 
self-referential processing). This fMRI study used a passive self-referential processing 
paradigm to study schema (in)congruent information processing in patients with 
chronic major depressive disorder (cMDD) (n = 17) and non-patient controls (n = 18). 
Participants were instructed to decide whether a presented word was an existing word 
or a non-word. Stimuli consisted of positive, negative, negative depression related and 
neutral personality trait words and non-words. Participants also completed an explicit 
and an implicit measure of positive and negative self-associations. There was a 
significant interaction between group and word category in the left medial prefrontal 
cortex (mPFC) and in the left dorsolateral prefrontal cortex (dlPFC). Non-patient 
controls had relatively increased activity in the mPFC during processing of negative 
depression related vs. neutral words whereas patients with cMDD had relatively 
decreased activity. Non-patient controls had relatively increased dlPFC activity during 
processing of positive vs. neutral words whereas patients with cMDD had relatively 
decreased activity. Explicit self-descriptiveness ratings of negative depression related 
words were negatively correlated with signal change in the mPFC during processing of 
negative vs. neutral stimuli and with signal change in the dlPFC during processing of 
positive vs. neutral stimuli for all participants. Implicit self-associations with negative 
depression vs. positive stimuli did not differ between the groups and were unrelated to 
BOLD signal change. Our results suggest that cMDD is characterized by distinct neural 
processing of emotional self-relevant stimuli in the mPFC and the dlPFC. 
 
Keywords: chronic major depressive disorder; neuroimaging; self-referential processing; 
implicit self-associations 
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Introduction	
Major depressive disorder (MDD) is a common mood disorder characterized by sad 
mood, a loss of interest and other emotional, cognitive and physical disturbances 
(American Psychiatric Association, 2013). It is estimated that about 20% of depressed 
patients do not recover within 2 years and thus develop a chronic depression (for a 
review see: Hölzel, Härter, Reese, & Kriston, 2011). Compared to episodic depression, 
chronic depression is associated with more negative health outcomes, increased service 
use and higher economic costs (Arnow & Constantino, 2003; Howland, 1993; Smit et al., 
2006; Torpey & Klein, 2008; Wells, Burnam, Rogers, & Hays, 1992). Given the negative 
consequences that are associated with chronic depression it is important to understand 
the underlying neurological disturbances in chronic depression. 
 The aim of the current study was to explore the neural correlates of self-referential 
processing in patients with chronic major depressive disorder (cMDD) and to determine 
its association with explicit and implicit measures of self-associations. Self-referential 
processing has been defined as the experience of stimuli “as strongly related to one’s 
own person” (Northoff, 2007, p.3). According to cognitive models of depression, 
negative beliefs about the self are organized in cognitive schemas (Beck, Rush, Shaw, & 
Emery, 1979). When confronted with schema congruent (i.e. negative) information, 
people with depression tend to process this information with regard to the self (i.e. self-
referential processing). This schema-congruent information processing is believed to 
operate on an automatic level of information processing (Segal, 1988). 
 Functional neuroimaging studies in non-patients have shown that self-referential 
processing relies primarily on the so called cortical midline structures (CMS; for a 
review see: Northoff et al., 2006). The CMS include the medial prefrontal cortex (mPFC), 
medial orbitofrontal cortex (MOFC), anterior cingulate cortex (ACC), and the posterior 
cingulate cortex (PCC). Functional neuroimaging studies in patients with depression 
have emphasized the important role of CMS abnormalities during self-referential 
processing (for reviews see: Lemogne, Delaveau, Freton, Guionnet, & Fossati, 2012; 
Nejad, Fossati, & Lemogne, 2013). Lemogne, et al. (2009) found increased activity in the 
dorsal part of the medial frontal gyrus during self-referential processing (vs. general 
processing) of both positive and negative words in patients with MDD but not in non-
patient controls (Lemogne et al., 2009). In a similar study, Yoshimura et al. (2010) found 
increased activity in patients with MDD, when compared to non-patient controls, in the 
mPFC during self-referential processing of negative words. In another study, Grimm et al. 
(2009) found increased activity in CMS in non-patient controls during self-referential 
processing vs. passive viewing of positive and negative pictures whereas patients 
showed generally lower signal intensities. Thus, whereas some studies found increased 
activity in mPFC in depressed patients vs. non-patient controls during self-referential 
processing (Lemogne et al., 2009; Yoshimura et al., 2010) other studies found evidence 
for an opposite pattern (Grimm et al., 2009). Moreover, results of previous studies were 
mixed with regard to stimulus type (pictures or words) and stimulus valence (positive, 
negative). 
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The present fMRI study adds three new elements to the existing research of 
abnormalities in self-referential processing during depression. First, previous 
neuroimaging studies on self-referential processing in depressed patients have focused 
on patients with non-chronic MDD. To the best of our knowledge no study to date has 
determined the neural correlates of self-referential processing in patients with cMDD. 
 Second, previous neuroimaging studies on self-referential processing in depressed 
patients primarily relied on explicit processing paradigms. This means that participants 
in these studies were explicitly instructed to make a judgment regarding the self-
relatedness of a stimulus. One limitation of explicit processing paradigms is that 
instructing participants to engage in self-referential processing elicits controlled rather 
than more automatic self-referential processing (Lemogne et al., 2011). However, 
according to theory, patients with depression tend to automatically process schema 
congruent information (Segal, 1988). Passive processing paradigms might therefore 
more closely resemble the way in which depressed patients process positive and 
negative information. In a passive processing paradigm depressed participants are 
presented with either schema congruent (negative stimuli) or schema incongruent 
(neutral or positive stimuli) information. It has been shown that passive processing 
paradigms are a valid alternative to explicit self-referential processing paradigms 
(Rameson, Satpute, & Lieberman, 2010). 
 Third, in the current study, changes in neural activity during processing of 
emotional personality traits were related to measures of explicit and implicit self-
associations. The self-relatedness of personality traits can be assessed explicitly by 
asking participants to evaluate the degree to which a certain personality trait describes 
the self. Such an approach requires the participant to reflect upon the own self and to 
make an explicit judgment about the self in relation to the personality trait. Yet, 
schematic information processing is thought to operate on an automatic, implicit level 
(Segal, 1988). Compared to explicit self-associations, implicit self-associations might 
therefore more closely be related to neural correlates of self-referential processing of 
schema congruent information. Implicit self-associations can be assessed using a single 
category (self) implicit association test (SC-IAT) (Karpinski & Steinman, 2006). Recently, 
a depression specific SC-IAT has been proposed to measure implicit self-associations 
with negative depression related stimuli (Lemmens et al., 2014). No differences with 
regard to implicit self-associations between patients with episodic depression and non-
patient controls were found (Lemmens et al., 2014). In another study using an IAT, it has 
been shown that the duration of a depressive episode (i.e. chronicity) was associated 
with stronger implicit self-depressed associations in patients with depression (Elgersma, 
Glashouwer, Bockting, Penninx, & de Jong, 2013). Thus although one previous study 
found no differences on the depression specific SC-IAT (Lemmens et al., 2014) we expect 
that patients with a longer duration of depressive episodes (i.e. chronic depression) 
have stronger depression specific self-associations on the SC-IAT compared to non-
patient controls, and that this association correlates with the brain responses associated 
with self-referential processing. 
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In sum, this study investigates the neural correlates of self-referential processing in 
patients diagnosed with cMDD using a passive processing paradigm when compared to 
matched non-patient controls. In addition, we examined explicit and implicit self-
associations with positive and negative personality traits in the same group of 
participants. It is hypothesized that 1) patients with cMDD show a differential activation 
pattern in areas of the brain that have previously been associated with self-referential 
processing (i.e. CMS) during presentation of schema-congruent (negative and 
depression-related negative trait words) vs. schema incongruent (neutral or positive 
trait words) compared to non-patient controls; 2) increased neural activity in brain 
areas of self-referential processing is positively correlated with explicit and implicit self-
associations of personality traits. 
Methods	
Participants 
Participants in this study were initially 19 patients with cMDD, of which one was 
excluded because of language difficulties. For the remaining 18 cMDD patients 18 non-
patient controls were recruited who were matched on age, gender, education level and 
left/right-handedness. One left handed patient could not be matched to a left handed 
non-patient control and was therefore matched to a right handed non-patient control 
participant. After data acquisition, one cMDD patient had to be excluded because of 
technical problems with the MRI scans. Thus, 17 cMDD and 18 non-patient controls 
constituted the final sample. Patients in this study were recruited from a specialized 
secondary mental health facility in the Netherlands (Riagg Maastricht) as part of a 
single-case series study testing the effects of schema therapy for chronic depression 
(Clinicaltrials.gov identifier: NCT01153867). Scanning sessions took place before the 
intervention phase of the study. Diagnostic status of patients was assessed with the 
Structured Clinical Interview for DSM-IV axis I disorders (SCID-I) by trained clinicians. 
Patients were included if they met the DSM-IV criteria for a cMDD and if they had a score 
of 20 or higher on the Beck Depression Inventory second edition (BDI-II). Patients were 
excluded if they had a bipolar disorder, a psychotic disorder, alcohol or substance 
dependence, autism spectrum disorder or if they met criteria for a DSM-IV cluster-A or 
cluster-B personality disorder as assessed with the SCID-II for DSM-IV personality 
disorders. One patient with co-morbid borderline personality disorder was included in 
error but is analyzed here. Patients with acute suicide risk were also excluded. Patients 
who took antidepressant medications were excluded, unless they were stable on 
medication for 3 months or longer prior to study intake. Nine (53%) of the patients with 
chronic depression took antidepressant medication at the time of the study and were 
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stable on medication (at least 3 months prior to the start of the study)1. Eligible 
participants with MRI contra-indications were excluded during recruitment. 
 Non-patient control participants were recruited via posters and via a participant 
database. Diagnostic status of non-patient controls was assessed with the SCID-I 
interview by a trained interviewer (FR). Non-patient controls were excluded if they met 
the DSM-IV criteria for a current axis-I disorder or any lifetime mood disorder. All 
participants received verbal and written information about the study and signed written 
informed consent. The study protocol was approved by the medical ethical committee of 
the University Hospital Maastricht, the Netherlands.  
 Table 1 provides an overview of the demographic and clinical characteristics of the 
sample. There were no statistically significant differences on any of the demographic 
variables between the two groups. The average BDI-II score of patients was 30.47 (SD = 
9.68), indicating severe depression. The average BDI-II score of non-patient controls 
was 2.67 (SD = 2.77) (Table 1). 
 
Table	1.	Demographic and clinical characteristics of the sample. 	
 
Measure 
Patients 
(N = 17) 
Controls 
(N = 18) 
t-test  
(p-value) 
χ2  
(p-value) 
Age, M (SD) 40.41 (17.77) 42.67 (18.73) .72 - 
Gender, n  
 female 
 male 
 
12  
5  
 
13  
5  
- .92 
 
Education level, n (%) 
 low 
 medium 
 high 
 
1 
5 
11 
 
2 
4 
12 
- .80 
BDI-II score 30.47 (9.68) 2.67 (2.77) <.001 - 
Note. BDI-II = Beck Depression Inventory second edition. 
 
Materials and Procedure 
Word stimuli 
The word stimuli for the self-referential processing task were selected from Andersons’s 
list of personality trait words (Anderson, 1968) and from words that have previously 
been used in a SC-IAT for depression, designed to measure implicit depressive self-
associations (Lemmens et al., 2014). All selected words were rated during a pilot test in 
an independent sample (N = 13) on valence and arousal on a scale ranging from 1 to 9, 
with higher scores representing more negative valence and less arousal, respectively 
(see Table 2). Based on the mean valence and arousal ratings during the pilot test, 80 
                                                        
1 Medication dosage of one patient taking venlafaxine was increased from 75 mg. to 150 mg. two month 
prior to start of the study. 
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personality trait words were selected and categorized into four equal unambiguous 
categories: 1) positive words (e.g. happy; pleasant; brilliant); 2) general negative words 
(e.g. arrogant; inattentive; dishonest); 3) depression related negative words (e.g. 
worthless; guilty; indecisive); 4) neutral words (e.g. moderate; casual; objective);2 
During pilot testing, general negative and negative depression related word stimuli were 
rated as more negative compared to neutral and positive words (all p-values < .05). 
Valence ratings of negative and negative depression related words did not differ 
significantly (p = .27). Selected words from the different categories were matched on the 
average word length. Although care was taken to also match word stimuli from the 
different categories on arousal levels as closely as possible, the selected neutral words 
were rated as less arousing in the pilot test compared to the positive and negative words 
(p < .01 and p < .001, respectively). Negative words were rated as slightly more arousing 
compared to negative depression related words (p < .01). In addition to the personality 
trait words, participants were presented with 20 non-words which consisted of a 
random composition of letters. Non-words were included to keep the participant 
focused on the task. The participant was instructed to press a button when a non-word 
was presented. 
 
Table	2.	Valence and Arousal ratings of selected word stimuli during pilot testing.	
Word category Valence M (SD) Arousal M (SD) 
Neutral 4.67 (0.92) 5.52 (0.94) 
Positive 2.21 (0.42) 4.49 (0.63) 
Negative 7.68 (0.58) 4.14 (0.72) 
Negative depression related 7.81 (0.49) 5.03 (1.00) 
Note. N = 13; Higher valence scores represent more negative valence ratings; Higher arousal scores 
represent less arousal. 
Questionnaires 
Beck depression inventory second edition - The Beck Depression Inventory second edition 
(BDI-II) is a 21-item self-report instrument to asses depressive symptom severity during 
the past two weeks (Beck, Steer, & Brown, 1996). In the present study the Dutch version 
was used and depressive symptom severity during the past week was assessed. The 
reason why symptom severity during the past week instead of the past two weeks was 
assessed was that patients in this study completed the BDI every week as part of a 
waiting-list phase of a treatment study that followed the fMRI experiment. The Dutch 
BDI-II has been shown to have good psychometric properties (van der Does, 2002). 
 
Implicit task – Single-category implicit associations test - A depression specific single-
category implicit association test SC-IAT (Lemmens et al., 2014) was used in order to 
                                                        
2 A list of all 80 personality trait words with valence and arousal ratings can be requested from the 
corresponding author. 
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assess implicit negative self-associations. The task started with a practice block in which 
12 positive and 12 negative words (attributes) were presented, followed by two test 
blocks. The test blocks included a third word category (self-stimuli). During the test 
blocks the self-stimuli shared a response key with either the positive or the negative 
attributes (counterbalanced). Each test block started with 12 practice trials (7 attributes 
and 5 self-stimuli). The practice trial was followed by the presentation of 72 critical 
trials consisting of 30-self-stimuli and 43 attributes. Six negative stimuli were selected 
to reflect main themes in depression (rejected, harmful, worthless, redundant, helpless, 
and vulnerable) and positive stimuli represented their counterparts (beloved, pleasant, 
powerful, successful, perfect, and valuable). In addition six self-stimuli were selected: I, 
me, self, my, own, mine. A more detailed description of the task design is provided 
elsewhere (Lemmens et al., 2014). 
fMRI passive self-referential processing task design and stimulation protocol 
This study used a 2 (group: non-patient controls, cMDD) X 5 (word type: positive, 
negative general, negative depression related, neutral, non-word) between-subject 
design. Personality trait words (positive, negative general, negative depression related 
or neutral) and non-words were presented in a slow-event related design with a 
presentation duration of 4000 ms. Word categories were presented in a fixed order, 
which differed per run, with personality trait words within categories and non-words 
presented randomly. Stimuli presentation was separated by a fixation cross with a 
random presentation duration of 2000, 3000, 4000 or 5000 ms. The participant was 
instructed to press a button whenever a non-word appeared. The task consisted of two 
runs with a duration of 12 min per run. The order of runs was counterbalanced between 
participants. In each run 100 words were presented (20 from each category). In the 
second run the same stimuli as in the first run were presented but in a different random 
order. Thus in total 200 word stimuli were presented during the session. Task 
instructions and stimuli were presented using E-Prime and projected on a screen behind 
the scanner that participants viewed through an angled mirror.  
Procedure  
Before the first run, participants rated their current mood state along four 100 mm VAS. 
Prior to each run, participants were instructed to read each word and to press a button 
with the left index finger when they detect a non-word. The purpose of this task 
instruction was to keep participants focused. As part of the experimental procedure, 
participants also underwent two resting state scans and a diffusion tensor imaging scan 
(results reported separately). Overall, the scanning session lasted about 60 min. 
Immediately after the scanning session non-patient control participants completed the 
SC-IAT. Patients completed the SC-IAT on a different day prior to the scanning session as 
part of a larger test battery. Following the scanning session, participants were asked to 
indicate how nervous they felt prior to the scanning session and how good they were 
able to concentrate during the scanning sessions on two 100 mm VAS. Participants were 
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also asked to rate the valence of each personality trait word and to indicate how much 
each personality trait word described themselves on a scale from 1 to 5. 
fMRI Data acquisition 
Anatomical images were acquired using a Magnetom Allegra 3T scanner (Siemens 
Healthcare, Netherlands) located at the Faculty of Psychology and Neuroscience, 
Maastricht University with a T1-weighted gradient echo (196 slices, TR = 2250 ms, TE = 
26 ms, flip angle = 90°, field of view = 256 mm and voxel dimensions 1 x 1 x 1 mm3). 
Two functional runs were obtained with a T2*-weighted echo planar imaging sequence 
consisting of 32 slices with a 3 mm slice thickness. TR was set at 2000 ms, with an TE of 
30 ms and a flip angle of 90°. The field of view was 192 mm with a voxel size of 3 x 3 mm 
isotropic resolution. During each run 380 volumes were acquired. A slice tilt correction 
of -30 was used to minimize inhomogeneity artefacts (Weiskopf, Hutton, Josephs, & 
Deichmann, 2006). 
fMRI data preprocessing 
Data pre-processing and analyses were conducted with Brainvoyager QX v2.4 (Brain 
Innovations, Maastricht, The Netherlands). The first two volumes of the functional 
images were omitted due to an unstable signal. For the functional data a slice scan 
timing correction was performed by sinc interpolation and the data was motion 
corrected using a 3D motion correction with sinc interpolation and high-pass temporal 
filtering. The data was smoothed using a 4 mm full-width-at-half-maximum Gaussian 
filter. The skull was removed by an automated brain peeling procedure. Functional 
images were then co-registered to structural images and subsequently normalized using 
the Talairach and Tournoux transformation procedure. 
fMRI analyses 
Data analyses were conducted in three steps. First, individual participants’ BOLD signals 
were modeled in an event-related design using a general linear model (GLM) with 5 
predictors, denoting the personality trait words in either positive, negative general, 
negative depression related, neutral or non-words. Conditions in the GLM were modeled 
as boxcar functions and convolved with a 2-gamma hemodynamic response function. 
First-level GLM analyses conducted on individual participants’ fMRI signal were 
submitted to a second-level random effects analysis, treating participants as a random 
factor in order to identify a network of brain regions involved in processing of 
personality trait words in general. In these analyses all personality trait words were 
contrasted with the non-words. A resulting map of brain regions indicating positive 
activity was selected at a conservative False Discovery Rate (FDR) of 0.005. Based on the 
resulting map a VTC mask was created and subsequent analyses focused on group X 
word type interactions within this mask. Volumes-of-interest (VOIs) resulting from the 
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group X word type interaction analysis were identified and defined within this map, 
using a cluster size threshold of 3 and a significance level of p < .025. Using this 
approach a total of 2 VOIs were identified (see Table 3). Within each VOI the beta 
weights were averaged across participants for each category of word-stimuli (positive, 
negative general, negative depression related, neutral). To further explore the group X 
word type interactions in order to investigate our hypothesis, VOI beta weights were 
exported to the statistical package SPSS version 21. In these simple effects analyses a 
Bonferroni adjusted significance level alpha (.05/3) was used to avoid inflation of the 
Type-I error rate. To visualize group X word type interactions bar-plots were created for 
each VOI displaying the mean signal change of critical word stimuli vs. neutral words for 
each group. 
 
Table	3. Areas showing significant personality group X word type interactions 
Brain region L/R Talairach 
coordinates (x,y,z) 
BA Cluster size 
(voxels) 
Medial prefrontal cortex L -8, 60, 10 10 111 
Premotor cortex / dorsolateral prefrontal cortex L -25, 17, 39 8 139 
Note. L/R = Left / Right; BA = Brodmann area; Talairach coordinates refer to the center of gravity of each 
VOI. 
Analyses of implicit and explicit self-associations 
The SC-IAT effect was analyzed using the improved d-score algorithm (Greenwald, 
Nosek, & Banaji, 2003). Higher scores on the SC-IAT represent stronger self-associations 
with positive words than with negative words. To test for differences in explicit and 
implicit self-associations between the two groups, independent sample t-tests were used. 
Results	
Subjective measures 
Post session questionnaire 
After the scanning sessions participants were asked to answer questions regarding their 
experiences during scanning. In this questionnaire participants were asked to rate on 
100 mm VAS how nervous they were prior to the experiment (0 = very nervous – 100 = 
not nervous at all) and their concentration level during scanning (0 = very concentrated 
– 100 = not concentrated at all). On average, participants were relatively calm during 
scanning (M = 71.86, SD = 28.13) and were able to concentrate on the task (M = 25.43, 
SD = 22.72). Depressed patients were significantly more nervous prior to the experiment 
(M = 58.76, SD = 30.13) compared to non-patient controls (M = 84.22, SD = 19.88; t(33) = 
297, p = .006. Participants from the two groups did not differ in their ability to 
concentrate during the experiment, t(33) = -1.59, p = .12. 
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Explicit self-associations and valence ratings 
Immediately after the scanning session participants were asked to rate each word that 
was presented during the experiment on valence and self-relatedness (Figure 1). 
Patients rated general negative and negative depression related words as significantly 
more self-descriptive than non-patient controls, t(33) = -3.48, p = .001, and t(33) = -9.09, 
p < .001, respectively. A significant group X negative word type interaction indicated that 
patients rated the negative depression related words as more self-descriptive than 
general negative words, compared to non-patients, t(33) = 6.73, p < .001. Non-patient 
controls rated positive trait words significantly more self-descriptive compared to 
patients, t(33) = 6.22, p < .001. There were no statistically significant differences in the 
self-descriptiveness ratings for neutral words, t(33) = -0.12, p = .91. The two groups did 
not differ with respect to the valence ratings. Both patients and non-patient controls 
rated the general negative and the negative depression related words as more negative 
than the neutral words, t(34) = -15.94, p < .001 and t(34) = -16.11, p < .001, respectively. 
On average, the positive trait words were rated as more positive than the neutral words, 
t(34) = 13.96, p < .001. 
 
 
Figure	 1.	 Mean self-descriptiveness (left side) and valence (right side) ratings of general negative, 
negative depression related, neutral and positive words.	
Implicit self-associations 
There were no statistically significant differences between the mean SC-IAT scores of 
patients (M = -0.08, SD = 0.37) and non-patient controls (M = 0.09, SD = 0.35; t(33) = -
1.32, p = .20), indicating that implicit self-associations did not differ between the two 
groups. 
fMRI results 
The whole brain analyses, contrasting personality-trait words with non-words across all 
participants, revealed a functional network of brain areas as depicted in Figure 2. A VTC 
mask was created based on this network and subsequent analyses focused on group X 
word type interactions within this network. Most brain areas within this network belong 
37
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to the so called cortical midline structures (mPFC, MOFC, PCC) that have previously been 
associated with self-referential processing. In addition to the CMS the network included 
parts of the left dorsolateral prefrontal cortex, pre-motor cortex and the left temporal 
lobe (see Table 4). Within each of these regions the group (non-patient control vs. cMDD) 
X word type interactions were subsequently tested. Two regions that showed significant 
group X word type interactions were identified: mPFC and Premotor cortex/ dlPFC 
(Table 3). 
 
Figure	2.	Functional network of brain areas in
the cortical midline structures active during
processing of personality-trait words vs. non-
words.	
 
Table	4. Areas selected for mask showing significant word X non-word interactions 
Brain region L/R Talairach coordinates (x,y,z) BA Cluster size (voxels) 
Bilateral posterior cingulate cortex L/R -4, -55, 16 23 7152 
Ventromedial prefrontal cortex L/R -5, 44, -1 32 6431 
Anterior prefrontal cortex L -11, 48, 11 10 91 
Dorsolateral prefrontal cortex L -24, 24, 43 8 451 
Fusiform gyrus L -32, -36, -10 37 95 
Middle temporal gyrus L -44, -72, 24 39 406 
Superior temporal gyrus L -47, 14, -26 38 252 
Inferior temporal gyrus L -62, -5, -17 21 818 
 
Medial prefrontal cortex 
Within the left medial prefrontal cortex (mPFC), there was a significant interaction 
between group and word type, F(3, 31) = 3.38, p = .031. Subsequent tests contrasting 
each category of emotional personality trait words with neutral words, between and 
within groups, were conducted at a Bonferroni adjusted significance level alpha of .016 
(.05/3). Thus only p-values < .016 were considered statistically significant. Non-patient 
controls had a greater BOLD signal in the left mPFC during processing of negative 
depression related vs. neutral word stimuli whereas patients with cMDD had a 
decreased BOLD response during processing of negative depression related vs. neutral 
word stimuli, F(1, 33) = 10.38, p = .003. This group difference was also reflected in a 
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significant negative correlation between BOLD signal changes in negative depression 
related vs. neutral words and the BDI-II total score (r = -.42, p = .011), showing that 
higher depressive symptom severity, across all participants, was associated with 
decreased BOLD signal for this contrast. The BOLD signal of the two groups did not 
differ significantly during processing of positive vs. neutral stimuli, F(1, 33 ) = 3.65, p 
= .064 or during processing of general negative vs. neutral word stimuli, F(1, 33) = 5.78, 
p = .022 (see Figure 3). Within group comparisons of emotional personality trait words 
vs. neutral words revealed that non-patient controls showed an increased BOLD signal 
in the left mPFC during processing of negative depression related vs. neutral personality 
trait words, t(18) = -2.93, p = .009. The other within group contrasts for non-patient 
control participants were not significant (all p-values > .016). Within the group of 
depressed patients none of the within group contrasts were significant (all p-
values > .016). Moreover, post-hoc tests revealed that the group x negative word type 
(general negative vs. depression related words) contrast failed to reach significance, F(1, 
33) = 0.02, p = .876, suggesting that the evidence for the specificity of the effect for 
negative depression words is mixed. Similarly, the group x positive vs. negative 
depression words contrast failed to reach significance, F(1, 33) = 0.79, p = .381. 
Premotor cortex / dorsolateral prefrontal cortex 
In the following the premotor cortex/dorsolateral prefrontal cortex VOI will be referred 
to as dlPFC. The interaction between word stimuli and group within the left dlPFC was 
significant, F(3, 31) = 3.19, p = .037. Subsequent tests contrasting each category of 
emotional personality trait words with neutral words, between and within groups, were 
conducted at a Bonferroni adjusted significance level alpha of .016 (.05/3). Thus only p-
values < .016 were considered statistically significant. Non-patient controls showed a 
greater BOLD signal in the left dlPFC during processing of positive vs. neutral word 
stimuli whereas patients with cMDD had a decrease in BOLD signal during processing of 
positive vs. neutral word stimuli, F(1, 33 ) = 6.72, p = .014. This group difference was 
also reflected in a significant correlation between BOLD signal changes in positive vs. 
neutral words and the BDI-II total score (r = -.40, p = .016), showing that higher BDI-II 
scores were associated with decreased BOLD signal for this contrast. The BOLD signal of 
the two groups did not differ statistically significantly during processing of general 
negative vs. neutral stimuli, F(1, 33) = 0.79, p = .380 or during processing of negative 
depression vs. neutral word stimuli, F(1, 33) = 3.20, p = .083 (see Figure 3). Within 
group comparisons of emotional personality trait words vs. neutral words for the non-
patient control group were not significant (all p-values > .016). Within the group of 
depressed participants none of the within group contrasts were significant (all p-
values > .016). Although the groups differed significantly only for the positive vs. neutral 
words, the evidence for the specificity of the effect for positive words was limited as the 
groups did not differ significantly on the positive vs. negative depression word 
categories, F(1, 33) = 0.89, p = .887. 
 Parameter estimates for BOLD signal changes in emotional words vs. neutral word 
contrasts within the mPFC and the dlPFC were correlated with the concentration ability 
CHAPTER 2 
 40 
ratings, nervousness ratings, the mean mood ratings prior to the task and the word 
valence and self-descriptiveness ratings. In order to avoid an inflation of the Type-I 
error rate in these analyses only correlations within contrasts that were significant in 
the initial analyses were investigated. Thus, correlations between BOLD signal change 
during processing of negative depression related words vs. neutral words and these 
variables were evaluated within the mPFC and correlations between BOLD signal change 
during processing of positive vs. neutral words and these variables were evaluated 
within the dlPFC.  
 Within the mPFC the self-descriptiveness ratings of negative depression related 
words were negatively correlated with BOLD signal changes during processing of 
negative depression related vs. neutral words (r = -.34, p = .045). This shows that 
explicit ratings of negative depression words as self-descriptive, across all subjects, were 
associated with decreased BOLD signal during processing of negative depression related 
words vs. neutral words. All other variables were unrelated to BOLD signal changes (all 
p-values > .05). 
Correlations between subjective measures and BOLD signal change 
Within the dlPFC there was a significant negative correlation between self-
descriptiveness ratings of negative and negative depression related words and BOLD 
signal change during processing of positive vs. neutral word stimuli (r = -.40, p = .018 
and r = -.46, p = .005). This shows that explicit ratings of negative (depression related) 
words as self-descriptive, across all subjects, were associated with decreased BOLD 
signal during processing of positive vs. neutral words. All other variables were unrelated 
to BOLD signal changes (all p-values > .05). 
 Results of additional correlational analyses, including associations between 
explicit and implicit self-associations as well as correlations between BOLD signal 
change in the MPFC and the DLPFC are provided in the online supplemental material. 
Correlations between implicit self-associations and BOLD signal change 
Implicit self-associations did not correlate statistically significantly with parameter 
estimates for BOLD signal change in the mPFC or in the dlPFC during processing of 
emotional vs. neutral words (all p-values > .05). 
Correlations between use of antidepressants and BOLD signal change 
About half (53%) of the patients in this study took antidepressant medication at the 
time of the study. None of the within group contrasts of BOLD signal change for 
emotional vs. neutral words in the mPFC and dlPFC were correlated with antidepressant 
medication use (all p-values > .05). 
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Figure	3. Sagittal view displaying the left mPFC (upper display) and the left premotor cortex / dlPFC 
(lower display). The bar chart on the right of the image displays parameter estimates between the two 
groups for each word category relative to neutral words. The error bars represent the standard error of 
the mean.  
Note. * = statistical significant at a Bonferroni adjusted significance level alpha of .016.	
 
Discussion	
The current study is the first to examine the neural correlates of self-referential 
processing in patients with cMDD. We used functional Magnetic Resonance Imaging 
(fMRI) during the presentation of positive, general negative, negative depression related, 
and neutral personality trait words. Furthermore, we assessed explicit and implicit self-
associations with positive and negative depression related personality trait words in 
patients with cMDD and in non-patient controls. 
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 On the neural level, processing of negative depression related words vs. neutral 
words was associated with relatively more neural activity in the left medial prefrontal 
cortex (mPFC) in non-patient controls and with relatively lower neural activity in 
patients with cMDD. Moreover, explicit, but not implicit, self-associations with negative 
depression words were associated with decreased BOLD signal change in the mPFC 
during processing of negative depression related words. The mPFC belongs to the so 
called cortical midline structures and has previously been associated with self-
referential processing (Northoff, 2007; Northoff et al., 2006). Previous neuroimaging 
studies in depressed patients and non-patient controls have either reported decreased 
(Grimm et al., 2009) or increased activity in the mPFC during self-referential processing 
(Lemogne et al., 2009; Yoshimura et al., 2010). It has been argued that the decreased 
activity in the mPFC in depressed patients during self-referential processing, that was 
also found in the current study, might reflect increased resting state activity in 
depressed patients such that task stimuli do not induce strong signal changes in patients 
(Grimm et al., 2009). In line with this explanation, it has been shown, for example, that 
increased resting state activity in the ventromedial prefrontal cortex in patients with 
depression compared to non-patient controls reduces less while looking at negative 
pictures (Sheline et al., 2009). 
 The evidence for the stimulus-specificity of the decreased signal strength during 
processing of emotional words vs. neutral words in patients vs. non-patient controls in 
the mPFC for negative depression related personality words vs. neutral words was 
mixed. Only this word contrast reached Bonferroni-corrected significant difference 
between groups. However, groups did not differ significantly as to the negative 
depression vs. general negative words and negative depression vs. positive words 
contrasts. The negative depression related words that were used in the present study 
describe core themes in depression. Reduced stimuli induced activity by these words in 
depressed patients might reflect a heightened resting state activity in brain areas that 
are activated by these stimuli in non-patient subjects (Grimm et al., 2009). In line with 
this, it has been argued that control tasks that are not very demanding (e.g. passive 
viewing) are more likely to allow for spontaneous self-referential processing to occur 
(Lemogne et al., 2012). Given the non-demanding control task in the current study, it is 
possible that patients with cMDD in the current study engaged in spontaneous self-
referential processing during the control task such that negative depression related 
stimuli did not induce a signal change in the mPFC. The mixed evidence for word 
specificity might however also indicate that there was a more general blunting, a 
possibility that is discussed later, with blunting perhaps increased in the negative words 
specifically related to depression.  
 There was a significant interaction between word category and group in the left 
dorsolateral prefrontal cortex (dlPFC). Processing of positive personality trait words vs. 
neutral words was associated with a relative increased neural activity in the dlPFC in 
non-patient controls and with a relative decrease in neural activity in patients with 
cMDD. In line with these findings, one previous neuroimaging study in patients with a 
milder form of chronic depression (dysthymic disorder) found hypoactivity in the dlPFC 
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compared to non-patient controls during processing of positive pictures (Ravindran et 
al., 2009). It has been suggested that reduced activity in the dlPFC during processing of 
positive vs. neutral stimuli might reflect decreased attention towards positive stimuli in 
patients with depression (Ravindran et al., 2009). In line with these findings, stimulation 
of the left dlPFC with repetitive Transcranial Magnetic Stimulation results in decreased 
depressive symptoms in patients with treatment-resistant depression (Avery et al., 2006; 
Fitzgerald et al., 2003; Pascual-Leone, Rubio, Pallardó, & Catalá, 1996) and there is 
evidence that dlPFC activity in patients with depression increases during treatment with 
antidepressants (Fitzgerald, Laird, Maller, & Daskalakis, 2008). It should be noted 
however that the evidence for the word category specificity of the dlPFC response was 
limited, as the response to positive words when compared to other emotional word 
categories did not differ significantly between groups. This might hint at a more general 
blunting of dlPFC responses during processing of emotional words in cMDD. 
 In the present study, depressive symptom severity was negatively associated with 
BOLD signal changes in the mPFC during processing of negative depression related 
personality words vs. neutral words. Moreover, there was a negative correlation 
between depressive symptom severity and BOLD signal changes in the dlPFC during 
processing of positive vs. neutral words. This finding is in line with one previous study 
demonstrating negative correlations between neural activity in the dorsomedial 
prefrontal cortex and depressive symptom severity during self-referential processing 
(Grimm et al., 2009). It should be noted, that these correlations do not necessarily imply 
that BOLD signal changes in these areas fluctuate on a continuum with depressive 
symptom severity. The correlations with depressive symptom severity should rather be 
seen as an additional test of the group differences in BOLD signal changes were one 
group had very low depressive symptom severity (non-patient controls) and the other 
group high depressive symptom severity (cMDD). 
 The finding of the current study that processing of emotional relative to neutral 
words was generally associated with decreased BOLD signal change in patients suggests 
that patients with chronic depression show a general blunting response when 
confronted with emotional stimuli. It has been argued previously that MDD is 
characterized by blunted emotional reactivity, not only to positive emotional stimuli but 
also towards negative emotional stimuli (Rottenberg, Gross, & Gotlib, 2005). This is also 
referred to as the emotion-context insensitivity hypothesis (Rottenberg et al., 2005). 
This hypothesis has been supported in a recent meta-analysis (Bylsma, Morris, & 
Rottenberg, 2008) in patients with depression for self-reported emotions, as well as for 
physiological emotional response indicators (Bylsma et al., 2008). Blunted emotional 
responses to everyday negative stressors have also been associated with lower recovery 
from depression at 18 month follow-up thus depression chronicity (Peeters, Berkhof, 
Rottenberg, & Nicolson, 2010). Moreover, it has been shown that depressed patients 
show blunted response pattern towards positive and negative words during a lexical 
decision task in brain areas related to language processing (Canli et al., 2004). Although 
our findings of decreased signal strength in patients with cMDD in the left mPFC were 
only significant for negative depression related words, it should be noted that the 
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direction of signal change between the two groups was similar for positive and negative 
words, and posthoc comparisons between the emotional word categories did not 
support word specificity (Figure 3). The fact that the pattern was similar for positive and 
general negative words further support the idea that patients with chronic depression 
show a blunted response to all emotional stimuli although this might be more 
pronounced for negative depression related stimuli. It has been argued previously that 
findings like this support the hypothesis that depressive mood has inhibitory effects on 
emotional processing (Rottenberg, 2007). 
 Different explanations might account for differences between previous studies 
assessing neural correlates of self-referential processing in depression and the results of 
the current study. Previous studies used explicit paradigms to study neural correlates of 
self-referential processing. In these studies, participants were explicitly instructed to 
process stimuli with regard to the self. In contrast, in the current study a passive 
processing paradigm was used to allow for a more “automatic” self-referential 
processing during the presentation of schema congruent personality trait words. The 
subjective word evaluation in the current study indicated that, on an explicit level, 
depressed patients indeed described negative depression related personality trait words 
as more self-descriptive (i.e. schema congruent), whereas non-patient controls 
described positive personality words as more self-descriptive. The current paradigm 
therefore seems to be well suited to study the more automatic aspects of self-referential 
processing in depressed patients. Two previous studies have shown that passive 
processing of self-relevant information relies on the same neural structures as self-
referential processing in explicit paradigms (Moran, Heatherton, & Kelley, 2009; 
Rameson et al., 2010). It is therefore unlikely that differences in the experimental 
paradigm account for differences with findings of previous studies. 
 Another explanation for divergent findings might be that previous studies included 
patients with depression in general without a specific focus on patients with cMDD (for a 
review see: Lemogne et al., 2012). It is possible that due to the long duration of 
depression (i.e. more than 2 years), patients with cMDD display a more emotionally 
numbing response toward emotional stimuli. 
 On an explicit, or subjective level, we found that patients with cMDD rated negative 
depression related personality traits as most self-descriptive whereas non-patient 
controls rated positive personality traits as most self-descriptive. On an implicit level 
there were no differences between the two groups with regard to negative self-
associations. These latter findings are in line with one previous study that used the same 
depression specific SC-IAT that was used in the current study (Lemmens et al., 2014). 
Based on previous research showing that implicit depressive-self associations are 
associated with depressive episode duration (Elgersma et al., 2013), we expected that 
chronically depressed patients in the current study would show increased implicit 
negative self-associations compared to non-patient controls that would correlate with 
brain responses associated with self-referential processing. 
 Future studies should aim to directly compare implicit negative self-associations in 
patients with episodic depression and patients with chronic depression. The fact that we 
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did not find a difference between the two groups could reflect a power problem since 
the current study relies on a relatively small sample. In line with this, patients in the 
current study indeed endorsed more implicit negative self-associations whereas non-
patient controls endorsed more positive implicit self-associations and this difference 
might have been statistically significant in a larger sample. An alternative explanation 
for the lack of differences in implicit self-associations is that the two groups completed 
the SC-IAT at different time points: Non-patient controls completed the SC-IAT after the 
scanning session thus shortly after having been exposed to the same stimuli in the 
scanner. Patients completed the SC-IAT on a different day, as part of a treatment study 
baseline assessment. 
 Several limitations should be considered when interpreting these results. First, the 
current study did not include a clinical control group and it therefore remains unclear 
how specific the findings of the current study are with respect to chronic depression. It 
would be interesting, for example, to compare patients with cMDD to patients with non-
chronic MDD to determine the specificity of the results. Second, about half of the 
patients in the current study took antidepressant medication at the time when the study 
was conducted and it is unclear if this has influenced the results of the current study. 
However, results showed that antidepressant medication use was not associated with 
the main findings in the current study. Third, the sample size of the current study was 
relatively small and it was therefore not possible to investigate association between 
study variables and BOLD signal changes in multivariate analyses. Fourth, the initially 
intended matching did not succeed completely, as one cMDD participant had to be 
excluded due to technical problems and one other cMDD participant could not be 
matched on handiness. Lastly, one cMDD participant suffered from borderline 
personality disorder which might have influenced the individual’s responses. 
 Clinically, our findings suggest that patients with chronic depression show a 
blunted response when confronted with emotional stimuli. Emotional processing is an 
important aspect of emotion focused treatments for depression (Greenberg & Watson, 
2006) and in treatments with a strong experiential component, such as schema therapy 
(Young, Klosko, & Weishaar, 2003). We have argued previously, that treatment for 
chronic depression could benefit from a stronger focus on emotional processing (Renner, 
Arntz, Leeuw, & Huibers, 2013). Future studies should investigate the impact of 
treatment that focusses on emotional processing (e.g. schema therapy) on the neural 
reactivity to emotional stimuli. 
 In conclusion, our findings suggest that chronic depression is characterized by a 
distinct neural processing of emotional self-relevant stimuli in the left mPFC and left 
dlPFC. The observed pattern might represent an emotional numbing response towards 
emotional stimuli in general. Future studies should determine the specificity of these 
findings with respect to chronic depression and the stability of these patterns of neural 
activity over a course of treatment for depression that has a strong focus on emotional 
processing techniques such as schema therapy or emotion focused therapy for 
depression. 
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Online	supplementary	material		
Associations between explicit and implicit self-associations 
In the overall sample, implicit self-associations did not correlate with explicit self-
associations of the same positive personality traits (r = -.1, p = .57) or with explicit self-
associations of the same negative depression related personality traits (r = -.17, p = .32). 
Within the group of depressed patients there was a significant negative correlation 
between implicit self-associations and explicit self-associations of positive personality 
trait words (r = -.70, p = .002), showing that more positive implicit self-associations in 
depressed patients were related to less positive explicit self-associations. 
Correlations between BOLD signal change in MPFC and DLPFC 
To test whether signal changes between the different brain regions were correlated, the 
parameter estimates for BOLD signal changes during processing of emotional vs. neutral 
words in the MPFC and DLPFC were correlated (see Table1 appendix). Within the MPFC 
signal change during processing of the different word categories was highly positively 
intercorrelated (rs between .77-.86; all p-values < .001). Similarly, within the DLPFC 
signal change during processing of the different word categories was highly positively 
intercorrelated (rs between .71-.88; all p-values < .001). Bold signal during processing of 
neutral words in the MPFC was positively correlated with the bold signal in the DLPFC 
during processing of neutral (r = .50, p = .002) positive (r = .48, p = .004), negative (r 
= .37, p = .029) and negative depression related (r = .40, p = .017) stimuli. BOLD signal in 
the MPFC during processing of positive words was significantly associated with BOLD 
signal in the DLPFC during processing of positive words (r = .38, p = .026). 
Appendix	Table	1	
Correlations between BOLD signal changes during word processing in the MPFC and DLPFC 
 1 2 3 4 5 6 7 
1. MPFC neutral        
2. MPFC positive .83***       
3. MPFC negative .77*** .86***      
4. MPFC negative depression .84*** .85*** .85***     
5. DLPFC neutral .50** .33 .32 .21    
6. DLPFC positive .48** .38* .31 .25 .88***   
7. DLPFC negative .37* .19 .27 .14 .83*** .76***  
8. DLPFC negative depression .40* .30 .32 .22 .75*** .84*** .71*** 
Note. MPFC = medial prefrontal cortex; DLPFC = dorsolateral prefrontal cortex; *** < .001; ** < .01; * < .05 
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Abstract	
Background: Major depressive disorder (MDD) is associated with increased default 
mode network (DMN) resting-state connectivity. The aim of this study was to investigate 
the effects of a sad mood induction on the DMN resting state connectivity in patients 
with a current chronic major depressive disorder (cMDD) and matched non-patient 
controls.  
 
Methods: Eighteen cMDD patients and 18 matched non-patient controls underwent a 6 
min functional magnetic resonance imaging (fMRI) scan while resting quietly, before 
and after a sad mood induction consisting of mood suggestive music combined with 
autobiographical recall. A two-level seed-based functional connectivity analysis was 
used to assess posterior cingulate cortex (PCC) based DMN functional connectivity of the 
two resting-state measurements.  
 
Results: The mood induction procedure had a significant effect on self-reported mood 
ratings in both cMDD and in non-patient controls. PCC connectivity with the 
parahippocampal gyrus, the superior temporal gyrus and the anterior inferior temporal 
cortex increased in cMDD patients following the sad mood induction, whereas it 
decreased in non-patient controls. PCC connectivity with the anterior prefrontal cortex 
and the precuneus decreased in cMDD patients following the sad mood induction, 
whereas it increased in non-patient controls.  
 
Conclusions: Present findings are in line with neurobiological models of depression of 
increased connectivity of the DMN in cMDD patients. It is suggested that the changes in 
DMN connectivity following the sad mood induction reflect the activation of latent 
negative-schemas and/or ruminative processes and a failure to exert cognitive control 
over negative memory retrieval in patients with cMDD. 
 
Keywords: chronic major depressive disorder, resting-state, functional connectivity, 
default mode network, posterior cingulate cortex 
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Introduction	
Major depressive disorder (MDD) is a relatively common, mental disorder that often 
takes a chronic course (1). The default mode network (DMN), a brain network which has 
well-documented associations with self-referential processing (2), rumination (3) and 
autobiographic memory (4), plays a key role in the neuropathology of MDD (5). 
Numerous studies have now demonstrated that patients with MDD show increased DMN 
resting-state functional connectivity, compared to non-patient controls (6). 
 Although the finding of increased connectivity in the DMN of MDD patients seems 
to be fairly consistent, connectivity within this network might not necessarily be stable. 
Indeed, studies now show that DMN connectivity is modulated by the mood-state of 
participants (7, 8). Harrison et al. used a mood induction procedure which required 
healthy participants to recall sad and neutral autobiographical memories during fMRI 
(7). They found a decrease in functional connectivity within the DMN between the 
neutral and the sad mood induction recall condition. Zamoscik et al. (2014) studied the 
effect of negative autobiographical life events recall on connectivity between the 
Posterior Cingulate Cortex (PCC) and the parahippocampal gryus (PHG), which are two 
DMN nodes implicated in autobiographical memory. Results showed that remitted 
depressed participants had stronger connectivity between the PCC and the PHG during 
the recollection of negative life events compared to non-patient controls (8). These 
findings support the idea that DMN connectivity in healthy and previously depressed 
participants is not stable, but rather dynamic, and that it is influenced by changes in 
emotional states such as sad mood. 
 The present resting state fMRI study advances previous research on modulation of 
DMN connectivity in three ways. First, whereas previous studies reveal important 
mechanisms as to how DMN connectivity can be modulated by a sad mood challenge in 
healthy or previously depressed individuals, it is unclear how patients with a current 
MDD modulate connectivity in the DMN following a sad mood challenge. To the best of 
our knowledge no study to date has tested the effects of a sad mood induction on resting 
state DMN connectivity in currently depressed individuals. Second, given that 
connectivity within the DMN is positively correlated with depressive chronicity (9), it is 
intriguing to study connectivity in patients with chronic major depressive disorder 
(cMDD). Third, in previous studies DMN connectivity was assessed during the mood 
induction but it is not clear how resting state DMN connectivity is influenced after sad 
mood has been triggered. 
 The aim of the present study was to investigate resting state connectivity of the 
DMN in patients with a current cMDD and matched non-patient controls before and after 
a sad mood induction. Based on previous findings it is hypothesized that compared to 
non-patient controls, cMDD patients would show increased connectivity in the DMN 
following a sad mood induction. Demonstrating modulation of connectivity in the DMN 
by a sad mood challenge in patients with current MDD is clinically important, because 
increased connectivity in the DMN following a mood challenge might reflect ruminative 
processes or activation of latent maladaptive schemas, defined as memory structures 
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that influence cognitions, emotions and behavior, which are primary treatment targets 
in psychotherapy for depression. 
Methods	and	Materials	
Participants 
Eighteen patients with a chronic major depressive disorder (cMDD) and 18 age, gender, 
education level, and left/right handedness matched non-patient control participants 
without any current axis-I disorder participated in this study. One left handed patient 
could not be matched with a left handed control participant and was therefore matched 
with a right handed control participant. Patients were recruited from a specialized 
secondary care outpatient unit in the Netherlands (Riagg Maastricht) as part of a 
treatment study testing the effects of long term psychotherapy (schema therapy) for 
cMDD (Clinicaltrials.gov identifier: NCT01153867). All patients were scanned before the 
start of the intervention phase of the treatment study.  
 Participants were excluded if they had MRI contraindications. Study inclusion 
criteria for patients were a current diagnosis of cMDD according to the diagnostic 
criteria of the Diagnostic and Statistical Manual of Mental Disorders fourth edition 
(DSM-IV), assessed with the structured clinical interview for axis-I disorders (SCID-I) by 
trained interviewers and a Beck Depression Inventory second edition (BDI-II) score of 
20 or higher at study entry. Exclusion criteria for patients were the presence of bipolar 
disorder, psychotic disorders, alcohol or substance dependence, or autism spectrum 
disorders. Patients meeting criteria for a DSM-IV cluster-A or cluster-B personality 
disorder as assessed with the SCID-II interview were also excluded. One patient with co-
morbid borderline personality disorder was included in error but is analyzed here. 
Patients with acute suicide risk were excluded. Use of antidepressant medication at 
study entry was an exclusion criterion, unless patients were stable on medications for 
three month or longer prior to study entry. Ten patients (55.6%) took antidepressant 
medication at least 3 month prior to study entry. 
 Participants in the non-patient control condition were recruited via poster 
advertisements and a database of volunteer study participants. Control participants 
were excluded if they met the DSM-IV criteria of any current axis-I disorder or if they 
met the criteria for a lifetime mood disorder, as assessed with the SCID-I interview by a 
trained interviewer. 
 The study protocol was approved by the medical ethical committee of the 
academic community hospital Maastricht. All participants enrolled in the study received 
verbal and written information about the purpose and procedure of the study and 
signed written informed consent. 
 Demographic and clinical characteristics of the sample are summarized in Table 1. 
The two groups did not differ statistically significantly on any of the demographic 
variables. The mean BDI-II score of patients was 30.50 (SD = 9.39), indicating severe 
depression. The average BDI-II score of non-patient controls was 2.67 (SD = 2.77). Seven 
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(38.9%) of the patients had a comorbid axis-I disorder and 14 (77.8%) had a comorbid 
personality disorder. The mean number of previous depressive episodes was 3.38 (SD = 
2.39; Median = 3.5). 
	
Table	1.	Demographic and clinical characteristics of the sample.		
 cMDD 
(N = 18) 
Controls 
(N = 18) 
t-test  
(p-value) 
χ2  
(p-value) 
Age, M (SD) 41.17 (17.53) 42.67 (18.73) .81 - 
Gender, n (%)  
 female 
 male 
 
13 (72.2) 
5 (27.8) 
 
13 (72.2) 
5 (27.8) 
- 
 
1.00 
Education level, n (%) 
 low 
 medium 
 high 
 
1 (5.6) 
6 (33.3) 
11 (61.1) 
 
2 (11.1) 
4 (22.2) 
12 (66.7) 
- .68 
BDI-II score 30.50 (9.39) 2.67 (2.77) <.001 - 
Note. BDI-II = Beck Depression Inventory second edition. 
 
Procedure 
This study used a mixed design with group (non-patient control, cMDD) as between-
subject factor and two fMRI runs (pre-mood induction, post-mood induction) as within 
subject factor. The procedure of this study is summarized in Figure 1. First, participants 
underwent a resting-state scan, which lasted 6 min. Directly after the first resting-state 
scan, participants were asked to rate their current mood along four visual analogue 
scales (VAS) using an MR compatible joystick. The four VAS scales measured mood on a 
bipolar continuum between negative and positive, dull and glad, secure and anxious, and 
sad and happy. After the initial mood ratings, participants received the instructions for 
the mood induction and the volume of the music that was used in the mood induction 
protocol (see below) was adjusted to a level that participants could hear the music loud 
and clear.  
 The mood induction consisted of mood suggestive music in combination with 
autobiographical recall of a personal sad event (8 min) in order to induce a sad mood-
state. The participants were instructed to recall a personal sad event from their own life 
while listening to “Adagio for Strings” by Samuel Barber for 8 min via headphones. Mood 
suggestive music in combination with autobiographical recall reliably induces short 
lasting sad mood-states (10) and the specific piece of music has successfully been used 
in our previous studies (11, 12). After the music was started the anatomical scan was 
started and the music volume was increased by approximately 10% to account for the 
noise of the scanner. Directly after the mood induction, participants again indicated their 
current mood-state on the four VAS scales. Following this the second resting-state fMRI 
scan was started which again lasted 6 minutes. After the second resting-state scan 
participants again indicated their current mood-state on the four VAS scales. Following 
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this part of the experiment, participants engaged in a self-referential processing task and 
received a diffusion tensor imaging Scan (results not reported here). 
 Directly after the scanning session participants were asked to indicate whether 
they had difficulties to immerse in a sad mood-state due to the noise of the scanner 
along a 100 mm VAS scale ranging from 0 = not at all to 100 = very much. 
 
 
Figure	1. Overview of the design of the current study. The sad mood induction occurred between the two
resting-state scans, during structural imaging. 
 
Measures 
Beck Depression Inventory  
Depressive symptom severity was assessed with the Beck Depression Inventory second 
edition (BDI-II), a 21-item self-report instrument (13). In the present study the Dutch 
version of the BDI-II was used which has been shown to have high internal consistency 
in a Dutch sample of psychiatric patients (Cronbach's α = .92) and adequate construct 
validity with other depression scales (rs between .79 and.85; 14). 
Image acquisition 
Anatomical images were acquired using a Magnetom Allegra 3T scanner (Siemens 
Healthcare, Netherlands) located at the Faculty of Psychology and Neuroscience, 
Maastricht University with a T1-weighted gradient echo (196 slices, TR = 2250 ms, TE = 
26 ms, flip angle = 90°, field of view = 256 mm and voxel dimensions 1 x 1 x 1 mm3). A 
T2*-weighted functional measurement was acquired using a standard echo-planar 
imaging (EPI) sequence (TR 2000 ms, TE 30 ms, flip angle = 90°, 32 slices, 180 volumes, 
3 x 3 x 3 mm3). A slice tilt correction of -30 was used to minimize inhomogeneity 
artefacts (15). 
fMRI data preprocessing 
Data pre-processing and analyses were conducted with Brainvoyager QX v2.4 (Brain 
Innovations, Maastricht, the Netherlands). The first two volumes of the functional 
images were omitted due to magnetization artifacts. Preprocessing of the remaining 
functional data included slice time correction using sinc interpolation, 3D motion 
correction using sinc interpolation, spatial smoothing (Gaussian kernel with full-width-
at-half-maximum of 4 mm) and linear trend removal. Individual functional datasets 
were then co-registered with structural images of the same participant and 
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subsequently normalized using the Talairach and Tournoux transformation procedure 
(16). Talairach coordinates were subsequently transformed to Montreal Neurological 
Institute (MNI) coordinates based on (; all coordinates reported in this article are MNI 
coordinates17). Individual anatomical datasets were then averaged to create a group-
based anatomical brain mask to exclude voxels belonging to the outside of the brain. 
Resting-state functional connectivity analysis 
In order to determine change in DMN connectivity following the sad mood induction, we 
conducted a seed based connectivity analysis. The PCC was selected as seed because this 
region has been shown to reveal connectivity in the DMN most consistently (18). The 
anatomical location of the PCC seed was based on the results of a separate self-
referential processing task, performed in the same experimental session by the same 
participants, following the resting-state scans (19). In this task a whole-brain Random 
Effects (RFX) ANOVA analyses was used to contrast personality trait words with non-
words. This analysis resulted in the functional localization of the cortical midline 
structures involved in self-referential processing (20), including the PCC. The peak voxel 
of the left PCC (5 mm sphere around MNI: -9, -56, 25; Figure 2) was selected as seed, 
which is comparable in location to regions that previous studies have used to reveal the 
DMN (e.g. 8, 21). 
 
Figure	 2. PCC seed selected for 
the current analyses (5 mm 
sphere around MNI: -9, -56, 25) 
based on the peak voxel of a 
separate self-referential proces-
sing task performed by the same 
participants in the same session, 
after the resting-state scans.	
 
To perform the group seed based analysis in Brainvoyager QX, single study design 
matrix (SDM) files were created for each run of each participant using the NeuroElf 
MATLAB (Mathworks, Inc.) toolbox (www.neuroelf.net) and a resting state analysis 
toolbox developed at Maastricht University (www.vincentvandeven.weebly.-
com/software.html).	These SDM files included the BOLD time series of the PCC seed 
region and 122 z-normalized nuisance confound regressors: six 3D head motion 
parameters and their first derivatives, mean signal from the ventricles and white matter, 
global signal, and signal oscillations at a frequency above 0.1 Hz (sine-cosine pairs). The 
resulting SDM files were then used to run an RFX GLM to find voxels that showed 
correlation with the PCC seed for each run of each participant. The Pearson correlation 
coefficients (r) maps were then transformed using Fisher’s r-to-z transformation3, to 
yield variates that are approximately normally distributed. The resulting F-map showed 
                                                        
3 z = 0.5 Ln [(1 +r)/(1-r)] 
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all voxels that had a significant correlation with the PCC seed at a conservative false 
discovery rate (FDR) of 0.001 for all participants over all runs. This map was 
transformed into a DMN mask (Figure 3), which was used to limit the final main effects 
and groups x mood induction analyses to the hypothesized DMN network.  
 In the final analysis, first, the main effect of group on the first resting-state scan 
(pre-mood induction) and the main effect of run (resting-state pre/post-mood induction) 
was computed to replicate earlier findings of increased DMN connectivity in depressed 
patients and to determine the effect of the mood induction on DMN connectivity in 
general, respectively. Second, a repeated measures ANOVA analysis with group (non-
patient control vs. cMDD) as between subject factor and mood induction (pre/post) as 
within-subject factor was conducted to test for the hypothesized difference in the effects 
of the mood induction between the two groups. The resulting three F-maps were 
thresholded at a p-value of 0.01 and a cluster size threshold of 135 mm³ (5 voxels) as 
determined by the cluster-level statistical threshold estimator plugin (BrainVoyager QX; 
1000 Monte Carlo simulations). 
 
 
Figure	3. PCC based functional connectivity mask resembling the default mode network. 
Results	
Behavioral Data 
Post session questionnaire 
On average participants reported some difficulties to immerse in a sad mood-state due 
to the noise of the scanner (M = 44.44, SD = 32.63) on a VAS scale ranging from 0 to 100, 
with higher scores indicating more difficulties. Importantly, there were no differences in 
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self-reported difficulties to immerse in a sad mood-state due to the noise of the scanner 
between the two groups, t(34) = -0.57, p = .56. 
Manipulation check 
Prior to and directly after the mood induction and following the second resting-state 
scan, participants indicated their current mood-state on four VAS scales ranging from 0 
to 100 with higher scores indicating more positive mood-states. To reduce statistical 
testing, an average mood scale of all four VAS scales was constructed per mood 
assessment moment. These average mood VAS scales had a high internal consistency, 
Cronbach's alpha = .91, .88, and .85. Figure 4 is an overview of the repeated mood 
ratings per group. First we tested whether the mood induction had an effect on the 
current mood-state of the overall sample. For the overall sample, mood ratings prior to 
the mood induction (M = 65.02, SD = 21.97) were significantly higher than following the 
mood induction (M = 50.06, SD = 19.46; t(35) = 6.25, p < .001). Within group 
comparisons revealed a significant decrease in current mood-state for both the non-
patient control participants and cMDD patients, ( t(17) = 6.04, p < .001 and t(17) = 3.18, 
p = .005, respectively). The decrease in current mood-state from pre-mood induction to 
post-mood induction was slightly stronger in non-patient control participants, but the 
interaction effect did not reach the conventional level of statistical significance F(1, 34) = 
3.87, p = .057. The mood-state at the end of the experiment remained at a lower level 
compared to pre-mood induction assessment for both patients (t(17) = 2.76, p = .01) and 
non-patient controls (t(17) = 3.46, p < .01). At each time point there was a significant 
main effect of group, showing that patients reported a lower mood-state at pre-mood 
induction, t(34) = -7.58, p < .001, at post-mood induction, t(34) = -5.11, p < .001, and 
after the second resting-state scan, t(32) = -5.29, p < .001. 
 
Figure	4. Mood ratings prior to the mood induction (T1), after the 
mood induction (T2) and at the end of the experiment (T3); higher 
scores represent more positive mood 
59
CHAPTER 3 
 60 
fMRI results resting-state functional connectivity 
Main effect group  
Prior to the mood induction and in line with previous findings, cMDD patients showed 
greater connectivity between the PCC and the medial temporal gyrus (52,-68,28), the 
dorsolateral medial prefrontal cortex (10,61,30), the precuneus (-6,-65,29), the anterior 
prefrontal cortex ( -6,57,30), the PCC (-6,56,10), the superior occipital gyrus (-45,-78,34) 
and the medial temporal gyrus (-58,-59,15) compared to the non-patient controls prior 
to the mood induction. 
Main effect pre- to post-mood induction 
Indicative of the success of the experimental manipulation, there was an overall 
significant decrease in connectivity from pre-mood induction to post-mood induction in 
the precuneus (-6,-58,35), and in two separate clusters of the parahippocampal gyrus (-
13,-33,-1 and -36,-25,-18). 
Group on mood induction interaction 
Five ROIs with significant group (cMDD/non-patient controls) × mood induction 
(pre/post) interactions were identified (Figure 5; Table 2), including the anterior 
inferior temporal cortex, the superior temporal gyrus, the uncus / anterior 
parahippocampal gyrus, the anterior prefrontal cortex, and the precuneus. In line with 
our hypothesis the anterior inferior temporal cortex, the superior temporal gyrus and 
the uncus / anterior parahippocampal gyrus showed increased connectivity after the 
mood induction in the cMDD patients compared to the non-patient controls. However, 
the precuneus and anterior prefrontal cortex showed the opposite pattern, with 
increased connectivity after the mood induction for the non-patient controls compared 
to the patients. 
Association of PCC connectivity with subjective measures 
Depressive symptom severity and mood reactivity was correlated with change in 
connectivity from pre to post-mood induction across groups (Table 3). Depressive 
symptom severity correlated negatively with change in connectivity between the PCC 
and the anterior prefrontal cortex and the precuneus and positively with the remaining 
areas. Mood reactivity correlated positively with change in connectivity between PCC 
and the anterior prefrontal cortex and the precuneus, showing that more negative mood 
ratings following the sad mood induction were associated with a stronger increase in 
connectivity in these areas. 
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Figure	 5. Significant group (cMDD/non-patient controls) × mood induction 
(pre/post) interactions. The y–axis of the graphs depicts the mean z values of 
functional connectivity of the PCC with the DMN. 
 
 
Table	2.	Region of interest details identified for the group (cMDD/non-patient controls) × mood induction 
(pre/post) interactions.	
      Average 
connectivity  
change Fisher’s Z 
Cohen’s d 
(change within 
groups) 
Brain region L/R MNI (x,y,z) Cluster 
size 
Voxels
F p-value cMDD controls  cMDD controls 
Anterior inferior 
temporal cortex 
 L -49,9,-34 262 13.83 <.001 0.11	 -0.15	 0.37	 -0.46	
Uncus / parahippocampal 
gyrus 
L -26,-11,-28 178 18.96 <.001 0.15	 -0.15	 0.45	 -0.49	
Anterior prefrontal 
cortex 
 L -16,52,18 633 27.61 <.001 -0.14	 0.18	 -0.42	 0.57	
Superior temporal gyrus  L -32,-53,21 184 28.98 <.001 0.14	 -0.11	 0.53	 -0.43	
Precuneus  R 10,-52,31 615 4.44 .043 -0.07 0.03 -0.25 0.09 
Note. L/R = Left / Right; Cohen’s d = Mean difference/pooled SD. 
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Table	3.	Correlations between change in PCC functional connectivity, depressive symptom severity, and 
mood reactivity 
PCC connectivity with BDI-II Mood reactivity 
Anterior inferior temporal cortex .52** -.01 
Uncus / parahippocampal gyrus .57** -.12 
Anterior prefrontal cortex -.53*** .37* 
Superior temporal gyrus .63*** -.07 
Precuneus -.36* .48** 
Note. * p < .05; ** p <. 01; *** p <. 01; BDI-II = Beck Depression Inventory second edition; Mood reactivity = 
Average mood ratings following the mood induction – average mood ratings before the mood induction, 
with positive scores indicating stronger mood reactivity. 
	
Discussion	
The aim of the current fMRI study was to investigate resting state connectivity of the 
DMN in patients with a current cMDD and matched non-patient controls before and after 
a sad mood induction. The mood induction consisted of mood suggestive music in 
combination with autobiographical recall and resulted in increased negative mood 
ratings in both cMDD patients and non-patient controls. Using a PCC seed, main effect 
analyses of group prior to the mood induction replicated previous findings showing 
increased DMN connectivity in patients with depression (for a review see: 6). 
Importantly, main effect analyses of mood induction showed that DMN connectivity, 
particular in the precuneus and parahippocampal gyrus, is modulated by the current 
mood-state of participants. 
 The main focus of the present study was on the hypothesized increase in DMN 
connectivity following the sad mood induction in cMDD patients, possibly reflecting an 
increased ruminative self-focus (3, 22) or activation of latent dysfunctional schemas. In 
line with this hypothesis, results showed increased connectivity with the PCC following 
the sad mood induction in cMDD patients in the anterior inferior temporal cortex, the 
superior temporal gyrus and the parahippocampal gyrus. Following the sad mood 
induction, the precuneus showed a slight decrease in connectivity with the PCC in cMDD 
patients and the anterior prefrontal cortex showed increased connectivity with the PCC 
in non-patient controls. This suggests that specifically temporal areas and the 
parahippocampal gyrus are associated with increased PCC connectivity in cMDD 
patients, following the sad mood induction, whereas other DMN regions show an 
opposite pattern. 
 The increase in DMN connectivity in cMDD patients in the present and previous 
studies might be interpreted as activation of latent dysfunctional schemas. Dysfunctional 
schemas can be conceptualized as latent memory structures that have coded past 
experiences and when activated by a triggering event influence cognitions, emotions and 
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behavior (e.g. 23). It has been shown previously, that negative memory retrieval 
differentially activates the temporal gyrus, when contrasted with positive memory 
retrieval (24). In line with these findings, it has been argued, that the ease with which 
dysfunctional schemas in depression are activated by external triggers is related to 
increased task negative connectivity with, among other brain regions, the 
(para)hippocampus (5). In general, the present finding of increased DMN connectivity, 
following the sad mood induction in cMDD patients supports neurobiological models of 
ruminative thoughts in depression, proposing that increased parahippocampal activity 
is involved in ruminative thoughts (25). Importantly, in the current study the mood 
induction procedure was not conducted during but before functional imaging of the 
second resting-state scan. The increased connectivity following the mood induction in 
patients vs. controls therefore likely reflects a relatively natural reaction of patients, 
after being challenged with sad mood, rather than compliance of the task instruction to 
recall sad autobiographical events or processing of external stimuli. 
 The finding of the current study of decreased DMN connectivity in non-patient 
controls, following the sad mood induction are in line with those of a previous fMRI 
study that reported decreased functional connectivity of the DMN during recall of sad 
autobiographical events combined with mood suggestive music in healthy participants 
(7). These findings suggest that a sad mood induction in healthy participants results in 
more negative mood as reflected in self-report data, but not in the activation of negative 
latent schemas or dysfunctional cognitive processing as indicated by the neuroimaging 
data. In line with this finding, a recent study found increased DMN connectivity in 
remitted depressed patients, compared to healthy controls, following a sad mood 
induction (8). Together, results from these two previous studies that used a mood 
challenge and the present study suggest that the DMN network can be modulated by 
subjective mood-states and that the increased connectivity in remitted (8) and currently 
depressed participants likely reflects activation of latent dysfunctional schemas and/or 
increased rumination about negative issues. Non-fMRI studies have shown that remitted 
depressed patients cannot be distinguished from healthy participants on measures of 
dysfunctional cognitions or schemas (for a review see: 26). However, when challenged 
with a mood induction, remitted depressed patients activate latent negative schemas 
(26) and the strength of this cognitive reactivity might predict subsequent relapse (27). 
 PCC – anterior prefrontal cortex connectivity was increased in non-patients 
controls and decreased in cMDD patients following the sad mood induction. Anterior 
prefrontal cortex subdivisions have previously been associated with cognitive control of 
memory retrieval (e.g. 28, 29). It is possible that the increased connectivity following the 
sad mood induction in non-patients controls in the current study reflects an attempt to 
control retrieval of negative memories. In contrast, patients with cMDD might fail to 
control retrieval of negative memories following the sad mood induction. This 
argumentation is in line with non-fMRI studies suggesting that depression is associated 
with impairments in cognitive control (for a review see: 30) and with theoretical models 
proposing that reduced prefrontal control in combination with activation of negative 
schemas in depression gives rise to a downward spiral of rumination and negative affect 
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(31). Interestingly, in the current study PCC connectivity with the anterior prefrontal 
cortex positively correlated with mood reactivity across participants. Thus, the stronger 
the emotional trigger the more readily cognitive control over memory retrieval might be 
recruited. Clinically, these findings suggest that patients with cMDD fail to control or 
stop negative memory retrieval once they are in a sad mood-state. In contrast, non-
depressed individuals control memory retrieval during sad mood possibly reflecting a 
coping strategy that prevents healthy individuals from entering a negative downward 
spiral of dysfunctional cognitive processing and negative affect. 
 A limitation of this study is that it did not include a clinical control group and 
therefore the specificity of the present findings with regard to chronic depression 
remains unclear. It is possible, for example, that patients with non-chronic depression 
show comparable connectivity following the sad mood induction. Moreover, about half 
of the patients participating in this study took antidepressant medication at the time 
when the study was conducted and it is unclear if this has influenced the results. 
 In conclusion, the present study suggests that DMN connectivity increases in cMDD 
patients but not in controls following a sad mood induction. This finding has important 
clinical implications, as the increased DMN connectivity triggered by sad mood might 
reflect the activation of latent negative schemas and/or ruminative processing in 
depression. Patients with cMDD might fail to exert cognitive control over memory 
retrieval processes once sad mood is triggered whereas non-patients controls seem to 
increase cognitive control processes possibly in an attempt to cope with the sad mood-
state. This coping strategy prevents non-depressed individuals from entering a negative 
downward spiral of dysfunctional cognitive processing and negative affect. Increasing 
cognitive control in patients with depression either through neurostimulation (e.g. 32) 
or through behavioral interventions might be a fruitful avenue in the treatment of cMDD. 
Future research should determine if treatment for cMDD that specifically focusses on 
decreasing the impact of these negative schemas (e.g. schema therapy; 33) has an impact 
on DMN connectivity following a sad mood induction, in patients with cMDD. 
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Abstract	
Background: Early maladaptive schemas (EMSs) are hypothesized to be stable, trait-like, 
enduring beliefs underlying chronic and recurrent psychological disorders. We studied 
the relation of EMSs with depressive symptom severity and tested the stability of EMSs 
over a course of evidence-based outpatient treatment for depression in a naturalistic 
treatment setting.  
 
Methods: The sample consisted of depressed outpatients (N = 132) treated at a 
specialized mood disorders treatment unit in the Netherlands. Participants completed 
measures of depressive symptom severity and maladaptive schemas before treatment 
and 16-weeks after starting with treatment.  
 
Results: Specific maladaptive schemas (failure, emotional deprivation, abandonment/-
instability) were cross-sectionally related to depressive symptom severity. Moreover, 
the schema domain impaired autonomy & performance at pre-treatment related 
positively to depression levels at the 16-week follow-up assessment, whereas the 
schema domain overvigilance & inhibition at pre-treatment related negatively to 
depression levels at the follow-up assessment when controlling for pre-treatment 
depression severity. Finally, all EMSs demonstrated good relative stability over the 
course of treatment.  
 
Conclusions: Our results suggest that specific EMSs are related to depressive symptom 
severity in clinically depressed patients, that specific schema domains predict treatment 
outcome, and that schemas are robust to change over time, even after evidence-based 
outpatient treatment for depression. 
 
Keywords: Depression; early maladaptive schemas; core beliefs; cognitive vulnerability 
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Introduction	
According to the cognitive theory of depression (Beck, 1964) negative beliefs about the 
self, the world, and the future incorporated in stable cognitive schemas are the key 
vulnerability factor to depression. In most accounts of cognitive theory, dysfunctional 
cognitions can best be understood in terms of a hierarchical model of generality with 
automatic thoughts at the most superficial level, dysfunctional attitudes at an 
intermediate level, and cognitive schemas at the deepest level (Clark and Beck, 1999; 
Segal, 1988). While depressogenic cognition have usually been assessed at the level of 
automatic thoughts or dysfunctional attitudes (Segal and Swallow, 1994), studies 
assessing dysfunctional cognition at the schema level in depressed patients are sparse. 
One reason for this might be that schemas are usually considered as implicit cognitive 
structures that are not readily accessible (Segal, 1988). 
 Young recently revised the schema concept, emphasizing early maladaptive 
schemas (EMSs) as key structures in the development of psychopathology (Young, 
1995). EMSs are defined as stable, trait-like, enduring beliefs about oneself and the 
world that are rooted in early childhood experiences (Young et al., 2003). EMSs are in 
many ways comparable to the cognitive theory concept of core beliefs, defined as the 
cognitive content of schemas (Clark and Beck, 1999) though there are also important 
differences between these two concepts (James et al., 2004). For example, core beliefs in 
depression were usually divided into three broad categories (helplessness, inadequacy, 
and unloveability), whereas EMSs are more specific. To date, 18 specific EMSs were 
identified and divided into five broader domains (see Table 1). 
 Although the concept of EMSs provides a valuable extension to the cognitive theory 
of depression concepts of automatic thoughts and dysfunctional attitudes, studies 
relating EMSs to depressive symptoms in depressed patients are relatively sparse. In 
non-clinically depressed samples it has been shown that the EMSs failure, 
defectiveness/shame, and self-sacrifice were associated with depressive symptom 
severity (Calvete et al., 2005). Another study found that the EMSs defectiveness/shame, 
insufficient self-control, vulnerability, and incompetence/inferiority were cross-
sectionally related to depressive symptom severity in undergraduate students (Harris 
and Curtin, 2002). In a mixed clinical sample with mainly depressed patients it was 
found that the total score on the schema questionnaire (SQ; Young and Brown, 1994) 
was related to depressive symptom severity, even after controlling for neuroticism and 
other personality dimensions, suggesting that EMSs explain variance in depressive 
symptom severity beyond other trait-like constructs that are known to be related to 
depressive symptoms, like neuroticism (Thimm, 2010). In another clinical sample with 
mainly depressive symptoms it has been shown that the EMSs abandonment/instability, 
defectiveness/shame, failure, subjugation, and vulnerability to harm were cross-
sectionally related to depression severity (Petrocelli et al., 2001). In depressed patients 
the schema domains undesirability, impaired autonomy & performance, and impaired 
limits were cross-sectionally related to depression severity (Halvorsen et al., 2009). 
Finally, another study found that in depressed outpatients the EMSs 
CHAPTER 4 
 72 
defectiveness/shame, self-sacrifice, and insufficient self-control were related to 
depressive symptom severity (Shah and Waller, 2000).  
 Taken together, studies relating schema domains and specific EMSs to depressive 
symptom severity found that a wide range of EMSs are related to depressive symptom 
severity, especially those belonging to the impaired autonomy & performance and to the 
disconnection & rejection domains. While previous research has exclusively focused on 
the concurrent relation between EMSs and depressive symptoms, the relation of EMSs 
with symptom improvement during treatment for depression remains unclear. 
 When studying the relation between EMSs and depressive symptoms in depressed 
patients, it is important to also determine whether EMSs remain stable in the context of 
change in depressive symptoms (i.e., during treatment). A fundamental assumption in 
schema-theory is that EMSs are stable, trait-like constructs that are resistant to change 
(Young et al., 2003). Accordingly, one would not expect EMSs to change over the course 
of short-term outpatient treatment that is focused on reducing depressive 
symptomatology instead of decreasing EMSs. Riso and colleagues (2006) examined the 
long-term stability of EMSs in 55 depressed outpatients over a course of 2.5 to 5 years 
and found that EMSs exhibited good stability, comparable with that of personality 
disorder features (Riso et al., 2006). Similarly, Wang et al., (2010) found moderate 
stability for most EMSs in depressed patients after 9 years follow-up. While these 
studies suggest that EMSs exhibit good long term stability in depressed patients, the 
stability of EMSs over a course of outpatient treatment for depression remains unclear. 
To the best of the authors’ knowledge, the present study is the first to investigate the 
stability of EMSs in depressed patients over a course of outpatient treatment for 
depression. 
 Previous work on the stability of EMSs has emphasized the importance of 
considering both absolute stability and relative stability when studying change in EMSs 
over time (Riso et al., 2006). Absolute stability refers to the stability in the mean level of 
the construct under study over time, whereas relative stability refers to the degree to 
which relative differences between individuals remain over time (Santor et al., 1997). It 
has been shown that, in the context of acute change in depressive symptoms (i.e., during 
depression treatment), dysfunctional cognitions can show large changes in mean level 
stability in the presence of strong relative stability (Beevers and Miller, 2004; Zuroff et 
al., 1999). Such findings suggest that measures of dysfunctional cognitions in depressed 
individuals tap both mood dependent, state-like properties, as evident in changes in 
mean level stability, as well as mood independent, trait-like properties, as evident in 
strong relative stability (Beevers and Miller, 2004; Zuroff et al., 1999). Given that EMSs 
are likely related to depression severity and given that depression severity scores are 
likely to decrease during treatment. both absolute and relative stability should be 
considered when studying the stability of EMSs in the context of symptom change. 
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Table	1. – A brief description of the five schema domains and all 18 early maladaptive schemas (EMSs), 
based on Young et al. 2003. 
Schema domains and early 
maladaptive schemas 
Description 
Disconnection	&	
Rejection	
Schemas that involve expectations that one’s needs for security and stability 
will not be met in a predictable manner. 
Abandonment / Instability The perceived instability or unreliability of those available for support. 
Mistrust / Abuse The expectation that others will intentionally hurt, abuse, humiliate, cheat, 
lie, manipulate or take advantage. 
Emotional Deprivation The expectation that one’s desire for emotional support, nurturance, 
empathy or protection by others will not be met. 
Defectiveness / Shame The feeling that one is defective, bad, unwanted, inferior, or invalid. 
Social Isolation The feeling that one is isolated from the world, different from others and not 
part of a community. 
 
Impaired	Autonomy	&	
Performance	
Schemas that involve expectations about oneself and the environment that 
interfere with one’s perceived ability to function independently and to 
perform successfully. 
Dependence / 
Incompetence 
The belief that one is not able to handle everyday responsibilities without 
help from others. 
Vulnerability to Harm or 
Illness 
Exaggerated fear that an unpreventable medical, emotional or external 
catastrophe will strike. 
Enmeshment Excessive emotional involvement with significant others at the expense of 
individualization 
Failure The belief that one has failed or will fail in areas of achievement.  
 
Impaired	Limits	 Schemas involving a deficiency in internal limits and responsibility to others. 
Entitlement The belief that one is superior to others and entitled to special rights and 
privileges. 
Insufficient Self-Control A pervasive difficulty or refusal to exercise sufficient self-control and 
frustration tolerance to achieve personal goals. 
Other-Directedness	 Schemas that involve an excessive focus of the desires and feelings of others 
Subjugation Surrendering of control to others to avoid negative consequences. 
Self-Sacrifice The excessive focus of meting needs of others at the expense of one’s own 
gratification. 
Approval-Seeking An excessive focus on gaining approval, recognition, or attention from others. 
 
Overvigilance	&	
Inhibition	
Schemas that involve an overemphasis on suppressing one’s spontaneous 
impulses and feelings 
Negativity A lifelong focus on the negative aspects of life while minimizing the positive 
aspects. 
Emotional Inhibition Inhibiting spontaneous action, feelings, or communication to avoid 
disapproval by others or feelings of shame. 
Unrelenting Standards The belief that one must strive to meet very high standards to avoid criticism. 
Punitiveness The belief that people should be harshly punished for mistakes. 
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 In the present study, we sought to further examine the relation between EMSs and 
depressive symptoms and the stability of EMSs over a course of outpatient treatment for 
depression in patients diagnosed with Major Depressive Disorder (MDD). We 
hypothesized that (1) EMSs from the disconnection & rejection and from the impaired 
autonomy & performance domains are cross-sectionally related to depressive symptom 
severity; (2) high initial levels of EMSs domains are negatively related to the 
improvement of depressive symptoms over the course of treatment; (3) EMSs remain 
relatively stable over a course of outpatient treatment for depression. 
Method	
Participants 
The present report is based on a sample of 132 depressed outpatients treated at the 
mood disorder treatment program of the Academic Community Mental Health Center 
Maastricht (RIAGG Maastricht, The Netherlands). In this secondary care facility, 
depressed individuals are preferably treated with cognitive therapy (CT), interpersonal 
therapy (IPT), antidepressant medication (ADM), or a combination of psychotherapy 
and medication. The inclusion criteria for participation in the present study was a 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric 
Association, 1994) diagnosis of MDD as assessed by the Structured Clinical Interview for 
DSM-IV (SCID-I; First et al., 1996). Participants were excluded if they had a primary 
diagnosis other than MDD, high acute suicide risk, or insufficient Dutch language skills. 
The mean age of the sample was 40.7 years (SD = 12.06); 58% were female; 33.3% were 
married, 25% were single, 17.4% cohabited with their partner, 17.4% were divorced, 
3.8% were widowed, and 3.1% had a spouse but did not live together. At pre-treatment, 
the sample was characterized by moderate to severe levels of depressive symptom 
severity according to the Beck Depression Inventory second edition (BDI-II; Beck et al., 
1996), M = 29.42, SD = 10.33. The mean number of previous depressive episodes was 
1.82 (SD = 3.17). Of the overall sample, 42.2% also had a comorbid Axis-I diagnosis in 
addition to a primary diagnosis of MDD. Comorbid anxiety disorders were the most 
common (31.8%) followed by substance-related disorders (10.6%), eating disorders 
(7.6%) and somatoform disorders (3%). There were no statistically significant 
differences between patients with comorbid Axis-I diagnosis and patients without 
comorbid Axis-I diagnosis with respect to BDI-II pre-treatment levels (time 1), t(130) = -
1.43, p = .16, BDI-II levels at the 16-week follow-up assessment (time 2), t(83) = -1.28, p 
= .21, total SQ score at time 1, t(130) = -1.76, p = .08, or total SQ score at time 2, t(83) = -
0.64, p = .52. 
 Of the overall sample of 132 patients that entered the study and completed 
questionnaires at time 1, 85 patients (64%) also completed the questionnaires at time 2. 
Patients who completed both assessments reported a higher mean age at pre-treatment 
(M = 43.04, SD = 12.24), compared to patients who did not provide a time 2 assessment 
(M = 36.45, SD = 10.59), t(130) = 3.10, p = .002. There were no statistical significant 
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differences in gender distribution χ2(1, N = 132) = 1.21, p = .27. Moreover, the two 
samples did not differ statistically significantly with respect to pre-treatment depressive 
symptom severity, t(130) = 0.19, p = .85 or pre-treatment EMSs (all p values > .003).4 
Therefore, we considered the sub-sample of completers as representative for the overall 
sample with respect to symptom severity, EMSs, and gender distribution. 
 Of the overall sample, 51 patients (38.6%) received CT, 29 patients (22%) received 
a combination of CT and ADM, 21 patients (15.9%) received IPT, 12 patients (9.1%) 
received a combination of IPT and ADM, 12 patients (9.1%) received ADM, and seven 
patients (5.3%) received other treatments.  
Measures 
SCID-I 
As part of the routine diagnostic procedure at the clinical site, Axis-I diagnosis was 
assessed at an initial diagnostic assessment using the SCID-I (First et al., 1996). The 
interview was administered by trained master or doctoral-level psychologists, 
psychotherapists, psychiatrists, and senior psychiatric residents. 
BDI-II 
Depression severity was assessed using the BDI-II (Beck et al., 1996), a 21-item self-
report instrument assessing depressive symptoms during the last two weeks. Each item 
is represented by four statements in terms of increasing severity. For each statement a 
score of 0 - 4 is assigned resulting in a total score of 0 to 63. In the present study the 
Dutch version of the BDI-II was used, which was shown to possess high internal 
consistency in a Dutch sample of psychiatric patients (Cronbach's α = .92) as well as 
adequate construct validity with related depression rating scales (rs between .79 - .85; 
van der Does, 2002). In the present study, internal reliability coefficient alpha for the 
BDI-II total score was excellent both at time 1 (α = .87) and at time 2 (α = .94). 
Schema Questionnaire 
The Schema Questionnaire (SQ) is a 205-item self-report instrument, designed to assess 
16 specific EMSs (Young and Brown, 1994). 5  These 16 EMSs are (1) 
abandonment/instability, (2) defectiveness/shame, (3) emotional deprivation, (4) 
mistrust/abuse, (5) social isolation, (6) dependence/incompetence, (7) vulnerability to 
harm and illness, (8) enmeshment, (9) failure to achieve, (10) social undesirability, (11) 
entitlement/grandiosity, (12) insufficient self-control/selfdiscipline, (13) self-sacrifice, 
(14) subjugation, (15) emotional inhibition, and (16) unrelenting standards. See Table 1 
for a brief description of each EMS. The EMS social undesirability is no longer 
                                                        
4 Bonferonni-corrected significance level α: .05/15 
5 Although to date 18 EMSs were identified, the 205-item version of the SQ that was used in the current 
study does only measure 16 EMSs. This is because the listing of EMSs has been updated more recently 
than the SQ that was used in this study. The EMSs that are not covered by the 205-item SQ are approval-
seeking/recognition-seeking, negativity/pessimism, and punitiveness. 
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considered a separate schema in schema theory and is therefore omitted from the 
present study. Thus, the present report is based on 15 EMSs covered by the 205-items 
version of the SQ. Each item is phrased as a negative core belief regarding oneself or 
ones relation to others. Items are rated along a 6 point scale ranging from 1 (Completely 
untrue of me) to 6 (Describes me perfectly). In the present study the Dutch version of the 
original 205-item version was used (Sterk and Rijkeboer, 1997). High internal reliability 
was reported in a Dutch sample of psychiatric patients for all SQ subscales (Cronbach's α 
= .74 - .92; Rijkeboer and van den Bergh, 2006). In the present study internal reliability 
coefficient alpha of the SQ was good to excellent for all subscales both at time 1 (median 
α = .88; range .78 - .92) and at time 2 (median α = .92; range .78 - .94). 
Procedure 
Patients who were referred to the treatment program underwent an intake procedure 
consisting of an open interview as part of the general intake procedure at the clinic and a 
SCID I interview (First et al., 1996). Moreover, patients received verbal and written 
information about evidence-based treatment options at the clinic. To formulate 
treatment recommendations, clinical history and diagnoses were discussed in an 
interdisciplinary team meeting. The final choice of treatment modality was taken in 
agreement between patient and therapist. In some cases (e.g., chronic depression) the 
therapist actively advised ADM in combination with psychotherapy. ADM treatment 
consisted of selective serotonin reuptake inhibitors (SSRIs) according to national and 
international guidelines (American Psychiatric Association, 2000; National Institute of 
Clincial Evidence, 2004) or in case of previous SSRI non-response venlafaxine or a 
tricyclic agent. CT and IPT consisted of weekly therapy sessions (50 minutes each) by 
experienced therapists, with the possibility of biweekly booster sessions in later stages. 
CT was provided according to the treatment manual by Beck et al., (1979) and IPT was 
provided according to the treatment manual by Klerman et al., (1984). All therapists 
received appropriate training and had weekly meetings to discuss ongoing cases and 
difficulties. Patients who were willing to participate in the study provided written 
informed consent. Time 1 measures were obtained before the patient started with 
treatment and time 2 measures were obtained 16-weeks after the initial assessment. 
Statistical Analyses 
To test hypothesis 1, we first computed Pearson correlations between the total scores 
on the five schema domains and the BDI-II at time 1. We then conducted a stepwise 
multivariate regression analysis with a backward deletion procedure. In all multivariate 
regression analyses with backward deletion procedures, a predictor was removed from 
the model when the partial F value reached a significance level of α > .10 and the model 
was rerun with the respective predictor omitted. In the first analysis, the five schema 
domains at time 1 were simultaneously entered as predictors and the BDI-II total score 
at time 1 was entered as dependent variable. We repeated this analysis entering four 
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schema domains in the regression analysis because it has been suggested that four 
schema domains provide a better description of the underlying EMS (Hoffart et al., 
2005). Following this analysis, a second multivariate regression analysis was conducted 
with specific EMSs at time 1 as predictors and BDI-II total scores at time 1 as dependent 
variable. Given the limited sample size in the current study and the relative large 
amount of predictors (15 EMSs) we decided to only enter those EMSs belonging to the 
schema domains that were significantly related to depressive symptom severity in the 
first regression analysis.  
 To test hypothesis 2, we conducted a hierarchical multivariate linear regression 
analysis with the BDI-II total score at time 2 as dependent variable. In the first step, the 
BDI-II total score at time 1 was entered in the model. In the second step, the mean scores 
on the 5 schema domains at time 1 were entered. Given the limited sample size for the 
time 2 assessments, we did not conduct a separate analysis for specific time 1 EMSs as 
predictors of the time 2 BDI-II total score. 
 To test hypothesis 3, we followed the analytic procedure emphasized by previous 
research on the stability of EMSs (e.g., Riso et al., 2006; Wang et al., 2010). First, Pearson 
correlations between EMSs at time 1 and EMSs at time 2 were calculated. Then, rank 
order stability was derived from standardized beta weights of multivariate regression 
models after controlling for depression severity at both time points. We used separate 
regression equations for each individual EMS with the time 2 EMS score as dependent 
variable, the time 1 EMS score as predictor and the BDI-II total score at both time points 
as covariates. High relative stability in these analyses is indicated by large test-retest 
correlations and large standardized beta coefficients (Santor et al., 1997). To determine 
the absolute stability of EMSs we conducted a series of paired-sample t-tests with a 
Bonferroni adjusted significance level alpha (.05 / 15) to control for multiple testing. We 
also computed effect sizes for all mean differences using Cohen’s d. In these analyses, 
statistically significant mean differences in EMSs between the two time points are 
indicative for poor absolute stability. We also determined effects of the different 
treatment conditions on change in depressive symptom severity and change in EMSs by 
including dummy coded variables for the different treatment conditions in the 
regression models of change described above. In these models the CT condition was 
used as the reference condition. 
Results	
First, we examined diagnostic statistics to test for assumptions of linear regression 
analyses. Although all schema domains displayed statistically significant and moderate 
to strong intercorrelations (rs between .51 – .75), the assumption of non-perfect 
collinearity was met (Tolerance was > .2 and VIF < 10) for all regression models; Visual 
inspection of normality plots suggested that error terms were normally distributed; The 
assumption of independent errors was met (Durbin Watson test between 1.81 and 2.01); 
All standardized residuals were in the range of -3 and 3, suggesting that there were no 
outliers or influential cases. 
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Concurrent relations between depressive symptom severity, schema domains and specific 
EMSs – Hypothesis 1 
Table 2 shows means, standard deviations, and Pearson correlations between BDI-II 
total scores at time 1 and the five schema domains at time 1. All schema domains 
correlated highly and statistically significantly with the BDI-II total score at time 1. The 
mean endorsement of the five schema domains at time 1 ranged from 2.49 to 3.14. To 
date there are no norm scores available for the SQ. The mean endorsement of schema 
domains in the present study is comparable to the mean endorsement of schema 
domains previously reported in depressed samples (e.g., Halvorsen et al., 2009). 
 
Table	2. Means, standarddeviations, and Pearson correlations between BDI-II scores and the five schema 
domains at time 1. 
Measure 1 2 3 4 5 6 7 
1. T1 BDI-II 29.42  
(10.33) 
      
2. T1 Total schemas .63 2.71  
(0.73) 
     
3. T1 Disconnection & Rejection .60 .94 2.72  
(0.93) 
    
4. T1 Impaired Autonomy & performance .59 .89 .73 2.49 
(0.75) 
   
5. T1 Impaired Limits .41 .80 .71 .68 2.59 
(0.73) 
  
6. T1 Other-directedness .54 .83 .71 .73 .51 3.14 
(0.84) 
 
7. T1 Overvigilance & Inhibition .50 .86 .75 .70 .70 .71 2.81  
(0.84) 
Note. Off-diagonal shows correlation coefficients; Diagonal shows means and standarddeviations; N = 132; 
T1 = time 1; BDI-II = Beck Depression Inventory-II. All correlation coefficients are significant (p < .001; 
two-tailed). 
 
Table 3 summarizes the results of the stepwise multivariate regression analysis. The 
BDI-II total score at time 1 was entered as dependent variable and the five schema 
domains at time 1 as independent variables. In the final model, the schema domains 
impaired autonomy & performance and disconnection & rejection remained as 
significant predictors of BDI-II total scores at time 1, β = .34, t(129) = 3.48, p < .001, and 
β = .35, t(129) = 3.53, p < .001, respectively. Together these two schema domains 
explained 41% of the variance in BDI-II total scores at time 1. We repeated the analysis 
with the four schema domains proposed by Hoffart et al. (2005) and again found that 
impaired autonomy & performance and disconnection & rejection remained as 
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significant predictors of BDI-II total scores at time 1, β = .40, t(129) = 3.86, p < .001, and 
β = .43, t(129) = 3.92, p < .001, respectively. 
 
Table	3. Summary of multivariate linear regression analysis with backward deletion predicting time 1 
depressive symptom severity with schema domains at time 1. 
 Model 1  Model 2  Model 3  Model 4   
Predictor B (SE) β B (SE) β B (SE) β B (SE) β 
Constant 7.72 (3.09)*  7.75 (3.07)*  8.97 (2.71)**  7.12 (2.49)**  
T1 Overvigilance & 
Inhibition 
0.38 (1.46) .03       
T1 Other 
Directedness 
1.01 (1.42) .08 1.13 (1.34) .09     
T1 Impaired Limits -2.34 (1.56) -.16 -2.21 (1.48) -.16 -2.42 (1.45) -.17   
T1 Impaired 
Autonomy & 
Performance 
4.88 (1.65)** .35 4.91 (1.64)** .36 5.56 (1.44)** .40 4.74 (1.36)** .34 
T1 Disconnection & 
Rejection 
4.17 (1.38)** .38 4.26 (1.33)** .38 4.72 (1.21)** .43 3.85 (1.09)** .35 
R² .43  .43  .42  .41  
ΔR² .43  .00  -.01  -.01  
Note. N = 132; T1 = Time 1; *p < .05; **p < .01 
 
To determine which specific EMSs from the impaired autonomy & performance and 
disconnection & rejection domains were related to depressive symptom severity, all 
EMSs from these two domains were included in another multivariate stepwise 
regression analysis. Table 4 summarizes the results of the initial model with all EMSs as 
predictors, the next to final model, and the final model. In the final model, three specific 
EMSs remained as significant predictors of depressive symptom severity: 
abandonment/instability, β = .31, t(127) = 2.99, p = .003, failure, β = .41, t(127) = 5.11, p 
< .001, and emotional deprivation, β = .19, t(127) = 2.22, p = .028. Moreover, the EMS 
enmeshment remained as a marginally significant predictor of depressive symptom 
severity, β = -.14, t(127) = -1.83, p = .07. The final model explained 48% of the variance 
in BDI-II total scores at time 1. 
Relation between EMSs at time 1 and depressive symptom severity at time 2 – Hypothesis 2 
Table 5 summarizes the results of the multivariate hierarchical regression model 
predicting reduction in depressive symptoms with the five schema domains at time 1. 
The BDI-II total score at time 2 was entered as dependent variable. The BDI-II total score 
at time 1 was entered as predictor at step 1 and the five schema domains at time 1 were 
simultaneously entered as predictors at step 2. At step 1, time 1 depression severity was 
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a significant predictor of time 2 depression severity, β = .75, t(83) = 10.29, p < .001, 
explaining 56% of the variance in the BDI-II total score at time 2. Adding the five schema 
domains at step 2 significantly improved the hierarchical regression model, ΔR² = .06, p 
= .035. At step 2, time 1 scores on the overvigilance & inhibition domain were negatively 
related to the BDI-II total score at time 2, β = -.29, t(78) = -2.20, p = .031. Moreover, there 
was a marginally significant positive relation between the impaired autonomy & 
performance domain and time 2 depression severity, β = .27, t(78) = 1.97, p = .053.  
 
Table	4. Summary of multivariate linear regression analysis with backward deletion predicting time 1 
depressive symptom severity with domain specific EMSs at time 1. 
 Model 1  Model 5  Model 6  
Predictor B (SE) β  B (SE) β  B (SE) β 
Constant 7.91 (2.49)**  7.92 (2.47)**  8.06 (2.32)  
T1 Dependence/Incompetencea 0.08 (1.28) .01     
T1 Vulnerability to Harma 0.41 (1.18) .03     
T1 Defectiveness/Shameb 1.19 (1.48) .11     
T1 Social Inhibitionb -1.40 (1.11) -.16     
T1 Mistrust/Abuseb 0.95 (1.14) .09 1.10 (1.08) .11   
T1 Enmeshmenta -1.78 (0.95) -.15 -1.66 (0.92) -.14 -1.68 (0.92) -.14 
T1 Emotional Deprivationb 1.50 (0.93) .17 1.22 (0.84) .14 1.63 (0.73)* .19 
T1 Abandonment/Instabilitya 2.55 (1.29) .26 2.60 (1.14)* .26 3.09 (1.03)** .31 
T1 Failurea 3.95 (.98)** .41 3.98 (0.77)** .42 3.96 (0.77)** .41 
R² .49  .48  .48  
ΔR² .49  -.01  .00  
Note. N = 132; T1 = Time 1; aschema domain impaired autonomy and performance; bschema domain 
disconnection and rejection; *p < .05; ** p < .01. 
 
Table	5. Summary of multivariate hierarchical regression analyses testing whether schema domains at 
time 1 predict depressive symptom severity at time 2. 
Step Predictor B (SE) β t R² ΔR² 
Step 1 T1 BDI-II 0.95 (0.09) .75 10.29** .56 .56 
Step 2 T1 BDI-II 0.77 (0.12)  .61 6.34** .62 .06 
 T1 Impaired Limits -1.04 (2.11) -.06 -.49   
 T1 Other Directedness .01 (2.02) .00 .01   
 T1 Disconnection & Rejection 3.61 (1.93) .25 1.87   
 T1 Impaired Autonomy & Performance  4.72 (2.40) .27 1.97   
 T1 Overvigilance & Inhibition -4.74 (2.15)* -.29 -2.20   
Note. N = 85; T1 = Time 1; BDI-II = Beck Depression Inventory-II; *p < .05; **p < .01. 
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Stability of EMSs over the course of treatment – Hypothesis 3 
Absolute stability 
The absolute stability of EMSs over the course of treatment was determined by paired 
sample t-tests. The results of this analysis are summarized in Table 6. After controlling 
for multiple testing, there was a statistically significant but small decrease in the total SQ 
score from time 1 to time 2, t(84) = 4.50, p = .003, d = 0.29. Moreover, patients 
statistically significantly improved on 10 EMSs (Abandonment/instability, 
mistrust/abuse, emotional deprivation, dependence/incompetence, vulnerability to 
harm, insufficient self-control, subjugation, self-sacrifice, emotional inhibition, 
unrelenting standards) with small to medium effect sizes (Cohen's d between 0.15 - 0.35; 
Cohen, 1988). To compare stability of EMSs to symptom level stability, we also 
computed change in BDI-II total scores and found a statistically significant decrease in 
BDI-II total scores from time 1 (M = 29.55, SD = 10.63) to time 2 (M = 21.24; SD = 13.42), 
t(84) = 8.59, p < .001, d = 0.69. 
Relative stability 
The relative stability of EMSs over the course of treatment was determined by 
correlational and regression analyses. Table 6 shows stability correlations between 
EMSs at both time points. Time 1 EMSs subscales correlated highly and statistically 
significantly with time 2 EMSs subscales (Bivariate stability coefficients r between .68 
and .87, p < .001). After controlling for depression severity at both time points in 
regression analyses, the stability coefficient (β) decreased slightly but remained 
statistically significant (βs between .58 and .82, p < .001) suggesting that EMSs exhibit 
high relative stability over the course of 16-weeks outpatient treatment for depression. 
Differences in change of depressive symptoms and change in EMSs between treatment 
conditions 
Adding the different treatment conditions to the regression model of change in 
depressive symptom severity did not significantly improve the model (ΔR² = .04, p = .59). 
Moreover, there was no differences in change of the total SQ score between treatment 
conditions (all p-values > .05). With respect to specific EMSs, there was less change in 
the EMS self-sacrifice in the IPT condition compared to the CT condition, β = .14, t(84) = 
1.96, p = .05 and there was less change in the EMS unrelenting standards in the other-
treatments condition compared to the CT condition, β = .13, t(84) = 2.03, p < .05. 
Differences in change in EMSs between treatment responders and treatment non-
responders 
We also determined the relative stability of EMSs between treatment responders 
(defined as a drop in BDI-II levels by more than 50%) and treatment non-responders. 
Non-responders reported greater change on the EMS social inhibition compared to 
CHAPTER 4 
 82 
responders, β = -.17, t(84) = -2.27, p < .05. Change scores on the other EMSs did not 
differ statistically significantly between responders and non-responders (all p-
values > .05). 
 
Table	6. Relative and absolute stability of EMSs from time 1 to time 2. 
 
 
Relative stability Absolute stability  
 
 
 
 
 Time 1 Time 2 
Variable Stability6 Stability7 M (SD) M (SD) Paired  
t test 
df d 
SQ total .82** .62** 2.62 (0.76) 2.39 (0.80) 4.50** 84 0.29 
Abandonment/Instability .80** .63** 2.76 (1.03) 2.46 (1.06) 4.12** 84 0.29 
Mistrust/Abuse .85** .75** 2.57 (1.02) 2.36 (1.05) 3.44* 84 0.20 
Emotional Deprivation .87** .82** 2.75 (1.21) 2.49 (1.24) 3.88** 84 0.21 
Defectiveness/Shame .78** .58** 2.22 (0.96) 2.07 (0.99) 2.05 84 0.15 
Social Isolation/Alienation .79** .66** 2.85 (1.20) 2.60 (1.23) 2.85 84 0.21 
Dependence/Incompetence .79** .59** 2.51 (0.98) 2.29 (0.96) 3.15* 84 0.23 
Vulnerability to Harm .81** .70** 2.26 (0.86) 1.97 (0.79) 5.18** 84 0.35 
Enmeshment .74** .68** 2.05 (0.89) 1.90 (0.96) 2.07 84 0.16 
Failure .77** .63** 2.78 (1.09) 2.59 (1.22) 2.22 84 0.16 
Entitlement/Grandiosity .68** .62** 2.18 (0.69) 2.01 (0.68) 2.96 84 0.25 
Insufficient Self-Control .80** .70** 2.74 (0.89) 2.47 (0.94) 4.22** 84 0.29 
Subjugation  .80** .71** 2.77 (1.04) 2.57 (1.02) 2.70* 84 0.19 
Self-Sacrifice .79** .65** 3.40 (0.90) 3.18 (1.00) 3.35* 84 0.23 
Emotional Inhibition .81** .72** 2.62 (1.05) 2.29 (1.02) 4.70** 84 0.32 
Unrelenting Standards .79** .77** 2.80 (0.90) 2.52 (0.94) 4.22** 84 0.30 
Note. N = 85; SQ = Schema questionnaire; Effect sizes (ds) were calculated by dividing the mean difference 
with the pooled standard deviation and may be interpreted as small to medium (Cohen, 1988). *p < .05 
(Corrected for multiple testing); **p < .01 (Corrected for multiple testing). 
 
Discussion	
The aims of this study were to relate EMSs to depressive symptom severity during a 
course of outpatient treatment for depression and to determine the relative and 
absolute stability of EMSs over the course of treatment. We found that, after controlling 
for overlap among schema domains, EMSs from the domains impaired autonomy & 
performance and disconnection & rejection were related to depressive symptom 
                                                        
6 Bivariate stability correlations. 
7 Stability coefficient after controlling for depression severity at both time points in regression analyses. 
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severity in a naturalistic sample of outpatients suffering from MDD. This finding is 
largely in line with previous findings relating EMSs to depressive symptom severity (e.g., 
Calvete et al., 2005; Harris and Curtin, 2002) and suggests that depressed patients are 
characterized by a specific set of EMSs. In particular, in cross-sectional analyses we 
found that the EMSs abandonment/instability, emotional deprivation, and failure were 
positively related to depressive symptom severity when controlling for overlap among 
EMSs. Moreover, the EMS enmeshment was marginally significantly negatively related to 
depressive symptom severity. These four EMSs accounted for 48% of the variance in 
depressive symptom severity with the failure schema accounting for the largest part. It 
should be noted, however, that there were weak to strong intercorrelations (rs 
between .27 - .64) among these four EMSs which makes it difficult to determine the 
individual importance of each predictors. These findings are consistent with the 
cognitive model of depression, placing schemas or core beliefs in the domains of failure, 
loss, and worthlessness at the core of depressive symptoms (Beck, 1964, 1987).  
 We also investigated the validity of schema domains at pre-treatment as predictors 
of improvement in depressive symptom severity over the course of treatment and found 
that the schema domain overvigilance & inhibition was negatively related to depressive 
symptom severity whereas the schema domain impaired autonomy & performance was 
positively related to depressive symptom severity assessed 16-weeks after the start of 
treatment. The relation between impaired autonomy & performance and depressive 
symptom severity at time 2 was slightly below the threshold of statistical significance 
and should therefore be interpreted with caution. The finding that EMSs from the 
overvigilance & inhibition domains at pre-treatment were negatively related to 
depressive symptom severity at the time 2 assessment was unexpected and is difficult to 
explain in the context of schema theory. Patients with high scores on this EMS domain 
are typically characterized by a suppression of spontaneous feelings and impulses or by 
a preoccupation of meeting high internalized standards of performance (Young et al., 
2003). One possible, explanation of this finding is that patients who score high on this 
schema domain might tend to deny or inhibit their negative emotions in self-report of 
depressive symptoms. Hence, they might report less depressive symptoms at time 2 
because of a high inhibition of emotions. An alternative explanation, suggested by one of 
the anonymous reviewers, is that patients with high scores on this schema domain work 
harder in therapy because of their high internalized standards of performance and 
therefore obtain better results. Both explanations are speculative and require further 
testing. The finding that impaired autonomy & performance levels at pre-treatment 
were positively related to depressive symptoms at time 2 suggest that depressed 
patients with increased expectations about themselves and others that interfere with 
their perceived ability to function independently or perform successfully show less 
symptom improvement in treatment for depression. However, given the relatively low 
percentage of explained variance in BDI-II scores, the robustness of these findings is 
questionable and replication in more controlled studies is needed. Moreover, it should 
be noted that studies on the psychometric properties of the SQ have yielded mixed 
results regarding the higher-order factor structure (Hoffart et al., 2005; Lee et al., 1999; 
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Schmidt et al., 1995; Soygüt et al., 2009). Therefore, our findings regarding the 
predictive validity of schema domains should be interpreted with caution. 
 Consistent with our third hypothesis, we found high relative stability of EMSs from 
time 1 to time 2 in the context of statistically significant and large decreases in 
depressive symptom severity. Moreover, the relative stability of EMSs remained high 
when controlling for depressive symptom severity at both time points. Given that none 
of the treatment protocols in the present study explicitly target EMSs this finding was 
expected. In terms of absolute stability, we found a statistically significant but small 
(Cohen’s d between 0.15 – 0.35) decrease in 10 EMSs (Abandonment/instability, 
mistrust/abuse, emotional deprivation, dependence/incompetence, vulnerability to 
harm, insufficient self-control, subjugation, self-sacrifice, emotional inhibition, 
unrelenting standards) whereas decrease in depressive symptom severity was 
statistically significant and moderate (Cohen’s d = 0.69). Given the high relative stability 
and the low effect sizes for the mean differences, our findings suggest that EMSs remain 
stable in depressed patients over a course of outpatient treatment. This finding is 
consistent with earlier research on the stability of EMSs in depressed patients (Riso et 
al., 2006; Wang et al., 2010) and the notion that EMSs represent stable, trait-like 
constructs (Young et al., 2003). Moreover, our results extend previous findings on the 
stability of EMSs in depression that have primarily focused on the long-term stability of 
EMSs (Riso et al., 2006; Wang et al., 2010) to the relative stability of EMSs in the context 
of symptom change.  
 We also determined the stability of EMSs in the different treatment conditions and 
found no substantial differences between treatment conditions, except for the EMS self-
sacrifice which changed less in the IPT condition compared to the CT condition and for 
the EMS unrelenting standards which changed less in the other-treatments condition, 
compared to the CT condition. However, given the lack of random assignment to 
treatment conditions in the current study, these results should be interpreted with 
caution. Overall, our results indicate that there are no substantial differences in change 
in EMSs across treatment conditions. There is a need to replicate these findings in more 
controlled settings. 
Limitations 
First, we did not include a clinical control group with psychopathology other than 
depression in this study and therefore no conclusions regarding the specificity of our 
findings can be drawn. Second, we did not assess Axis-II psychopathology. Given that 
patients with Axis-II psychopathology generally exhibit high scores of EMSs (Nordahl et 
al., 2005), it is desirable to assess and control for Axis-II comorbidity when studying the 
relation between EMSs and depressive symptoms. Third, we determined cross-sectional 
relations between EMSs and depressive symptoms. While theory would suggest that 
EMSs drive depression, the nature of our research design and analyses does not allow 
for drawing causal conclusions from our findings. Fourths, in this study no other 
measures of dysfunctional cognitions was obtained. It would be interesting to 
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investigate how EMSs relate to depressive symptoms over a course of treatment, 
relative to measures of dysfunctional surface cognitions, like automatic thoughts. Fifth, 
the sample in the current study was characterized by relatively severe levels of 
depression and hence the range of BDI-II scores was restricted, which might have led to 
an underestimation of correlation coefficients between BDI-II and EMSs scores. Finally, 
we did not assess the recently identified EMS approval-seeking/recognition-seeking, 
negativity/pessimism, and punitiveness that are covered by the latest version of the SQ 
(Young, 2006). Future research on the relation between EMS and depressive symptoms 
should also assess these additional EMS. 
Clinical Implications 
Despite these limitations the present study has important implications for clinical 
settings and future research. First, we found that specific EMSs were related to 
depressive symptom severity in depressed patients. This finding needs further 
replication in more controlled settings with clinical control groups in order to determine 
the specificity of these EMSs to depression. We also found that schema domains at pre-
treatment were related to change in depressive symptom severity over the course of 
treatment. Therefore, it might be valuable, for prognostic reasons, to assess EMSs prior 
to treatment. Future studies should also address the causal direction of the relation 
between EMSs and change in depressive symptoms. For example, it would be interesting 
to test whether change in EMSs is a possible mechanism that leads to improvement from 
depressive symptoms, as theory would suggest. 
 Our results suggest that EMSs in depressed patients remain relatively stable in the 
context of change in depressive symptoms during evidence-based short-term 
treatments for depression. One consequence might be that patients leave treatment with 
reduced symptomatology but with a largely unaltered underlying vulnerability for 
future depressive episodes. This might be especially problematic for depressed patients 
with high levels of EMSs and might lead to an increased risk for subsequent relapse. For 
example, it has been shown that chronically depressed patient exhibit statistically 
significantly higher scores on all schema domains as compared to non-chronically 
depressed patients (Riso et al., 2003). Given that EMSs are likely to represent a core 
vulnerability factor to psychopathology, depressed patients with highly dysfunctional 
EMSs (i.e., chronically depressed patients) might benefit from long-term treatments that 
are specifically designed to alter underlying EMSs, such as schema-focused therapy 
(Young et al., 2003). 
In conclusion, the current study provides further empirical support that specific EMSs 
are related to depressive symptoms and that these dysfunctional schemas are robust to 
change, even in the context of evidence-based outpatient treatment for depression. 
Moreover, our findings suggest that specific schema domains assessed before treatment 
predict depressive symptom severity 16-weeks after the initial assessment. Replication 
of these findings in more controlled settings is needed. 
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Abstract	
Background: The personality dimensions neuroticism and extraversion likely represent 
part of the vulnerability to depression. The stability over longer time periods of these 
personality dimensions in depressed patients treated with psychological treatment or 
medication and in untreated persons with depression in the general population remains 
unclear. Stability of neuroticism and extraversion in treated and untreated depressed 
persons would suggest that part of the vulnerability to depression remains stable over 
time. The current study addressed the question whether treatment in depressed 
patients is related to changes in neuroticism and extraversion.  
 
Methods: Data are from 709 patients with major depressive disorder participating in a 
cohort study (Netherlands Study of Depression and Anxiety; NESDA). We determined 
the two-year stability of extraversion and neuroticism in treated and untreated persons 
and related change in depression severity to change in personality over time.  
 
Results: Neuroticism decreased from baseline to two-year follow-up (d = 0.73) in both 
treated and untreated persons. Extraversion did not change significantly after 
controlling for neuroticism and depression severity at baseline and follow-up. Decreased 
depressive symptoms over time were related to decreased neuroticism (d = 1.91) 
whereas increased depressive symptoms over time were unrelated to neuroticism (d = 
0.06). Limitations: Patients were not randomized to treatment conditions and the 
groups are therefore not directly comparable. 
 
Conclusions: Treated patients with depression in the general population improve just as 
much on depression severity and neuroticism as untreated persons with depression. 
This suggests that changes in neuroticism in the context of treatment likely represent 
mood-state effects rather than direct effects of treatment. 
 
Keywords: neuroticism; extraversion; major depression; treatment seeking. 
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Introduction	
The relation between Major Depressive Disorder (MDD) and the personality dimensions 
of neuroticism and extraversion has been studied in clinical settings and in population 
based studies (for an overview: Kotov et al., 2010). These studies have shown that MDD 
is positively associated with neuroticism and negatively with extraversion. Moreover, 
clinical and population based studies have identified neuroticism as an important 
vulnerability factor for MDD (Boyce et al., 1991; Fanous et al., 2007; Hettema et al., 2006; 
Hirschfeld et al., 1989; Kendler et al., 2006; Kendler et al., 2004; Ormel et al., 2004), 
whereas low extraversion appears to be associated only weakly to MDD (Kendler et al., 
2006). 
 While neuroticism and extraversion likely represent part of the vulnerability to 
MDD, they are also known to change with the current mood state. For example, Karsten 
et al. (2012) used data from the Netherlands Study of Depression and Anxiety (NESDA; 
Penninx et al., 2008) and found that the occurrence of a depressive disorder was 
associated with an increase in neuroticism and a decrease in extraversion (Karsten et al., 
2012). Similarly recovery from a depressive disorder was associated with decreased 
neuroticism and increased extraversion (Karsten et al., 2012), suggesting that 
neuroticism and extraversion are mood state dependent. In this study treatment status 
was not taken into account so it remains unclear whether treatment is related to the 
observed changes in neuroticism and extraversion. 
 The stability of neuroticism and extraversion in patients with MDD has also been 
studied in the context of randomized clinical trials (RCTs) and in naturalistic treatment 
studies (Berlim et al., 2013; Ekselius and von Knorring, 1999; Hellerstein et al., 2000; 
Tang et al., 2009). Studying the stability of neuroticism and extraversion in the context 
of RCTs is important to determine which aspects of treatment are related to change in 
personality. Tang et al. (2009), for example, showed that neuroticism decreased and 
extraversion increased in patients with MDD taking selective serotonin reuptake 
inhibitors (SSRIs) compared to patients taking a pill placebo. Interestingly, change in 
personality did not depend on improvement from depressive symptoms suggesting that 
change in personality is not a mere epiphenomenon of improved depressive state (Tang 
et al., 2009). In a naturalistic treatment study it has been shown that a 4-week trial of 
high frequency repetitive transcranial magnetic stimulation was related to decreased 
levels of neuroticism at post-treatment and the authors suggested that these 
improvements in neuroticism were likely independent from improvements in 
depressive state (Berlim et al., 2013). These findings suggest that treatment for MDD 
may have an impact on the personality of patients with MDD independent of the impact 
of treatment on depression itself.  
 In RCTs comparing the impact of depression treatment on change in personality 
the control condition usually consists of a placebo group (e.g., Ekselius and von Knorring, 
1999; Hellerstein et al., 2000; Tang et al., 2009) but patients assigned to placebo usually 
also experience substantial symptom reduction. To more directly test whether 
treatment for depression is related to change in personality it is necessary to compare 
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treated and untreated persons with depression. This can be done in population based 
studies because not all depressed persons in the general population seek treatment. 
 Another issue that has not been addressed in RCTs is the long-term stability of 
personality in treated and untreated persons with depression. Assessing the long term 
stability of personality traits in depressed patients is important because stability of 
personality traits in the context of change in depressive state would suggest that part of 
the vulnerability to depression remains intact, increasing the risk for subsequent relapse. 
For example, in a recent meta-analysis of longitudinal studies it has been shown that 
personality and personality disorders remain relatively stable over time and that 
patients under treatment for various mental disorders do not report more change in 
personality than non-patients (Ferguson, 2010). Such findings suggest that part of the 
vulnerability, in terms of the underlying personality, remains stable over longer periods 
of time in depressed patients in the general population, regardless of treatment status. 
 When studying the stability of personality in treated and untreated persons with 
depression in the general population some differences between RCTs and population 
based studies should be taken into account. In RCTs patients usually receive highly 
effective treatments under optimal conditions, whereas at the population level many 
depressed patients do not always receive adequate health care (Kessler et al., 2003; 
Young et al., 2001). Moreover, patients with MDD in RCTs might differ from patients 
with MDD in the general population on a number of clinically relevant variables such as 
comorbidity. 
 The present study draws data from the Netherlands Study of Depression and 
Anxiety (NESDA), to determine the two-year stability of neuroticism and extraversion in 
patients treated with psychological treatment and/or antidepressant medication and in 
untreated persons with depression. Moreover, we sought to relate in both untreated and 
treated persons the change in depressive symptoms over time to change in neuroticism 
and extraversion over time. The following questions were addressed in this study: 1) Is 
treatment in patients with MDD at the population level related to change in neuroticism 
and extraversion? 2) Are changes in depressive symptoms over time in untreated and 
treated persons with depression related to changes in neuroticism and extraversion? 
Methods	
Sample 
The present report is based on data from an ongoing longitudinal cohort study, the 
Netherlands Study of Depression and Anxiety (NESDA; N = 2981). This ongoing multi-
site cohort study determines predictors, course and consequences of depression and/or 
anxiety disorders in the Netherlands. Participants were healthy controls, persons with 
remitted depressive and/or anxiety disorders and persons with a current depressive 
and/or anxiety disorder. Participants were recruited from primary care (n = 1610), 
secondary care (n = 807) and from the general population (n = 564). General exclusion 
criteria of NESDA were a primary diagnosis of psychotic, obsessive compulsive, bipolar 
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or severe addiction disorder. Participants who were not fluent in Dutch were also 
excluded. The NESDA study protocol was centrally approved by an Institutional Review 
Board and locally by the review boards of all participating sites and all participants 
signed written informed consent. A more detailed description of the NESDA study is 
available elsewhere (Penninx et al., 2008). 
 The current study used data from the baseline assessment, the one year follow-up 
assessment (FU1) and the two-year follow-up assessment (FU2). Psychopharmaca use 
was assessed at baseline at FU1 and at FU2 and coded according to the Anatomical 
Therapeutic Chemical (ATC) classification system (WHO, 2007). Patients who took any 
of the following medications when entering the study or during the study period were 
excluded from the analyses: antipsychotics (ATC code: N05A), anxiolytics (ATC code: 
N05B), hypnotics or sedatives (ATC code: N05C), psychostimulants (ATC code: N06B), 
or anti-dementia drugs (ATC code: N06D) Patients taking any of these drugs during the 
study period were excluded from the analyses because we aimed to study change in 
personality in untreated and treated persons receiving treatment for depression and not 
for anxiety or other disorders. Of the overall NESDA sample of 2981 participants, 1115 
(37.4%) had a diagnosis of current MDD (6-month recency) at baseline. Of these 1115 
patients, 393 (35%) were excluded from the analyses because they reported to have 
used one of the drugs above in the time period under study. Therefore, 722 patients with 
MDD were further considered for this study, of whom 13 persons had missing follow-up 
data, leading to an ultimate 709 persons with MDD as the final study sample. 
Treatment status 
Treatment status was defined by the use of antidepressant medication (ADM) and by 
self-reported contact with a psychologist or psychiatrist at any time between baseline 
and FU2. Patients who received treatment (psychological or medication) at baseline 
were also classified as treated. ADM use was assessed by self-report questionnaires and 
by inspection of drug containers that participants brought to the baseline and 2-year FU 
interview and classified according to the World Health Organization ATC classification 
system (WHO, 2007). Psychological treatment was assessed by the Trimbos/iMTA 
questionnaire for costs associated with psychiatric illness (TIC-P; Hakkaart-van Roijen, 
2002) and defined as self-reported contact with a psychologist, psychiatrist or contact 
with a secondary care facility. To identify participants as treated no restrictions were 
placed on the number of contacts with a psychological health care provider. Based on 
these criteria, 520 (73.3%) people were classified as treated and 189 (26.7%) were 
classified as untreated. 
Measures 
CIDI.	 The Composite International Diagnostic Interview (CIDI) is a fully structured 
interview based on the Diagnostic and Statistical Manual of Mental Disorders (4th ed; 
DSM–IV; American Psychiatric Association, 1994) criteria (World Health Organization, 
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1997). Excellent inter-rater reliability and validity has been reported for the CIDI 
(Andrews and Peters, 1998; Wittchen, 1994). In the NESDA study, the CIDI was used to 
determine the presence of current and lifetime mood disorders, anxiety disorders and 
alcohol abuse or dependence. The CIDI was conducted at baseline and at FU2. 
 
IDS-SR.	The Inventory of Depressive Symptoms Self-Report version (IDS-SR; Rush et al., 
1996) is a 30-item self-report questionnaire measuring depressive symptom severity 
over the past seven days. Excellent internal consistency (Cronbach's alpha .92) and high 
correlations with the Hamilton Rating Scale for Depression (Hamilton, 1960) have been 
reported (Rush et al., 2003). In the current study the IDS-SR was obtained at baseline, 
FU1, and at FU2. 
 
NEO-FFI.	The revised NEO Five-Factor Inventory (NEO-FFI) is a widely used self-report 
instrument designed to measure the following higher order personality traits: 
neuroticism, extraversion, openness to experience, agreeableness, and 
conscientiousness (Costa and McCrae, 1995). Good internal consistency (Cronbach's 
alpha range .87 - .92) has been reported for the domain scales (Costa and McCrae, 1992). 
Although in the NESDA study all five subscales of the NEO-FFI have been assessed, the 
present report focuses on the neuroticism and extraversion scales because these two 
scales have most consistently been associated with depression. In the current study, the 
NEO-FFI was obtained at baseline and at FU2. 
Statistical analyses 
SPSS version 19 for Windows was used for statistical analyses. First, we computed 
Pearson correlations between depressive symptom severity and personality dimensions 
at baseline to determine concurrent relations. Pearson correlations between 
neuroticism at baseline and neuroticism at FU2 and between extraversion at baseline 
and extraversion at FU2 in treated and untreated persons were computed as an index of 
stability of these personality traits over time. 
 Multilevel Modeling (MLM) was used to predict change in depressive symptom 
severity and change in neuroticism and extraversion over time as a function of 
treatment status. MLM of longitudinal data has several advantages above ordinary least 
square regression analyses because it can deal with missing data and include time 
varying covariates in the analyses. Model building was guided by the following analytic 
procedure: First we added time as a predictor to the model (Model 1). In this model a 
significant main effect of time indicates that the dependent variables changes across the 
various assessment moments. Next we added treatment status and the interaction 
between treatment status and time as predictors (Model 2). In this model a significant 
time x treatment status interaction indicates that change in the dependent variable over 
time is different for treated and untreated persons. Following this we added personality 
scores as predictors to the model of change in depression severity and we added 
depression severity scores as predictors to the models of change in neuroticism and 
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extraversion (Model 3). Finally we added the potential confounding variables gender, 
age, level of education and recruitment setting (Final Model). To compare the fit 
between the various models we compared change in deviance using a Χ² test with 1 
degree of freedom. 
 We also determined the relation between change in personality and change in 
depression severity in treated and untreated persons. To test whether change in 
personality predicts change in depressive symptom severity we added the neuroticism 
(at baseline and FU2) x time interaction and the extraversion (at baseline and FU2) x 
time interaction as predictors to the model of change in depressive symptom severity. 
To test whether the relation between change in personality and change in depressive 
symptom severity depends on treatment status, we also added the neuroticism (at 
baseline and FU2) x time x treatment status and the extraversion x time x treatment 
status three-way interactions to the model predicting change in depressive symptom 
severity. In these analyses neuroticism and extraversion were included as time varying 
covariates.  
 To test whether change in depressive symptom severity predicts change in 
personality, we conducted two separate MLM analyses, one with change in neuroticism 
as dependent variable and one with change in extraversion as dependent variable. To 
determine whether change in depressive symptoms predicts change in personality we 
entered the depressive symptoms (at baseline and FU2) x time interaction and the 
depressive symptoms (at baseline and FU2) x time x treatment status three-way 
interaction as predictor variables in both analyses. In these models, depressive 
symptoms severity was entered as time varying covariate. 
 In all models, continuous independent predictors were standardized by 
subtracting the sample mean from the individual score and dividing the result by the 
standard deviation of the mean to facilitate the interpretability of various predictors that 
are measured on different scales. In all MLMs we used an unstructured covariance 
structure for repeated measures over time and a Maximum Likelihood estimation 
method in order to be able to compare model fit. We computed effects sizes (Cohens’d) 
for all models based on estimates from the multi-level analyses (Feingold, 2009). Time 
was coded as follows: 0 = baseline, 1 = FU1, 2 = FU2. Treatment seeking was centered 
and coded -0.5 = untreated and 0.5 = treated. 
Results	
Sample characteristics 
Demographic and clinical characteristics of the treated and the untreated group are 
shown in Table 1. Depressive symptom severity at baseline was significantly higher in 
the treated group (M = 31.46, SD = 11.92) compared to the untreated group (M = 28.91, 
SD = 11.47). Baseline levels of extraversion were significantly higher in the untreated 
group (M = 36.87, SD = 7.16) compared to the treated group (M = 34.88, SD = 6.99). It 
should be noted that these statistical differences are not necessarily clinically 
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meaningful given that in a large sample also small mean differences can reach statistical 
significance. To estimate the clinical meaningfulness of these differences we also 
compute the effect size (Cohens’d) of the differences between the groups. The effect size 
of the difference between the groups was 0.22 for depression severity and 0.28 for 
extraversion, reflecting small effects (Cohen, 1988). The two groups also differed with 
respect to source of recruitment. The majority of people in the treated group were 
recruited from secondary care facilities (60.4%), followed by recruitment from primary 
care facilities (33.3%) and by recruitment from the general population (6.3%). Most 
people from the untreated group were recruited from primary care facilities (58.2%) 
followed by recruitment from secondary care facilities (26.5%) and by recruitment from 
the general population (15.3%). Gender was equally distributed among the two groups. 
 
Table	1. Demographic and clinical characteristics at baseline for treated and untreated persons. 
Characteristic Treated (n = 520) Untreated (n = 189)  
 Mean (SD) N (%)  Mean (SD) N (%)  t Chi-
Square 
Age (years) 39.95 (11.69) - 38.80 (12.77) - -1.16 - 
Female - 337 (64.1) - 138 (70.4) - 2.56 
Education level (years) 11.86 (3.27) - 11.70 (3.16) - -0.57 - 
Number of previous 
episodes8 
5.21 (10.13) - 6.16 (11.63) - 1.04 - 
Recurrent MDD - 280 (53.2) - 113 (57.7) - 1.13 
Anxiety disorder - 330 (62.7) - 114 (58.2) - 1.26 
Depressive symptom 
severity 
31.46 (11.92) - 28.91 (11.47) - -2.53* - 
Neuroticism 42.08 (6.59) - 41.05 (6.84) - -1.81 - 
Extraversion 34.88 (6.99) - 36.87 (7.16) - 2.72** - 
Note. * = p < .05; ** = p < .01. 
 
Concurrent relations between depressive symptom severity and the personality dimensions 
neuroticism and extraversion 
At baseline, neuroticism correlated positively with depressive symptom severity (r = .56; 
p < .001) and negatively with extraversion (r = -.50; p < .001); extraversion correlated 
negatively with depressive symptom severity (r = -.45; p < .001). 
                                                        
8 Median number of previous episodes was two in the overall sample, in the treatment seeking group and 
in the non treatment seeking group. 
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Modeling change in depressive symptom severity, neuroticism and extraversion 
Change in depressive symptom severity 
First, we modeled change in depressive symptom severity over time by treatment status 
using MLM. Table 2 summarizes the results of the four most informative models. In all 
models there was a significant main effect of time (p < .01) indicating that depressive 
symptoms decreased over time (d = 0.89). In the final model, there was a significant 
main effect of time (F(1, 547.75) = 216.83, p < .001), after adjusting for neuroticism and 
extraversion levels and other potential confounding variables. The interaction between 
time and treatment status was not significant (F(1, 547.74) = 3.39, p = .07), suggesting 
that decrease in depressive symptoms did not depend on treatment status (Figure 1 A). 
 
Table	2. Predicting change in depressive symptom severity over time. 
Parameter Model 1 Model 2 Model 39 Final Model10 
Intercept 28.74 (0.49)** 27.58 (0.59)** 28.45 (0.50)** 29.32 (1.08)** 
Time -4.35 (0.23)** -4.06 (0.28)** -4.06 (0.28)** -4.06 (0.28)** 
Treatment status - 3.92 (1.18)** 1.71 (0.99) 2.06 (0.98)* 
Time*Treatment 
status 
- -1.00 (0.55) -1.01 (0.55)  -1.02 (0.55) 
-2*log likelihood 11693.205 11682.059 11335.160 11299.817 
Δ deviance - 11.14** 346.90** 35.34** 
Note. ** p < .01; * p < .05; All continuous predictor variables were standardized before entered into the 
model. 
Stability of neuroticism and extraversion 
To determine the stability of the personality dimensions neuroticism and extraversion 
over time in the two groups, we first determined Pearson correlations between 
neuroticism and extraversion at baseline and neuroticism and extraversion at FU2. In 
both groups, neuroticism at baseline correlated moderately and statistically significant 
with neuroticism levels at FU 2 (untreated: r = .64, p < .001; treated r = .59, p < .001) and 
the correlation coefficients of the two groups did not differ statistically significantly, z = 
0.78, p = .43. Extraversion at baseline also correlated moderately and statistically 
significant with extraversion at FU2 in both groups (untreated: r = .77, p < .001; treated: 
r = .72, p < .001) and the correlation coefficients did not differ between groups, z = 1.10, 
p = .27. The overall stability coefficient between extraversion at baseline and 
extraversion at FU2 (r = .74) was stronger than the stability coefficient between 
neuroticism at baseline and neuroticism at FU2 (r = .60; z = 3.99, p < .001). 
 
                                                        
9 Adjusted for neuroticism and extraversion at baseline and at FU2 
10 Adjusted for potential confounding variables: gender, age, level of education and recruitment setting 
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Mean level stability of neuroticism and extraversion 
Both groups experienced a statistically significant decrease in mean neuroticism levels 
from baseline to FU2 (mean decrease untreated: -4.23, p < .001; mean decrease treated: 
-3.68, p < .001) and a statistically significant increase in the mean level of extraversion 
(mean increase untreated: 1.67; p < .001; mean increase treated: 1.68; p < .001). To 
compare the mean level change in neuroticism and extraversion in the current sample 
with a non-depressed control group, we also calculated the mean level stability of 
persons in the same study (Penninx et al., 2008) without any depressive or anxiety 
disorders (N = 652). Mean neuroticism levels in the non-depressed group also decreased 
statistically significantly from baseline to FU2 (mean decrease: -1.44, p < .001) as did the 
mean level of extraversion (mean decrease: -1.32; p < .001). The mean decrease in 
neuroticism in the non-depressed group statistically significantly differed from the 
mean decreased in the untreated (t (714) = 3.50, p < .001) and the treated group (t(1032) 
= 4.74, p < .001). The mean difference in extraversion in the non-depressed group also 
statistically significantly differed from the mean difference in extraversion in the 
untreated (t(714) = 3.18, p < .01) and treated group (t(1032) = 5.79, p < .001). 
 Next we modeled change in neuroticism and extraversion over time as a function 
of treatment status using MLM (Table 3). In all models, predicting change in neuroticism 
over time there was a significant main effect of time (p < .01), indicating that 
neuroticism decreased over time (d = 0.73). In the final model the significant main effect 
of time remained after controlling for depressive symptom severity and extraversion 
levels and for potential confounding variables F(1, 474.05) = 92.45, p < .001. The 
interaction between time and treatment status was not significant (F(1, 464.61) = 0.40, p 
= .53), indicating that decrease in neuroticism did not differ between treated and 
untreated persons (Figure 1 B). 
In the initial model predicting change in extraversion over time there was a significant 
main effect of time (p < .01) indicating that extraversion increased over time, however, 
after controlling for neuroticism and depression severity at baseline and follow-up 
change in extraversion over time was not significant anymore (F(1, 512.51) = 0.01, 
p=.91). The interaction between time and treatment status was also not significant (F(1, 
478.23) = 2.13, p = .15), indicating that extraversion remained stable over time in both 
treated and untreated persons (Figure 1 C).		
Differences in change in depression severity and personality between different types of 
treatment 
To test whether change in depressive symptom severity, neuroticism or extraversion 
differed between different types of treatment (medication, psychotherapy, or both 
medication and psychotherapy) we added dummy coded variables for the different 
types of treatment to the final multilevel models. In these analyses the untreated group 
was used as the reference condition. There were no differences between type of 
treatment and change in depressive symptom severity, change in neuroticism or change 
in extraversion (all p-values > .05). 
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Relation between change in personality and change in depression severity 
In the model predicting change in depressive symptom severity over time, the 
neuroticism x time x treatment status and the extraversion x time x treatment status 
three-way interactions were not significant (F(1, 550.42) = 0.48, p = .49 and F(1, 549.68) 
= 1.67, p = .20, respectively). Therefore, we removed the non-significant three-way 
interactions from the model and the model was rerun. The interactions between time 
and neuroticism and the interaction between time and extraversion were not significant 
(F(1, 734.65) = 0.22, p = .64 and F(1, 667.54) = 0.15, p = .70, respectively), indicating that 
change in personality over time did not predict change in depressive symptom severity 
over time. 
 In the model predicting change in neuroticism over time the depressive symptom 
severity x time x treatment status interaction was not significant (F(1, 549.64) = 0.20, p 
= .66) and was therefore removed from the model. There was a significant interaction 
between depressive symptom severity and time, F(1, 683.96) = 25.89, p < .001. To 
interpret the interaction term, we plotted the neuroticism total scores at baseline and at 
FU2 separately for the low- and high change in depressive symptom severity groups 
(Figure 2), defined as one SD below and above the mean change in depressive symptom 
severity. Patients in the high change group (n = 82) reported a mean decrease of 27.70 
(SD = 6.04) on the IDS whereas patients in the low change group (n = 76) reported a 
mean increase of 5.93 (SD = 3.63) on the IDS. As can be seen in Figure 2, persons in the 
high decrease in depressive symptoms group significantly decreased on neuroticism 
from baseline to FU2 whereas increased depressive symptoms were unrelated to 
changes in neuroticism from baseline to FU2 (ES within decrease in depressive 
symptoms group d = 1.91; ES within increased depressive symptoms group: d = 0.06). In 
the model predicting change in extraversion over time the depressive symptom severity 
x time x treatment status interaction was not significant (F(1, 546.24) = 0.99, p = .32) 
and was therefore removed from the model. After removing the non-significant three-
way interaction from the model, the interaction between depressive symptom severity 
and time was not significant, F(1, 650.31) = 1.69, p = .19, indicating that change in 
depressive symptoms did not predict change in extraversion. 
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Table	3. Predicting change in the personality dimensions neuroticism and extraversion over time. 
 Neuroticism	
Parameter Model 1 Model 2 Model 311 Final Model12 
Intercept 41.27 (0.30)** 40.82 (0.38)** 41.24 (0.30)** 41.06 (0.68)** 
Time -3.65 (0.30)** -3.71 (0.37)** -3.21 (0.33)** -3.18 (0.33)** 
Treatment status - 1.51 (0.75)* -0.03 (0.60) -0.08 (0.58) 
Time*Treatment status - 0.20 (0.73) 0.40 (0.66) 0.42 (0.66) 
-2*log likelihood 6250.052 6245.145 5854.975 5795.704 
Δ deviance - 4.907* 390.17** 59.271** 
 
Parameter 
Extraversion	    
Model 1 Model 2 Model 313 Final Model14 
Intercept 33.80 (0.32)** 34.43 (0.40)** 34.44 (0.34)** 34.87 (0.79)** 
Time 1.53 (0.23)** 1.36 (0.29)** 0.03 (0.27) -0.05 (0.27) 
Treatment status - -2.13 (0.79)** -0.98 (0.67) -0.98 (0.66) 
Time*Treatment status - 0.57 (0.57) 0.94 (0.50) 0.64 (0.50) 
-2*log likelihood 6054.320 6047.172 5735.104 5693.581 
Δ deviance - 7.15** 312.07** 41.25** 
Note. ** = p < .01, * p < .05; All continuous predictor variables were standardized before entered into the 
model.  
Discussion	
The aim of this study was to determine the two-year stability of neuroticism and 
extraversion in treated and untreated persons with major depressive disorder (MDD) in 
the general population. We determined the stability of depressive symptom severity, 
neuroticism and extraversion over a period of two years in depressed patients who 
sought treatment for mental health problems during the study period and in depressed 
persons who did not. Depressive symptom severity and neuroticism scores significantly 
decreased statistically during the study period regardless of treatment status. These 
findings are in line with previous findings from the NESDA study showing that 
depressive symptoms decrease over time regardless of treatment status (Penninx et al., 
2011) and with findings from another cohort study in the Netherlands showing that 
treated depressed patients in primary care have similar outcomes than unrecognized 
depressed patients not receiving treatment (Kamphuis et al., 2011). Contrary to our 
findings an earlier cohort study found that treated depressed patients have better 
outcomes than untreated persons with depression (Angst, 1998) whereas in another 
                                                        
11 Adjusted for depressive symptom severity at all time points and for extraversion at baseline and FU2  
12 Adjusted for potential confounding variables: gender, age, level of education, recruitment setting 
13 Adjusted for depressive symptom severity at all time points and for neuroticism at baseline and FU2 
14 Adjusted for potential confounding variables: gender, age, level of education, recruitment setting 
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population based study it has been shown that treated depressed patients had worse 
outcome than untreated persons with depression (Wang, 2004). It should be noted that 
our finding that treatment status was not related to change in depression, neuroticism 
and extraversion over time does not suggest that receiving treatment does not impact 
these variables. Treated and untreated persons in this study were not randomized and 
the effect of a given treatment on change in depression severity and personality traits 
can only be determined in randomized trials because observational studies suffer from 
confounding by indication when comparing treated and non-treated patients. 
 It has been shown previously, in the context of RCTs, that depression treatment is 
related to decreases in neuroticism (Ekselius and von Knorring, 1999; Hellerstein et al., 
2000; Tang et al., 2009). However, previous studies determined the short-term stability 
of neuroticism over a course of depression treatment with SSRIs whereas the current 
study determined the long term (two-year) stability of neuroticism and extraversion in 
treated and untreated persons with depression in the general population. Another 
explanation for the discrepant findings, as suggested by one of the anonymous reviewers, 
is that the current study did not differentiate between specific types of antidepressants 
whereas previous RCTs focused specifically on SSRIs. It is possible that SSRIs have 
stronger effects on changes in neuroticism than other types of antidepressants. 
Determining the specific impact of different types of antidepressants on changes in 
neuroticism and other personality traits requires randomization to different types of 
antidepressants and is therefore an issue for future RCT based studies.  
 We also determined relations between change in depressive symptom severity and 
change in personality in treated and untreated persons with depression and found that 
change in depression was associated with change in neuroticism independently of 
treatment status. Patients experiencing strong symptom reduction reported more 
decrease in neuroticism over time compared to patients experiencing an increase in 
depressive symptoms over time (Figure 2). Moreover, changes in neuroticism and 
extraversion were not associated with changes in depressive symptoms. This finding 
suggests that changes in depressive state might drive changes in the underlying 
personality rather than the other way around, which is in line with findings showing 
that neuroticism and extraversion in depressed patients are mood-state dependent 
(Karsten et al., 2012). It should be noted, however, that the current research design and 
analytic approach does not allow drawing any causal conclusions. Identifying the causal 
directions of the relation between changes in personality and depression is thus an issue 
for future research. 
Limitations 
The findings of this study should be interpreted in the light of several limitations. First, 
patients in this study were not randomized to treatment conditions and might therefore 
not be directly comparable. Persons in the treated and in the untreated group differed 
with respect to severity of depressive symptoms and extraversion scores at baseline. 
Therefore any differences between the two groups cannot be solely attributed to 
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treatment status. Second we did not assess treatment adequacy. It should be noted 
however that a previous NESDA study found that treatment adequacy was unrelated to 
improvement in depressive symptoms (Prins et al., 2011). Third, we homogenized the 
sample by excluding patients who took medication not directly related to depression 
(including anxiolytics) during the study period. This might limit the generalizability of 
our findings to depressed patients with more diverse symptoms. Fourth, we determined 
cross-sectional relations between change in depression levels and change in personality. 
Given that in the present analysis personality was only assessed at two time points we 
could not determine any temporal relations between change in depression severity and 
change in personality. Finally, we did not determine the stability of other personality 
dimensions in treated and untreated persons. It has been shown in a previous NESDA 
study that the personality dimension of conscientiousness also changes with depressive 
state (Karsten et al., 2012). 
Implications 
Despite these limitations the results of this study have several implications for clinical 
settings and future research. We found that in a large sample of patients with MDD, 
treatment status was unrelated to change in neuroticism and extraversion. We also 
found that change in depression predicted change in neuroticism rather than the other 
way around. These findings suggest that changes in neuroticism might be driven by 
improved depressive state (the mood-state effect) rather than by receiving treatment 
for depression. From a clinical point of view this suggests that treatment for depression 
should focus on depressive symptoms rather than on the underlying personality 
structure because treating the underlying personality structure of depressed patients 
might not improve depressive symptom severity. Future research studying the stability 
of personality in the context of treatment should also take into account untreated 
persons with MDD who improve in depression severity in order to be able to distinguish 
mood-state effects from more direct effects of treatment on personality. Given that in 
our study the treated group differed from the untreated group with respect to several 
clinical and demographic variables it is not possible to draw any conclusions regarding 
the causal effect of treatment status on change in neuroticism and extraversion. Future 
research should determine characteristics of depressed persons in the general 
population who profit from seeking treatment for depression with respect to changes in 
neuroticism and extraversion. Finally, in line with what has previously been reported in 
the NESDA sample (Karsten et al., 2012) our finding that neuroticism changes with 
depressive state suggest that personality assessment is partly clouded by the current 
mood state. 
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Abstract	
Background: The degree to which interpersonal problems of depressed patients improve 
over the course of cognitive therapy (CT) and relate to the quality of the therapeutic 
alliance and to symptom improvement, remain unclear.  
 
Methods: We analyzed data of adult outpatients (N = 523) with major depressive 
disorder participating in a clinical trial to determine the factor structure of the Inventory 
of Interpersonal Problems-Circumplex (IIP-C) and to relate the observed factor scores to 
the quality of the therapeutic alliance and symptom improvement over the course of CT. 
Patients received 16-20 sessions protocol (50-60 minutes each) of individual CT 
according to the treatment manual by Beck et al. (1979).  
 
Results: We found a three-factor structure (interpersonal distress, agency, and 
communion) of interpersonal problems. Interpersonal distress decreased (d = .90), but 
interpersonal style did not change substantively during CT (communion d = .03; agency 
d = .14). High initial agency scores related negatively to the therapeutic alliance (β = -
.12), whereas high initial communion scores related positively to the therapeutic 
alliance (β = .15). Elevated pre-treatment interpersonal distress scores were related to 
both weaker therapeutic alliances (β = .13) and higher symptom levels throughout 
treatment (β = .10). Limitations: All patients in this study had recurrent MDD and it is 
therefore uncertain whether the results would generalize to patients with other 
psychiatric disorders.  
 
Conclusions: This study supports the use of the IIP-C as a comprehensive measure of 
patients' interpersonal style and interpersonal distress. The IIP-C measured before CT 
showed some predictive validity with respect to therapeutic alliance measured at the 
midpoint and therapy outcome. The clinical importance of these findings is discussed. 
 
Keywords: Recurrent Depression, Cognitive Therapy, Personality, Interpersonal Style, 
Therapeutic Alliance 
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Introduction	
Interpersonal problems refer to persistent difficulties that individuals experience in 
their social relationships (Horowitz et al., 1988; Horowitz et al., 1993). Patients seeking 
psychotherapy usually report some degree of such problems in addition to their primary 
symptoms (Horowitz et al., 1988). Moreover, patients with major depressive disorder 
(MDD) are significantly more distressed by their interpersonal problems than non-
depressed individuals (Barrett and Barber, 2007). The broad aim of the present study 
was to document further the range of interpersonal problems in depressed patients, to 
determine the extent to which these problems change over a 12-14 week protocol of 
cognitive therapy (CT; Beck et al., 1979), and to examine relations among interpersonal 
problems, the therapeutic alliance, and therapy outcome. 
 Recent efforts to conceptualize interpersonal problems in patients with various 
clinical problems have relied primarily on the interpersonal circumplex, in which stable 
interpersonal dispositions are mapped along a two-dimensional space ranging from 
agency to submission on one axis and from communion to coldness on the other 
(Horowitz et al., 2006; Wiggins, 1982)15. Agency refers to persons’ influence over others 
and includes traits such as autonomy, independence, and dominance, whereas 
communion describes involvement with others and includes traits such as cooperation 
and caring. One of the most frequently used assessment tools in this context is the 
Inventory of Interpersonal Problems-Circumplex version (IIP-C; Alden et al., 1990; 
Horowitz et al., 1988). 
 Previous research has investigated the stability of the IIP-C. Vittengl et al. (2003), 
for example, assessed interpersonal problems before and after CT in outpatients with 
recurrent MDD, and found that general distress decreased substantially following 20 
sessions of CT, whereas agency and communion scores remained unchanged. From 
these findings, the authors concluded that the agency and communion dimensions of the 
IIP-C represent stable interpersonal styles, whereas general distress represents a state-
like aspect of interpersonal functioning. In an attempt to replicate these findings, 
Holtforth et al. (2006) administered the IIP-C to a group of psychiatric outpatients with 
primarily anxiety and affective disorders, before and after an average of 29 sessions of 
eclectic psychotherapy. In contrast to the findings by Vittengl et al. (2003), Holtforth and 
colleagues found that both general distress and interpersonal style (agency and 
communion) changed during therapy, although distress changed more. Given the 
inconsistent findings, there is a need to investigate further the (in)stability of general 
distress and interpersonal style over the course of different types of psychotherapy. 
 Another relevant question is to what extent interpersonal style and distress relate 
to the therapeutic alliance and therapy outcome. Interpersonal theories of 
psychotherapy suggest that patients’ friendly-submissive behaviors are complementary 
                                                        
15 In the circumplex literature, the x-axis of the circumplex usually was referred to as love, warmth or 
nurturance and the y-axis as dominance, power, or status. More recently, however, the superordinate 
terms communion and agency have been used for the x-axis and y-axis, respectively. 
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to therapists’ friendly-dominant behaviors (Kiesler, 1983; Kiesler and Watkins, 1989; 
Tracey, 1993). Accordingly, patients' having a friendly-submissive interpersonal style 
should facilitate the therapeutic relationship and positively affect therapy outcome. In 
contrast, hostile-dominant behaviors likely would conflict with therapy goals, thus 
contributing to a poor therapeutic alliance and treatment outcome (Tracey, 1993). In 
terms of IIP-C structure, theory suggests that high communion and low agency are 
associated with better therapeutic relationships and outcomes. Consistent with this, 
most research to date indicates that in naturalistic settings, outpatients scoring high on 
the communion dimension show more symptom improvement over the course of short-
term psychodynamic psychotherapy (Filak et al., 1986; Gurtman, 1996; Schauenburg et 
al., 2000). 
 Findings regarding the role of agency in predicting therapy outcome and symptom 
reduction over time are mixed. Some (Borkovec et al., 2002; Gurtman, 1996), but not all 
(Filak et al., 1986; Schauenburg et al., 2000) studies report an association between high 
agency scores and poor treatment outcome. Moreover, Ruiz et al. (2004) found that 
neither communion nor agency was associated with treatment outcome after controlling 
for general distress. Thus, although most studies support the influence of interpersonal 
style on therapy outcome, there are also contradictory findings and indications that 
outcomes are better accounted for by general distress. 
 Studies relating interpersonal style and distress to the quality of the therapeutic 
alliance found that interpersonal problems in the hostile-dominant domain (i.e., high 
agency, low communion) prior to treatment predicted a poor working alliance (Connolly 
Gibbons et al., 2003; Muran et al., 1994; Puschner et al., 2005). Moreover, IIP-C general 
distress factor has been associated with poor working alliance (Constantino and Smith-
Hansen, 2008), whereas interpersonal problems in the friendly-submissive domain (i.e., 
low agency, high communion) have been associated with better alliance (Constantino 
and Smith-Hansen, 2008; Muran et al., 1994; Puschner et al., 2005). In contrast, Paivio & 
Bahr (1998) found that the IIP-C octant scales social avoidance and non-assertiveness, 
reflecting low agency and high communion, related negatively to working alliance. 
 Previous research relating the IIP-C to therapy outcome and the therapeutic 
alliance either categorized patients’ reports into interpersonal problem areas based on 
the predominant interpersonal problem theme, or used IIP-C parameters to predict 
outcome or therapeutic alliance. The computation of IIP-C parameters is based on octant 
scores, which all mark a general distress factor that correlates with anxiety and 
depression symptoms (Horowitz et al., 2000). Accordingly, a clear distinction between 
interpersonal style and general distress cannot be made, and some have argued that to 
identify unique effects of interpersonal style on outcome, the general distress factor 
should be controlled before examining the octant scales (Vittengl et al., 2003). 
 One possibility for controlling general distress is to obtain orthogonal factor scores 
from IIP-C scales that converge highly with the underlying IIP-C structure (Vittengl et al., 
2003). This can be done by factor analyzing the IIP-C scales, thereby creating 
independent factor scores representing both interpersonal style and general distress. 
Identification of orthogonal factor scores simplifies the interpretation of interpersonal 
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distress distinct from interpersonal style, as captured by the communion and affiliation 
factors. Vittengl et al. (2003), for example, applied principal components analysis to IIP 
octant scales and found a three-factor structure resembling the three IIP-C dimensions 
general distress, agency, and communion. Accordingly, to address the clinically 
important issues of stability and change of interpersonal style and distress, as well as 
the relations of these constructs with therapy outcome and the therapeutic alliance, 
factor scores extracted from the IIP-C scales are preferred over octant scales. Yet, to the 
best of our knowledge, no published study has addressed the relation of patient’s initial 
interpersonal style and distress with therapy outcome and the therapeutic alliance using 
orthogonal factor scores as predictors. 
 Therefore, we sought first to replicate previous findings demonstrating a stable 
IIP-C circumplex structure (Alden et al., 1990; Horowitz et al., 2000; Vittengl et al., 2003). 
Although the IIP-C circumplex structure has been demonstrated in depressed patients 
(Vittengl et al., 2003), the number of outpatients in the present study is about four times 
larger, thus providing a more reliable estimate of the underlying factor structure. We 
hypothesized that (1) the IIP-C would demonstrate a three-factor structure, consisting of 
general distress, agency, and communion factors, both pre- and post-CT. Second, we 
examined interpersonal problems in depressed patients before and after CT in terms of 
general distress and angular placement in the circumplex, and hypothesized that (2) the 
interpersonal style of depressed patients would fall between non-assertiveness and 
social-avoidance. Third, we sought to determine whether the dimensions of communion 
and agency represent trait-like interpersonal styles, and hypothesized that (3) the 
distress factor would decrease from pre- to post-CT, whereas interpersonal style would 
remain stable. 
 Following this analysis, we assessed the clinical validity of the IIP-C in predicting 
therapeutic alliance and therapy outcome and hypothesized that (4) the distress and 
agency factors would relate negatively to improvement of depressive symptoms, 
whereas the communion factor would relate positively to symptom improvement. 
Finally, with respect to therapeutic alliance, we hypothesized that (5) distress and 
agency would relate negatively, and communion positively, to the quality of the 
therapeutic alliance. 
Methods	
Sample 
The present report is based on patients participating in the acute phase of the 
‘Continuation Phase Cognitive Therapy Relapse Prevention (C-CT-RP) Trial’ 
(ClinicalTrials.gov Identifiers: NCT00118404, NCT00183664 and NCT00218764). A 
more detailed description of this multi-stage study is available elsewhere (Jarrett and 
Thase, 2010). Study protocols were approved annually by the Institutional Review 
Boards at the two treatment sites (The University of Pittsburgh Medical Center and The 
University of Texas Southwestern Medical Center) and all 523 out-patients enrolled in 
CHAPTER 6 
 110 
the study provided written informed consent. The primary inclusion criteria for 
participation in the study were: a) a principal diagnosis of recurrent MDD according to 
the Diagnostic and Statistical Manual of Mental Disorders (4th ed; DSM–IV; American 
Psychiatric Association, 1994) criteria as assessed by the Structured Clinical Interview 
for DSM-IV (SCID-I; First et al., 1996) a history of inter-episode recovery with or without 
antecedent dysthymic disorder, c) a score of at least 14 on the 17-item version of the 
Hamilton Rating Scale for Depressive Symptoms (HRSD-17; Hamilton, 1960) and d) age 
between 18 and 70 years. 
 Patients were excluded if they had a poorly controlled medical disorder that might 
be correlated with depressed mood either directly or through medication intake; had a 
DSM-IV diagnosis of any psychotic or organic mental disorder; were pregnant or planned 
to become pregnant within the next year; or had an active alcohol or drug dependence, 
bipolar disorder or predominant obsessive compulsive disorder, eating disorder or 
borderline personality disorder. Moreover, patients were excluded if they were unable 
to complete questionnaires in English, declined protocol requirements or previously had 
failed to respond to cognitive therapy or fluoxetine. 
 The average age of the sample entering the acute phase (N = 523) was 42.4 years 
(SD = 12.1); 67.5% were female; mean education level was 15.1 years (SD = 2.93); 32.5% 
were married, 30.2% single, 19.9% divorced, 5.7% separated, 2.3% widowed and 9.4% 
lived together with their partner. Patients’ mean age of MDD onset was 21.2 years (SD = 
10.8); median length of current episode was 10 months, mean 25.0 months (SD = 45.1). 
Mean pretreatment HRSD was 20.4 (range = 13–31; Two patients entered the protocol 
in error, with HRSD-17 scores of 13 at one of the two diagnostic visits; during cognitive 
therapy one responded and one dropped out.	
Procedure 
Acute-phase cognitive therapy. The acute-phase protocol consisted of 16 to 20 sessions, 
each lasting between 50 and 60 min, across 12 to 14 weeks. Therapy was conducted by 
experienced, research-certified therapists according to the methods of Beck et al. (1979). 
The first eight sessions occurred twice weekly. Thereafter, patients who experienced at 
least a 40% reduction of HRSD scores were seen weekly, whereas those with less 
improvement received four additional weeks of twice weekly sessions; 410 completed at 
least 14 of 16 protocol sessions (early responders) or 18 of 20 protocol sessions (late 
responders). 
Assessments 
To assess changes in symptom severity, therapists completed the HRSD-17 (Hamilton, 
1960) weekly during cognitive therapy, as did an independent evaluator at patient exit 
or end of treatment. Adequate internal consistency (rs = .46 – .97), interrater reliability 
(rs = .82 – .98) and retest reliability (rs = .81 – .98) have been reported for the HRSD 
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(Bagby et al., 2004). In the current study we found good interrater reliability (ICC = .91) 
for the HRSD in a multilevel analysis based on 28 patients rated by 4-14 clinicians each. 
 Inventory of Interpersonal Problems.	The Inventory of Interpersonal Problems (IIP; 
Horowitz et al., 1988) is a 127-item self-report questionnaire assessing interpersonal 
difficulties with eight subscales (overly nurturant, intrusive, domineering, vindictive, 
cold, socially avoidant, nonassertive, exploitable). Each item is phrased as a statement 
and respondents rate their agreement on a Likert scale ranging from 1 (not at all) to 5 
(extremely). In this study, responses to the IIP were scored according to the circumplex 
system, which is based on 64 items assessing interpersonal problems within two 
dimensions: agency and communion (IIP-C; Alden et al., 1990). Acceptable internal 
consistency (median α = .81, range .76–.88, N = 800) and test-retest reliability (median r 
= .73, range .56–.83, N = 60) of the IIP-C have been reported (Horowitz et al., 2000). In 
the present study internal consistency (coefficient alpha) for the overall score was .92 
pre-treatment and .95 post-treatment. The IIP-C subscales were also shown to 
demonstrate moderate relations with the Beck Depression Inventory (median r = .38, 
range = .33–.43, N = 495) and Beck Anxiety Inventory (median r = .36, range = .31–.39, N 
= 495). The IIP-C was collected at the beginning, middle and end of the acute phase. 
 Working Alliance Inventory. The Working Alliance Inventory (WAI; Horvath and 
Greenberg, 1989) is a 36-item self-report measure of the therapeutic alliance, with 
therapist and client versions. Only the client form (WAI-C) was analyzed here because it 
has been shown to predict outcome better than the therapist version (Horvath and 
Symonds, 1991). The WAI has three subscales: task agreement, goal agreement and 
bond development. Each item is rated on a 7-point Likert-type scale. High internal 
consistency has been reported for the three subscales (.89–.92) and the overall scale 
(.87–.93; Horvath and Greenberg, 1989). The WAI-C has been shown to converge 
moderately with the California Psychotherapy Alliance Scales (r = .74; Gaston, 1991) and 
the Penn Helping Alliance Scales (r = .85; Alexander et al., 1986; Hatcher and Barends, 
1996). The WAI-C was obtained at the middle and at the end of the acute phase. In the 
present study, internal consistency (coefficient alpha) was .94 for the overall WAI-C 
score at the middle of the acute phase. 
Statistical analyses 
Unless stated otherwise, SPSS version 18 for Windows was used for statistical analyses. 
To investigate hypothesis (1), a principal components analysis was conducted with 
planned rotations (Vittengl et al., 2003). Principal components analysis was used 
because the circumplex scales of the IIP were also derived using principal components 
analysis (Alden et al., 1990). Factors were extracted based on observation of the scree 
plot and rotated orthogonally using the Procrustes procedure in Stata version 10 for 
Windows. Orthogonal rotations were used in order to match the underlying circumplex 
structure closely. Hypothesis (2) was investigated by computing the IIP-C structural 
summary (Gurtman and Balakrishnan, 1998) based on national gender norms (Horowitz 
et al., 2000). Angular scores were plotted in the circular space. To investigate hypothesis 
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(3), correlations between pre- and post-treatment factor scores were evaluated. Because 
factor scores have means of zero, IIP-C parameters obtained from the structural 
summary were compared using paired-sample t-tests. Multilevel Modeling (MLM) was 
used to predict change in depressive symptom severity over the course of cognitive 
therapy as a function of pre-treatment interpersonal style and general distress 
(hypothesis 4). We applied intention-to-treat analysis, in which all available HRSD total 
scores were included (523 patients; 1–19 HRSD assessments). Time, interpersonal style, 
distress and the interactions among these factors were modeled as fixed effects and 
patients’ intercepts as a random effect. Hypothesis (5) was investigated using multiple 
regression analysis. The WAI-C total score at Session 7 was entered as the dependent 
variable and the distress, agency and communion factors, as well as interactions among 
them, were entered as predictors. Non-significant interaction terms were removed from 
the model and the model was re-run. 
Results	
Cross-sectional associations 
First we determined Pearson correlations among the study variables at the baseline 
assessment. The distress and agency factors related negatively to the WAI-C total score 
(r = -.13 and r = -.12, respectively) whereas communion related positively to this 
variable (r = .14). Moreover, Distress correlated negatively with symptom severity at 
baseline (r = .23), whereas agency and communion were unrelated to baseline symptom 
severity (r = .04 and r =-.05, respectively). 
IIP-C Circumplex Structure and Stability (Hypothesis 1)  
Separate principal components analysis of the pre- and post-treatment scales identified 
three orthogonal factors at each time point. The rotated factor loadings are summarized 
in Table 1. To visualize—and guide the interpretation of—the three factors and to 
demonstrate the circumplex structure of the IIP-C, factor loadings pre- and post-
treatment were transformed into circular degree scores and plotted against the 
hypothetical circumplex structure (see Figure 1). Although the observed values did not 
converge perfectly with the expected circumplex structure, visual inspection of Figure 1 
suggests that the circumplex space is adequately covered by the obtained factor loadings. 
To quantify the convergence between the theoretical circumplex structure and the 
obtained structure, correlations between the observed and expected angles were 
computed. The observed factor loadings both pre- and post-treatment correlated highly 
with the hypothesized circumplex structure (.99), strongly supporting our first 
hypothesis. 
 
  
STABILITY OF INTERPERSONAL PROBLEMS 
 
Table	1.	Rotated factor loadings of the Inventory of Interpersonal Problems – Circumplex Version 
 Pre-treatment Post-treatment 
 
Scale 
Factor 1 
Distress 
Factor 2 
Agency 
Factor 3 
Communion 
 Factor 1 
Distress 
Factor 2 
Agency 
Factor 3 
Communion 
Overly Nurturant 0.75 -0.20 0.63 0.64 -0.10 0.56 
Intrusive 0.71 0.57 0.47 0.76 0.52 0.59 
Domineering 0.64 0.78 -0.09 0.74 0.76 -0.07 
Vindictive 0.75 0.47 -0.48 0.68 0.44 -0.52 
Cold 0.73 0.08 -0.66 0.66 0.07 -0.65 
Socially Avoidant 0.70 -0.50 -0.44 0.74 -0.48 -0.52 
Nonassertive 0.70 -0.68 0.11 0.75 -0.70 0.14 
Exploitable 0.72 -0.52 0.46 0.69 -0.50 0.47 
N = 510 for pre-treatment factor scores and N = 356 for post-treatment factor scores. 
	
	
	
Figure	 1. Angular placement of factor loadings for the Inventory of
Interpersonal Problems – Circumplex Version pre- and post-treatment;  
Note. N = 510; Numbers on the x-axis and y-axis represent factor loadings 
for factor 1 (distress).	
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Description of Interpersonal Problems Pre- and Post-Treatment (Hypothesis 2) 
Descriptive and change statistics of the IIP-C octant scales using standardized z-scores 
are shown in Table 2. Socially avoidant, nonassertive and exploitable problems were 
somewhat more prominent both pre- and post-treatment, whereas intrusive, 
domineering and vindictive problems were less prominent both pre- and post-treatment. 
No octant scale means reached very high levels of distress (T-score > 70) pre- or post-
treatment. Patients in our sample improved statistically significantly on all octant scales, 
with medium effect sizes (Cohen, 1988), such that no octant scale means indicated 
clinically significant distress (T-score > 60) post-treatment. To describe the sample’s 
mean location in the circumplex space further, we computed the vector direction (angle) 
that reflected the most prominent form of interpersonal style. The results (see Figure 2) 
indicate that the predominant interpersonal style both pre- and post-treatment fell 
between social avoidance (225º) and non-assertiveness (270º). 
 
Table	 2.	 Descriptive and change statistics for the Inventory of Interpersonal Problems Circumplex 
Version pre- and post-treatment 
 
 
IIP-C Octant Scale 
Pre-treatment 
M (SD) 
 
 
T score 
Post- treatment
M (SD) 
 
 
T score 
 
Paired 
t-test 
 
 
DF 
 
ES (d) 
Overly Nurturant 1.20 (1.14) 64 0.42 (1.13) 56 13.2 352 0.69 
Intrusive 0.67 (1.16) 57 0.11 (1.06) 51 11.1 352 0.58 
Domineering 0.73 (1.25) 59 0.13 (1.13) 50 10.4 352 0.50 
Vindictive 0.84 (1.06) 59 0.20 (1.00) 51 12.7 352 0.62 
Cold 1.14 (1.06) 61 0.42 (1.05) 54 13.7 353 0.68 
Socially Avoidant 1.62 (1.24) 67 0.77 (1.25) 58 14.1 352 0.68 
Nonassertive 1.62 (1.20) 66 0.89 (1.17) 59 12.7 354 0.62 
Exploitable 1.33 (1.12) 62 0.59 (1.16) 55 13.4 352 0.65 
N = 353–355 (due to missing values on some subscales). All t-values are statistically significant at p < 0.01 
(corrected for multiple testing) and reflect decreased interpersonal problems post-treatment. 
Effect sizes (ds) were calculated by dividing the mean difference with the pooled standard deviation and 
may be interpreted as medium (Cohen, 1988). 
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Figure	 2. Predominant interpersonal style and mean general distress
before and after acute-phase cognitive therapy;  
Note. N = 356; Numbers on the x-axis and y-axis represent standardized
general distress scores, with scores above 1 representing clinical
significant distress. 
Stability and Change in General Distress and Interpersonal Style (Hypothesis 3) 
Table 3 shows Pearson correlations between the pre- and post-treatment factor scores. 
Correlations between the pre- and post-treatment factors were moderate (r = .54) for 
distress and somewhat stronger for agency and communion (r = .68 and r = .74, 
respectively). Moreover, both of the latter were statistically significantly stronger than 
the former, z = -2.97, p < .01; and z = 4.47, p < .01, respectively. To investigate 
interpersonal changes further, mean changes of distress, agency and communion from 
pre-treatment to post-treatment were tested using closely related IIP-C parameters 
computed earlier. The general distress factor was approximated as the mean z-score of 
the IIP-C octant scales. The agency and communion factors were approximated by the 
normative agency and communion scale scores (Horowitz et al., 2000). The general 
distress, agency and communion factors converged strongly with these approximations 
both pre-treatment (rs = 1.00, .88, .85, respectively) and post-treatment (rs = 
1.00, .82, .82, respectively). 
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Table	3.	Correlations of the IIP-C factor scores pre- and post-treatment 
 Post-treatment 
Pre-treatment Distress Agency Communion 
Distress .54** -.05 .00 
Agency .06  .68** .11* 
Communion .02 -.09 .74** 
* Correlation is significant at p < .05 (two-tailed); ** Correlations are significant at p < .01 (two-tailed); N = 
352. 
 
Table 4 summarizes the results of the paired samples t-tests between the pre- and post-
treatment IIP-C parameters. General distress decreased significantly from pre-treatment 
(M = 1.15, SD = .75) to post-treatment (M = .45, SD = .81; t(354) = 17.60, p < .01, d = .90), 
whereas the communion dimension remained stable (t(351) = -0.76 p > .05, d = .03). 
Scores on the agency dimension also increased significantly from pre-treatment (M = -
.47, SD = .79) to post-treatment (M = -.37, SD = .67; t(352) = -3.28, p < .01), but the 
magnitude of this effect was small (d = .15). 
	
Table	4.	Mean differences of IIP-C parameters distress, agency and communion as computed from the 
structural summary pre and post-treatment 
 
IIP-C Parameter 
Pre- treatment 
Mean (SD) 
Post- treatment 
Mean (SD) 
 
Paired t-test 
 
DF 
 
Cohen’s d 
Distress 1.15 (.75) 0.45 (.81) 17.60* 354 .90 
Agency -.47 (.79) -.37 (.67) -3.28* 352 .14 
Communion -.07 (.65) -.05 (.61) -.76 351 .03 
* Mean difference is significant at p < .01; N = 352–355. 
 
Relations of Interpersonal Style and General Distress with Change in Depressive Symptoms 
(Hypothesis 4) 
We used MLM to predict change in depressive symptoms over the course of cognitive 
therapy as a function of time, pre-treatment interpersonal style and general distress 
(Table 5). There were significant main effects for time, F(18, 6037.76) = 461.12, p < .01 
and distress, F(1, 521.12) = 24.82, p < .01. To determine the relative importance of the 
effect of distress on symptom levels, we calculated standardized beta weights by 
standardizing all continuous variables before entering them into the model. The relation 
between general distress and symptom levels was relatively small (β = .10). There was a 
significant interaction between distress and time, F(18, 6039.16) = 2.06, p < .01 and a 
marginally significant interaction between agency and time, F(18, 6038.06) = 1.56, p 
= .06. To interpret these interaction terms, we plotted HRSD total scores over the course 
of cognitive therapy separately for the low- and high-distress groups and for the low- 
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and high-agency groups (Figure 3), defined as one SD below and above the respective 
IIP-C factor-score mean. Patients with higher baseline distress scores had significantly 
higher mean symptom scores over the course of treatment. Patients with high baseline 
agency had lower symptom scores in the middle of cognitive therapy and slightly lower 
symptom scores at the end of cognitive therapy. 
 
Table	5.	General distress, agency and communion as predictors of change in depressive symptom severity 
(HRSD) over the course of cognitive therapy 
 
Parameter 
Numerator 
DF 
Denominator  
DF 
 
F 
p-value (F) 
Intercept 1 518.03 4003.54 <.01 
Time 18 6037.76 461.12 <.01 
Distress 1 521.12 24.82 <.01 
Agency 1 519.23 2.19 >.05 
Communion 1 513.81 0.30 >.05 
Distress*Time 18 6039.16 2.06 <.01 
Agency*Time 18 6038.06 1.56 >.05 
Communion*Time 18 6036.08 0.58 >.05 
 
Relations of Interpersonal Style and General Distress with Therapeutic Alliance 
(Hypothesis 5) 
The results of the multiple regression analysis are summarized in Table 6. High general 
distress and high agency were negatively related to WAI-C total scores (β = -0.13, t(380) 
= -2.64, p < 0.01 and β = -0.12, t(380) = -2.46, p < 0.05, respectively), whereas high 
communion was positively related to WAI-C total scores (β = .15, t(380) = 2.91, p < 0.01). 
This pattern of effects was found for all WAI-C subscales except between the general 
distress factor and task subscale. Whereas all variables in the model predicted 
therapeutic alliance in the expected direction, the total variance in WAI-C scores 
explained by these three factors was small (R² = .053). To determine whether the 
relations between interpersonal styles and distress with the therapeutic alliance remain 
once depressive symptom severity is controlled for, we added the HRSD total score at 
baseline to the regression model. All predictors remained significant and adding the 
HRSD baseline score did not improve the overall model (Δ R² = 0.0). Moreover, HRSD at 
baseline was unrelated to the WAI-C total score (β = -0.03, t(380) = -0.54, p = .59). 
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Figure	3. Change in depressive symptom severity over the course of CT
predicted by IIP general distress and IIP agency. Note. Upper graph shows 
significant interaction between time moment and distress for the low and 
high distress group. Lower graph shows marginally significant interaction
between time and agency for the low and high agency groups. 
 
 
Table	6.	General distress, agency, and communion as predictors of mid-treatment therapeutic alliance 
 
Factor 
Total WAI-C 
β (SE) 
Task 
β (SE) 
Bond 
β (SE) 
Goal 
β (SE) 
General Distress -0.13** (0.03) -0.09 (0.04) -0.14** (0.04) -0.13* (0.04) 
Agency -0.12* (0.03) -0.12* (0.04) -0.12* (0.04) -0.10* (0.04) 
Communion  0.15** (0.03)  0.14** (0.04)  0.14** (0.04)  0.12* (0.04) 
*p < 0.05; **p < 0.01; N = 384.	
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Discussion	
We investigated the structure and stability of the IIP-C (Alden et al., 1990) over the 
course of a 16-to-20 session protocol of cognitive therapy in a large group of adult 
outpatients with recurrent MDD. Consistent with earlier studies, applying principal 
components analysis to IIP-C subscales (Holtforth et al., 2006; Horowitz et al., 1988; 
Vittengl et al., 2003), we found the hypothesized factor structure, consisting of general 
distress, agency and communion factors both before and after cognitive therapy. 
Moreover, when the agency and communion factor loadings were arranged in a circular 
space, they closely matched the corresponding circumplex octant scales’ theoretical 
angular placements. This finding further supports the robustness of the IIP-C as a 
measure of interpersonal functioning. 
 In terms of angular placement in the circumplex, we found that the sample’s 
predominant interpersonal style fell between social avoidance and non-assertiveness 
both before and after cognitive therapy. This is consistent with previous research 
investigating interpersonal profiles in patients with depression (Barrett and Barber, 
2007). Moreover, although patients experienced significant distress in most areas of 
interpersonal functioning, on average, none of the eight interpersonal areas reached 
very high levels of interpersonal distress (i.e., means > 2 SD above the normative sample) 
either before or after cognitive therapy. However, 73% of individual patients reported 
very high levels of distress in at least one octant scale. Thus, patients with depression in 
this sample presented with a wide range of interpersonal problems with high levels of 
distress.  
 Following the description of interpersonal profiles, we investigated which aspects 
of interpersonal problems changed over the course of cognitive therapy. Consistent with 
previous research reporting improvement on most (Crits-Christoph et al., 2005) or all 
(Holtforth et al., 2006; Huber et al., 2007; Vittengl et al., 2003) IIP-C subscales, mean 
scores on all IIP-C subscales were reduced to non-clinical levels following therapy. 
Moreover, cross-correlations between pre- and post-treatment factor scores and mean-
score comparisons of the corresponding IIP-C parameters revealed that this 
improvement was due largely to reduced distress, whereas interpersonal style remained 
largely stable, as hypothesized. Contrary to our expectations, agency also decreased at 
post-treatment, although the effect size was small and not likely to be clinically 
meaningful. As such, our findings are largely consistent with previous findings (Crits-
Christoph et al., 2005; Vittengl et al., 2003), suggesting that the IIP-C captures both state-
like (general distress) and trait-like (interpersonal style) constructs. 
 Our findings differ from those of Holtforth et al. (2006) who reported change on all 
IIP-C dimensions after psychosocial treatment for depression. There are at least two 
possible explanations for the divergent findings in our study. First, patients in the 
Holtforth et al. (2006) study received a eclectic psychotherapy, with therapists free to 
draw upon process-experiential and interpersonal interventions in addition to 
cognitive-behavioral strategies. One prior study of 66 patients with MDD found that 
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process-experiential therapy may be more effective in reducing interpersonal problems 
than cognitive therapy (Watson et al., 2003), but this hypothesis requires further testing. 
 Perhaps more importantly, patients in the Holtforth et al. study received an 
average of 29 sessions (range = 5–127) of eclectic psychotherapy, whereas out-patients 
in this study received a maximum of 20 cognitive therapy sessions. It has been shown 
previously that the number of therapy sessions is related, in a dose-response fashion, to 
improvement in interpersonal problems in patients with depression (Barkham et al., 
2002). 
 The present study also addressed the predictive validity of the IIP-C for the 
therapeutic process and outcome. We tested interpersonal style and distress factor 
scores as predictors of change in depressive symptom severity over the course of 
cognitive therapy and hypothesized that the distress and agency factors would be 
related negatively to improvement of depressive symptoms, whereas the communion 
factor would be related positively to symptom improvement. In general, our findings 
that high levels of distress related negatively to symptom improvement whereas high 
agency levels related positively to symptom improvement are contrary to what we 
hypothesized based on theoretical grounds (Tracey, 1993) and prior research (Alden 
and Capreol, 1993; Gurtman, 1996; Muran et al., 1994). One reason for these divergent 
findings may be that previous studies categorized patients into quadrants of 
interpersonal problems based on their angular displacement score (Gurtman, 1996). 
Classification of patients into quadrants may oversimplify the diversity of the 
interpersonal problems experienced by patients with recurrent depression. Moreover, 
such a classification does not control for the general distress factor that should be 
detached from interpersonal style before investigating effects of interpersonal style on 
outcome. More valid results may be obtained by using dimensional scores, such as factor 
scores, that differentiate between interpersonal style and general distress. 
 Finally, we found support for our hypothesis that high scores on the communion 
factor at baseline would predict high alliance, whereas high scores on the agency and 
general distress factors would predict poor alliance. This finding is consistent with the 
idea that a friendly-submissive interpersonal style is complementary to the more active 
and directive style of cognitive therapists (Kiesler, 1983; Tracey, 1993). Although 
interpersonal style and distress at baseline consistently predicted therapeutic alliance in 
the expected direction, these effects were very small. In this context, it should be noted 
that the mean patients’ alliance rating was very high, with very little variability (M = 6.1, 
SD = 0.67), probably reflecting a ceiling effect. Accordingly, interpersonal style and 
distress may explain a greater amount of total variance if there were more variation in 
the therapist-patient alliance. 
Limitations 
The study results should be interpreted in light of several limitations. First, given the 
study’s inclusion/exclusion criteria, all patients had recurrent MDD. It is therefore 
uncertain whether or not these findings would generalize to the broader population of 
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patients with other psychiatric disorders. Second, therapists' interpersonal style was not 
assessed. Because patients with an interpersonal style that is complementary to their 
therapists’ may develop the best alliance, therapists’ interpersonal style also should be 
accounted for rather than assuming that all therapists are friendly-dominant. Finally, the 
results of all analyses were based on a self-report measure of interpersonal problems. It 
has been shown that self-reported interpersonal problems on the IIP-C do not 
necessarily converge with observer-rated interpersonal problems (Leising et al., 2007). 
Implications 
Despite these limitations, the present study has important implications for clinical care 
and future research. First, the finding that the IIP-C showed a stable circumplex 
structure before and after cognitive therapy provides further evidence that the IIP-C can 
be used as a comprehensive measure of interpersonal constructs before and after 
treatment. Second, future research that uses the IIP-C should differentiate between 
interpersonal style and general distress, rather than treat interpersonal problems as a 
unidimensional construct. In the present study, interpersonal distress, but not 
interpersonal style, decreased during cognitive therapy. According to the cognitive 
theory of depression, dysfunctional thoughts are at the core of depression. Dysfunctional 
thoughts often contain interpersonal themes, such as the belief that one is inferior or 
will be rejected in interpersonal situations. Cognitive theory assumes that broad 
behavioral change across domains is possible, including reduction in interpersonal 
problem levels during cognitive therapy, as shown in the current analyses. At the same 
time, cognitive theory does not assume that the person's basic personality will change 
during short-term therapy. Therefore, our finding that interpersonal style remained 
stable during cognitive therapy for depression (i.e., although patients became less 
distressed about their interpersonal relations, their basic level of agency and 
communion did not change) is largely in line with what might be expected based on the 
cognitive theory of depression. Future research should investigate the stability of 
interpersonal distress and interpersonal style in other forms of psychotherapy that 
explicitly target personality or interpersonal functioning. Third, in the present study we 
determined the predominant interpersonal style of patients with MDD and related 
interpersonal style and distress to therapy outcome and the quality of the therapeutic 
alliance. Recent research in patients with anxiety disorders suggests that interpersonal 
subtypes exist within diagnostic homogeneous groups, and that these subtypes relate 
differently to treatment outcome (Cain et al., 2010; Salzer et al., 2011). Based on these 
studies, a next step might be to attempt to identify interpersonal subtypes in MDD. 
However, recent data in the personality trait domain indicates that subtyping is strongly 
sample-based and therefore should only be attempted on population representative 
samples (Eaton et al., 2010). Thus, identifying possible subtypes is an issue for future 
research. Whereas the present study further supported the use of the IIP-C as a 
comprehensive circumplex measure of interpersonal functioning, more research is 
needed investigating the predictive validity of the interpersonal style and distress 
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components of the IIP-C in patients with different types of psychopathology and in 
different treatment settings. 
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Abstract	
Background: Patients with depression often report impairments in social functioning. 
From a patient perspective, improvements in social functioning might be an important 
outcome in psychotherapy for depression. Therefore, it is important to examine the 
effects of psychotherapy on social functioning in patients with depression.  
 
Method: We conducted a meta-analysis on studies of psychotherapy for depression that 
reported results for social functioning at post-treatment. Only studies that compared 
psychotherapy to a control condition were included (Thirty-one studies with 2956 
patients).  
 
Results: The effect size of psychotherapy on social functioning was small to moderate, 
before (g = 0.46; 95% CI:0.32;0.60) and after adjusting for publication bias (g = 0.40; 95% 
CI:0.25;0.55). Univariate moderator analyses revealed that studies using care-as-usual 
as a control group versus other control groups, studies conducted in the United States 
versus other countries and studies that used clinician-rated instruments versus self-
report yielded higher effect sizes. Higher quality studies yielded lower effect sizes 
whereas the number of treatment sessions and the effect size on depressive symptoms 
were positively related to the effect size of social functioning. When controlling for these 
and additional characteristics simultaneously in multivariate metaregression, the effect 
size of depressive symptoms, treatment format and number of sessions were significant 
predictors. The effect size of social functioning remained marginally significant, 
indicating that improvements in social functioning are not fully explained by 
improvements in depressive symptoms.  
 
Conclusions: Psychotherapy for depression results in small to moderate improvements 
in social functioning. These improvements are strongly associated with but not fully 
explained by improvements in depressive symptoms. 
 
Keywords: Depression, Social functioning, Psychotherapy, Meta-analysis 
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Introduction	
Social functioning can be defined as the degree to which a person is able to fulfil various 
roles in different social environments such as at work, at home, in relationships or 
during leisure activities (Bosc, 2000). Patients with depression usually report deficits in 
social functioning in addition to depressive symptoms (Hirschfeld et al., 2000). These 
impairments are often long-lasting and are equal to or exceed those of chronic medical 
illnesses such as myocardial infarction and diabetes (Hays et al., 1995). Impairments in 
social functioning in depression strongly contribute to the increased burden of 
depression (Eaton et al., 2008, Greenberg et al., 2003) and predict depressive relapse 
and recurrences (e.g. Judd et al., 2000, Leon et al., 1999, Solomon et al., 2004, Vittengl et 
al., 2009). Impairments in social functioning in depression are also related to high 
economic costs. The impact of depression on work functioning, which is one important 
aspect of the broader concept of social functioning, often exceeds those of other chronic 
illnesses. In 2011 about 13.3 million work days were lost due to depression and anxiety 
disorders in the UK (Office of National Statistics, 2012). Findings like this stress the 
importance of including social functioning as an outcome measure in treatment studies 
of depression. 
 Treatment outcome studies in depression usually focus on the effects of treatment 
in improving depressive symptom severity rather than social functioning. For example, 
several meta-analyses have shown that different types of psychotherapy for depression 
are moderately effective in reducing depressive symptoms (e.g., Barth et al., 2013, 
Cuijpers et al., 2008a) but no meta-analysis to date has quantified the effects of 
psychotherapy on social functioning in depression. Definitions of response and 
remission in depression outcome studies are exclusively based on relative and absolute 
improvements in symptom severity. Although measures of symptom severity usually 
also include, to some extent, aspects of social functioning, improvements in social 
functioning are usually not explicitly included in the definition of response, remission or 
recovery from depression. The World Health Organization conceptualizes health as “…a 
state of complete physical, mental and social well-being and not merely the absence of 
disease or infirmity” (World Health Organization, 1948, p. 2). Moreover, from a patient 
perspective improvements in social functioning might be a preferred treatment outcome. 
For example, Zimmerman et al. (2006) found that among 535 outpatients with MDD a 
return to a normal level of functioning at work, home or school was rated among the 
three most important factors in determining whether a depression was in remission. 
Similarly, in a qualitative study on treatment goals of depressed outpatients it was found 
that patients with MDD commonly articulate improving one’s social and family 
relationships as desired treatment goals (Battle et al., 2010). Mintz and colleagues (1992) 
compiled data from 10 published treatment studies (psychotherapy and antidepressants) 
and found that one aspect of social functioning, work impairment, improved with 
symptom remission, although improvements in work functioning were slower than 
symptomatic improvements. 
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Given that no meta-analysis to date has estimated the effects of psychotherapy for 
depression on social functioning, it is not clear how large the effects of psychotherapy 
for depression on social functioning are, whether these effects are smaller, equal or 
exceed the effects of psychotherapy on symptom severity and whether these effects 
differ between different types of psychotherapy. The aim of this meta-analysis was to 
summarize the effects of psychotherapy for depression on improvements in social 
functioning. We hypothesized that psychotherapy for depression has positive effects on 
social functioning; that there are no differences between different types of 
psychotherapy for depression on improvements in social functioning; and that the 
effects of psychotherapy for depression on social functioning are positively correlated 
with the effects of psychotherapy for depression on depressive symptom severity. 
Methods	
Study selection 
For study selection we used a database of 1476 papers on the psychological treatment 
for depression. A more detailed description of the methods that were used to build the 
database is available elsewhere (Cuijpers et al., 2008c). This database is continuously 
updated, available to other researchers (www.evidencebasedpsychotherapies.com) and 
has been used in a series of meta-analyses previously. 
 For the current meta-analyses we included studies comparing the effects of 
psychological interventions for depression with a control condition (waiting-list, care-
as-usual, or placebo). We further included only studies that classified depression 
according to a diagnostic interview or elevated depression levels on validated self-
report questionnaires. Studies in children and adolescents (age below 18) were 
excluded, as were studies that did not provide post-treatment means and standard 
deviations (or other statistics from which these could be computed) of depression 
severity or social functioning. Studies on continuation or maintenance treatments were 
also excluded as were studies on unguided self-help treatments. We defined instruments 
that assess social functioning as any instruments that have the goal to assess functioning 
in any of the following social domains: interpersonal contacts, partner relation, work or 
study, leisure or recreation activities. Studies specifically assessing marital or dyadic 
adjustment or studies assessing global functioning were not included. We included 
studies that assessed social functioning based on self-report, observer or clinician 
ratings. 
Quality assessment 
We used four criteria from the Cochrane risk of bias assessment tool (Higgins et al., 2011) 
to assess the quality of the included studies: random sequence generation (rated 
positive if the randomization scheme was generated correctly); allocation concealment 
(rated positive if allocation to conditions was conducted by an independent party); 
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blinding of outcome assessment (rated positive if assessors were blind to treatment 
condition); handling of incomplete outcome data (rated positive if intention-to-treat 
analyses were conducted).  
Statistical analyses 
For the univariate analyses we used the program Comprehensive Meta-Analysis. We 
calculated the effect size (Hedges g) for each comparison between psychotherapy and a 
control group as an indicator of the difference between the two groups at post-test. To 
calculate the effect sizes the average score of the experimental group at post-test was 
subtracted from the average score of the control group at post-test and the result was 
divided by the pooled standard deviation. To correct for small sample bias we followed 
the procedures suggested by Hedges and Olkin (1985). We calculated separate effect 
sizes for social functioning and depression. Mean effect sizes were calculated using a 
random effects model in order to account for the heterogeneity among studies. The 
random effects model assumes that all included studies are estimating different 
(underlying) effect sizes. To test the homogeneity of effect sizes we calculated the I² and 
the Q-statistic (Higgins et al., 2003). Publication bias was assessed by visual inspection 
of the funnel plot and by the trim and fill procedure which provides an adjusted estimate 
of the overall effect size, after adjusting for publication bias (Duval and Tweedie, 2000). 
A random effects model was used to look for missing studies.  
 We used meta-regression analyses to test whether there was a relationship 
between the effect sizes of social functioning and the effect sizes of depression severity. 
For categorical study characteristics a series of subgroup or moderator analyses was 
conducted using a mixed effect model. Tests for significance between the different 
subgroups were conducted using a fixed effects model. For continuous variables, meta-
regression analyses were used. Multivariate analyses were conducted using Stata/SE 
12.0 for Windows. In these analyses the weighted effect size in social functioning at 
post-treatment was the dependent variable and the effect size of depressive symptom 
severity at post-treatment along with potential confounding variables were entered as 
predictors. 
Results	
Selection and inclusion of studies 
Three hundred fifty two Randomized Clinical Trials (RCTs) were included in the 
database. Of these studies 204 included a control group. Of these studies, and the 
corresponding duplicate studies, the methods section and results sections were checked 
to determine whether a measure of social functioning was included. Thirty-one studies 
met our inclusion criteria, reported social functioning at post-test and were included in 
the meta-analyses comparing the effects of psychotherapy (versus control group) on 
social functioning. 
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Description of included studies 
Characteristics of the included studies are provided in Table 1. The total number of 
participants in the 31 included studies was 2,956 (1,655 in the treatment condition and 
1,301 in the control conditions). In 11 of the 31 studies participants were recruited 
through the community, 13 used clinical referral and seven relied on other recruitment 
strategies. Seventeen studies focused on adults in general, eight studies only included 
women (two only women with postpartum depression, one only infertile women, one 
only women seeking care following miscarriage, one only women with a history of 
childhood trauma), five studies specifically focused on older adults, and one study 
included adults with a general medical condition. Some studies compared more than one 
type of psychotherapy to a control group resulting in a total number of 39 comparisons 
between psychotherapy and a control group. In 18 of the 39 comparisons CBT (including 
three studies on coping with depression course) was compared to a control group; six 
comparisons were between IPT and a control group; four comparisons were between 
problem solving and a control group and the remaining 11 comparisons were between a 
control group and acceptance and commitment therapy, behavioural activation, dialectic 
behavioural therapy, guided self-help, integrative and instrumental reminiscence 
therapies, interpersonal counselling, psychodynamic therapy or supportive therapy. The 
control group consisted of care-as-usual (19 studies), wait-list-control (eight studies) or 
other control conditions (four studies; active socialization, meditation, pill placebo). 
Various instruments were used to assess social functioning: the social adjustment scale 
(self-report or clinician rated or modified version; Weissman et al., 1978) was used by 
14 studies; the social functioning subscale of the Medical Outcomes Study Short-Form 
Health Survey (Ware and Sherbourne, 1992) was used by five studies; the inventory of 
interpersonal problems (Horowitz et al., 2000) was used by two studies; two studies 
used the Sheehan disability scales (Sheehan, 1983) to assess social functioning; the 
remaining studies used other instruments to assess social functioning. 
Quality of included studies 
Sixteen studies reported to have used an adequate sequence generation (method to 
generate the random allocation sequence); in 18 studies random allocation to conditions 
was conducted by an independent researcher; in 24 studies assessors were blind to 
treatment condition; intention-to-treat analyses was conducted in 23 of the included 
studies. Eight studies met all four quality criteria. 
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Meta-Analyses 
Effects of psychotherapy on social functioning 
Between study heterogeneity was large (Q = 129.22; p < .001; I² = 70.59) and therefore 
random effect models were used in subsequent analyses. Figure 1 provides an overview 
of the effect sizes of social functioning per study. The mean effect of psychotherapy on 
social functioning was small to moderate (Hedges’ g = 0.46; 95% CI:0.32;0.60) and 
significantly different from zero (z = 6.42, p < .001).  
 
Figure	 1. Standardized effect sizes (Hedges’ g) of the effects of 
psychotherapy for depression on social functioning compared to 
control conditions. ACT-E, Acceptance and commitment therapy 
with extensive email support; ACT-M, acceptance and commitment 
therapy with minimal email support; CBT, cognitive behavioural 
therapy; CI, confidence interval; CWD, Coping With Depression 
course; Inst, instrumental reminiscence; Integ, integrative 
reminiscence therapy; IPT, interpersonal psychotherapy; NDC, non-
directive counselling; NRCTNRT, non-religious CBT, non-religious 
therapist; NRCTRT, non-religious CBT, religious therapist; PST, 
problem solving therapy; RCTNT, religious CBT, non-religious 
therapist; RCTRT, religious CBT, religious therapist 
 
The funnel plot and Duvall and Tweedie’s Trim and Fill procedure suggested the 
presence of possible publication bias (Figure 2). After adjusting for publication bias 
using the Trim and Fill procedure, the overall effect size for the random effects model 
was g = 0.40 (95% CI:0.25;0.55). 
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Figure	2. Funnel plot of standard error by Hedges's g. 
 
We also computed the effect size of psychotherapy on depressive symptom severity in 
the included studies. The effect size of psychotherapy on depressive symptom severity 
was moderate (Hedges’ g = 0.58; 95% CI:0.44;0.72) and significantly different from zero 
(z = 8.06, p < .001). After adjusting for publication bias using the Trim and Fill procedure, 
the overall effect size for the random effects model dropped to g = 0.43; 95% 
CI:0.28;0.58). 
Sensitivity analyses 
In six studies more than one type of psychotherapy was compared with the same control 
group and therefore the effect sizes from these comparisons were not independent. We 
conducted two sensitivity meta-analyses by first including only the largest effect size per 
study and then only including the smallest effect size per study. When only including the 
largest effect sizes, the overall effect size was (Hedges’ g = 0.43; 95% CI: 0.27; 0.58) and 
significantly different from zero (z = 5.43, p < .001). These estimates did not change after 
adjusting for publication bias. When only including the smallest effect sizes, the overall 
effect size was (Hedges’ g = 0.38; 95% CI:0.24; 0.53) and significantly different from zero 
(z = 5.16, p < .001). These estimates did not change after adjusting for publication bias. 
 One study was based on data of patients with residual depressive symptoms (Scott 
et al., 2000). In a sensitivity analysis, excluding this study, the effect size remained the 
same (g = 0.46; 95% CI:0.31;0.60). To test if one single individual study had a strong 
impact on the overall effect size, we conducted a number of additional sensitivity 
analyses in which the effect size was computed after excluding one study. In these 
analyses the effect size estimates ranged from 0.43 to 0.48, indicating that no individual 
study had a strong impact on the overall effect size. 
Subgroup analyses 
The results of the univariate subgroup analyses for studies comparing psychotherapies 
to a control group are shown in Table 2. Studies comparing psychotherapy to care-as-
usual resulted in smaller effect sizes (g = 0.33, 95% CI:0.16; 0.50), compared to studies 
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comparing psychotherapy to other control groups (g = 0.63, 95% CI:0.42; 0.84, p < .001). 
Studies that used an individual treatment format resulted in larger effect sizes (g = 0.50, 
95% CI:0.33; 0.67) compared to studies that used a group format (g = 0.28, 95% CI:-0.05; 
0.60, p < .01). Moreover, studies that were conducted in the US resulted in larger effect 
sizes (g = 0.55, 95% CI:0.34; 0.75), compared to studies that were conducted outside the 
US (g = 0.38, 95% CI:0.19; 0.56, p < .01). Finally, studies that used clinical rating scales to 
assess social functioning reported larger effect sizes (g = 0.91, 95% CI:0.54; 1.28) 
compared to studies that relied on self-reported social functioning (g = 0.39, 95% 
CI:0.24; 0.55, p < .01).  
 We also tested whether studies that compared IPT or CBT respectively, to a control 
group resulted in differential effect sizes compared to studies comparing other types of 
treatment to a control group. No differences in effect size estimates emerged for studies 
comparing IPT to a control group versus studies comparing other types of treatment to a 
control group (p = .42) or studies comparing CBT to a control group versus studies 
comparing other types of treatment to a control group (p = .57). To further investigate 
whether one broader cluster of psychotherapies resulted in differential effect sizes, we 
pooled the different types of psychotherapies into 2 broad clusters: The cognitive-
behavioural cluster (acceptance and commitment therapy, behavioural activation, 
cognitive behavioural therapy, coping with depression course, dialect behavioural 
therapy, problem solving therapy) and a psychodynamic-interpersonal cluster 
(interpersonal psychotherapy, interpersonal counselling, psychodynamic counselling). 
Studies comparing treatments from the cognitive-behavioural cluster to control groups 
resulted in effect sizes (g = 0.50, 95% CI:0.32; 0.68) comparable to those in studies 
comparing treatments from the psychodynamic-interpersonal cluster to a control group 
(g = 0.32, 95% CI:0.31; 0.60, p = .14). The other study characteristics were unrelated to 
the effect size of social functioning. 
Meta-Regression-Analysis 
We conducted a series of meta-regression analyses to test whether selected study 
characteristic were related to the effectsize of psychotherapy at post-treatment. There 
was a significant association between the effect size of social functioning and the effect 
size of depression (slope: 0.71; 95% CI:0.55;0.88; p < .001) suggesting that with each 
increase in the effect size of depressive symptom severity by one, the effect size of social 
functioning increased by 0.71 (see Figure 3). The number of treatment sessions was also 
statistically significantly related to the effect size (slope: 0.03; 95% CI:0.01;0.05; p < .01), 
indicating that studies with more treatment sessions resulted in higher effect sizes. The 
slope of 0.03 indicates that for each increase in 5 sessions, an increase in the effect size 
for social functioning of 0.15 was observed. 
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Table	2. Meta-analyses of studies comparing psychotherapy vs. control groups: Subgroup analyses testing 
associations between effect sizes and study characteristics. 
Subgroup Analysis Ncomp ES (g) 95% CI Z Q I² p 
Control Group 
 Care as Usual  
 Other 
 
21 
18 
 
0.33 
0.63 
 
0.16; 0.50 
0.42; 0.84 
 
3.71 
5.90 
 
55.55 
58.07 
 
64.00 
70.73 
 
<.001 
Format 
 Individual 
 Group 
 
26 
8 
 
0.50 
0.28 
 
0.33; 0.67 
-0.05; 0.60 
 
5.65 
1.69 
 
95.17 
23.00 
 
73.73 
69.57 
 
<.01 
Target Group 
 Adults 
 Older Adults 
 
33 
6 
 
0.48 
0.32 
 
0.33; 0.63 
-0.05; 0.68 
 
6.22 
1.71 
 
119.96 
6.56 
 
73.32 
23.75 
 
.10 
Definition Depression 
 MDD 
 Other 
 
19 
20 
 
0.39 
0.53 
 
0.20; 0.59 
0.32; 0.74 
 
3.96 
5.04 
 
46.61 
82.10 
 
61.38 
76.86 
 
.51 
Country 
 US 
 Other 
 
20 
19 
 
0.55 
0.38 
 
0.34; 0.75 
0.19; 0.56 
 
5.27 
4.00 
 
73.87 
45.95 
 
74.28 
60.83 
 
<.01 
Instrument used 
 Self-Report 
 Clinician Rated 
 
31 
7 
 
0.39 
0.91 
 
0.24; 0.55 
0.54; 1.28 
 
4.97 
4.83 
 
88.14 
31.73 
 
65.97 
81.09 
 
<.01 
Gender 
 Females only 
 Mixed group 
 
8 
31 
 
0.48 
0.45 
 
0.17; 0.79 
0.29; 0.61 
 
3.05 
5.59 
 
27.63 
100.59 
 
74.66 
70.18 
 
.32 
IPT vs. other 
 IPT 
 Other 
 
6 
33 
 
0.47 
0.46 
 
0.12; 0.81 
0.30; 0.61 
 
2.65 
5.78 
 
16.78 
111.79 
 
70.20 
71.37 
 
.42 
CBT vs. other 
 CBT 
 Other 
 
18 
21 
 
0.51 
0.41 
 
0.30; 0.72 
0.22; 0.61 
 
4.83 
4.16 
 
70.58 
58.31 
 
75.91 
65.70 
 
.57 
Note. CAU, Care as usual; CBT, cognitive behavioural therapy; CI, confidence interval; ES, effect size 
(Hedges’ g); IPT, interpersonal psychotherapy; MDD, major depressive disorder. Analyses were conducted 
according to the random effects model; p values of the differences between subgroups are based on fixed 
effects 
  
EFFECTS OF PSYCHOTHERAPY ON SOCIAL FUNCTIONING 
 
 
Figure	3. Relation between effect size for depressive symptom severity and effect size 
for social functioning. Meta-regression analysis. 
Multivariate Analyses 
We conducted a series of multivariate meta-analyses with the effect size of social 
functioning as dependent variable and the effect size of depression severity as predictor. 
Additionally, we entered the same variables that were used in the univariate subgroup 
analyses as predictors. First a full model, including all potential predictors was 
computed. We then removed the least significant predictor from the model until a model 
with only significant predictors remained (backward deletion). The results of these 
analyses are reported in Table 3.  
 In the full model, including all predictors, the effect size of depression severity was 
a significant predictor of the effect of psychotherapy on social functioning, b = 0.93; 95% 
CI:0.61; 1.25, p < .001. The other predictors were not statistically significantly related to 
the effect size of psychotherapy for social functioning. In the model including all 
predictors, the effect of psychotherapy on social functioning (constant) was not 
significant (p = .49). 
 Next, non-significant predictors were removed step-for-step, until only significant 
predictors remained. After removing non-significant predictors step-for-step, the effect 
size of depressive symptom severity remained as a significant predictor of the effect size 
of social functioning (b = 0.81; 95% CI:0.59; 1.03, p < .001), indicating that stronger 
effects of psychotherapy on depressive symptom severity were positively associated 
with stronger effects of psychotherapy on social functioning. Moreover, the treatment 
delivery format significantly predicted the effect size on social functioning (b = -0.32; 95% 
CI:-0.56; -0.09, p < .01), indicating that studies that used individual treatment settings 
reported stronger effects than studies that used a group psychotherapy format. The 
number of treatment sessions was also statistically significantly associated with the 
effect size of social functioning (b = 0.03; 95% CI:0.01; 0.06, p = .01), indicating that the 
effect size increased by 0.03 with each additional treatment session. In the final model, 
the effect of psychotherapy on social functioning (constant) remained marginally 
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significant (b = -0.27; 95% CI:-0.55; 0.01, p = .055), indicating that on the one hand 
improvements in social functioning in psychotherapy for depression are strongly related 
to improvements in depressive symptom severity while on the other hand social 
functioning improves at least in part independent from depressive symptoms. 
 
Table	 3. Regression coefficients of selected study characteristics predicting the effect size of social 
functioning: Multivariate meta-regression analyses. 
 Full Model Final Model 
 B 95% CI SE p  B 95% CI SE p 
ES depression 0.93 0.61; 1.25 0.15 <.001 0.81 0.59; 1.03 0.11 <.001 
Format -0.32 -0.77; 0.13 0.22 0.15 -0.32 -0.56; 0.09 0.12 <.01 
#Sessions 0.04 -0.04; 0.11 0.04 0.32 0.03 0.01; 0.06 0.01 0.01 
IPT vs. other -0.19 -0.63; 0.25 0.21 0.37 - - - - 
CBT vs. other -0.17 -0.58; 0.24 0.20 0.40 - - - - 
Type Instrument 0.20 -0.58; 0.98 0.37 0.60 - - - - 
Gender -0.10 -0.55; 0.34 0.21 0.64 - - - - 
Quality 0.04 -0.16; 0.23 0.09 0.70 - - - - 
Def. Depression -0.06 -0.49; 0.38 0.21 0.79 - - - - 
Target Group -0.05 -0.49; 0.38 0.21 0.80 - - - - 
Type Control -0.01 -0.45; 0.43 0.21 0.96 - - - - 
Country -0.00 -0.48; 0.47 0.23 0.99 - - - - 
Constant -0.31 -1.24; 0.61 0.44 0.49 -0.27 -0.55; 0.01 0.14 .055 
Note. CBT, Cognitive behavioural therapy; CI, confidence interval; ES, effect size; IPT, interpersonal 
psychotherapy; S.E., standard error. To build the final model the least significant variable was dropped in 
a backwards regression analyses until only significant predictors remained. Additional analyses that were 
entered in the full model were: type of control group, format (group v. individual), country where the trial 
was conducted, type of instrument used (self-report v. clinician rated), number of treatment sessions, type 
of diagnosis [DSM-IV-based major depressive disorder (MDD)v. cut-off on depression questionnaire], 
target group (older adults v. adults), gender (females only v. mixed groups), type of treatment (CBT v. 
other and IPT v. other), quality of the trial. None of these characteristics were significantly related to the 
effect size of change in social–interpersonal functioning in the multivariate analyses (all p values > 0.05). 
 
Discussion	
The aim of this meta-analysis was to summarize the effect of psychotherapy for 
depression on improvements in social functioning. We found 31 studies with a total of 
2,956 participants that compared psychotherapy for depression with a control group 
and assessed social functioning at post-treatment. Before and after adjusting for 
publication bias, the overall effect size was small to moderate. These findings suggest 
that depressed patients receiving psychotherapy for depression can benefit not only in 
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terms of amelioration of depressive symptoms but also in terms of improved functioning 
in various social roles such as work, recreational and interpersonal relations. This is 
important since impairments in these areas strongly contribute to the burden of disease 
in depression (Eaton et al., 2008, Greenberg et al., 2003). After controlling for the effects 
of psychotherapy on depressive symptom severity and selective study characteristic in 
multivariate meta-analyses, the effects of psychotherapy on social functioning remained 
marginally significant, indicating that changes in social functioning are not fully 
explained by changes in depressive symptom severity. In other words, our results 
suggest that social functioning improves as depressive symptoms improve, although the 
direction or nature of the presumed causal relation remains unknown. These findings 
are in line with previous studies showing that changes in psychosocial functioning are 
intercorrelated with changes in depressive symptom severity (e.g. Dunn et al., 2012, 
Vittengl et al., 2004). 
 It should be noted that the current research design does not allow determining the 
temporal relation of this association. It is not clear whether improvements in depressive 
symptom severity drive improvements in social functioning or the other way around. To 
determine the temporal relation between these constructs it would be necessary to 
establish a timeline with repeated assessments of both constructs during treatment 
(Kazdin, 2007). One previous process-outcome study on the effects of cognitive therapy 
on change in psychosocial adjustment found that improvements in psychosocial 
adjustment, assessed four times during treatment, predicted subsequent reductions in 
depressive symptoms rather than the other way around (Dunn et al., 2012). Future RCT 
based studies with control groups and repeated assessments of functioning and 
depressive symptoms throughout treatment should aim to determine the causal relation 
between these variables. 
 Overall, the effect size of social functioning was smaller than the effect size of 
depressive symptom severity. This finding is in line with previous studies showing that 
impairments in social functioning often persist, even after symptomatic recovery (e.g. 
Coryell et al., 1993). Different explanations might account for this finding. For example, 
it is possible that social functioning takes more time to improve compared to depressive 
symptom severity in psychotherapy for depression. This explanation is in line with the 
findings of a previous meta-analysis showing that recovery from work impairments in 
depression takes longer than symptom remission (Mintz et al., 1992). On the other hand, 
impairments in social functioning might be more persistent even in the long run and 
additional treatment might be necessary to improve social functioning to a premorbid 
level. Our finding that social functioning improved less than depressive symptom 
severity might have important prognostic implications for the course of depression 
following treatment. For example, it has been shown that residual impairments in social 
functioning following treatment are related to relapse and recurrences (e.g. Leon et al., 
1999, Vittengl et al., 2009). Such findings stress the importance of including social 
functioning as main outcome in treatment studies and in current definitions of response 
and remission. It should be noted that after adjusting for publication bias the effect size 
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of social functioning (g = 0.40) was comparable to the adjusted effect size of depressive 
symptoms (g = 0.43). 
 We conducted a number of subgroup analyses to test whether selective study 
characteristics were differentially related to the effects of psychotherapy on social 
functioning. In interpreting the results of these analyses, it should be noted that 
significant associations in these analyses should not be interpreted in terms of causal 
associations. Our univariate subgroup analyses indicated that studies that compared 
psychotherapy to care-as-usual resulted in smaller effect sizes compared to studies 
comparing psychotherapy to other control conditions. This finding is in line with 
previous meta-analyses summarizing the effects of psychotherapy on depressive 
symptom severity (e.g. Cuijpers et al., 2008d). In our subgroup analyses studies with a 
care-as-usual control condition were mainly compared to studies with a waiting list 
control condition and it is therefore not surprising that studies with care-as-usual as 
control condition resulted in smaller effect sizes. Our subgroup analyses further showed 
that studies that were conducted in the US and studies that used clinician-rated scales to 
assess social functioning yielded higher effect sizes compared to studies that were 
conducted in other countries or studies that relied on self-reported instruments of social 
functioning. Although speculative, it is possible, that US based studies have a higher 
treatment delivery quality and therefore achieve higher effect sizes. The finding that 
clinician-rated instruments yielded higher effect sizes than self-reported instruments is 
in line with the results of an earlier meta-analysis showing that clinician-rated 
instruments were associated with higher effect-sizes of depressive symptom severity 
(Cuijpers et al., 2010). In the current meta-analysis only three studies (seven 
comparisons) used a clinician-rated instrument of social functioning and hence this 
finding should be interpreted with caution. Based on our findings it is not clear whether 
one type of assessment of social functioning is preferable over the other and therefore it 
is probably best to include both in future studies and clinical practice when assessing 
social functioning.  
 There were no differences in improvements in social functioning between different 
types of psychotherapeutic interventions (CBT versus others; IPT versus others). When 
interpreting these results it is important to keep in mind that these findings are based 
on separate sets of comparisons and not on direct comparisons of different types of 
psychotherapies. Such indirect comparisons might be confounded by differences in 
patient populations and other study characteristics and the results should therefore be 
interpreted with caution. Our findings are in line with previous meta-analyses reporting 
that different types of psychotherapy are approximately equally efficacious in reducing 
depressive symptoms (Cuijpers et al., 2008a). IPT specifically focuses on social 
functioning (Weissman et al., 2000) and one might therefore expect that studies that 
included IPT would result in larger effect sizes of improvements in social functioning, 
compared to studies on other forms of psychotherapy. It is unclear how our finding that 
improvements in social functioning were not different between IPT studies and other 
studies relates to the literature on the mechanisms of change in depression. It is possible, 
for example, that IPT based studies in this meta-analyses resulted in initially stronger 
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improvements in social functioning but that these differences were not present anymore 
at post-treatment. However, it is impossible to test this hypothesis in the current 
research design. Future RCT based studies with repeated assessments throughout 
treatment should aim to determine the temporal pattern of improvements in social 
functioning in different types of psychotherapy for depression. 
 We found that the number of therapy sessions was positively associates with the 
effect size of social functioning, even after controlling for the effects on depressive 
symptom severity in multivariate analyses. This finding suggests that patients with 
depression might benefit from longer term treatments or continuation treatments in 
terms of improvements in social functioning. The relation between the number of 
therapy sessions and the effect size of social functioning was rather small. Our analyses 
suggest that an increase of 5 therapy sessions is associated with an increase in the effect 
size of social functioning of 0.15. This finding is in line with the findings of a recent meta-
analysis showing that there is a small association between the number of therapy 
sessions and the effect size of depressive symptom severity (Cuijpers et al., 2013). In the 
current meta-analysis studies on continuation and maintenance treatments were 
excluded and it therefore remains unclear if continued treatment is related to further 
improvements in social functioning. In the univariate and multivariate meta-analyses we 
found that the treatment delivery format was significantly associated with 
improvements in social functioning. Studies that used an individual treatment format 
resulted in higher effect sizes compared to studies that used a group format. On 
theoretical grounds one might argue that group settings should result in stronger 
improvements in social functioning because group therapy by definition takes place in a 
social interpersonal context allowing, for example, to practice social and interpersonal 
conflicts in vivo in the group. Empirically, our finding that individual treatments resulted 
in higher effect sizes of social functioning is in line with the results of a previous meta-
analysis showing that an individual treatment format for depression is associated with 
higher effect sizes of depressive symptom severity (Cuijpers et al., 2008b). 
 Several important limitations should be mentioned. First, the number of studies 
was relatively small and accordingly it was not possible to compare effect sizes between 
specific types of treatment other than CBT and IPT. For example, it would be interesting 
to test whether psychotherapies for depression that focus on engagement in 
psychosocial activities (for example behavioural activation) are related to stronger 
improvements in psychosocial adjustments compared to other forms of psychotherapies. 
A related limitation of this meta-analysis is that comparisons between different types of 
psychotherapies were based on separate sets of comparisons and not on direct 
comparisons of different types of psychotherapies. The number of comparative outcome 
studies in the current meta-analysis was too small to allow for such a direct comparison. 
Second, on average the quality of included studies was rather low. Since quality was 
negatively associated with the effect size, it might be that the effect sizes in the current 
meta-analysis were overestimated. Third, we compared the effects of psychotherapy 
versus control groups at one assessment moment and hence we could not draw any 
conclusions regarding the temporal relations between changes in social functioning and 
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changes in depressive symptom severity. The current meta-analysis was based on study 
level data. Another approach that might also allow for analyses of temporal relations 
and a more fine-grained analysis of predictors would have been to conduct an individual 
patient-level meta-analysis based on the original datasets of included studies. Finally, we 
assessed overall improvements in social functioning rather than domain specific 
improvements. It is possible, for example, that some aspects of functioning show 
stronger improvements (e.g. recreational functioning) than others (e.g. work 
functioning). 
 Despite these limitations, our findings have important implications for clinical 
practice and future research. First, the results of this meta-analysis suggest that 
psychotherapy for depression is associated with improvements in social functioning. 
This is an important finding, since improvements in social functioning are probably a 
highly desirable outcome from a patient perspective. Second, future research should aim 
to determine the temporal relation between social functioning and depressive symptom 
severity by assessing both depressive symptom severity and social functioning 
repeatedly throughout treatment. Finally, compared to the total number of RCTs on 
different types of psychotherapies for depression, the number of studies that included 
measures of social functioning as treatment outcome was relatively small, which reflects 
the current focus of treatment outcome studies on depressive symptom severity rather 
than functioning. Including social functioning as main outcome, in addition to 
symptomatic improvements, in treatment studies for depression might add to a more 
complete definition of treatment effects. 
 In conclusion, psychotherapy for depression has small to moderate positive effects 
on the social functioning of depressed patients and no differences between different 
types of psychotherapies emerged. 
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Abstract	
Schema Therapy (ST) is an integrative treatment approach to chronic lifelong problems	
with an established effectiveness for treating personality disorders. This article 
describes the adaptation of ST to chronic depression by reviewing the literature on the 
underlying risk factors to chronic depression. A model of chronic depression is 
presented, describing the interplay between empirically supported risk factors to 
chronic depression (early adversity, cognitive factors, personality pathology, 
interpersonal factors). We provide a treatment protocol of ST for chronic depression 
describing techniques that can be used in ST to target these underlying risk factors. 
Based on the current body of empirical evidence for the underlying risk factors to 
chronic depression, ST appears to be a promising new treatment approach to chronic 
depression as it directly targets these underlying risk factors. 
 
Keywords: Chronic depression, Schema therapy, Early maladaptive schemas, Risk factors 
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Introduction	
Schema Therapy (ST) is an integrative treatment approach combining cognitive, 
behavioral, experiential and psychodynamic elements and techniques (Young, Klosko, & 
Weishaar, 2003). Influenced by the cognitive theory of depression, Young elaborated on 
the schema concept and developed ST as a novel treatment for clients with chronic 
psychological disorders. Empirical research on the effectiveness of ST is in its initial 
stage. While there is evidence for the effectiveness of ST in treating clients with 
borderline personality disorder (Farrell, Shaw, & Webber, 2009; Giesen-Bloo et al., 2006; 
Nadort et al., 2009; Nordahl, Holthe, & Haugum, 2005) and clients with Cluster-C, 
paranoid, histrionic and narcissistic personality disorders (Bamelis, Evers, Spinhoven, & 
Arntz, 2012) there is a lack of research on ST for chronic axis-I disorders. In addition to 
the effects of ST on personality pathology, a recent large randomized controlled trial 
found that ST also has positive effects on co-morbid depression in clients with primarily 
Cluster-C personality disorders (Bamelis, et al., 2012). Such findings raise the question 
whether ST is also a valuable treatment for clients with primary depressive symptoms. 
 Chronic depression is a relatively common (affecting 19% of depressed clients; 
Keller, Hanks, Kocsis, & Klein, 1995) and difficult to treat (Kocsis, 2003; Riso & Newman, 
2003) mental disorder. Four types of chronic depression are distinguished in the 
literature: chronic major depressive disorder, dysthymic disorder, double depression, 
and recurrent major depressive disorder (MDD) without full interepisode recovery 
(Klein, 2010). Whereas these subtypes appear to be rather homogenous with respect to 
etiology and clinical features, they can be clinically distinguished from episodic forms of 
depression (McCullough et al., 2003). Compared to episodic forms of depression, chronic 
depression has a stronger negative impact on the quality of life (Wells, Burnam, Rogers, 
& Hays, 1992), results in more suicide attempts and hospitalizations (Arnow & 
Constantino, 2003; Torpey & Klein, 2008), is associated with greater service use 
(Howland, 1993), and higher economic costs (Smit et al., 2006), stressing the 
importance of effective treatment protocols for chronic forms of depression. 
Treatment	of	Chronic	Depression	
Common treatment approaches to chronic depression include antidepressant 
medication (ADM; Kocsis, 2003), cognitive therapy (CT; Riso & Newman, 2003), 
cognitive behavioral analysis system of psychotherapy (CBASP; McCullough, 2003), and 
combined psychotherapy and medication treatments (Thase, 1999). Although 
psychotherapy and ADM treatments have an established effectiveness in the treatment 
of chronic depression, the effect sizes of psychotherapy in reducing depressive 
symptoms are small (Cuijpers et al., 2010) and remission rates of ADM treatment for 
chronic depression usually fall well below 50% (Kocsis, 2003), reflecting the need for 
more effective treatment approaches for chronic depression. Higher response and 
remission rates are obtained in ADM and psychotherapy combination treatments 
(Browne et al., 2002; Keller et al., 2000; Manber et al., 2008; Pampallona, Bollini, Tibaldi, 
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Kupelnick, & Munizza, 2004; Thase et al., 1997). For example, in a large randomized 
clinical trial (RCT) N = 681 outpatients with chronic depression were randomized to 
either ADM treatment (nefazodone), CBASP, or a combination treatment (Keller, et al., 
2000). In line with earlier studies of psychotherapy or ADM treatment for chronic 
depression, about half (48%) of the clients in the ADM and CBASP alone groups 
responded to treatment. In the combination group more than two thirds of the clients 
(73%) responded to treatment (Keller, et al., 2000) which is in line with the notion that 
combined treatments for chronic depression results in more positive outcomes 
(Pampallona, et al., 2004). 
 Although these results seem promising, the initial effects of treatments for chronic 
depression are often not maintained and continuation phase treatment (4-9 months) 
and/or maintenance phase treatments (1 year or more) are necessary to reduce relapse 
and recurrences. For example, Gelenberg et al. (2003) randomized outpatients with 
chronic depression, who achieved and maintained a clinical response during acute-
phase and continuation phase treatment for chronic depression, to either 52 weeks of 
nefazodone (Selective Serotonin Reuptake Inhibitor; SSRI) or pill placebo. The authors 
found that the risk for recurrence at the end of the 1 year maintenance phase was 
statistically significantly lower in the nefazodone group (30.3%) compared to the 
placebo group (47.5%). Yet, clients who were initially treated to remission (in the acute 
phase of the same study) with CBASP did not show lower relapse rates compared to 
clients who were treated to remission with nefazodone. These findings suggest that 
CBASP does not add any prophylactic effects above ADM in the treatment of chronic 
depression (Gelenberg, et al., 2003). Moreover, augmentation with CBASP to continued 
ADM treatment in chronically depressed non-responders has been shown to have no 
beneficial effects above continued ADM treatment alone (Kocsis et al., 2009). Finally, 
combination treatment of CBASP and ADM in the acute phase seems to be superior to 
either treatment alone only for a subgroup of moderately depressed clients but not for 
chronically depressed clients with more severe depressions (Stulz, Thase, Klein, Manber, 
& Crits-Christoph, 2010), stressing the need of exploring new treatment options for 
chronically depressed clients. 
 CBASP is the only type of psychotherapy that was specifically developed for the 
treatment of chronic depression and therefore might be superior to other types of 
psychotherapy used in chronic depression. In a recent study, clients with early-onset 
chronic depression were randomized to either CBASP or interpersonal psychotherapy 
(IPT) (Schramm et al., 2011). Although remission rates were remarkably higher in the 
CBASP group (57%) compared to the IPT group (20%) these effects could not be 
maintained at a one-year follow-up assessment, suggesting that the initial effects of 
CBASP are not enduring and that chronically depressed clients did not profit more from 
CBASP compared to IPT in the long run. 
 One important reason for the lack of enduring effects of current treatment 
approaches for chronic depression, including CBASP, might be the relatively small 
number of treatment sessions. For example, in the study by Keller et al. (2000), 
chronically depressed outpatients received 16 - 20 sessions of CBASP with a mean 
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number of 16 sessions. In a recent meta-analysis of psychotherapy for chronic 
depression it has been shown that the effects of psychotherapy for chronic depression 
increase in a dose-response relationship with the number of therapy sessions (Cuijpers, 
et al., 2010). It is therefore likely that a longer course of psychotherapy is necessary to 
reach higher levels of remission at follow-up in the treatment of chronic depression. 
 Another treatment approach to depression that should be mentioned is emotion 
focused therapy (EFT; Greenberg & Watson, 2006). EFT is an integrative treatment 
approach based on client centered, experiential, and cognitive techniques with 
established evidence as a treatment of acute depression (Ellison, Greenberg, Goldman, & 
Angus, 2009; Watson, Gordon, Stermac, Kalogerakos, & Steckley, 2003). EFT is 
concerned with identifying and changing emotional structures (emotional schemes) that 
consist of emotions, cognitions, sensations and behavioral tendencies. Results from 
process-outcome studies suggest that emotional processing is indeed an important 
predictor of therapy outcome in depression (Castonguay, Goldfried, Wiser, Raue, & 
Hayes, 1996; Watson & Bedard, 2006). This finding suggests that treatment for (chronic) 
depression might benefit from a focus on emotional processing in addition to 
interpersonal and cognitive interventions. 
 Taken together, while current treatment protocols for chronic depression are 
effective in treating clients to initial remission, these effects are only maintained with 
extensive continuation and maintenance treatments. Moreover, the response rates and 
effect sizes for current ADM and psychotherapeutic treatments for chronic depression, 
including CT and CBASP, are rather small, stressing the need to explore novel, long-term 
treatment options for this group of clients. Therefore, the aims of this article are to 
discuss the theoretical application of a promising new long-term treatment approach to 
chronic depression, schema therapy (ST), and to provide an overview of a treatment 
protocol of ST for chronic depression that is currently being tested in a single-case series. 
Basic	Concepts	of	Schema	Therapy	
Early Maladaptive Schemas 
According to the original ST model, Early Maladaptive Schemas (EMS’s) are at the core of 
psychopathology (Young, et al., 2003). EMS are stable, trait-like, enduring beliefs about 
oneself and the world that are rooted in early adverse childhood experiences (Young, et 
al., 2003). Adverse childhood experiences include failure to meet the basic needs of the 
child, traumatic events, over nurturance, or a strong internalization of parents 
dysfunctional thoughts, feelings and behaviors. For example, children of overly 
nurturant parents might develop a strong dependence schema. EMS are in many ways 
comparable to the concept of core beliefs in CT (Clark & Beck, 1999). However, there are 
also important differences between these two concepts (James, Southam, & Blackburn, 
2004). Whereas core beliefs in depression are usually divided into three broad 
categories (helplessness, inadequacy, and unloveability) EMSs are more specific. To date, 
18 specific EMSs were identified and divided into five broader categories (see Table 1). 
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According to the ST model, EMS remain latent until triggered by life events and once 
triggered they can evoke powerful emotional reactions in the individual. For example, a 
student with a strong failure schema might experience strong feelings of sadness, 
worthlessness and guilt after failing an exam. Given that EMS are assumed to be at the 
core of psychopathology, change from maladaptive to more adaptive schemas and 
coping responses is the ultimate goal of ST. 
 
Table	1. A brief description of all 18 early maladaptive schemas according to Young et al. (2003). 
Early Maladaptive Schema Description 
Abandonment / Instability The perceived instability or unreliability of those available for support. 
Mistrust / Abuse The expectation that others will intentionally hurt, abuse, humiliate, 
cheat, lie, manipulate or take advantage. 
Emotional Deprivation The expectation that one’s desire for emotional support, nurturance, 
empathy or protection by others will not be met. 
Defectiveness / Shame The feeling that one is defective, bad, unwanted, inferior, or invalid. 
Social Isolation The feeling that one is isolated from the world, different from others and 
not part of a community. 
Dependence / Incompetence The belief that one is not able to handle everyday responsibilities 
without help from others. 
Vulnerability to Harm or Illness Exaggerated fear that an unpreventable medical, emotional or external 
catastrophe will strike. 
Enmeshment Excessive emotional involvement with significant others at the expense 
of individualization 
Failure The belief that one has failed or will fail in areas of achievement.  
Entitlement The belief that one is superior to others and entitled to special rights and 
privileges. 
Insufficient Self-Control A pervasive difficulty or refusal to exercise sufficient self-control and 
frustration tolerance to achieve personal goals. 
Subjugation Surrendering of control to others to avoid negative consequences. 
Self-Sacrifice The excessive focus of meting needs of others at the expense of one’s 
own gratification. 
Approval-Seeking An excessive focus on gaining approval, recognition, or attention from 
others. 
Negativity A lifelong focus on the negative aspects of life while minimizing the 
positive aspects. 
Emotional Inhibition Inhibiting spontaneous action, feelings, or communication to avoid 
disapproval by others or feelings of shame. 
Unrelenting Standards The belief that one must strive to meet very high standards to avoid 
criticism. 
Punitiveness The belief that people should be harshly punished for mistakes. 
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Coping Strategies 
Clients with strong EMS develop dysfunctional coping strategies in order to cope with or 
compensate for the negative emotions that they might experience when schemas are 
activated (Young, et al., 2003). In the schema model three types of coping responses are 
described: (1) schema avoidance (behaviors aimed at avoiding activation of the schema), 
(2) schema surrender (behaviors that confirm the schema), and (3) schema 
overcompensation (behaviors that are opposite to the schema). These coping strategies 
are maladaptive because they maintain the underlying schema. For example, clients with 
a strong mistrust and abuse schema might engage in schema surrender coping by being 
drawn into abusive relationships, thereby confirming the validity of their schema. 
Adaptation	of	ST	to	chronic	depression	
Like other mental disorders, chronic depression is unlikely to be caused and maintained 
by a single underlying factor, but likely to arise from a set of multiple interacting factors. 
Since the introduction of chronic depression as a separate category in the DSM-III a 
number of studies have been conducted to determine underlying risk factors to chronic 
depression by comparing clients with episodic forms of depression to chronically 
depressed clients. While there is now evidence for a number of developmental and 
cognitive risk factors, the empirical evidence for the causal relation of these factors to 
chronic depression is inconsistent, which might be largely due to an over reliance on 
correlational research designs (Hölzel, Härter, Reese, & Kriston, 2011). Four risk factors 
to chronic depression that have received the most consistent empirical support in the 
literature are (1) early adversity, (2) personality (pathology), (3) cognitive factors, and 
(4) interpersonal factors. In order to describe the interplay between these factors we 
developed a cognitive schema model of chronic depression (Figure 1). In this model the 
effect of distal risk factors (early adversity) on chronic depression is mediated by 
proximate risk factors (early maladaptive schemas & dysfunctional attitudes). Proximate 
risk factors are triggered by current life events, such as the experience of loss or failure, 
and they are maintained by avoidance related coping strategies (schema avoidance) and 
interpersonal behaviors that lead to schema maintenance. Interpersonal behaviors that 
are related to the avoidance of social situations or the avoidance of conflict (non-
assertiveness) in turn contribute to the maintenance of depression through a lack of 
positive social reinforcement. In this model, distal risk-factors can best be understood as 
characteristics that increase the vulnerability of a person to experience proximate risk-
factors. For example, experiencing childhood abuse might increase the vulnerability of 
developing a strong abandonment/instability schema. 
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Figure	1. Cognitive schema model of chronic depression 
 
Proximate risk-factors can best be understood as characteristics that more directly 
contribute to chronic depression in the context of recent triggering events. According to 
the model in Figure 1, a recent triggering event (for example the recent experience of 
abandonment or loss) can activate underlying EMS (for example 
abandonment/instability) which in turn directly contributes to chronic depression. 
Although three different types of dysfunctional coping mechanisms have been 
mentioned earlier, only schema avoidance was included in the model because this 
coping strategy is hypothesized to be the predominantly used coping strategy in clients 
with chronic depression. In the following section we review the empirical evidence for 
each of the four risk factors to chronic depression and describe how they can be targeted 
in ST. 
Early	Adversity	
Early adversity is an umbrella term for childhood experiences such as, sexual, physical, 
and emotional abuse, physical and emotional neglect and parental behaviors such as 
rejection, indifference, or overcontrol. Compared to non-chronic forms of depression, 
chronic depression is more often characterized by early onset (Hölzel, et al., 2011) and 
hence the relation of developmental factors, especially early adversity, and chronic 
depression has been emphasized. Previous studies relating early adversity to chronic 
depression found that, compared to non-chronic forms of depression, clients with 
chronic depression more often report childhood adverse events (Brown, Craig, Harris, 
Handley, & Harvey, 2007; Brown & Moran, 1994; Hayden & Klein, 2001; Lizardi & Klein, 
2000) and the experience of such events has been shown to be related to lower 
remission rates following a 12-week protocol of ADM (Klein et al., 2009). One large 
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cohort study found that especial emotional abuse was related to risk for depression and 
that risk for depression (lifetime and current) increased gradually with the number of 
early adverse events in childhood (Chapman et al., 2004). 
 Childhood adversity usually precedes the onset of depression by several years and 
the relation between childhood adverse events and chronic depression is likely 
mediated by proximal risk factors (Klein & Santiago, 2003). According to cognitive 
models of depression the way in which children cognitively organize adverse childhood 
experiences in cognitive schemas determines whether the child will develop depression 
at a later age (Ingram, 2003). In terms of the schema model, EMS are proximate risk 
factors that might mediate the relation between childhood adversity and 
psychopathology (Young, et al., 2003). In line with this, there is evidence that the 
relation between childhood adversity and depressive symptoms is mediated by specific 
sets of EMS in non-clinical (Harris & Curtin, 2002) and in clinical samples (Cukor & 
McGinn, 2006; Lumley & Harkness, 2007; McGinn, Cukor, & Sanderson, 2005). It has also 
been shown that the relation between childhood adversity and depression is mediated 
by a depressotypic schema organization in young adults (Lumley & Harkness, 2009), a 
finding that has led to the conclusion that EMS in depression should be a focus of 
treatment in clients with a history of early adversity. 
 Childhood adversity in the treatment of chronic depression is associated with 
decreased response to ADM (Hayden & Klein, 2001; Kaplan & Klinetob, 2000) and 
higher response rates to psychotherapy (Nemeroff et al., 2003). Chronically depressed 
clients with a history of childhood adversity might therefore benefit more from forms of 
psychotherapy that specifically target childhood adversity. ST places special emphasis 
on childhood adversity. According to the schema model such experiences are the origin 
of EMS. In schema therapy experiential strategies, like imagery of traumatic events, are 
used to help the clients re-experience traumatic events in a safe therapeutic context, 
thereby decreasing the impact of the clients EMS.  
Cognitive	Factors	
Dysfunctional cognitions in depression are usually conceptualized in terms of a 
hierarchical model of generality with automatic thoughts at the most superficial level, 
dysfunctional attitudes at an intermediate level, and cognitive schemas (or core beliefs) 
at the deepest level (Clark & Beck, 1999; Segal, 1988). Most studies on cognitive factors 
in depression have focused on negative cognitions at the level of automatic thoughts or 
dysfunctional attitudes in relation to the onset and recurrences of depressive episodes 
and found that negative cognitive styles were related to increased likelihood of 
depression onset and recurrences (e.g., Alloy & Abramson, 1999; Alloy et al., 2006; 
Burcusa & Iacono, 2007; Lewinsohn, Joiner, & Rohde, 2001; Mongrain & Blackburn, 
2005).  
 One previous study that has related cognitive factors to the course of depression 
focused on core beliefs at deeper levels of processing and found that avoidant and 
paranoid beliefs, as assessed with the Personality Beliefs Questionnaire (Beck & Beck, 
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1991), were related to poor outcome in cognitive therapy for depression (Kuyken, 
Kurzer, DeRubeis, Beck, & Brown, 2001). In one prospective study, it has been shown 
that initially non-depressed individuals with high levels of negative cognitive styles and 
high levels of dysfunctional attitudes were more likely to experience a chronic course of 
depression at a 2.5 year follow-up assessment, compared to individuals with low levels 
of negative cognitive styles and dysfunctional attitudes (Iacoviello, Alloy, Abramson, 
Whitehouse, & Hogan, 2006). In line with this, it has been shown in a prospective design 
that individuals with highly dysfunctional cognitions were lees likely to improve from a 
major depressive episode (Dent & Teasdale, 1988; Lewinsohn, Steinmetz, Larson, & 
Franklin, 1981). 
 Studies assessing dysfunctional cognitive processing at the schema level in 
chronically depressed clients are rare. In one study it was found that clients with chronic 
depression exhibit higher levels of EMS compared to non-chronically depressed clients, 
even after controlling for depressive symptom severity and personality disorders (Riso 
et al., 2003). Moreover, it has been shown that depressed clients are characterized by 
specific EMS (failure, emotional deprivation and abandonment/instability) and that 
these schemas remain relatively stable following outpatient treatment for depression 
(Renner, Lobbestael, Peeters, Arntz, & Huibers, 2012). These findings suggest that 
current outpatient treatments for depression leave the underlying vulnerability to 
depression, in terms of EMS, largely untouched and that depressed clients with high 
levels of EMS might benefit from ST (Renner, Lobbestael, et al., 2012) . 
 ST builds on CT and hence draws from cognitive techniques that are also applied in 
CT for depression to decrease negative thinking patterns. The ultimate goal of ST is to 
decrease schematic processing that is dominated by EMS (Young, et al., 2003). Using 
cognitive techniques, clients learn to gather evidence that is disconfirming their schemas 
and by doing so to understand, on a rational level, that their schema is false. Moreover 
experiential techniques are used to help the client to feel on an emotional level that their 
schema is false. These different levels of schematic processing refer to the idea that 
there are different levels of meaning corresponding to rational propositional meanings 
(knowing cognitively) and holistic implicational meanings (knowing emotionally; 
Teasdale, 1999). CT and ST both target maladaptive schemas at the deepest (schema) 
level of cognition but ST also draws on experiential techniques to do so. By drawing 
from both cognitive and experiential techniques, ST appears to be better equipped to 
enable change in dysfunctional schematic processing at the schema level. 
Personality	Pathology	
Several studies have demonstrated increased rates of axis-II psychopathology in clients 
with chronic forms of depression compared to clients with episodic forms of depression 
(Anderson et al., 1996; Fava et al., 1996; Hayden & Klein, 2001; Holmstrand, Engström, 
& Träskman-Bendz, 2008; Pepper et al., 1995). A number of theoretical models have 
been proposed to account for the relation between personality (disorders) and 
depression (Bagby, Quilty, & Ryder, 2008; Farmer & Nelson-Gray, 1990) but the large 
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majority of studies relating personality disorders to chronic depression is based on 
cross-sectional data and hence the causal direction of this relation remains unclear. 
 Most studies on the relation between PD and depression focus on the impact of PD 
on treatment outcome. Recent meta-analyses suggest that comborbid PD doubles the 
risk of poor outcome in MDD treatment and hence it has been stressed that PD 
comorbidity should be addressed in depression treatment (Newton-Howes, Tyrer, & 
Johnson, 2006). Relatively fewer studies investigated the relation between PD and 
treatment outcome in chronically depressed clients. One study found that comorbid PD 
had no negative impact on treatment outcome in chronic depression (Maddux et al., 
2009) whereas in another study it was found that comorbid PD, especially BPD, 
predicted lower remission rates in depressed clients (Skodol et al., 2011). A number of 
possible explanations might account for these differential findings. The study of Maddux 
and colleagues (2009) drew data from a randomized controlled trial whereas the study 
of Skodol and colleagues (2011) related PDs to the course of depression in a prospective 
epidemiological study. Whereas the former study excluded clients with severe BPD, the 
latter study found that especially BPD clients had lower remission rates of depression. 
Whether or not co-morbid PDs have a negative impact of treatment outcome in 
depression might therefore depend in part on the types of PDs that are studied.  
 Although it remains to be investigated which specific PDs have a negative impact 
on treatment outcome in chronic depression, the findings that PD comorbidity is 
common in chronic depression, and has a negative impact on treatment outcome in 
episodic forms of depression suggests that PD should be addressed in the treatment of 
chronic depression. 
 ST was specifically developed for clients with chronic characterological problems 
who often present with axis-II disorders (Young, et al., 2003). With a special emphasis 
on characterological dysfunctional life patterns, ST has been shown to be an effective 
treatment for clients with BPD (Giesen-Bloo, et al., 2006) and clients with Cluster-C, 
paranoid, histrionic and narcissistic personality disorders (Bamelis, et al., 2012). Both 
BPD and Cluster-C personality disorders frequently co-occur with chronic depression 
(Farmer & Nelson-Gray, 1990; Rothschild & Zimmerman, 2002; Russell et al., 2003) and 
have been shown to be related to shorter survival times to depressive relapse (Ilardi, 
Craighead, & Evans, 1997). Treating the underlying vulnerability to chronic depression 
likely also involves treating the underlying personality (features) that might drive 
depression and depressive relapse. 
Interpersonal	Factors	
Depressed clients are characterized by an interpersonal style that can best be described 
as a blend between social-avoidance and non-assertiveness (Barrett & Barber, 2007; 
Renner et al., 2012). This depressogenic interpersonal style remains stable after 
cognitive therapy (CT) for depression (Renner, Jarrett, et al., 2012). Studies relating 
interpersonal problems to depression chronicity are rare. In a cross-sectional design, it 
has been shown that chronically depressed inpatients report higher scores on the social 
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avoidance subscale of the inventory of interpersonal problems, compared to non-
chronically depressed inpatients (Ley et al., 2011). In a prospective study, it has been 
shown that interpersonal problems were related to depression chronicity at a follow up 
assessment and that interpersonal problems partially mediated the relation between 
childhood adversity and chronic depression (Brown & Moran, 1994). Joiner (2000) 
developed a model of chronic depression with a strong emphasis on interpersonal 
factors. According to this model, chronic depression is characterized by increased 
negative-feedback seeking, reassurance seeking, and conflict avoidance, and accordingly 
these interpersonal difficulties should be addressed in the treatment of chronic 
depression (Joiner, 2000). Finally, it has been shown that the relation between a 
socially-avoidant interpersonal style and depression is likely mediated by reduced social 
positive reinforcement (Carvalho & Hopko, 2011; Ferster, 1973). 
 One form of psychotherapy that specifically focusses on interpersonal stressors is 
Interpersonal Therapy (IPT) for depression (Klerman, Weissman, Rounsaville, & 
Chevron, 1984). IPT focuses on a number of interpersonal sources of distress including 
interpersonal problems, role transitions, grief or interpersonal deficits that are assumed 
to give rise to depressed mood. IPT for depression is a time limited structured form of 
psychotherapy that focuses on a current acute episode of depression (Klerman, et al., 
1984). For example if a client suffers from symptoms of depression following a job 
promotion, role transition might be the focus of treatment. In contrast to the focus on 
recent interpersonal sources of distress in IPT, in the current theoretical framework 
interpersonal problems are conceptualized as rigid behavioral patterns in interpersonal 
situations. ST aims to break patterns such as a general avoidance of conflict (non-
assertiveness) or avoidance of social-situations by drawing from behavioral pattern 
breaking techniques. Pattern breaking is the last step in schema therapy and crucial to 
avoid relapse and recurrences (Young, et al., 2003). In order to achieve pattern breaking, 
the client and therapist work out a list of targets and then start with the most 
problematic behaviors. Flash cards and homework assignments are used to practice 
healthy behaviors outside the therapy session whereas imagery and role-playing 
techniques of problematic interpersonal behaviors might be used during the therapy 
session. Additionally, ST draws from classical behavioral techniques such as 
assertiveness training in order to target interpersonal problems (Young, et al., 2003). 
 It should be noted that these techniques to target interpersonal problems are not 
unique to ST. These techniques might also be used in other therapy models such as CT, 
IPT, or in assertiveness training. The strength of ST in using these techniques is that the 
client and the therapist can identify and deal with EMS and schema modes that prevent 
the client from developing a more healthy interpersonal style. For example, clients with 
chronic depression might have a strong side to themselves that protects them from 
feelings of vulnerability (detached protector mode). In order to break through 
interpersonal patterns of behavior such as avoidance of conflict it might be necessary to 
bypass these protective sides to the self. 
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Similarities	and	differences	with	other	treatment	approaches	
Several of the ST techniques that can be used to address the risk-factors of chronic 
depression are not unique to ST but are also common to other forms of psychotherapy 
like CT or emotion focused therapy (EFT). It is therefore important to distinguish these 
approaches from ST and to highlight the distinctive features of ST that might make this 
approach superior to current approaches in the treatment of chronic depression. In this 
section we highlight some of the features that distinguish ST from CT because these two 
approaches are probably the most similar. For a detailed comparison of ST with other 
psychotherapy models, including emotion focused therapy, see (Young, et al., 2003). 
 Schema therapy is based on CT and therefore these two treatment approaches 
bear great similarity (Young, et al., 2003). For example, both treatments target 
maladaptive schemas by means of empirical verification (collaborative empiricism) to 
change these cognitive structures. In addition to these pure cognitive techniques ST also 
places great emphasis on experiential techniques to identify specific schemas and to 
change schemas (Young, et al., 2003). Previous research has shown that experiential 
techniques such as imagery rescripting have positive effects on depression in patients 
with primarily recurrent and chronic depression (Brewin et al., 2009). Moreover, in ST 
the therapeutic relationship is used as an active ingredient to change schemas whereas 
the therapeutic relationship in CT is seen as a basis for cognitive techniques to be 
effective rather than a therapeutic technique in itself (Young, et al., 2003). In this regard 
schema therapists are equipped with a richer toolbox of therapeutic techniques that can 
be used to target schemas from different perspectives. Another important difference 
between these two treatment approaches is that ST places a greater emphasis on early 
childhood experiences whereas traditional CT places more emphasis on the “here and 
now” (Beck, Rush, Shaw, & Emery, 1979). Accordingly, in ST the techniques described 
above are also used to explore the origin of schemas in the past and to link past events to 
current problems.  
 As was argued, chronic depression is often rooted in adverse early childhood 
experiences that give rise to rigid, trait-like early maladaptive schemas and co-occurring 
personality pathology. It is therefore important that treatment of chronic depression 
takes into account the developmental aspects of this disorder and targets the various 
risk-factors via multiple channels. Traditional CT is primarily focused on the “here and 
now” and has a stronger emphasis on purely cognitive and behavioral techniques. The 
strength of ST as a treatment for chronic depression is that it draws from various 
therapeutic techniques, not only cognitive behavioral, and has a strong focus on the 
developmental context in which schemas develop.  
Treatment	protocol	
The treatment protocol of ST for chronic depression is based on the basic protocol of ST 
developed by Young et al. (2003). The treatment protocol of ST for chronic depression 
can be divided into three phases: (1) Exploration, (2) Change, (3) Relapse prevention. In 
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the first two phases sessions should be scheduled weekly, whereas in the last phase the 
frequency of sessions should be decreased to give the client more autonomy and 
responsibility.  
Phase I - Exploration (session 1-10) 
There are three main goals in the first phase of treatment. First, clients need to 
understand the concept of schemas and identify their predominant schemas. Second, 
relations between the clients’ predominant schemas, their current problems and their 
history are established. Third, the therapist helps the client to experience the feelings 
that are associated with their schemas by drawing from experiential techniques. For 
example, imagery of childhood events can be used to identify predominant underlying 
schemas. In these exercises, the client is instructed to recall a distressing event from 
their childhood while the therapist observes the affective reactions of the client. Client 
and therapist then move from more general images to more specific images that include 
significant others (for example the parents) in order to cover the whole range of early 
maladaptive schemas experienced by the client (Young, et al., 2003). In contrast to the 
imagery techniques that are used in the change phase, imagery in the exploration phase 
does not include rescripting of the images. 
Phase II – Change 
In the change phase different therapeutic techniques and interventions are used to work 
on change in EMS, emotional experiences and dysfunctional behaviors. Four types of 
interventions are used in the change phase: (1) cognitive techniques, (2) experiential 
techniques, (3) the therapeutic alliance, (4) behavioral techniques.  
Cognitive techniques 
Cognitive techniques are used to help the client to develop a more rational and objective 
way of thinking. The goal is to develop a more realistic view of the self and the world. 
The specific techniques that are used here are largely drawn from techniques that are 
used in cognitive therapy for depression (Beck, et al., 1979). 
Experiential techniques 
Experiential techniques are used to work on emotional experiences within the session. 
Experiential techniques that can be used in ST for chronic depression are imagery 
(rescripting) and chair dialogues. Imagery (rescripting) of current problematic 
situations and past experiences is used to teach the client to take different positions in, 
for example, unsafe, negative childhood experiences. By using these techniques the 
client learns to deal with experiences of incapacity and despair, to express basic needs to 
others, to develop healthy defense mechanisms, to create a sense of safety in 
problematic situations, and to adequately express negative emotions such as anger. The 
therapist takes a limited reparenting stance in this phase by acting as a good parent to 
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meet the needs that the clients’ inner child has missed in the past within the appropriate 
boundaries of therapeutic context. The aim is to provide the client with the needs that 
were not met in the past in order to make the way for further development. For example, 
the therapist provides the client with solace and support while at the same time 
provides clear boundaries.  
 Another important experiential technique that can be used in ST for chronic 
depression is chair dialogue. Chair dialogues have their roots in Gestalt Therapy and are 
also used in other therapy models for depression such as emotion focused therapy 
(Greenberg & Watson, 2006). In chair dialogues, every chair represents a different side 
of the self of the client. In schema therapy terms these different sides of clients are 
referred to as schema modes. For example, depressed clients might have a strong overly 
demanding side (demanding parent mode) to themselves while at the same time the 
healthy part of the self (healthy adult mode) might be weak. Although chair dialogues 
are usually conducted between two sides of the client it is also possible that more than 
two sides (modes) are involved (multiple chair dialogue). During chair dialogues the 
client is trained to set boundaries to the impact of his/her own punishing and overly 
demanding sides while at the same time training to further develop and strengthen the 
own healthy side (health adult mode) that can care for the inner vulnerable child side 
(vulnerable child mode) of the client. During chair work the therapist guides the 
different sides (modes) of the client through the dialogues. 
Therapeutic alliance 
The therapeutic alliance is an important instrument in ST. The therapist confronts the 
client with the client’s in-session behaviors that are driven by the client’s underlying 
EMSs by means of empathic confrontation. For example, a client who constantly inquires 
about the wellbeing of the therapist might repeat patterns of earlier learned 
parentification behaviors towards the parents. By means of empathic confrontation and 
exploration of these behaviors the client can learn to take a different stance. As was the 
case with the experiential techniques, the therapist takes the position of a good parent 
(limited reparenting) by exploring the needs of the client that were not met during 
childhood. The therapist tries to provide the client with these needs on the one hand 
while on the other hand provide the clients with the means to independently care for 
his/her basic needs. 
Behavioral techniques 
Important behavioral techniques that can be used in ST for chronic depression include 
role-playing, homework assignments, behavioral experiments and assertiveness training. 
By using these techniques, the client learns to put the cognitive and emotional insights 
learned in therapy into action. For example, a student who is afraid of rejection and 
negative feedback by his/her supervisor can be encouraged by the therapist to discuss 
these issues with the supervisor and making his/her needs known by asking for 
objective feedback.  
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Phase III – Relapse prevention 
During the last phase of therapy the client and therapist create a plan on how to prevent 
relapse. This includes an analysis of situations and events that might have the potential 
to trigger relapse and a plan for how to cope with these situations. During this last phase 
of therapy, sessions are scheduled with lower frequencies. The client receives more 
control over the sessions and the healthy adult side of the client that was developed 
during the previous phase is further coached and supported by the therapist in order to 
give way to the development of more confidence and autonomy.  
Concluding	remarks	
ST has become a promising treatment approach for clients with difficult to treat 
personality disorders. While there is a need for further research on the effectiveness of 
ST for axis-II disorders, it is also important to consider new adaptations of ST to chronic 
axis-I disorders. We have argued that ST is a potentially effective treatment for chronic 
depression as it targets important underlying risk factors to chronic depression. It 
should be noted, however, that there is no empirical evidence to date that ST is an 
effective treatment for clients with chronic depression. In order to test whether ST is a 
potentially effective treatment for chronic depression, we are currently conducting a 
single-case series of ST for chronic depression in the Netherlands (ClinicalTrials.gov 
Identifier: omitted for blinded review purpose). In this study 20 clients with chronic 
MDD receive up to 75 individual sessions of ST. In addition to standardized assessment 
instruments for depressive symptom severity and potential mediators of treatment 
outcome we are using an interview technique to assess schemas and core beliefs on an 
idiosyncratic level. Moreover, we are using functional Magnetic Resonance Imaging 
(fMRI) to study the underlying neural mechanisms of change in ST. The results of this 
study will provide the first empirical evidence on the effectiveness of ST as a novel 
treatment approach to chronic MDD and first insights into the underlying 
(neurobiological) working mechanisms of ST for chronic depression. 
 Besides the need to test whether ST is a potentially effective treatment for chronic 
depression it is also important to further study basic concepts of schema theory in 
(chronically) depressed clients. There is now some evidence that depressed clients are 
characterized by a specific set of EMS, yet, research into schema modes in depression is 
absent. The working model of chronic depression that we presented is based on 
underlying factors that have received the most consistent empirical support to date. As 
new evidence emerges, the model can be adapted to describe the role of specific schema 
modes in chronic depression.  
 In conclusion, ST is a promising new treatment approach for clients with severe 
chronic depressions because it directly targets the underlying vulnerability to chronic 
depression, as described in our working model, and is therefore likely to lead to positive 
and enduring outcomes. Future research on the effectiveness of ST for chronic 
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depression needs to be conducted comparing ST to other treatment options for chronic 
depression in larger samples in the context of randomized clinical trials. 
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Abstract	
The aim of this study was to test the effects of individual schema therapy (ST) on 
depressive symptom severity, recovery from depression, global symptomatic distress 
and improvements in overall functioning in patients with a DSM-IV diagnosis of chronic 
major depressive disorder (cMDD). Using a multiple-baseline single case series design, 
patients with cMDD (N = 25) first completed weekly assessments during a 6 to 24 weeks 
non-treatment baseline phase. After this baseline phase, patients entered a 12 week 
exploration phase during which symptoms and underlying schemas were explored and 
treatment goals were set; this phase also functioned as an attention control condition. 
Next, patients received up to 65 sessions of individual ST at a specialized secondary 
mental health care facility. During all three phases depressed symptoms and overall 
functioning was assessed every week, resulting in an average of 100 repeated weekly 
assessments per participant, whereas global symptom severity was assessed every four 
weeks. Of the overall sample five patients dropped out during the baseline period, none 
dropped out during exploration or treatment. Of the remaining 20 patients who started 
treatment, 40% responded and 35% remitted. Diagnostic assessments at post-treatment 
were available from 12 patients. Of these 12 patients, 58% did not meet the diagnostic 
criteria for a depressive disorder anymore and were therefore considered recovered. 
Mixed model regression analyses yielded significant time within intervention effects for 
all continuous outcomes: When compared to the baseline period, the intervention phase 
had a significant, large effect on depressive symptom severity (Cohen’s d between 0.91 
and 1.30), moderate to large effects on global symptomatic distress (Cohen’s d between 
0.64 and 0.86), and large effects on improvements in overall functioning (Cohen’s d 
between 0.93 and 0.96). These findings provide preliminary evidence that ST is an 
effective treatment for patients with cMDD. 
 
Keywords: schema therapy; chronic depression; single case series; long-term psycho-
therapy 
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Introduction	
About one in five patients with depression develops a chronic course defined as the 
presence of depressive symptoms for two years or longer (Keller, Hanks, Kocsis, & Klein, 
1995). Compared to non-chronic depression, chronic forms of depression are associated 
with a lower quality of life (Wells, Burnam, Rogers, & Hays, 1992), increased suicide 
attempts and hospitalizations (Arnow & Constantino, 2003; Torpey & Klein, 2008), 
greater service use and higher economic costs (Howland, 1993; Smit et al., 2006). 
Pharmacological and psychotherapeutic interventions for chronic depression are 
effective but meta analyses have shown that the effect sizes of psychotherapy are 
generally low (d = 0.23; Cuijpers, van Straten, et al., 2010) and about half of the patients 
with chronic forms of depression do not remit following treatment with antidepressant 
medication (for a review see: Kocsis, 2003). The most positive treatment results are 
obtained when psychotherapy and pharmacotherapy are combined, with effect sizes 
exceeding those of either treatment alone (Cuijpers, van Straten, et al., 2010; Spijker, van 
Straten, Bockting, Meeuwissen, & van Balkom, 2013). Given the negative consequences 
of chronic depression and the relatively low effects of current treatments, there is a need 
to further explore new treatment options. The aim of the present study was to test the 
effects of up to 75 individual sessions of schema therapy (ST) for patients with chronic 
major depressive disorder (cMDD). 
 Compared to patients with non-chronic depression, patients with chronic 
depression more frequently report a history of childhood adversity (Brown, Craig, 
Harris, Handley, & Harvey, 2007; Brown & Moran, 1994; Hayden & Klein, 2001; Lizardi 
& Klein, 2000) and increased rates of personality disorders (Fava et al., 1996; Hayden & 
Klein, 2001; Holmstrand, Engström, & Träskman-Bendz, 2008; Pepper et al., 1995). Such 
developmental factors and personality (disorders) can be conceptualized as underlying 
vulnerability to cMDD, meaning that they might increase the risk for developing 
depression as well as contributing to the maintenance of depression and thereby to 
depression chronicity. We have argued previously, that current treatments for (chronic) 
depression might not adequately take these factors into account, thereby leaving the 
underlying vulnerability to chronic depression untouched (Renner, Arntz, Leeuw, & 
Huibers, 2013). Given that chronic depression is often rooted in negative childhood 
events and personality pathology, current short-term, symptom focused treatments for 
chronic depression might fall short in addressing these factors sufficiently. Moreover, a 
recent meta-analysis has shown that the effects of psychotherapy for chronic depression 
have a dose-effect relationship with the number of treatment sessions (Cuijpers, van 
Straten, et al., 2010). Thus patients with chronic depression likely benefit more from 
long-term psychotherapy that focusses on present symptoms as well as on the 
underlying vulnerability. 
 ST is an integrative long-term psychotherapy for chronic and difficult to treat axis-I 
and axis-II disorders (Young, Klosko, & Weishaar, 2003). In ST special emphasis is 
placed on early childhood experiences and the relation of these experiences with 
current problems. Empirical evidence suggests that ST is effective in treating adults with 
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borderline personality disorder (Giesen-Bloo et al., 2006; Nadort et al., 2009; Nordahl & 
Nysaeter, 2005), and Cluster-C, paranoid, histrionic and narcissistic personality 
disorders (Bamelis, Evers, Spinhoven, & Arntz, 2013). We have previously argued that 
ST is also a potential effective treatment for patients with chronic depression (Renner et 
al., 2013). Moreover, we have shown that patients with depression are characterized by 
a distinct set of early maladaptive schemas and have argued that depressed patients 
might benefit from addressing these schemas in ST (Renner, Lobbestael, Peeters, Arntz, 
& Huibers, 2012).  
 Most studies to date have focused on the effects of ST for personality disorders. In 
2009 our group started a single-case series of ST for cMDD as a first attempt to test 
whether ST is a potentially effective treatment for patients with cMDD too 
(ClinicalTrials.gov Identifier: NCT01153867). Since then, a number of studies have 
emerged supporting the effects of ST (techniques) for (chronic) depression. Brewin et al. 
(2009) reported positive and large effects of imagery rescripting, a key-technique in ST, 
on depressive symptom severity as a stand-alone intervention for treating patients with 
chronic depression. Carter et al. (2013) compared ST with cognitive therapy (CT) in a 
randomized controlled trial (RCT) focusing on patients with MDD. On average, 
participants received 22.3 sessions of ST (Carter et al., 2013), a less intense treatment 
protocol than we have previously suggested for patients with chronic depression 
(Renner et al., 2013). At the end of the study no differences emerged between the two 
conditions on the main study outcomes (Carter et al., 2013). In the ST condition 50% of 
the patients remitted (40% in CT) and 56% of those randomized to ST recovered (50% 
in CT) (Carter et al., 2013). Results did not differ for a subgroup of patients with chronic 
depression (67%), suggesting that this relatively short ST protocol for depression was as 
effective as CT for patients with and without chronic depression (Carter et al., 2013). 
Another study tested the effects of ST in women with chronic depression (dysthymic 
disorder, double depression or cMDD), using a single-case series design (Malogiannis et 
al., 2014). Following an eight week baseline period, 12 patients with chronic depression 
received up to 60 sessions of individual ST. The authors found large effects of ST on 
depressive symptom improvements and approximately 60% of patients remitted during 
treatment (Malogiannis et al., 2014). 
 Although findings from these studies are promising, there is a need to further test 
the effects of ST for patients with cMDD with an appropriate amount of sessions. The 
study by Carter et al. (2013) primarily focused on patients with non-chronic depression 
and had a limited number of treatment sessions which might not be sufficient for 
patients with cMDD. The study by Malogiannis et al. (2014) did not include multiple 
baselines in the case series making it more difficult to attribute effects to treatment 
rather than passing of time. Moreover, Malogiannis et al. (2014) did only include women 
with chronic depression thereby limiting the generalizability of findings. The current 
study advances previous studies by testing the effects of up to 75 individual sessions of 
ST in patients with cMDD using a multiple-baseline single-case series design. We 
compared the effects of ST relative to a (quasi-random) baseline (i.e. waiting list) period 
in 25 patients with cMDD. The strength of this design above an open-trial design or a 
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single-case series design without multiple baselines is that, just like in an RCT, 
symptomatic improvements during treatment can be attributed to the intervention 
rather than to the passing of time (Kazdin, 1982). In this respect, the baseline period in 
the current single-case series serves the purpose of a waiting-list control group in an 
RCT. An extra asset of the current study is that, in addition to the baseline period, we 
included an exploration phase during which no interventions aimed to change 
symptoms were used. The exploration phase thus served as an extra control condition 
enabling us to test if symptomatic improvements occur due to the intervention or due to 
non-specific factors such as receiving empathy or attention for one’s problems (see 
Arntz, Sofi, & van Breukelen, 2013, for a similar design). 
Methods	
Participants 
Twenty-five patients with cMDD participated in this study. Patients were recruited from 
a specialized secondary mental health facility in the Netherlands (RIAGG Maastricht, The 
Netherlands). Inclusion criteria were a primary diagnosis of cMDD, defined as meeting 
the DSM-IV criteria for MDD for at least two years as assessed by the Structured Clinical 
Interview for DSM-IV Axis-I Disorders (SCID-I; First, Spitzer, Gibbon, & Williams, 1997); 
a score of at least 20 on the Beck Depression Inventory second edition (BDI-II; Beck, 
Steer, & Brown, 1996); and age between 18-65 years. Patients were excluded if they had 
a medical condition that might be correlated with depression either directly or through 
medication intake; had a DSM-IV current or past diagnosis of major depression with 
psychotic features; current or past bipolar disorder; current or past psychotic disorder; 
alcohol or drug dependence or a autism spectrum disorder, as assessed with the SCID-I. 
Patients with cluster-A or cluster-B personality disorders, as assessed with the 
Structured Clinical Interview for DSM-IV Axis-II Disorders (SCID-II), were also excluded. 
Additional exclusion criteria were acute suicide risk and inability to speak and read the 
Dutch language. Patients taking antidepressant medication were excluded, unless they 
were stable on medication for at least three months prior to the screening procedure.
16 The study was approved by the medical ethical committee of the University Hospital 
Maastricht, The Netherlands and the local ethics committee of the specialized secondary 
mental health facility where treatment was provided (RIAGG Maastricht). All patients 
enrolled in the study signed written informed consent. Prior to patient recruitment, this 
study has been registered at clinicaltrials.gov (identifier: NCT01153867). 
 The study took place between December 2010 and March 201417. Table 1 provides 
an overview of the demographic and clinical characteristics of the sample. 
                                                        
16 Medication dosage of one participant taking venlafaxine was increased from 75 mg. to 150 mg. two 
month prior to start of the study. 
17 At the end of the funding period for this study 7 patients out of the 25 patients who originally started 
with the study were still in treatment, receiving low-frequency ST (about 1 session per month). For the 
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Table	1. Overview of the demographic and clinical characteristics of the sample  
Variable Mean (SD) / Frequency (%) 
Age 41.36 (16.45) 
Gender 
 Female 
 Male 
 
20 (80%) 
5 (20%) 
Country of origin 
 Netherlands 
 Other 
 
23 (92%) 
2 (8%) 
Marital status 
 Single 
 Partner 
 Married 
 Divorced 
 
10 (40%) 
6 (24%) 
7 (28%) 
2 (8%) 
Education level 
 Low 
 Medium 
 High 
 
1 (4%) 
8 (32%) 
16 (64%) 
Work Situation 
 Paid work or student 
 Unemployed 
 Retired 
 Other 
 
10 (40%) 
3 (36%) 
9 (36%) 
3 (12%) 
BDI-II score at screening 32.96 (9.37) 
# previous episodes  2.80 (2.14) 
Secondary Axis-I diagnosis 
 None 
 Anxiety Disorder 
 Other 
 
14 (56%) 
6 (24%) 
5 (20%) 
Secondary Axis-II diagnosis 
 None 
 Depressive PD 
 Avoidant PD 
 Obsessive Compulsive PD 
 Dependent PD 
 
9 (32%) 
9 (36%) 
7 (28%) 
6 (24%) 
1 (4%) 
Antidepressant use at baseline 11 (44%) 
Note. BDI-II = Beck Depression Inventory – second edition. 
Design 
We used a single case series design with multiple quasi random baselines across 
participants and 12 months follow-up (follow-up data not reported here). The study 
consisted of three phases: Phase 1: The baseline phase was a 6 – 24 weeks waiting 
period that served as a no-treatment control phase. The duration of the baseline phase 
was quasi-random (dependent on the waiting time at the clinic). Phase 2: The 
                                                                                                                                                                             
patients that were still in treatment at the end of the study no post treatment SCID interviews were 
available. 
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exploration phase lasted 12 weeks and consisted of 8 to 10 sessions that served as an 
extra control for receiving attention and empathy. The number of sessions in the 
exploration phase varied depending on individual progress in identifying and exploring 
underlying schemas. Phase 3: During the intervention phase, participants received up to 
65 individual sessions ST as described below. Therapists were instructed to not exceed a 
total of 75 sessions (exploration + intervention phase). During all study phases all 
primary and secondary outcomes were repeatedly assessed.	
Assessments 
Primary outcome measures 
Response, Remission and Recovery from depression 
Treatment response was defined as a 50% drop in depressive symptom severity, as 
assessed with the BDI-II, from the first baseline assessment to the last intervention 
assessment. Remission was defined as a mean score of six or lower on the QIDS-SR at the 
last intervention phase assessment, in line with a previous study in patients with 
chronic depression that compared QIDS-SR cutoffs of remission with established cutoffs 
on the Hamilton Rating Scale of Depression (Rush et al., 2003). We defined recovery from 
depression as the absence of a DSM-IV diagnosis of depression at post-treatment as 
assessed with the SCID-I interview. SCID-I post intervention interviews of 12 patients 
who completed treatment were available. 
Continuous primary outcome measures 
 BDI-II - The Beck Depression Inventory, second edition, was used to measure 
depressive symptom severity (Beck et al., 1996). Each of the 21-items of the BDI-II 
consists of four statements with increasing severity ranging from 0 to 3, resulting in a 
total score of 0 to 63 with higher scores representing more depressive symptom 
severity. The instructions of the original BDI-II were adapted in the current study, asking 
participants to evaluate depressive symptoms during the past week instead of the past 
two weeks because the BDI-II was administered once a week. The Dutch version of the 
BDI-II that was used in the present study has been shown to have good psychometric 
properties (van der Does, 2002). In the current study, the internal reliability coefficient 
alpha of the BDI-II at the initial baseline assessment was excellent (α = .91). 
 QIDS-SR - The Quick Inventory of Depressive Symptomatology self-report version 
is a 16-item self-report instrument measuring depressive symptom severity over the 
past seven days (Rush et al., 2003). This shortened version of the original 30-item 
version (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996) has been shown to highly 
correlate with clinical rating scales, such as the Hamilton Rating Scale for Depression, in 
patients with chronic depression (Rush et al., 2003). In the current study, the internal 
reliability coefficient alpha of the QIDS-SR at the initial baseline assessment was 
satisfactory (α = .75). 
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Continuous secondary outcome measures 
 BSI - The Brief Symptom Inventory is a 53-items self-report instrument measuring 
symptomatic distress along nine subscales (Derogatis, 1992). In the current study, a 
global severity index was calculated by averaging all scores. In the original BSI, 
participants rate each item along a 5-point scale to describe whether an item applies to 
them or not. In the present study the original scale was adapted to a 100mm Visual 
Analogue Scale (VAS) for two reasons: First, VAS scales might be more sensitive to 
subtle changes because respondents are not forced into a response category (Breivik, 
Bjornsson, & Skovlund, 2000). Second, we were concerned that due to the large number 
of repeated assessments participants might remember response categories which might 
introduce a socially desirable answering bias. Good psychometric properties have been 
reported for the BSI (de Beurs, 2004). In the current study, the internal reliability 
coefficient alpha of the BSI at the initial baseline assessment was excellent (α = .94). 
 ORS - The outcome rating scale (ORS) is a short, 4-item, self-report instrument that 
was designed to assess client functioning along three areas: individual functioning, 
interpersonal functioning, and social functioning (Miller, Duncan, Brown, Sparks, & 
Claud, 2003). In addition to these areas the questionnaire includes an item assessing 
overall wellbeing. In the current study the overall wellbeing scale was used in all 
analyses. The ORS has been shown to possess adequate psychometric properties (Miller 
et al., 2003). 
Procedure 
Schema Therapy for chronic depression 
Figure 1 provides an overview of the assessments during the different study phases. 
Patients completed the BDI-II and the ORS weekly during the baseline phase, the 
exploration phase and the intervention phase. The QIDS-SR and the BSI were completed 
on a monthly basis. These questionnaires were completed less frequent to decrease the 
burden of repeatedly completing lengthy questionnaires. The initial baseline assessment 
was conducted at the university. All remaining questionnaires were completed via the 
internet: Participants received an email once a week, on a fixed date, with personal login 
information for a secured website. On the website participants completed all 
questionnaires. The SCID-I and SCID-II was completed during intake and at the end of 
treatment in order to determine the diagnostic status of participants. The SCID 
interviews at intake were conducted by experienced clinicians at the mood disorders 
unit of the clinical site where treatment was provided. SCID interviews at the end of 
treatment were conducted by the therapists. 
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Figure	 1. Overview of the assessments in the different study phases. SCID-I/II = Structured Clinical 
Interview for DSM-IV Axis-I/II Disorders; BDI-II = Beck Depression Inventory – second edition; BSI = Brief 
Symptom Inventory; ORS = Outcome Rating Scale; QIDS-SR = Quick Inventory of Depressive 
Symptomatology – Self Report. 
 
The ST intervention consisted of 8 to 10 sessions exploration and up to 65 sessions 
active intervention with a combined maximum of 75 sessions lasting 50 minutes each. 
The definite number of sessions was dependent on the individual progress in therapy, in 
agreement between the patient and therapist. Therapy was provided in weekly sessions 
initially with lower frequency sessions in later stages of treatment. Therapy was 
conducted by experienced therapists (experience with schema therapy varying between 
5 and 12 years) according to the methods described by Young et al. (2003). Treatment in 
this study was divided into two phases, the exploration phase and the intervention 
phase. During the exploration phase the therapist helped the patient to understand the 
schema concept and to establish relations between the patients’ predominant schemas, 
current problems and his/her developmental history. The therapist also helped the 
patient to experience the feelings that are associated with the activation of these 
schemas. Thus during the exploration phase schemas and current problems are merely 
explored and no attempts are made to actively change schemas or resolve current 
problems. The intervention phase consisted of a maximum of 65 individual sessions of 
ST to work on change in underlying early maladaptive schemas, emotional experiences 
and dysfunctional behaviors. During this phase the underlying schemas are targeted by 
the use of cognitive techniques, experiential techniques, the therapeutic alliance (limited 
reparenting), and behavioral techniques (Young et al., 2003). Towards the end of the 
intervention phase a relapse prevention plan is established which includes an analysis of 
situations and events that could potentially trigger future depressive relapses. Coping 
strategies to deal with these situations are also included in the plan. A more detailed 
description of the treatment manual of ST for chronic depression can be found 
elsewhere (Renner et al., 2013) and a session-by-session protocol (in Dutch) is available 
from the first author. 
Statistical analyses 
Change in continuous primary and secondary outcome measures during the different 
treatment phases was modelled using mixed regression analyses in SPSS version 22. All 
available data was used in the analyses including data of participants who only provided 
baseline data for intent-to-treat principles and to increase the statistical power. 
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Statistical analyses of baseline and treatment effects were based on the methods 
described in (Arntz et al., 2013; Malogiannis et al., 2014). 
 First, we analyzed change in depressive symptoms during the baseline phase to 
determine whether symptom severity remained stable in the absence of active 
treatment. To determine the optimal model we compared the model fit for different 
autoregressive covariance structures (AR1 and ARMA1,1) and different representations 
of change over time (linear, quadratic, logarithmic). The optimal model for the main 
continuous outcome measure (BDI-II) had an ARMA1,1 covariance structure for the 
repeated part with a logarithmic representation of time in the fixed effects part of the 
model and included random intercepts and slopes in the random part. Change over time 
was best represented by log-transformed time, thus the fixed effect of log-transformed 
time was used to test time development of depressive symptoms during baseline. 
 Next, we tested treatment effects of the exploration and intervention phase versus 
the baseline phase in terms of average scores within the phases and linear change within 
the phases. The analytic approach is based on the following fixed effects: a general time 
effect, additional dummy coded variables for the exploration and treatment phases as a 
test of differences in average symptom levels within phases relative to baseline, and 
linear time variables, individually centered within each phase as a test of change in 
depressive symptoms (in addition to the general time effect) during the exploration 
phase and intervention phase. Again logarithmic transformed time represented the 
general time effect best, so the general time effect was based on logarithmic 
transformation of time effect coded 0 when the first assessment took place for an 
individual. In these models, random intercepts were added but random slopes were left 
out due to convergence problems. When the general time effect was non-significant in 
the full model it was deleted and the model was re-run without the general time effect. 
 To determine the strength of treatment effects we calculated two version of 
Cohen’s d. One based on the estimates of the mixed regression analyses by subtracting 
the last estimated treatment value from the last estimated baseline value and by 
dividing the result by the SD based on the variance of the random part of the model. The 
other version of Cohen’s d was obtained by subtracting the last observed value of the 
last treatment assessment from the last observed baseline value and by dividing the 
result by the SD of the last observed baseline assessment. The same approach was used 
to calculate effect sizes based on the last assessment in the exploration phase. 
Results	
Description of the data 
Overall, there were 2022 weekly assessment moments across the study phases. 
Participants completed 1557 weekly assessments (77% completion rate). On average, 
each participant received 10 weekly assessments during baseline (completion rate 
93.1%), 12 weekly assessments during the exploration phase (completion rate 89.2%), 
and 78 weekly assessments during the intervention phase (completion rate 72.5%). 
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Thus, during the course of the entire study (excluding the follow-up phase), on average, 
participants received 100 weekly assessment batteries.  
Number of treatment sessions 
On average, patients in this study received 52.6 sessions ST (combined exploration and 
intervention phase; SD = 14.01; min = 24 max = 74). Patients who completed treatment 
on average completed 54.6 sessions (SD = 14.56) whereas patients who were still in 
treatment at the end of the study period completed on average 48.71 sessions (SD = 
13.09). 
Dropout 
Of the 25 patients recruited for this study 5 (20%) dropped out during the baseline 
period. Three patients stopped with the study because they decided to start with a 
symptom focused treatment approach during the waiting time (two CBT; one 
antidepressants), one stopped because of a new job and lack of time and one stopped 
due to unspecified personal reasons. None of the 20 patients who started with treatment 
dropped out during the exploration or intervention phase. 
Primary outcomes 
Response, Remission and Recovery 
At the last intervention phase assessment, 8 out of 20 (40%) patients responded to 
treatment, defined as a 50% reduction in depressive symptom severity on the BDI-II. Of 
the 20 patients who started treatment, 7 (35%) reached remission, defined as a score of 
6 or lower on the QIDS-SR (Rush et al., 2003). Recovery from depression was defined as 
an absence of a DSM-IV diagnosis of depression at post-treatment. DSM-IV diagnoses as 
assessed with the SCID-I interview at post-treatment were available from 12 patients. 
The remaining 8 patients were still in treatment and therefore had no post treatment 
SCID data. Of the 12 patients with available DSM-IV diagnoses, seven (58%) recovered. 
Change in depression severity during baseline 
For all analyses of baseline effects we first determined the optimal representation of the 
time variable by comparing model fit for a linear, quadratic and log-linear 
representation of time. The log-linear time variable provided the best fit to the data for 
both the BDI-II total score as well as for the QIDS-SR total score. There was a statistically 
significant logarithmic decrease in the BDI-II total score during baseline, B = -2.03, 
t(25.83) = -2.56, p = .02, suggesting that depressive symptom severity decreased during 
the baseline phase. Figure 2 is a graphical representation of the change in symptoms 
during baseline based on the mixed regression estimates. As can be seen in Figure 2, 
there was a relatively steep decrease in symptoms during the first weeks of baseline 
which then leveled out during the course of time, such that at the end of the baseline 
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phase the average BDI-II score was still well above the cut-off at which patients were 
included. The effect size of change in BDI-II within the baseline phase was d = 0.39 for 
the observed values and d = 0.51 for the MLM derived estimates. The effect of log-
transformed time for the QIDS-SR was also significant during baseline, B = -1.68, t(27.87) 
= -2.81, p = .01, showing that participants’ QIDS-SR total score decreased initially during 
baseline before stabilizing again. The effect size of change in QIDS-SR within the baseline 
phase was d = 0.26 for the observed values and d = 0.27 for the MLM derived estimates. 
 
 
Figure	 2. Graphical representation of decrease in depressive symptoms during 
baseline. 
 
Treatment effects on depressive symptom severity 
First, we tested a model with a general log time effect across phases as a single predictor 
using an ARMA1,1 covariance structure for the repeated part and random intercepts 
with the BDI-II total score as dependent variable. There was a significant effect of time 
(log-transformed), B = -2.63, t(112.08) = -6.38, p < .001, suggesting that depressive 
symptoms decreased over time across phases. Next, we added dummy variables for 
condition, and linear time-within-phase (exploration and intervention)18 centered 
covariates to test for treatment effects (i.e. the slope within these phases relative to the 
slope of the general time effect). The results of these analyses are summarized in Table 2. 
In these analyses, the overall effect of log-transformed time became weaker, but 
remained significant, B = -2.31, t(567.46) = -3.67, p < .001. The time-intervention effect 
was significant, B = -0.07, t(68.95) = -2.75, p = .008, reflecting that the intervention had a 
significant impact on change in depressive symptoms that exceeded the overall decrease 
                                                        
18 Due to the inclusion of the overall time effect in the model it is usually redundant to also include a time-
within baseline covariate in these analyses. However, when the time-within baseline covariate was 
included in the model that also included the general time effect, the effect of time within intervention 
remained significant (p=.005). The addition of this linear time-within baseline effect was statistically 
possible because the general time effect was based on log-transformed time. 
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in symptoms over time. The time-exploration phase effect was not significant, B = 0.14, 
t(385.99) = 0.81, p = .42, suggesting that depressive symptoms did not change during 
the exploration phase. Figure 3 plots the MLM predicted means for the BDI-II across the 
different study phases. 
 Effect size estimates (Cohen’s d) for treatment effects were calculated by 
subtracting the last intervention phase assessment from the last baseline assessment 
and by dividing the result by the standard deviation. Based on the MLM estimates the 
effect size was d = 1.30 and based on the observed mean and SD at the last baseline 
assessment the effect size was d = 0.91. Based on the last exploration phase assessment 
effect size estimates for treatment effects were d = 1.42 and d = 0.95 for the MLM based 
and observed means and SDs, respectively. 
 We also tested a general time effect across phases for the QIDS-SR, using an 
ARMA1,1 covariance structure. Before adding dummy variables for condition, and time-
within-phase centered covariates, there was a significant effect of time, B = -1.54, 
t(95.83) = -4.28, p < .001, reflecting that depressive symptoms on the QIDS-SR decreased 
over time (not reported in Table). After adding dummy variables for condition, and 
time-within-phase centered covariates, to test for treatment effects, the general time 
effect became non-significant, indicating that the general time effect was actually caused 
by the intervention, as the effect of linear change within the intervention phase was 
significant, B = -0.18, t(47.40) = -2.30, p = .03, reflecting a decrease in QIDS-SR during 
intervention. All other effects were non-significant (Table 2). After removing the non-
significant general time effect from the model the intervention time effect remained 
significant, B = -.25, t(44.28) = -4.04, p < .001, (Table 2). The MLM predicted means of 
the QIDS-SR across the different treatment phases is shown in Figure 3. 
 Based on the MLM estimates of the model including the general time effect, the 
effect size for the QIDS-SR was d = 1.22 and based on the observed mean and SD at the 
last baseline assessment the effect size was d = 1.20. Based on the last exploration phase 
assessment effect size estimates for treatment effects were d = 1.23 and d = 0.93 for the 
MLM based estimates and observed means and SDs, respectively. 
Secondary outcomes 
As secondary continuous outcomes, we tested the effects of ST on general symptomatic 
distress and overall wellbeing. As in the primary analyses for continuous outcomes we 
first tested change in these variables during the baseline phase before testing for 
intervention effects. 
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Table	2. Results of mixed regression analyses testing the effects of schema therapy on primary outcome 
measures. 
 Beta SE DF t p 
BDI-II     
Intercept 32.92 2.32 41.47 14.19 <.001 
Time1  -2.31 0.63 567.46 -3.67 <.001 
Exploration 2.31 1.20 505.93 1.93 .06 
Intervention -0.88 2.03 344.49 -0.44 .66 
Time Exploration 0.14 0.17 385.99 0.81 .42 
Time Intervention -0.07 0.02 68.95 -2.75 .008 
QIDS-SR including general time effect    
Intercept 14.94 1.11 39.31 13.51 <.001 
Time1  -1.22 0.71 293.91 -1.72 .09 
Exploration 0.81 0.89 234.95 0.92 .36 
Intervention -1.29 1.61 244.13 -0.80 .43 
Time Exploration 0.81 0.97 290.52 0.84 .40 
Time Intervention -0.18 0.08 47.40 -2.30 .03 
QIDS-SR after deleting ns. general time effect   
Intercept 14.27 1.03 31.69 13.79 <.001 
Exploration -0.35 0.58 234.32 -0.60 .55 
Intervention -3.69 0.77 55.69 -4.78 <.001 
Time Exploration 0.26 0.91 308.50 0.28 .78 
Time Intervention -0.25 0.06 44.28 -4.04 <.001 
Note. 1 = Log transformed 
 
Change in global symptom severity (BSI) 
First we tested change in global symptom severity during baseline as assessed with the 
BSI. Change in global symptom severity during baseline was best described by a log-
transformed-time model. There was a significant decrease in global symptom severity 
during baseline, B = -3.76, t(37.82) = -2.04, p = .048. Next, we entered the dummy coded 
variables for the exploration and intervention phase as well as the time-within-phase 
centered variables as a test of linear change in global symptom severity within the 
different phases, relative to the baseline phase. In this model, the general effect of time 
was not significant, B = -2.96, t(307.20) = -1.52, p = .13 and neither was the time-within 
intervention phase fixed effect, B = -0.36, t(82.38) = -1.73, p = .09. However, after 
removing the non-significant general time effect from the model, there was a significant 
effect of time-within intervention phase, B = -0.54, t(32.53) = -3.24, p = .003, indicating 
that general symptom severity decrease within the intervention phase was responsible 
for the overall decrease. Change in the general symptom severity score across the 
different study phases is displayed in Figure 3. 
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 Based on the MLM estimates of the model excluding the non-significant general 
time effect, the effect size for the BSI was d = 0.86 and based on the observed mean and 
SD at the last baseline assessment the effect size was d = 0.64. Based on the last 
exploration phase assessment effect size estimates for treatment effects were d = 0.76 
and d = 0.44 for the MLM based estimates and observed means and SDs, respectively. 
Change in overall wellbeing (ORS) 
First, we investigated change in overall wellbeing during baseline. As for depressive 
symptom severity, change in overall wellbeing during baseline was best described by 
log-transformed time. There was a significant effect of time during baseline on overall 
wellbeing, B = 4.28, t(58.13) = 2.15, p = .04, indicating that overall wellbeing improved 
during the initial baseline assessments and stabilized subsequently. To test the effects of 
the intervention phase on overall wellbeing, we entered log-transformed time, the 
dummy coded variables for the exploration and intervention phase as well as the time-
within-treatment phase centered variables as a test of linear change in overall wellbeing 
within the different phases. In this model, the general effect of time was not significant, B 
= 3.00, t(560.50) = 1.69, p = .09. The results of these analyses are summarized in Table 3. 
There was a significant effect of the intervention phase on improvements in overall 
wellbeing, B = 0.10, t(219.37) = 2.17, p = .03, indicating that the intervention had a 
significant impact on improved overall wellbeing that exceeded the overall decrease in 
symptoms over time. After deleting the non-significant general time effect, the time 
effect of the intervention phase remained significant, B = 0.15, t(129.37) = 4.20, p < .001, 
(Table 3). Change in overall wellbeing across the different study phases is shown in 
Figure 3. 
 Based on the MLM estimates of the model excluding the non-significant general 
time effect, the effect size for improvements in overall wellbeing was d = 0.93 and based 
on the observed mean and SD at the last baseline assessment the effect size was d = 0.96. 
Based on the last exploration phase assessment effect size estimates for treatment 
effects were d = 0.98 and d = 1.12 for the MLM based estimates and observed means and 
SDs, respectively. 
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Table	3. Results of mixed regression analyses testing the effects of schema therapy on secondary outcome 
measures. 
 Estimate SE DF t P 
BSI     
Intercept 48.64 3.25 36.76 14.97 <.001 
Time1 -2.96 1.94 313.67 -1.52 .13 
Exploration 2.32 2.41 328.83 0.96 .34 
Intervention -2.07 4.39 277.91 -0.47 .64 
Time Exploration -1.00 2.56 326.30 -0.39 .70 
Time Intervention -0.36 0.21 86.02 -1.73 .09 
BSI after deleting ns. general time effect   
Intercept 47.11 3.07 29.97 15.36 <.001 
Exploration -0.47 1.58 233.61 -0.30 .77 
Intervention -7.95 2.09 30.85 -3.81 .001 
Time Exploration -2.37 2.41 318.75 -1.00 .33 
Time Intervention -0.54 0.17 32.53 -3.24 .003 
ORS     
Intercept 36.00 3.91 130.40 9.20 <.001 
Time1 3.00 1.78 560.50 1.69 .09 
Exploration -2.03 3.27 509.18 -0.62 .53 
Intervention 5.44 5.05 403.39 1.08 .28 
Time Exploration -0.3 0.47 568.61 -0.66 .51 
Time Intervention 0.10 0.05 219.37 2.17 .03 
ORS after deleting ns. general time effect   
Intercept 40.32 2.96 46.84 13.63 <.001 
Exploration 1.59 2.47 397.28 0.65 .52 
Intervention 13.10 2.21 177.91 5.91 <.001 
Time Exploration 0.01 0.43 774.10 0.03 .98 
Time Intervention 0.15 0.04 129.37 4.20 <.001 
Note.1Log transformed 
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Discussion	
The aim of this study was to test the effects of individual ST for cMDD on depressive 
symptoms, recovery from depression and improvements in overall wellbeing. We found 
that 40% of the patients responded to treatment whereas 35% remitted. Of the 
subsample of 12 patients who were reassessed with the SCID after treatment 
completion, 58% did not meet the DSM-IV criteria for a depressive disorder at post-
treatment anymore and were therefore considered to have recovered from depression. 
Relative to the overall decrease in symptoms over time, there was a significant effect of 
the ST intervention phase on depressive symptoms. After accounting for decreased 
symptom severity during the baseline phase, by considering the last baseline phase 
assessments, the effect sizes for decreased depressive symptoms during the 
intervention phase were large. The exploration phase had no effects on depressive 
symptom severity. 
 Although five patients dropped out during the baseline phase of the study, none of 
the patients in the current study dropped out from treatment. Previous studies of ST for 
personality disorder have also reported relatively lower dropout rates in ST compared 
to treatment as usual (Bamelis et al., 2013) or psychotherapy control conditions 
(Giesen-Bloo et al., 2006). ST places special emphasis on building a strong therapeutic 
relationship during the exploration phase (Young et al., 2003). Although speculative, it is 
possible that this protects from dropout during treatment because patients might feel 
more attached and committed to the therapy. In line with this, it has been shown that 
negative ratings of the therapeutic alliance predict dropout, and that the high treatment 
retention of ST probably relates to early strong therapeutic alliance (Spinhoven, Giesen-
Bloo, van Dyck, Kooiman, & Arntz, 2007). 
 Overall, our findings add to the accumulating evidence that ST is a promising new 
treatment for patients with (chronic) depression (Carter et al., 2013; Malogiannis et al., 
2014). Malogiannis et al. (2014) conducted a single case series for chronically depressed 
women and found comparable remission (41.6%) and recovery (60%) rates. In their 
study, relatively larger effect sizes for ST were reported when contrasted with baseline, 
using a clinical rating scale (Hamilton Rating Scale for Depression) to assess depressive 
symptom severity. A recent meta-analysis has shown that clinical rating scales of 
depressive symptoms usually result in larger effect sizes (Cuijpers, Li, Hofmann, & 
Andersson, 2010) and therefore differences in effect sizes in the current study can at 
least in part be attributed to differences in the outcome assessment format. Moreover, in 
the current study a more stringent control for change in symptoms over time was used, 
as we implemented multiple quasi-random baselines in our experimental design. Finally, 
in the study by Malogiannis et al. (2014) only 5 out of 12 patients fulfilled the criteria of 
cMDD, whereas the remaining patients had either a less severe form of chronic 
depression (dysthymic disorder) or an non-chronic depressive episode superimposed 
on a dysthymic disorder (i.e. double depression). Thus, differences in diagnostic groups 
might also account for differences in effect sizes obtained. 
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 Slightly higher remission rates were reported by (Carter et al., 2013) comparing 
the effects of a shorter ST protocol to cognitive therapy in a RCT. Half of the patients in 
the ST arm in the study by Carter and colleagues remitted. Carter et al. (2013) also 
included non-chronically depressed patients and although no differences were found for 
overall treatment effects between chronically depressed and non-chronically depressed 
patients, it is possible that the non-chronically depressed patients contributed to the 
slightly higher remission rates. 
 When benchmarking the findings of the current study against the effect size found 
in a recent meta-analysis of psychotherapy for chronic depression (d = 0.23; Cuijpers, 
van Straten, et al., 2010), ST in the current study seems to perform clearly above average. 
Although the results of the current study cannot directly be compared to meta-analytic 
findings based on RCTs, the stringent control phases in the current study allowed us to 
control for a general decrease in symptoms over time (baseline phase) and for possible 
effects of receiving attention and empathy (exploration phase). In this sense, the control 
phases in the current study are comparable to waiting-list control conditions (baseline 
phase) and non-active control treatment (exploration phase) conditions in an RCT. 
Interestingly, in the current study the exploration phase had no effects on changes in 
depressive symptoms or secondary outcomes which indicates that non-specific therapy 
factors such as empathy, receiving attention and the development of a therapeutic 
relationship had no direct effect on symptomatic improvements. Symptom reports even 
suggest worsening during this phase, an effect previously observed by Weertman and 
Arntz (2007) in a study in patients with personality disorders. Note however that 
although the exploration phase had no direct effects on symptoms in the current study it 
is possible that the received attention and empathy and the therapeutic bond that is 
built during this phase might still have had an effect on symptom improvements in later 
stages of treatment. 
 We also tested for improvements in global symptomatic distress and overall 
wellbeing as relevant secondary outcomes. Participants improved with moderate to 
large effect sizes on global symptomatic distress, indicating that the positive effects of ST 
on depressive symptoms extended to broader aspects of distress. Improvements in 
overall wellbeing during the intervention phase were also large, indicating that the 
positive effects of ST on depressive symptoms transferred to improvements in overall 
wellbeing. Relatively smaller effect sizes for social functioning, an aspect of overall 
wellbeing, were reported in a recent meta-analysis testing the effects of psychotherapy 
for depression on psychosocial functioning, even when treatment was contrasted with 
primarily waiting-list control conditions (Renner, Cuijpers, & Huibers, 2014), most 
closely resembling the baseline control phase in the current study. 
 The current study included a 6-24 weeks quasi-random baseline period. The 
purpose of this baseline period was to control for change in symptoms over time in the 
absence of active treatment. Unexpectedly, we found a significant, moderate, decrease in 
depressive symptom severity and in secondary continuous outcomes during baseline. 
This decrease could best be described by a log-linear curve, with a relatively strong 
initial decrease in symptoms which then leveled out during the course of the baseline 
CHAPTER 9 
 192 
period. At least two explanations might account for the decrease during baseline. 1) The 
decrease in symptoms during baseline represents a ‘true’ change in depressive symptom 
severity or 2) the decrease in symptoms during baseline represents a measurement 
artifact. In favor of the first explanation, it is possible, for example, that patients 
experienced a strong motivation to start with a novel, promising, treatment in an 
academic context. This might have led to an initial alleviation in depressive symptoms 
during the first weeks of the study (i.e. an expectancy effect) which then leveled out in 
the course of the baseline phase. In favor of the second explanation, it is possible that 
patients initially overestimated their symptom severity and that due to the repeated 
completion of and reflection on the questionnaires established a new, ‘true’, stable 
baseline. In line with the second explanation, it has been shown previously, that change 
in the BDI in the absence of treatment is a function of the frequency of test 
administration (Longwell & Truax, 2005) with weekly administration resulting in 
decreases in the overall score whereas BDI scores remain stable during bi-weekly or 
monthly administration. Moreover, based on data drawn from the National Institute of 
Mental Health Treatment of Depression Collaborative Research Program (Elkin, Parloff, 
Hadley, & Autry, 1985), it has been shown than patients with depression become more 
accurate in assessing their self-reported depressive symptom severity on the BDI over 
time (Fokkema, Smits, Kelderman, & Cuijpers, 2013). Given that patients in the current 
study, by definition, suffered from depression for at least two years, it is unlikely that 
they experienced a ‘true’ decrease in symptoms during baseline. This interpretation is 
speculative and based on the current study design it is not possible to empirically 
support either explanation. To determine if the frequency of assessments of depressive 
symptom severity introduces a measurement error, patients should be randomized to 
different frequencies of repeated assessments in the absence of treatment. 
 Overall, the finding that depressive symptoms decreased during baseline has 
important implications for treatment outcome studies. Depressed patients who are 
included in treatment outcome studies should be re-assessed several times until 
symptom severity is stable. If studies fail to do so it is possible that part of the initial 
decrease in symptoms seen in the first weeks of treatment is due to a measurement 
artifact.  
Limitations 
A number of important limitations should be considered when interpreting these results. 
First, we conducted a single case series study which by design does not include a control 
group which can be perceived as a limitation. However, by including a non-treatment 
multiple baseline phase and an exploration phase, we were able to attribute decreased 
symptoms over time to the ST intervention. Second, the rather strong decrease in 
depressive symptoms during the baseline phase complicated the detection and 
estimation of treatment effect sizes substantially. For a case-series, symptom levels are 
ideally stable during the baseline phase. Due to the unstable baseline in the current 
study we have to (implicitly) rely on extrapolation of change assessed during the 
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baseline to the exploration and intervention periods. Third, post-treatment SCID 
assessments were conducted by the therapists, who were not blind to the treatment and 
might therefore have been biased in their judgment. 
 In conclusion, the findings of this study add to the accumulating evidence that ST is 
an effective treatment for patients with cMDD. The fact that the two previous studies on 
ST for (chronic) depression and the current study were all conducted by independent 
research groups speaks to the generalizability of findings. The low dropout rates in 
previous ST studies and the absence of dropout in the current study highlight the 
acceptability of ST by patients. Although there is now emerging evidence that ST is an 
effective treatment for (chronic) depression, future RCT based studies in larger samples 
are needed to determine the efficacy of ST for chronic depression and the comparative 
efficacy of ST relative to other interventions. 
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Abstract	
Background: The underlying mechanisms of symptom change in schema therapy (ST) for 
chronic major depressive disorder (cMDD) have not been studied. Two potential key 
mechanisms underlying symptom change in ST are changes in schemas and the 
therapeutic alliance. One challenge in studying mechanisms of change is demonstrating 
that putative mechanisms precede change in symptoms.  
 
Method: To disentangle the temporal relations between schemas (proxied by negative 
idiosyncratic core-beliefs), the therapeutic alliance and depressive symptoms we drew 
data from a single-case series of ST for cMDD. Patients with cMDD (N = 20) received on 
average 78 repeated weekly assessments over a course of up to 65 individual sessions 
ST. Focusing on repeated assessments within-individuals, we tested whether change in 
core-beliefs and therapeutic alliance precedes, follows from or occurs concurrently with 
change in depressive symptoms. Weighted correlation coefficients and mixed regression 
were used to test each model.  
 
Results: In general, change in core-beliefs was not temporarily but concurrently related 
to changes in symptoms. Overall alliance ratings were not temporarily related to 
symptom change. Repeated goal and task agreement ratings (specific aspects of alliance) 
of the same session, completed on separate days, were at least in part predicted by 
concurrent changes in symptoms.  
 
Conclusion: Contrary to what would be expected based on theory, our findings suggest 
that change in core-beliefs does not precede change in symptoms. Instead, change in 
these variables occurs concurrently. Moreover, alliance ratings seem to be at least in 
part colored by changes in current mood state .  
 
Keywords: schema therapy; chronic depression; negative core-beliefs; therapeutic 
alliance; mechanisms of change 
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Introduction	
Major depressive disorder (MDD) is a common mood disorder accounting for the 
greatest disease burden among mental disorders worldwide (Whiteford et al., 2013). 
Although effective treatments for MDD are available, it is estimated that about 20% of 
depressed patients do not recover within two years (e.g. Spijker et al., 2002). When 
symptoms of MDD are present for two years or longer depression is considered to be 
chronic (cMDD). Current treatments for cMDD include psychotherapy, antidepressants 
or their combination (for a review see: Spijker, van Straten, Bockting, Meeuwissen, & 
van Balkom, 2013). Although psychotherapy is effective in treating cMDD, the effect 
sizes are rather small (Cuijpers et al., 2010) indicating that there is ample room for 
improvements. It has been argued that a better understanding of the underlying 
mechanisms that contribute to symptom change is the key to improving current 
treatments (Kazdin, 2007). The overall aim of the current study was to explore the 
impact of two potentially important mechanisms of symptom change, maladaptive 
schemas and the therapeutic alliance, during psychotherapy for cMDD. 
 We have previously argued that current treatments for cMDD are too time-limited 
and might not adequately take the underlying vulnerability of cMDD into account 
(Renner, Arntz, Leeuw, & Huibers, 2013). Schema therapy (ST) is a relatively new, long-
term, integrative, treatment for chronic axis-I and axis-II disorders (Young, Klosko, & 
Weishaar, 2003), with an established effectiveness for personality disorders (for a 
review see: Bamelis, Bloo, Bernstein, & Arntz, 2012). An emerging body of evidence 
suggests that ST is also effective for cMDD (Carter et al., 2013; Malogiannis et al., 2014; 
Renner, Arntz, Peeters, Lobbestael, & Huibers, 2014). We studied the effects of ST for 
cMDD in a single case-series and found that compared to a no-treatment control phase, 
as well as to an exploration phase, ST resulted in significant, large improvements in 
depressive symptom severity (Renner et al., 2014). 
 Although the evidence of ST for cMDD is emerging, the underlying mechanisms of 
ST for cMDD have not been investigated. The theoretical model of ST assumes that 
patients with psychological problems are characterized by a distinct set of early 
maladaptive schemas (Young et al., 2003). These schemas determine the way in which 
people perceive the world, themselves and others and can have a powerful impact on 
sensations, emotions and behavior (Young et al., 2003). The ultimate goal of ST is to 
decrease the impact of dysfunctional schemas and to replace them with more functional 
schemas. Theoretically, schemas might be related to depressive symptoms in at least 
three different ways: i) according to theory, change in schemas would be expected to 
drive subsequent change in symptoms during ST (Young et al., 2003), ii) contrary to 
theory, change in depressive symptoms drives subsequent change in schemas, iii) 
schemas change concurrently (i.e. at the same time) with depressive symptoms, 
suggesting that an unknown factor is driving change in both process and outcome. 
 Findings from previous studies that tested associations between schemas and 
change in symptoms during ST were mixed. Nordahl, Holthe, and Haugum (2005), for 
example, found that change in schemas from pre-treatment to post-treatment predicted 
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improvements in global symptom severity in a mixed outpatient sample. In contrast, 
Renner, van Goor, et al. (2013) found that, in a sample of young adults with personality 
disorders (features) receiving a shortened group ST intervention, changes in global 
symptom severity accounted for changes in schemas, rather than the other way around. 
Importantly, these studies did not take the temporal relation between changes in 
schemas and symptoms into account and it therefore remains unclear whether change 
in schemas precedes change in symptoms or the other way around. Thus, one aim of the 
current study was to explore temporal associations between changes in schemas and 
changes in depressive symptoms during ST for cMDD. 
 Another potential key mechanism underlying symptom change in ST is the 
therapeutic alliance. The concept of the therapeutic alliance can be conceptualized as the 
degree to which client and therapist agree on the goals of treatment, the methods used 
to achieve these goals and the personal bond between client and therapist (Bordin, 
1979). Research syntheses on the alliance – outcome relation have reported small to 
moderate correlations between the alliance and treatment outcome (e.g. Horvath, Del Re, 
Fluckiger, & Symonds, 2011). Although the therapeutic alliance is usually considered a 
common factor in psychotherapy research, it might be an especially important 
contributor to outcome in ST (Spinhoven, Giesen-Bloo, van Dyck, Kooiman, & Arntz, 
2007). In ST the therapeutic alliance is used as a therapeutic technique, for example in 
limited reparenting in which the therapist takes the position as it were of a good parent 
to meet the unmet childhood needs of the client (Young et al., 2003). Similarly, imagery 
rescripting of traumatic experiences, a key technique in ST, likely requires a strong trust 
relationship between therapist and client (Hoffart, Oktedalen, Langkaas, & Wampold, 
2013). Theoretically, the therapeutic alliance might be related to change in symptoms in 
at least three different ways: i) the alliance rating of a session predicts change in 
symptoms from pre-session to post-session, ii) changes in symptoms prior to a session 
predict subsequent alliance ratings, or iii) two repeated alliance evaluations of the same 
session, completed at different times, might change concurrently (i.e. at the same time) 
with changes in symptoms, for example because the level of depression colors the 
evaluation. These possible alliance outcome relations have not been addressed 
sufficiently in the psychotherapy outcome literature. Thus, another aim of the current 
study was to explore temporal associations between the alliance and changes in 
symptoms during ST for cMDD. 
 It has been argued that previous interpretations of the alliance-outcome 
relationship are problematic due to correlational research designs that did not 
disentangle the temporal relation between change in symptoms and alliance 
assessments (DeRubeis, Brotman, & Gibbons, 2005). Demonstrating temporal 
precedence between potential mechanisms and outcomes has been described as “the 
Achilles heel of treatment studies” ( Kazdin, 2007, p5). In order to demonstrate that a 
potential mechanism of symptom change precedes the observed effect in time it is 
necessary to establish a timeline (Kazdin, 2007). To establish a timeline it is necessary to 
assess symptoms and potential mechanisms of symptom change at multiple time points 
during treatment. We conducted a single case-series of ST for cMDD in which patients 
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received on average 78 repeated weekly assessments during the intervention phase of 
the study, allowing us to map out the temporal relationships between changes in 
symptoms and potential mechanisms of symptom change. Assessments were completed 
weekly from home (online) and sessions were initially scheduled weekly, yet with lower 
frequencies later in treatment. Due to this large number of repeated assessments and 
the independence of assessments and sessions (assessments occurred independent of 
treatment sessions) we were able to establish a timeline and examine the underlying 
temporal relations between potential mechanisms (schemas and therapeutic alliance) 
and symptom change. 
 Repeated assessment of schemas is challenging because schemas are a highly 
theoretical and complex construct and usually assessed with an extensive questionnaire 
in ST (Young, 2006). In this study we used ratings of the strength of a set of idiosyncratic 
core-beliefs about five domains (self, other, world, future, and interpersonal 
relationships) as a proxy of underlying schemas. Acknowledging that in this way we 
assessed only a part of what a schema can entail, we therefore refer to this variable as 
“core-beliefs” instead of “schema”. 
 The overall aim of the current study was to test potential mechanisms responsible 
for symptom change in ST for cMDD. Specifically, we tested temporal relations between 
change in core-beliefs and depressive symptoms and between (change in) the 
therapeutic alliance and depressive symptoms during ST for cMDD. We hypothesized 
that change in core-beliefs would predict subsequent symptom change rather than the 
other way around (hypothesis 1). Moreover, we hypothesized that change in symptoms 
from pre-session to post-session would be predicted by the alliance rating of that 
session (hypothesis 2). Finally, we hypothesized that change in depressive symptoms 
and change in core-beliefs would be concurrently related (hypothesis 3) as would be 
change in depressive symptoms and change in the therapeutic alliance (hypothesis 4). 
Note that the latter hypothesizes are not contradictory to the first two hypotheses as 
temporal and concurrent relations among these variables are not mutually exclusive. 
Formal mediation analyses (e.g., Kraemer, Wilson, Fairburn, & Agras, 2002) are not of 
part of this study, as there was no control treatment to compare with. 
Method	
Participants 
Twenty-five patients with a DSM-IV diagnosis of cMDD were included. Five patients 
stopped during the baseline period, before starting with the intervention. The current 
report is based on data from the remaining 20 patients who started with the 
intervention. Recruitment took place at a specialized secondary care facility in the 
Netherlands. Patients in the age range between 18-65 years, with a primary diagnosis of 
cMDD, defined as meeting the DSM-IV criteria for MDD for at least two years as assessed 
with the Structured Clinical Interview for DSM-IV Axis-I disorders (SCID-I; First, Spitzer, 
Gibbon, & Williams, 1997) and a score of 20 or higher on the Beck Depression Inventory 
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second edition (Beck, Steer, & Brown, 1996) were included. Exclusion criteria were a 
current or past diagnosis of MDD with psychotic features; current or past bipolar 
disorder; current or past psychotic disorder; alcohol or drug dependence or autism 
spectrum disorder, as assessed with the SCID-I. Moreover, patients with a cluster-A or 
cluster-B personality disorder as assessed with the Structured Clinical Interview for 
DSM-IV Axis-II Disorders (SCID-II; First, Spitzer, Gibbon, & Williams, 1994) were 
excluded. Additional exclusion criteria were acute suicide risk and inability to speak and 
read the Dutch language. Patients taking antidepressant medication were excluded, 
unless they were stable on medication for at least three months prior to the screening 
procedure.19  
 The study protocol was approved by the medical ethical committee of the 
University Hospital Maastricht, The Netherlands and the local ethics committee of the 
specialized secondary mental health facility where treatment was provided. All patients 
enrolled in the study signed written informed consent. Prior to patient recruitment, this 
study was registered (clinicaltrials.gov identifier: MASKED). 
Measures 
Beck Depression Inventory – second edition (BDI-II) – Depressive symptom severity was 
assessed with the BDI-II (Beck et al., 1996). The BDI-II assesses depressive symptom 
severity along 21-items with increasing severity ranging from 0 to 3 with higher scores 
representing more symptom severity. The Dutch version of the BDI-II was used in this 
study which had been shown to possess good psychometric properties (van der Does, 
2002). The instructions of the original BDI-II were adapted in the current study, asking 
participants to evaluate depressive symptoms during the past week instead of the past 
two weeks. 
 
Session Rating Scale (SRS) – The quality of the therapeutic alliance was assessed with the 
SRS (Duncan et al., 2003). The SRS is a brief, 4-item, instrument based on the definition 
of the therapeutic alliance by Bordin (1979) and measures the relational bond between 
client and therapist, goal agreement, and task agreement. An overall scale assesses 
whether the client feels that “there was something missing in the session” vs “overall the 
session was good for me” along a 100 mm. Visual Analogue Scale (VAS; Duncan et al., 
2003). We used the overall scale in all analyses and additional analyses for the bond, 
goal and task subscales are reported. Participants completed the SRS weekly and the 
instructions were to rate the last treatment session. Satisfactory psychometric 
properties have been reported for the SRS (Duncan et al., 2003). To validate the SRS in 
the current study, we correlated the SRS subscales with the respective subscales from 
the Working Alliance Inventory (WAI) – Client Version short form (Tracey & Kokotovic, 
1989) that patients completed once a month. At the initial alliance assessment, the 
                                                        
19 Medication dosage of one participant taking venlafaxine was increased from 75 mg to 150 mg two 
months prior to start of the study.   
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subscales bond, goal, and task of the WAI correlated positively with the bond, goal, and 
task items of the SRS (r = .85; r = .62; r = .86, respectively), demonstrating the construct 
validity of the SRS items. 
 
Core-Belief Ratings (CBR) – After session 6 of the exploration phase, the therapist 
conducted a negative core-belief interview with the patient as described in McBride et al. 
(2007). Patients were asked questions about automatic thoughts, underlying 
assumptions, expectations, attitudes and early life experiences during a structured 
interview (McBride et al., 2007). The identified idiosyncratic core-beliefs for the five 
domains self, other, world, future, and interpersonal relationships were then phrased as 
a statement about the self, others, etc. For example, a possible core-belief about the self 
would be: “I am a failure”. Based on the identified core-beliefs, 5 idiosyncratic VASs were 
constructed for each patient and included in the weekly assessment battery. Patients 
were asked to indicate the degree to which they agree with each statement on a 100mm 
VAS. In particular, patients read the following instructions: “Next you will be presented 
with a number of statements about how people can think about themselves, others, the 
world, the future and interpersonal functioning. Please indicate for each statement in 
how far you agree with the statement by setting a mark on the line”. Thus participants 
were not explicitly instructed to rate how much they agree with the statement right now 
(“state”) and neither how much they agree with the statement in general (“trait”). The 
average of the 5 domains that were assessed was used in all analyses. 
Procedure 
Depressive symptoms, core-beliefs and the therapeutic alliance were assessed once a 
week from home, by logging on to a secured website. If patients did not complete the 
questionnaires within two days, a reminder email was sent. Completion rate of weekly 
questionnaires during the intervention phase was 72.5%. Treatment sessions were 
scheduled independent of the weekly assessments. The ST intervention was divided into 
an exploration phase and an intervention phase. During the exploration phase schemas 
and symptoms were merely explored and no attempts were made to actively change 
schemas or resolve current problems. This phase served as an extra control phase to 
determine treatment effects. The intervention phase consisted of up to 65 individual 
sessions ST lasting 50 min each. In this phase, underlying schemas, emotional 
experiences and dysfunctional behaviors were targeted by the use of cognitive and 
experiential techniques, the therapeutic alliance (limited reparenting), and behavioral 
techniques (Young et al., 2003). Sessions were scheduled weekly initially and with lower 
frequency later in treatment. A more detailed description of the treatment manual of ST 
for cMDD is provided elsewhere (Renner, Arntz, et al., 2013). All analyses reported here 
are based on the intervention phase. 
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Analytical approach 
Due to the design of the study, different sequences of assessment – session combinations 
emerged between, as well as within, participants. In most instances weekly repeated 
assessments of depressive symptoms, core-beliefs, and the alliance of the previous 
session were separated by a treatment session. Thus, in these instances the participant 
completed an assessment some time before and some time after a therapy session. 
However, in other instances, for example when sessions were not scheduled weekly (e.g., 
due to illness or holidays), a treatment session was followed by a number of weekly 
assessments, resulting in repeated assessments of the therapeutic alliance of the same 
therapy session. Thus, in these instances the participant had a therapy session and 
completed at least two assessments on different days following the session. Given this 
data structure, we were able to test the three models of how change in core-beliefs could 
be related to change in depressive symptoms (illustrated and described in Figure 1) and 
the three models of how change in depressive symptoms could be related to the 
therapeutic alliance (illustrated and described in Figure 2). 
 To establish a timeline, we first computed the exact day of each session for each 
participant starting with day = 0 for the first session in the intervention phase and the 
exact day of each assessment moment for each individual participant. For the 
assessment moments, the date on which a participant actually completed the 
assessment was used rather than the date on which the assessment was sent to the 
participant. When the assessment completion and the treatment session fell on the same 
date the exact time of the session and the exact time of the assessment were compared 
to determine whether the alliance rating referred to the same day session or to the 
previous session. 
 Next, each of the models described in Figure 1 and Figure 2 was computed per 
participant. Two distinct approaches were used to consolidate data from individual 
cases. The first approach involved computation of average weighted correlation 
coefficients. Individual correlation coefficients were first calculated per participant and 
transformed into Fisher’s z-scores20. Next, individual z-scores were multiplied by the 
number of observations per participant, summed across participants and divided by the 
total number of observations in order to derive a weighted average. The weighted 
average z-score of each model was then back transformed to a correlation coefficient r21. 
This approach gives a descriptive overview of the (temporal) correlation between the 
variables under study. By computing the correlation coefficients per individual it is 
assumed that each row in the correlation matrix represents independent observations. 
Yet, the repeated observation within individuals are not independent and likely auto-
correlated. Moreover, it is unclear how a confidence interval for such an averaged 
coefficient should be determined. 
 
                                                        
20 Fisher’s z = 0.5*LN((1+r)/(1-r)) 
21 r = (EXP(2*z)-1)/(EXP(2*z)+1) 
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Model	tested	and	data	structure	 Description	of	model	tested	
Model	1:	∆	CBR	→	∆	BDI-II		 Change in core-beliefs predicts subsequent change in 
symptoms: Preceding change in core-beliefs (∆CBRT-
2,T-1) predicts subsequent change in depressive 
symptoms (∆BDI-IIT-1, T-0). 
Model	2:	∆	BDI-II	→	∆	CBR		 Change in symptoms predicts subsequent change in 
core-beliefs: Preceding change in depressive 
symptoms (∆BDI-IIT-2, T-1) predicts subsequent 
change in core-beliefs (∆CBRT-1,T-0). 
 
Model	3:	∆	BDI-II	↔	∆	CBR	 When symptoms change, core-beliefs change 
concurrently: Change in symptoms (∆BDI-IIT-1, T-0) 
predicts concurrent change in core-beliefs (∆CBRT-
1,T-0). 
Figure	1. Three models testing the relation between negative core-beliefs and depressive symptoms. BDI-
II = Beck Depression Inventory second edition; CBR = Core-beliefs Ratings; T = Time. For model 1 and 
model 2 four different versions are possible depending on whether there was 1) a session between the 
core-belief assessments and between the BDI-II assessments; 2) no session between the core-beliefs 
assessment and a session between the BDI-II assessments; 3) a session between the core-belief 
assessments and no session between the BDI-II assessments; 4) no session between the core-belief 
assessments and no session between the BDI-II assessments. For model 3 two different version are 
possible, depending on whether there was 1) a session between the repeated assessments or 2) no session 
between the repeated assessments. 
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Model	tested	and	data	structure	 Description	of	model	tested	
Model	1:	Alliance	Rating	→	∆BDI		
 
Note. The alliance rating at T-0 reflects the rating of the 
last treatment session (T-1).	
 
Therapeutic alliance predicts symptom change: 
Change in depressive symptoms from pre-
session (BDI-II T-2) to post-session (BDI-II T-0) 
is predicted by the therapeutic alliance rating 
(T-0) of that session (T-1).  
 
Model	2:	∆BDI	→	Alliance	Rating	
 
Note. The alliance rating at T-0 reflects the rating of the 
last treatment session (T-1).	
	
Symptom change predicts therapeutic alliance: 
The alliance rating (T-0) of the last session (T-
1) is predicted by change in depressive 
symptoms prior to the session (∆BDI T-3,T-2). 
Model	3:	∆BDI	↔	∆Alliance	
 
Note. Alliance ratings at T-1 and T-0 reflect ratings of 
the last treatment session (T-2). Therefore the arrows 
from the alliance ratings point backwards to the same 
session. 
Symptoms and alliance change ratings change 
concurrently: Change in two subsequent 
alliance ratings (∆Alliance Rating T-1, T-0) of 
the same session (T-2) is concurrently related 
to change in depressive symptoms (∆BDI-II T-1, 
T-0). 
Figure	2. Three models testing the relation between the therapeutic alliance and depressive symptoms. 
BDI-II = Beck Depression Inventory second edition; T = Time. 
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 To derive an aggregated coefficient of the strength of the (temporal) relations 
between study variables as well as a test of statistical significance, the second approach 
involved a multi-level analysis (MLA). In the MLA, the participant was entered as subject 
variable, and an index variable, starting at 0 at the first assessment for each individual 
and then incrementing by 1 for each subsequent assessment, was entered as repeated 
variable. For each model an autoregressive (AR1) covariance structure was specified. 
The fixed part of each model included a main effect for the predictor variable, a main 
effect of time as well as time × predictor interactions. Additional fixed effects for time 
and time × predictor interactions were specified since the strength of the core-beliefs – 
BDI-II relationship and the strength of the alliance – BDI-II relationship might change 
during treatment. The optimal representation of time, represented by the session 
number or by the day of assessment, was derived by comparing the model fit for linear 
and logarithmic representations of time. Backward deletion of non-significant predictors 
was used, starting with the interaction, to come to a final model. The dependent variable 
and fixed effects were specified per model as outlined below. 
Core-belief models 
Change scores for the BDI-II/CBR were calculated in a way that positive change scores 
reflected an increase in symptoms/core-beliefs. Average weighted correlation 
coefficients for the core-belief models were determined by entering scores for ∆CBR and 
∆BDI-II in a correlation matrix and by performing the computations outlined earlier. The 
strength of ∆CBR and ∆BDI-II associations might differ in instances in which change in 
these variables occurs in the context of a therapy session (likely representing change 
due to the session) vs instances in which the change occurs in the absence of a therapy 
session (likely representing natural fluctuations). Therefore, separate analyses were 
performed for instances in which there was 1) a session between the CBR and between 
the BDI-II assessments; 2) no session between the CBR assessments and a session 
between the BDI-II assessments; 3) a session between the CBR assessments and no 
session between the BDI-II assessments; 4) no session between the CBR and the BDI-II 
assessments. 
 To compute core-belief model 1, each instance in which two successive CBR 
assessments preceded two successive BDI-II assessments was considered (811 
instances). In the MLA, ∆BDI-II was entered as dependent variable and ∆CBR, time and 
the time × ∆CBR interaction were entered as fixed effects. The time × ∆CBR interaction 
in these analyses reflects the degree to which the strength of the relation between 
change in the core-belief ratings and subsequent change in depressive symptoms differs 
during the course of treatment. The beta value of the main effect of ∆CBR reflects the 
estimated change in depressive symptoms with each preceding 1 point change in core-
beliefs. 
 To compute core-belief model 2, each instance in which two successive BDI-II 
assessments preceded two successive CBR assessments was considered (813 instances). 
In the MLA, ∆CBR was entered as dependent variable and ∆BDI-II, time and the time × 
∆BDI-II interaction were entered as fixed effect. The time × ∆BDI-II interaction in these 
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analyses reflects the degree to which the strength of the relation between change in the 
depressive symptoms and subsequent change in core-belief ratings differs during the 
course of treatment. The beta value of the main effect of ∆BDI-II reflects the estimated 
change in core-beliefs with each preceding 1 point change in depressive symptoms. 
 To compute core-belief model 3, each instance in which two BDI-II and two CBR 
assessments occurred concurrently was considered (885 instances). In the MLA, ∆CBR 
was entered as dependent variable and ∆BDI-II, time and time × ∆BDI-II were entered as 
fixed effects. The time × BDI-II change score interaction in these analyses reflects the 
degree to which the strength of the relation between change in the depressive 
symptoms and concurrent change in core-belief ratings differs during the course of 
treatment. The beta value of the main effect of ∆BDI-II reflects the estimated change in 
core-beliefs with each concurrent 1 point change in depressive symptoms. The choice to 
enter ∆CBR as dependent variable in these analyses was purely conceptual and entering 
∆BDI-II as dependent and ∆CBR as independent variable in these analyses yields the 
same results. 
Alliance models 
Correlation coefficients for the alliance models were determined by constructing 
separate correlation matrices of: ∆BDI-II (post-session – pre-session) and the alliance 
rating of the session (alliance model 1); ∆BDI-II prior to a session and the alliance rating 
of the subsequent session (alliance model 2); ∆BDI-II and concurrent change in the 
alliance rating of the same session assessed on separate days (alliance model 3). 
Correlations were then weighted and aggregated as outlined above. Change scores were 
calculated in a way that positive change scores in the BDI-II reflected an increase in 
symptoms and positive change scores of the alliance reflected more positive alliance 
ratings. 
 To compute alliance model 1, each instance in which a pre-session BDI-II and a 
post-session BDI-II as well as an alliance rating of the session between the two BDI-II 
assessments was available was considered (497 instances). In the MLA, ∆BDI-II was 
entered as dependent variable and the alliance rating, time and the time × alliance 
interaction were specified as fixed effects. The time × alliance interaction reflects the 
degree to which the relation between the alliance and pre-session to post-session ∆BDI-
II differs during the course of treatment. The beta value of the main effect of the alliance 
reflects the estimated ∆BDI-II score from one session to the next for each additional 
increase by 1 in alliance ratings of the session. 
 To compute alliance model 2, each instance in which two successive BDI-II 
assessments, with no session in between, occurred prior to a session was considered 
(222 instances). In the MLA, the general alliance rating was entered as dependent 
variable and ∆BDI-II, time and the time × ∆BDI-II interaction were specified as fixed 
effects. The time × ∆BDI-II interaction reflects the degree to which the relation between 
∆BDI-II before the session and the alliance rating of the session differs during the course 
of treatment. The beta value of the main effect of ∆BDI-II reflects the estimated alliance 
rating for each 1 point improvement on the BDI-II prior to the session. 
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 To compute alliance model 3, all instances in which two successive BDI-II 
assessments with concurrent alliance assessments and with no session in between, 
occurred following a session were considered (432 instances). In these instances the 
repeated therapeutic alliance rating reflected an alliance rating of the same session. In 
the MLA, ∆alliance was entered as dependent variable and ∆BDI-II, time and the time × 
∆BDI-II interaction were entered as fixed effects. The time × ∆BDI-II interaction reflects 
the degree to which the relation between ∆BDI-II and ∆alliance rating of the same 
session differs during the course of treatment. The beta value of the main effect of ∆BDI-
II reflects the estimated concurrent ∆alliance ratings of the same session when the ∆BDI-
II increases by 1 point. 
Results	
Relation between change in core-beliefs and change in depressive symptoms 
The average weighted and unweighted correlation coefficients for the three core-belief 
models are shown in Table 1. Results of the MLA are summarized below and in Table 2. 
For all MLA log-linear time provided the best fit and was used as representation of time.  
 
Table	 1. Average weighted and unweighted correlation coefficient for the core-belief models and for 
different assessment – session sequences	
Core-Belief Models Overall Sequence 1 Sequence 2 Sequence 3 Sequence 4 
Model 1: weighted r ∆CBR –> ∆BDI-II 
(unweighted r) 
-.10 (-.10) -.08 (-.03) -.28 (-.80) -.10 (.69) .12 (.43) 
Model 2: weighted r ∆BDI-II –> ∆CBR 
(unweighted r) 
.10 (.19) -.03 (-.73) -.09 (-.41) -.05 (-.54) .02 (.32) 
Model 3: weighted r ∆BDI-II <–> ∆CBR 
(unweighted r) 
.35 (.34) .35 (.35) - - .33 (.26) 
Note. Sequence 1–4 refers to the four possible assessment – session sequences: Sequence 1 = only 
instances with a session between the CBR and BDI-II assessments were considered; Sequence 2 = only 
instances with a session between the BDI-II assessments but not between the CBR assessments were 
considered; Sequence 3 = only instances with a session between the CBR assessments but not between the 
BDI-II assessments were considered; Sequence 4 = only instances in with no session between the CBR 
assessments and no session between the BDI-II assessments were considered. 
Core-Belief Model 1 – Change in core-beliefs predicts subsequent change in symptoms 
The time × ∆CBR interaction was not significant (B = 0.02, t(722.21) = 1.41, p = .160) and 
therefore removed from the model. In the final model, the main effect of ∆CBR was not 
significant, B = 0.01, t(800.81) = 0.53, p = .600. When only instances in which the BDI-II 
assessments but not the CBR assessments were separated by a session were considered, 
there was a significant main effect of ∆CBR (after removing ns time interaction), B = -
0.09, t (196.61) = -2.14, p = .034, showing that improvements in core-beliefs prior to a 
session were associated with a worsening of depressive symptoms following the session. 
All other versions of assessment – session sequences revealed non-significant effects. 
CHAPTER 10 
 210 
Core-Belief Model 2 – Change in symptoms predicts subsequent change in core-beliefs 
The time × ∆BDI-II interaction was not-significant (B = 0.05, t (808.99) = 1.32, p = .188), 
and therefore removed from the model. In the final model, the main effect of ∆BDI-II was 
not significant, B = 0.04, t (805.64) = 0.70, p = .485, showing that improvements in 
depressive symptoms did not predict subsequent improvements in core-beliefs. When 
only instances in which a session occurred between the BDI-II assessments but not 
between the CBR assessments were considered, the time × ∆BDI-II interaction became 
significant, B = 0.17, t (194.81) = 2.31, p = .022. To interpret the meaning of this 
interaction we divided the overall time variable into four equal phases and then plotted 
the fixed predicted ∆CBR scores, derived from the MLA, against ∆BDI-II with separate 
lines for the four time phases, representing different stages of treatment (Figure 3). All 
other versions of assessment – session sequences revealed non-significant effects. 
Core-Belief Model 3 – Core-beliefs and depressive symptoms change concurrently 
The time × ∆BDI-II interaction was not-significant (B = 0.01, t(874.05) = 0.15, p = .877), 
and therefore removed from the model. In the final model, the main effect of change in 
BDI-II was significant, B = 0.66, t(873.65) = 13.23, p < .001, showing that improvements 
in depressive symptoms were concurrently associated with improvements in core-
beliefs. When only instances in which a session occurred between the two assessments 
were considered, the main effect of change in BDI-II remained significant (after deletion 
of ns. interaction), B = 0.60, t(478.10) = 8.74, p = < .001. When only instances in which 
no session occurred between the repeated assessments were considered, the time × 
∆BDI-II interaction became significant, B = -0.31, t(391.00) = -4.00, p = < .001. To 
interpret the meaning of this interaction we plotted the fixed predicted ∆CBR scores, 
derived from the MLA, against ∆BDI-II with separate lines for different phases of 
treatment (Figure 4). 
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Table	2.	Results of mixed regression analyses testing the relation between change in core-beliefs and 
change in depressive symptoms. 
 Beta	 SE DF t p 
Model	1	      
Intercept 0.05 0.54 454.99 0.09 .926 
Time  -0.03 0.10 452.39 -0.33 .743 
∆CBR	 -0.09 0.08 746.10 -1.18 .238 
Time x ∆CBR 0.02 0.01 772.21 1.41 .160 
Model	1	after	removing	ns.	interaction      
Intercept 0.09 0.54 450.92 0.17 .862 
Time  -0.04 0.10 448.08 -0.51 .676 
∆CBR	 0.01 0.02 799.79 0.51 .608 
Model	1	final      
Intercept -0.13 0.13 377.74 -1.00 .318 
∆CBR 0.01 0.22 800.81 0.53 .600 
Model	2	      
Intercept 0.14 0.84 489.93 0.17 .867 
Time  -0.06 0.16 486.93 -0.36 .721 
∆BDI	 -0.24 0.22 808.93 -1.09 .276 
Time x ∆BDI 0.05 0.04 808.99 1.32 .188 
Model	2	after	removing	ns.	interaction      
Intercept 0.26 0.84 486.99 0.31 .759 
Time -0.08 0.16 484.10 -0.50 .621 
∆BDI-II	 0.04 0.06 804.71 0.71 .481 
Model	2	final      
Intercept -0.15 0.19 417.49 -0.75 .451 
∆BDI-II 0.04 0.06 805.64 0.70 .485 
Model	3	      
Intercept 0.43 0.76 535.54 0.57 .572 
Time -0.09 0.14 533.31 -0.62 .535 
∆BDI	 0.63 0.21 871.10 3.01 .003 
Time x ∆BDI 0.01 0.04 874.05 0.15 .877 
Model	3	after	removing	ns.	interaction      
Intercept 0.44 0.75 537.28 0.58 .561 
Time -0.09 0.14 534.92 -0.64 .524 
∆BDI-II	 0.66 0.05 872.48 13.23 <.001 
Model	3	final      
Intercept -0.03 0.17 468.04 -0.17 .863 
∆BDI-II 0.66 0.05 873.65 13.23 <.001 
Note. All time variables are log transformed 
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Figure	3.	 Illustration of the significant time × ∆BDI-II interaction predicting 
subsequent change in core beliefs in instances in which a session occurred
between the BDI-II assessments but not between the CBR assessments. Positive 
change scores for the BDI-II reflect increased symptoms; Positive change scores 
for the CBR reflect an increase in negative core-beliefs. An increase in 
depressive symptoms from pre-session to post-session was associated with 
subsequent decrease in core-belief ratings in the absence of a session only in 
the early phase of treatment (first quartile). In later phases of treatment change
in depressive symptoms was unrelated to subsequent change in core-beliefs. 
 
 
Figure	 4.	 Illustration of the significant time × ∆BDI-II interaction 
predicting concurrent change in core beliefs in instances in which no 
session occurred between the concurrent BDI-II and CBR assessments. 
Positive change scores for the BDI-II reflect increased symptoms; Positive 
change scores for the CBR reflect an increase in negative core-beliefs. An 
increase in depressive symptoms was associated with an increase in 
negative core-beliefs and the strength of this association became gradually 
weaker during the course of treatment. 
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Relation between therapeutic alliance and depressive symptoms 
The average weighted and unweighted correlation coefficient for the three alliance 
models are summarized in Table 3. For all MLA the log-linear time variable provided the 
best fit to the data and was therefore used as representation of time. Model 1 and 2 were 
conducted with the log transformed session number as representation of time and with 
the log transformed day of assessment as additional sensitivity analyses. Model 3 was 
conducted with the log transformed day of assessment as representation of time 
because assessments for this model could also occur in the absence of a session. The 
results of the MLA of the alliance models are summarized below and in Table 4. All 
analyses were repeated separately for the subscales bond, goal and task (not reported in 
Table 4). 
 
Table	3. Average weighted and unweighted correlation coefficient for the alliance models	
Alliance Models Overall Bond Goal Task 
Model 1: weighted r Alliance –>∆BDI-II (unweighted r) .02 (-.15) .05 (-.07) .12 (.11 .07 (-.01) 
Model 2: weighted r ∆BDI-II–> Alliance (unweighted r) -.05 (-.06) -.05 (-.30) .01 (-.05) .01 (.18) 
Model 3: weighted r ∆BDI-II <–> Alliance (unweighted r) -.02 (.22) -.08 (-.46) -.15 (-.58) -.08 (-.04) 
 
Alliance Model 1 – Change in depressive symptoms is predicted by alliance 
The time × overall alliance interaction was not significant (B = 0.01, t(303.70) = 1.04, p 
= .30) and therefore removed from the model. In the final model, overall alliance was not 
significant, B = 0.01, t(261.59) = 0.64, p = .524, showing that change in depressive 
symptoms from pre-session to post-session was not predicted by the therapeutic 
alliance of that session. Similarly, separate analyses with the bond, goal, and task 
subscales revealed non-significant effects. Additional sensitivity analyses included MLAs 
with the log-transformed day of assessment as time variable and analyses in which only 
pre-session assessments were considered that occurred two days or less before the 
session because it could be argued that it is more likely that the session causes change in 
symptom severity from pre-session to post-session if the session occurs relatively 
shortly after the initial pre-session BDI-II assessment. These sensitivity analyses 
resulted in comparable results. 
Alliance Model 2 – Change in depressive symptoms predict alliance ratings 
The time × ∆BDI-II interaction was not significant (B = 0.15, t(185.32) = 0.91, p = .364) 
and therefore removed from the model. In the final model, ∆BDI-II was not significant, B 
= 0.05, t(162.55) = 0.41, p = .684, showing that changes in depressive symptoms prior to 
a session did not affect alliance ratings of the session. Similarly, separate analyses with 
the bond, goal, and task subscales revealed non-significant effects as did sensitivity 
analyses with the log-transformed day of assessment as time variable. 
CHAPTER 10 
 214 
Alliance Model 3 – Two subsequent alliance ratings of the same session change with 
changes in mood state 
The time × ∆BDI-II interaction was not significant (B = -0.08, t(424.78) = -0.95, p = .343) 
and therefore removed from the model. After removing the ns interaction there was a 
significant main effect of time, B = 0.67, t(262.95) = 2.05, p = .04, showing that in 
situations in which the therapeutic alliance of the same session was evaluated twice, on 
separate days, the second evaluation was more negative and that this effect was more 
profound in early phases of treatment but leveled out throughout treatment. In the final 
model, ∆BDI-II was not significant, B = 0.02, t(418.45) = 0.20, p = .844, showing that 
changes in the overall alliance rating of the same session did not vary with concurrent 
changes in depressive symptoms. 
 In the model including the bond subscale change score as dependent variable, the 
time × ∆BDI-II interaction was not significant, B = -0.11, t(425.82) = -1.27, p = .21, and 
therefore removed from the model. After removing the ns interaction there was a 
significant main effect of time B = 0.75, t(268.31) = 2.22, p = .027, showing that bond 
ratings increased over time. In the final model, the main effect of bond was not 
significant, B = -0.14, t(421.68) = -1.31, p = .190. In the model including the goal subscale 
change score as dependent variable, the time × ∆BDI-II interaction was significant, B = -
0.30, t(424.64) = -3.00, p = .003. Similarly, in the model including the task subscale 
change score as dependent variable, the time × ∆BDI-II interaction was significant, B = -
024, t(427.60) = -2.73, p = .007. To interpret the meaning of these interaction terms, we 
plotted the predicted change in the goal and task subscales, derived from the MLA, 
against change in BDI-II scores with separate lines representing different phases of 
treatment (Figure 5). To test the robustness of these findings, we conducted sensitivity 
analyses in which only instances were included in which two assessments moments 
occurred after a session because these alliance ratings might be more accurate. In these 
sensitivity analyses weighted concurrent correlations and results of MLA were 
comparable to those of the initial analyses. 
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Table	4.	Results of mixed regression analyses testing the relation between the therapeutic alliance and 
changes in depressive symptoms. 
 Beta	 SE DF t p 
Model	1	      
Intercept 1.81 3.02 285.06 0.60 .548 
Time -0.02 0.03 283.74 -0.66 .512 
Overall alliance	 -1.36 1.16 305.11 -1.17 .243 
Time x Overall alliance 0.01 0.01 303.70 1.04 .301 
Model	1	after	removing	ns.	interaction      
Intercept -1.05 1.21 258.34 -0.87 .385 
Time 0.01 0.01 262.29 0.78 .436 
Overall alliance	 -0.17 0.19 260.30 -0.91 .362 
Model	1	final      
Intercept -1.35 1.16 261.33 -1.16 .246 
Overall alliance 0.01 0.01 261.59 0.64 .524 
Model	2	      
Intercept 80.32 4.57 107.74 17.56 <.001 
Time 2.19 1.45 108.65 1.51 .134 
∆BDI-II	 -0.43 0.55 188.90 -0.79 .430 
Time x ∆BDI-II 0.15 0.17 185.32 0.91 .364 
Model	2	after	removing	ns.	interaction      
Intercept 79.91 4.55 106.08 17.55 <.001 
Time 2.31 1.44 107.23 1.60 .113 
∆BDI-II	 0.05 0.13 161.61 0.40 .687 
Model	2	final      
Intercept 86.60 1.83 33.50 47.25 <.001 
∆BDI-II 0.05 0.13 162.55 0.41 .684 
Model	3	      
Intercept -5.51 1.80 265.90 -3.06 .002 
Time 0.68 0.33 260.54 2.07 .039 
∆BDI-II	 0.48 0.48 425.07 0.99 .322 
Time x ∆BDI-II -0.08 0.09 424.78 -0.95 .343 
Model	3	after	removing	ns.	interaction      
Intercept -5.48 1.81 267.97 -3.03 .003 
Time 0.67 0.33 262.95 2.05 .041 
∆BDI-II	 0.03 0.10 418.85 0.25 .799 
Model	3	final      
Intercept -1.89 0.46 162.82 -4.09 <.001 
∆BDI-II 0.02 0.10 418.45 0.20 .844 
Note. All time variables are log transformed 
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Figure	 5.	 Illustration of the significant time × ∆BDI-II interactions 
predicting concurrent change in goal agreement (panel A) and task 
agreement (panel B). In general, repeated goal and task agreement 
ratings of the same session became more positive in situations in which 
depressive symptoms decreased concurrently, whereas goal and task 
agreement ratings of the same therapy session became more negative in 
situations in which depressive symptoms increased concurrently 
(dashed lines). In the first quartile of treatment this general pattern was 
reversed, such that repeated goal and task agreement ratings of the same 
session became more negative in situations in which depressive 
symptoms decreased concurrently and more positive in situations in 
which depressive symptoms increased concurrently (solid lines). 
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Discussion	
The aim of this study was to test potential mechanisms of symptom change in schema 
therapy (ST) for chronic major depressive disorder (cMDD). In particular, we focused on 
two potential key mechanisms of symptom change in ST, schemas (as proxied by 
negative idiosyncratic core-beliefs) and the therapeutic alliance. An innovative approach 
to study the temporal relation among these variables was applied, focusing on the 
within-person variance in these variables, i.e. differences in changes in these variables 
over time within participants. We proposed and tested six models of how negative core-
beliefs and the therapeutic alliance might be related to changes in depressive symptom 
severity during ST for cMDD (Figure 1 and Figure 2). 
 Changes in negative core-beliefs did not predict subsequent changes in depressive 
symptoms (core-belief model 1) as theory would suggest (Young et al., 2003). The only 
exception was found in instances in which changes in core-beliefs occurred in the 
absence of a therapy session and subsequent changes in depressive symptoms occurred 
following a therapy session. In these instances, improvements in core-beliefs prior to a 
session were associated with a worsening of symptoms following the session. It should 
be noted that this effect was rather small. Each improvement in core-beliefs by 1 point 
(on a scale from 0-100) was associated with an estimated subsequent increase in 
depressive symptoms, as assessed by the BDI-II, by 0.09 points. 
 Changes in depressive symptoms did not predict subsequent changes in negative 
core beliefs (core-belief model 2). However, when only instances in which a session 
occurred between the assessments of depressive symptoms but not between the 
assessments of core-beliefs were considered, there was a significant interaction of 
changes in depressive symptoms with time. In these instances, an increase in depressive 
symptoms was associated with a decrease in negative core-beliefs only early on in 
treatment. Later on in treatment changes in depressive symptoms were unrelated to 
changes in negative core beliefs. 
 Analyses of the concurrent core-belief model (core-belief model 3) suggest that 
changes in negative core-beliefs go together with concurrent changes in depressive 
symptoms. In other words, when symptoms improve core-beliefs improve concurrently. 
In general, this association remains stable throughout treatment, however in instances 
in which concurrent changes in these variables are evaluated in the absence of therapy 
sessions the association became weaker throughout treatment. 
 In general our findings regarding the core-belief models suggest that changes in 
negative core-beliefs do not precede (core-belief model 1) or follow (core-belief model 2) 
from changes in depressive symptom severity. Only in instances in which change in 
depressive symptoms occurred in the context of a therapy session and change in 
negative core-beliefs occurred in absence of a therapy session, change in these two 
variables was temporarily associated. One explanation for these findings could be that 
changes in core-beliefs in the absence of a therapy session do not represent structural 
changes in the underlying core-beliefs but rather naturalistic mood-fluctuations. In 
instances in which depressive symptoms improved prior to a session it might be more 
CHAPTER 10 
 218 
likely that mood partly regresses back at a subsequent assessment, contributing to the 
negative association. Similarly, in instances in which core-belief ratings become more 
positive in the absence of a therapy session, likely reflecting mood fluctuations rather 
than structural changes, the mood state might swing back in subsequent ratings, which 
would explain the negative association with changes in depressive symptom severity. In 
situations in which core-beliefs ratings occurred in the context of a therapy session, 
change in core-beliefs more likely reflects structural changes and in these instances no 
temporal association with changes in depressive symptoms was found. This explanation 
is highly speculative and other explanations for the observed findings are possible. The 
most robust evidence was found for a concurrent relation between changes in core-
beliefs and changes in depressive symptoms. One explanation for this finding could be 
that both measures might partly assess the same overall symptomatic distress factor. 
Another possibility is that improvement in both variables is driven by another, unknown 
process. Yet another explanation could be that the timing of assessments did not capture 
the timing in which changes in these variables took place and that an even more fine 
grained temporal analyses of processes is necessary to disentangle the temporal 
relations between these variables. For example, it is possible that change in negative-
core beliefs drives subsequent change in symptoms on the following day. With the 
current frequency of weekly assessments this would be erroneously reflected in a 
concurrent relation rather than a temporal relation between these variables. More fine 
grained analyses of temporality with repeated assessments every day (e.g. experience 
sampling) might shed more light on these process outcome relations, however 
practically it might be difficult to use such methodology over a very long treatment 
duration such as in ST for cMDD. 
 Another potential mechanism that might explain symptom change in ST for cMDD 
that was tested in the current study is the therapeutic alliance. In general, we found no 
evidence that the therapeutic alliance of a session was related to change in depressive 
symptoms from pre-session to post-session (alliance model 1). Thus our findings 
suggest that the alliance does not predict symptom change, when the temporal relation 
between alliance ratings and assessments of depressive symptoms is taken into account. 
Research synthesis on the alliance – outcome relation have reported small to moderate 
positive associations between alliance ratings and treatment outcome (Horvath et al., 
2011). However, these previous studies primarily relied on cross-sectional research 
designs, focusing on differences in alliance ratings between subjects when predicting 
treatment outcome rather than changes in alliance ratings within-subjects over time. 
Typically, in these studies between subject differences in alliance ratings assessed at the 
beginning of treatment are related to between subject differences in treatment 
outcomes. In the current analyses, repeated alliance ratings within-individuals were 
related to session-to-session changes. If the alliance would be related to better outcomes 
than this should be reflected in positive associations between session-to-session 
changes and alliance ratings of the session (alliance model 1) but this was not supported 
in the current study. Moreover, we found no evidence for the second alliance model, 
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stating that changes in depressive symptoms prior to a session would predict the 
subsequent alliance rating of the session. 
 The most robust evidence in the current study was found for the model predicting 
a concurrent association of changes in alliance ratings of the same therapy sessions and 
concurrent changes in depressive symptoms (alliance model 3). Findings of the current 
study suggest that changes in depressive symptoms are concurrently related to changes 
in the goal and task subscales of the alliance and that the strength of this association 
varies over the course of treatment. In particular, we found that repeated goal and task 
agreement assessments of the same session became more negative in situations in 
which depressive symptoms increased concurrently, indicating that alliance 
assessments are partly colored by the current level of depressive symptoms. Moreover, 
in an early treatment phase, this pattern was reversed showing that improvements in 
depressive symptoms were associated with more negative ratings of the goal and task 
agreement. One explanation for this finding might be that early on in treatment patients 
do not attribute improvements in symptoms to the specific techniques used in treatment 
whereas later on in treatment improved symptoms might be more readily attributed to 
the specific techniques (task agreement) used in treatment, resulting in the positive 
associations found in this study. 
 The findings of the current study should be interpreted in the light of several 
limitations. First, due to the design of this study the sample size was relatively small. It 
should be noted, however, that due to the frequent repeated assessments and the long 
duration of treatment a relatively large amount of data was available to test the 
proposed models. Second, in the current study we tested relatively straightforward 
models of how core-beliefs and the therapeutic alliance could be related to change in 
depressive symptoms. However, it is possible that the interrelationships between these 
variables are more complex but due to the relatively small sample size we were not able 
to test more complex multivariate models. Third, by design the current study did not 
include a control group and we were therefore not able to conduct formal mediation 
analyses. Fourth, we relied entirely on self-report measures to assess the variables 
under study, however, by assessing idiosyncratic core-beliefs we were able to assess 
only those core-beliefs that were particularly relevant for each individual client. Fifth, an 
important limitation is the way we assessed schemas. Ratings of explicit negative core-
beliefs might not tap the schema change processes that underlie ST. It is possible, for 
example, that changes in schemas first occur on more implicit levels, or in emotions 
before they are expressed in cognitions. It is possible, that our core-belief proxy-
assessment of schemas tapped cognitive, rather than emotional aspects of schemas. 
Similarly, it is possible, that initially a growth in positive beliefs occurs before a 
reduction in negative beliefs takes part. Yet another possibility would be that the change 
process starts with doubt in core-beliefs instead of a change in core-belief. The 
appropriate assessment during treatment of cognitive constructs hypothesized to 
underlie changes in symptoms remains a challenging issue. 
 In conclusion, the current study advances previous process outcome studies by 
introducing an innovative approach to study process – outcome relations. Focusing on 
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temporal relations between changes in negative core-beliefs and changes in depressive 
symptoms, we found mixed evidence for temporal relations. Based on the current 
analyses we can only conclude that changes in negative core-beliefs improve when 
depressive symptoms improve. Regarding the temporal precedence between the 
therapeutic alliance and symptom improvements, we found no evidence that change in 
symptoms was related to alliance ratings. However, alliance ratings seem to be at least 
in part colored by changes in current mood state. Disentangling the temporal relations 
between change in symptom levels and potential common factors of change (e.g. 
therapeutic alliance) and treatment specific factors of symptom change (e.g. schemas) 
remains an important challenge for future research that is far from resolved. 
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The primary aim of this dissertation was to test the effects of schema therapy for chronic 
depression in a single case-series and to explore underlying mechanisms of change in 
schema therapy for chronic depression. The secondary aim of this dissertation was to 
examine underlying neurological and psychological vulnerability factors to (chronic) 
depression, as well as the stability of psychological vulnerability factors throughout 
treatment. To address these aims, part I of this dissertation describes the results of two 
functional magnetic resonance imaging (fMRI) studies that were conducted in the same 
sample of patients with chronic depression and non-patient controls. In the first study 
the neural correlates of self-referential processing in patients with chronic depression 
and in healthy matched controls were determined (chapter	2). In the second study, the 
default mode network functional connectivity during rest was investigated in patients 
with chronic depression and healthy matched controls, before and after a sad mood 
induction procedure (chapter	3). Part II describes the results of four individual studies: 
one study on the stability of early maladaptive schemas during outpatient treatment for 
depression (chapter	4), one study on the two-year stability of the personality traits 
neuroticism and extraversion in treated and untreated persons with depression 
(chapter	5), one study testing the stability of interpersonal problems during cognitive 
therapy for depression (chapter	 6) and a meta-analysis quantifying the effects of 
psychotherapy for depression on psychosocial functioning (chapter	7). In the third part 
of this dissertation the theoretical application of schema therapy to treat patients with 
chronic depression is discussed (chapter	 8) and the results of a single case-series 
testing the effects of schema therapy for chronic depression are presented (chapter	9). 
The temporal relation of change in depressive symptoms and two potential underlying 
mechanisms of change, the therapeutic alliance and negative core-beliefs, in schema 
therapy for chronic depression are explored in chapter	10.  
 
In the current chapter a summary and critical discussion of the studies described in the 
previous chapters of this dissertation is presented. Methodological considerations 
relevant to this dissertation are also addressed in this chapter. Finally, implications of 
the results of this dissertation for clinical practice and future research are presented and 
the chapter ends with an overall conclusion. 
Summary	of	main	findings	
Part I – Neuroimaging studies in chronic depression 
In chapter	2 the neural correlates of self-referential processing in chronic depression 
and associations between neural activity in brain areas associated with self-referential 
processing and explicit and implicit measures of self-associations were investigated in 
order to shed light on the neural underpinnings of processing of negative self-relevant 
information in chronic depression. Patients with chronic depression and non-patient 
controls were presented with words that were either positive, neutral, general negative, 
depression related negative or non-words during functional Magnetic Resonance 
CHAPTER 11 
 226 
Imaging (fMRI). Participants were instructed to press a button whenever they detect a 
non-word. Compared to non-patient controls, patients with chronic depression had 
relatively decreased activity in the medial Prefrontal Cortex during processing of 
negative depression related vs. neutral words. Non-patient controls had relatively 
increased dorsolateral Prefrontal Cortex activity during processing of positive vs. 
neutral words whereas patients with chronic depression had relatively decreased 
activity. Explicit but not implicit measures of self-associations were correlated to brain 
activity in these areas. Based on these findings we concluded that, patients with chronic 
depression show, on the neural level, an emotional blunting response towards 
emotional stimuli. 
 
In chapter	3 the effects of a sad mood induction procedure on the default mode network 
resting state connectivity in the same sample of patients with chronic depression and 
matched non-patient controls was investigated using fMRI. Patients with chronic 
depression and non-patient controls underwent a 6-min fMRI scan while resting quietly, 
before and after a sad mood induction procedure. The sad mood induction procedure 
consisted of mood suggestive music in combination with autobiographical recall of a sad 
personal event. Based on a posterior cingulate cortex (PCC) seed, a functional 
connectivity analysis of the two resting-state measurements was conducted. PCC resting 
state connectivity with the left parahippocampal gyrus, the left superior temporal gyrus 
and the left anterior inferior temporal cortex increased in patients with chronic 
depression and decreased in non-patient controls following the sad mood induction. PCC 
connectivity with the left anterior prefrontal cortex decreased in patients with chronic 
depression and increased in non-patient controls, following the sad mood induction. PCC 
connectivity with the right precuneus decreased slightly in patients with chronic 
depression but not in non-patient controls, following the sad mood induction. We 
interpreted these findings as evidence of general increased default mode network 
functional connectivity in patients with chronic depression following a sad mood 
induction and argue that this increased connectivity might reflect the activation of 
negative latent schemas and/or decreased control over ruminative thoughts about sad 
experiences, triggered by the mood induction in patients with chronic depression. The 
finding of increased PCC – left anterior prefrontal cortex connectivity following the 
mood induction in non-patient controls was interpreted as evidence for a cognitive 
control mechanism preventing negative memory recall in non-patient controls, 
following the sad mood induction. 
Part II – Stability of underlying risk-factors for depression  
In part II of this dissertation it was tested if underlying psychological vulnerability 
factors to depression improve during treatment for depression. In chapter	4, we sought 
to study the relation between early maladaptive schemas and depressive symptom 
severity, as well as the stability of early maladaptive schemas during a course of 
outpatient treatment for depression. The sample consisted of 132 depressed outpatients 
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treated at a specialized mood disorder mental health care facility. Depressive symptom 
severity and early maladaptive schemas were assessed before and 16 weeks after 
starting with treatment. In multivariate linear regression analyses, the early 
maladaptive schemas emotional deprivation, abandonment and instability and failure 
were concurrently related to depressive symptom severity. Overall, patients with 
depression improved on most schemas from pre-treatment to post-treatment, but the 
effect sizes were rather small, whereas the effect size for improvements in depressive 
symptoms during treatment were moderate to large. Moreover, relative stability 
(regression) coefficients of schemas suggested that scores on the schema questionnaire 
remained relatively stable during the course of treatment, even after controlling for 
depressive symptom severity. Based on these findings we concluded that the underlying 
vulnerability in patients with depression, in terms of early maladaptive schemas, at least 
in part remains intact following outpatient treatment for depression. 
 
The personality traits neuroticism and extraversion (more precisely the opposite, 
introversion) might also represent part of the underlying vulnerability to depression. In 
chapter	5, the two-year stability of neuroticism and extraversion in 709 treated and 
untreated persons with depression, participating in the Netherlands Study of Depression 
and Anxiety was investigated. The personality trait neuroticism decreased over a period 
of two years in persons with depression who sought treatment and in persons with 
depression who did not seek treatment during the study period. Depressive symptoms 
also improved in all participants and these improvements were highly associated with 
improvements in neuroticism. Extraversion did not change during the study period. 
These findings show that changes in neuroticism during treatment likely represent 
mood-state effects, rather than structural changes attributable to treatment. 
 
The overall aim of chapter	6 was to study the stability of interpersonal problems over a 
course of 16-20 session individual cognitive therapy for depression, in order to 
determine if cognitive therapy has positive effects on interpersonal functioning. 
Moreover, we sought to explore associations between a patient’s interpersonal style, the 
therapeutic alliance and improvements in depressive symptoms. The sample consisted 
of 523 outpatients with recurrent major depressive disorder, participating in a multi-
stage two center study (Jarrett & Thase, 2010). Using a principal components analysis, 
we identified three orthogonal factors of the inventory of interpersonal problems that 
were labeled general distress, agency and communion. The general distress factor 
decreased over a course of cognitive therapy whereas the agency and communion 
factors remained stable. These findings show that interpersonal functioning can be 
conceptualized in terms of more stable, trait aspects (interpersonal style) and less stable 
state aspects (interpersonal distress). Whereas the state aspects improve during 
cognitive therapy for depression the interpersonal style of patients does not change 
during treatment with cognitive therapy. For example, patients with a predominantly 
submissive interpersonal style before treatment report to tend to remain predominantly 
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submissive in interpersonal situations after treatment but generally experience less 
distress. 
 
Interpersonal functioning can be seen as a specific aspect of the broader concept of 
social functioning. In this sense, chapter	 7 extended the scope of chapter	 6 by 
quantifying the effects of various forms of psychotherapy on the broader concept of 
social functioning in a meta-analysis. We included 31 published randomized controlled 
trials with 2956 patients that were either assigned to a psychotherapy condition or a 
control group. Relative to control groups, psychotherapy had small to moderate positive 
effects on the social functioning of patients. Moreover, the treatment format and the 
number of sessions significantly predicted the effect size of psychotherapy for social 
functioning, with studies using individual treatment formats and studies with more 
treatment sessions resulting in higher effect sizes. These positive effects were partly 
independent from the effects of psychotherapy on depressive symptom severity. The 
results of this study show that the positive effects of psychotherapy for depression on 
depressive symptom severity extend to improvements in social functioning. 
Part III –Schema therapy for chronic depression 
In chapter	8, the theoretical application of schema therapy as a novel psychological 
treatment for chronic depression was described. We summarize the role of four 
underlying vulnerability factors to chronic depression, namely early adversity, cognitive 
factors, personality pathology and interpersonal factors. My co-authors and I describe 
how these factors can be addressed in schema therapy for chronic depression and a 
global treatment protocol of schema therapy for chronic depression is provided.  
	
Chapter	 9 describes the results of a single case-series testing the effects of schema 
therapy for chronic depression. The study consisted of three phases, a 6 – 24 weeks 
baseline phase during which no treatment took place, a 12 week exploration phase, 
during which the underlying schemas were explored and related to current problems, 
and an intervention phase during which participants received up to 65 sessions of 
individual schema therapy for chronic depression. The primary outcome measure was 
depressive symptom severity assessed with the Beck Depression Inventory – second 
edition and the Quick Inventory of Depressive Symptomatology. Secondary outcome 
measures were global symptomatic distress, assessed with the Brief Symptom Inventory 
and overall functioning, assessed with the Outcome Rating Scale. Categorical outcomes 
included response, defined as a 50% reduction in depressive symptoms, remission, 
defined as a score of 6 or smaller on the Quick Inventory of Depressive Symptomatology, 
and recovery, defined as the absence of a depression diagnosis at post treatment 
according to the DSM-IV criteria, assessed with the SCID-I interview. At the end of the 
study period, eight patients were still in treatment and of these patients no post-
treatment SCID interviews were available. Relative to the baseline phase and 
exploration phase of the study, there was a significant decrease in depressive symptoms 
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and general symptomatic distress whereas overall functioning improved during the 
intervention phase. Depressive symptoms and global symptomatic distress initially also 
improved during the baseline phase but this effect leveled out in later weeks of the 
baseline phase. Effect sizes for improvements in depressive symptom severity, global 
symptomatic distress and overall functioning during the intervention phase were 
moderate to large. Following schema therapy, 40% of the patients responded to 
treatment, 35% remitted and 58% recovered. Recovery rates are based on a subsample 
of 12 patients for whom diagnostic status at post-treatment was assessed. The findings 
from this study suggest that schema therapy is a potentially effective treatment for 
patients with chronic depression. 
 
In chapter	10 the temporal relation between change in depressive symptoms and two 
potential mechanisms of change (negative core-beliefs and therapeutic alliance) in 
schema therapy for chronic depression were explored. In particular, six models of how 
change in depressive symptoms might be related to changes in negative core-beliefs and 
the therapeutic alliance were tested. The first three models tested whether 1) change in 
core-beliefs drives subsequent change in symptoms; 2) change in symptoms drives 
subsequent change in core-beliefs; or 3) whether core-beliefs and symptoms change 
concurrently (i.e. at the same time). The remaining three models tested whether 4) 
change in symptoms from pre-session to post-session is predicted by the alliance rating 
of that session; 5) change in depressive symptoms prior to a session predicts the alliance 
rating of that session; and 6) whether repeated assessments of the therapeutic alliance 
of the same session concurrently changes with changes in symptoms. Change in negative 
core-beliefs was concurrently related to changes in depressive symptoms, showing that 
core-beliefs improved together with improvement in symptoms. Change in core-beliefs 
and change in depressive symptoms were not temporarily related, showing that change 
in core-beliefs did not drive subsequent change in depressive symptoms and that change 
in depressive symptoms did not drive change in core-beliefs. Moreover, change in 
depressive symptoms was unrelated to the therapeutic alliance but alliance ratings were 
at least in part colored by changes in the current mood state: In general, in situations in 
which the goal and task agreement of the same session was evaluated twice, on separate 
days, the second evaluation was more positive in situations in which depressive 
symptoms decreased concurrently, whereas task and goal agreement ratings of the same 
therapy session became more negative in situations in which depressive symptoms 
increased concurrently. However, in the early phase of treatment (first quartile), task 
and goal agreement ratings of the same session became more negative in situations in 
which depressive symptoms decreased and more positive in situations in which 
depressive symptoms increased. From the findings of this study we concluded that, 
based on our current data, theoretical models of how change in core-beliefs is related to 
changes in symptoms are not supported. Moreover, the hypothesis that change in 
depressive symptoms is temporarily related to the therapeutic alliance was not 
supported.  
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Critical	discussion	of	the	main	findings	
The results of chapter	2 suggest that patients with chronic depression show, on a neural 
level, an emotionally blunted reaction in brain areas associated with self-referential 
processing (medial prefrontal cortex) when presented with emotional stimuli, especially 
negative depression related words. Such blunted emotional responses have previously 
been associated with lower remission rates from depression (Peeters, Berkhof, 
Rottenberg, & Nicolson, 2010). Clinically, these findings suggest that patients with 
chronic depression might benefit from treatment that specifically focuses on emotional 
processing. Findings from chapter	3 suggest that patients with chronic depression show 
increased resting-state functional connectivity following a sad mood induction in brain 
areas that have previously been suggested to be involved in schematic and ruminative 
processing (Disner, Beevers, Haigh, & Beck, 2011; Marchetti, Koster, Sonuga-Barke, & De 
Raedt, 2012). In contrast, non-patient controls show a relative decrease in connectivity 
within these brain areas. It is possible that the decreased connectivity following the sad 
mood-induction reflects an attempt of non-patient controls to not activate negative 
schemas that could be challenged by the mood induction and increased attempts to 
control ruminative tendencies that might have been activated during the mood-
induction (note that thinking about a sad personal event was part of the mood induction 
instruction). 
	 Chapters	4	 to	7 showed that a range of underlying psychological vulnerability 
factors to depression improved during treatment for depression. On the one hand, this 
indicates that the effects of current treatments for depression extend to other areas of 
functioning and psychological wellbeing, such as psychosocial functioning (chapter	7). 
On the other hand, the improvements in these variables were usually smaller than the 
improvements in depressive symptoms, suggesting that part of the underlying 
vulnerability to depression remains after treatment. Since current treatments for 
depression have a strong focus on reduction in depressive symptom severity, rather 
than a focus on, for example, changing personality, this finding is not surprising. Thus, 
overall the findings from chapters	 4	 to	 7 indicate that part of the underlying 
vulnerability to depression remains intact, following treatment, even if depressive 
symptoms improve. Although speculative this might explain, at least in part, the high 
relapse and recurrences found in depressed patients. 
 Early maladaptive schemas are one of the potential vulnerability factors to 
(chronic) depression that have been studied in this dissertation. The relation between 
specific sets of early maladaptive schemas and depressive symptoms that were found in 
chapter	4 are largely in line with the previous literature investigating such associations 
(Calvete, Estévez, López de Arroyabe, & Ruiz, 2005; Harris & Curtin, 2002). When the 
stability of early maladaptive schemas was assessed over the course of 16-weeks of 
outpatient treatment, we found that early maladaptive schemas remained relatively 
stable and that changes in the mean level from pre- to post-treatment were rather small. 
This finding is in line with two previous studies showing that early maladaptive schemas 
remain relatively stable over time (Riso et al., 2006; Wang, Halvorsen, Eisemann, & 
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Waterloo, 2010). However, this finding extends previous findings by showing that early 
maladaptive schemas remain stable even in the context of treatment for depression, 
indicating that the underlying vulnerability, in terms of early maladaptive schemas, 
remains stable during treatment for depression. Given that some early maladaptive 
schemas in this study were specifically related to depressive symptom severity, it is 
possible that patients with depression might benefit from treatment that aims to 
decrease the impact of these early maladaptive schemas, such as schema therapy. 
 The personality factors neuroticisms and extraversion have also often been 
discussed as two other potential vulnerability factors to (chronic) depression.	Chapter	5 
investigated the stability of neuroticism and extraversion, over a period of two years. 
We found that changes in these personality traits were largely driven by changes in the 
underlying mood state, rather than by treatment per se. This finding highlights an 
important methodological issue namely that, depending on the measurement 
instruments used, the assessment of personality variables can be strongly dependent on 
the current mood state (Karsten et al., 2012). While our study suggest that neuroticism 
changes with the current mood state a more fine grained analyses of the temporal 
relation between these personality traits and depressive symptoms might lead to 
different conclusions. In our study extraversion and neuroticism was only assessed at 
two time points and it therefore was impossible to disentangle temporal relations 
between changes in these variables and changes in depressive symptoms. 
 In chapter	 6 we showed that interpersonal problems, as assessed with the 
inventory of interpersonal problems (Horowitz, Rosenberg, Baer, Ureno, & Villasenor, 
1988), can be represented in terms of three underlying factors that describe state 
aspects of interpersonal functioning (interpersonal distress) as well as trait aspects 
(interpersonal style). In line with a previous study on the stability of these three factors 
during cognitive therapy for depression (Vittengl, Clark, & Jarrett, 2003), we found that 
general interpersonal distress decreased during treatment, whereas the interpersonal 
style of patients remained stable. Thus, patients who started treatment with a general 
socially avoidant interpersonal style, for example, tended to retain this general style of 
behavior in interpersonal situations following treatment with cognitive therapy. 
However, the distress that was experienced in interpersonal situations was decreased 
after cognitive therapy for depression. In terms of targeting the underlying vulnerability 
to depression it might be important to also achieve change in the interpersonal style 
during treatment for depression. Although speculative, the non-assertive and socially 
avoidant interpersonal style of depressed patients might contribute to relapse and 
recurrences if no alternative interpersonal behaviors (e.g. assertiveness) are learned in 
treatment. 
 In chapter	 7 we tested the impact of psychotherapy for depression on 
psychosocial functioning in a meta-analysis. Compared to a control group, 
psychotherapy resulted in significant improvements in psychosocial functioning with 
moderate effect sizes. The effects of psychotherapy on social functioning remained 
significant after controlling for the effects on depressive symptom severity. This 
indicates that improvements in psychosocial functioning were not fully accounted for by 
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improved depressive symptoms alone but that treatment also had positive effects on 
psychosocial functioning in addition to depressive symptoms. In multivariate meta-
regression analyses we found that the number of treatment sessions was related to the 
effect size of psychotherapy on social functioning, with studies that had included more 
treatment sessions resulting in higher effects. This suggests that more treatment 
sessions might be needed to repair the impaired psychosocial functioning in patients 
with depression. A previous meta-analysis has shown that patients with chronic 
depression also benefit from more treatment sessions in terms of symptomatic 
improvements (Cuijpers et al., 2010). Together, these findings highlight the importance 
of longer treatment durations in (chronic) depression in order to reach higher 
improvements on a symptomatic level and in terms of improved psychosocial 
functioning. 
 
In general, the findings from part I and part II of this dissertation suggest that patients 
with (chronic) depression might benefit from a more integrative treatment approach 
that takes the underlying psychological vulnerability factors to depression into account, 
such as schema therapy. In schema therapy a specific focus is given to break through the 
blunted emotional processing found in chronic depression (chapter	2) and the ultimate 
goal of schema therapy is to decrease the impact of negative latent schemas that might 
more readily be triggered by sad-mood in patients with chronic depression (chapter	3). 
Moreover, schema therapy is an integrative treatment approach that makes use of 
several techniques from different psychotherapeutic orientations to treat the various 
underlying risk-factors to depression, such as early maladaptive schemas (chapter	4), 
personality (chapter	5), and interpersonal and social functioning (chapters	6	and	7). 
 Chapter	 8 provides a theoretical model of how the underlying psychological 
vulnerability factors to chronic depression can be addressed in schema therapy. Based 
on a review of the underlying vulnerability factors, it is suggested that schema therapy 
could be an effective treatment for patients with chronic depression. To test this central 
claim of this chapter, we conducted a single case-series study of schema therapy for 
chronic depression (chapter	9). Findings from this study suggest that schema therapy 
has positive effects on depressive symptom severity, global symptomatic distress, and 
overall functioning, when compared to a baseline or exploration phase period. Although 
the findings from this study cannot be directly compared to findings from randomized 
controlled trials or meta-analyses, it is informative to benchmark the effect sizes and 
response and remission rates found in the study against those of previous studies. Table 
1 provides an overview of the main outcomes from chapter	 9 and compares these 
findings with effect sizes and response and remission rates found in previous studies 
quantifying or testing the effects of psychotherapy for chronic depression.  
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Table	1. Benchmarking the effects of the study described in chapter 9 with effects sizes and response and 
remission rates previously reported for psychotherapy for chronic depression. 
Study Type of Study Psychotherapy Main outcomes of interest for benchmarking 
Chapter 9 Single case series Schema therapy Remission: 35% 
Response: 40% 
 
Effect size (for improvement from last baseline to last 
intervention phase assessment): d between 0.91 and 
1.30 
Cuijpers  
et al. 2010 
Meta-analysis Various Mean effect size for contrast psychotherapy vs. control 
group: d = 0.23 
 
Mean effect size for improvement from baseline to 
post-test: d = 1.16 
Spijker et al. 
2013 
Systematic review Various Of three studies comparing psychotherapy for chronic 
major depressive disorder to a placebo condition, one 
resulted in an effect size of 0, one in a negative effect 
size and one in a moderate positive effect size. None of 
the contrasts between psychotherapy and placebo 
were significant. 
Keller et al. 
2000 
RCT CBASP Within the CBASP group, completers (ITT): 
Remission: 24% (33%) 
Overall response (response or remission): 52% (48%) 
Wiersma et 
al. in press 
RCT CBASP Within the CBASP group, completers (ITT): 
Remission: 26% (19.4%) 
Response: 41.2% (31.3%)  
 
Effect size (within CBASP group): d = 1.37 
Malogiannis 
et al. 2014 
Single case series Schema therapy Remission: 41.6% 
Overall response (response or remission): 58.2% 
 
Effect size (for improvements from baseline to post-
test): d between 2.01 and 2.84 
 
The overview of previous studies in Table 1 is not exhaustive. Studies in Table 1 were 
selected so that the comparison includes a meta-analysis/systematic review (Cuijpers et 
al., 2010; Spijker, van Straten, Bockting, Meeuwissen, & van Balkom, 2013), two major 
randomized clinical trials (Keller et al., 2000; Wiersma et al., in press) and a comparable 
single case-series testing the effects of schema therapy for chronic depression 
(Malogiannis et al., 2014). When benchmarking the effect sizes of the study described in 
chapter	9 with those reported in the meta-analysis by Cuijpers et al. (2010), schema 
therapy seems to perform above average. Response and remission rates of the study 
described in chapter	9 are roughly in line with those found for the cognitive behavioral 
analysis system of psychotherapy (CBASP; Keller et al., 2000; Wiersma et al., in press), a 
form of psychotherapy specifically developed for those with chronic depression. 
Moreover, response and remission rates of the current study are comparable with those 
of a recent single-case-series of schema therapy in a smaller sample of chronically 
depressed women (Malogiannis et al., 2014). It should be noted that the results of a 
single case-series cannot be directly compared to those of a randomized clinical trial or 
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findings from meta-analyses. However, in the study described in chapter	9, stringent 
control phases were used to control for a general decrease in symptoms over time 
(baseline phase) and to control for possible effects of receiving empathy and attention 
from the therapist (exploration phase). These phases resemble those of a waiting-list 
control condition (baseline phase) and of a non-active control treatment (exploration 
phase) in a RCT. Overall, our case-series study adds to the emerging body of evidence 
suggesting that schema therapy might be an effective treatment for chronic depression, 
at least as effective as current treatment options for chronic depression and potentially 
more effective, but more controlled and comparative treatment outcome studies, 
comparing schema therapy to other active treatments (e.g. treatment as usual) are 
needed to further build the evidence base of schema therapy for chronic depression. 
 In chapter	 10 the temporal relation between change in depressive symptoms 
during schema therapy and two potential mechanisms of change (negative core beliefs 
and the therapeutic alliance) in schema therapy for chronic depression were explored. 
We used an innovative approach to study the temporal relation between these variables, 
focusing on the within-person variance (i.e. changes in these variables within persons 
over time) rather than focusing on the between-person variance (i.e. differences in these 
variables between participants). By mapping out the temporal relations between these 
variables we were able to test six models on the temporal and concurrent relations 
between change in depressive symptoms, negative core-beliefs and the therapeutic 
alliance. We found that an increase in depressive symptoms from pre-session to post-
session was associated with a subsequent decrease in negative core-beliefs but only 
when change in symptoms but not change in core-beliefs occurred in the context of as 
session and only in the first quartile of treatment. One explanation for this finding could 
be that change in core-beliefs in the absence of a therapy session does not reflect 
structural changes in underlying beliefs but rather mood-state fluctuations and that it is 
more likely that mood-state returns to a baseline after a previous improvement. 
However, this explanation remains speculative and cannot be tested within this study. In 
line with the idea that fluctuations in core-beliefs in the absence of therapy session 
represent mood-state fluctuations, rather than structural changes, it was found that 
change in depressive symptoms predicted concurrent change (i.e. change at the same 
time) in core-beliefs but only in instances in which change in both variables occurred in 
the absence of therapy sessions. The finding that, in general (i.e. when ignoring 
assessment–session sequences), change in core-beliefs was not temporarily related to 
change in depressive symptoms was contrary to what would be expected based on 
theory. There are at least two possible explanations for this finding: 1) the theory is 
wrong and other mechanisms are responsible for changes in symptoms; 2) our approach 
to study temporal relations did not capture the critical change moments during 
treatment. While it would be too premature to accept the first explanation based on the 
current data, it is probably most fruitful to further explore innovative methods to study 
potential mechanisms of symptom change in the future.  
 The second potential mechanism of symptom change in schema therapy for 
chronic depression that was explored in this study was the therapeutic alliance. When 
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alliance ratings of the same therapy sessions were assessed repeatedly, specific aspects 
of the alliance (goal and task agreement) became more positive when depressive 
symptoms improved. However, taking different treatment phases into account revealed 
that in the first quartile of treatment these ratings became more negative when 
symptoms improved. One potential explanation for this finding could be that early on in 
treatment patients do not attribute improvements in symptoms to the specific 
techniques (task agreement) that were used. Again based on the current study this 
explanation remains speculative and alternative explanations cannot be ruled out. The 
finding that the overall therapeutic alliance ratings are not temporarily related to 
symptom changes was in contrast to previous findings that have reported moderate 
alliance outcome relations (Horvath, Del Re, Fluckiger, & Symonds, 2011). However, 
most previous studies were based on cross-sectional associations whereas the current 
study took the temporal relations between change in symptoms and alliance ratings 
from session to session into account. Based on our analyses, again at least two possible 
conclusions regarding the alliance – symptom change association can be drawn. 1) the 
therapeutic alliance in schema therapy for chronic depression is not temporarily related 
to changes in depressive symptoms and other mechanisms are responsible for changes 
in symptoms; 2) our approach to study alliance – symptom change relations did not 
capture the critical change moments during treatment. The finding that some aspects of 
the therapeutic alliance (goal and task agreement) were concurrently related to changes 
in depressive symptoms suggest that alliance assessments are in part colored by the 
current mood state of participants. In this context a fruitful avenue for future research 
might be the development of alternative alliance measures that are less affected by the 
current mood state. It might be interesting, for example, to explore possibilities of 
developing implicit measures of the therapeutic alliance. 
 
Overall, based on the studies conducted for this dissertation two important critical 
aspects should be mentioned. First, (chronic) depression entails more than just 
depressive symptoms and additional outcomes should be considered when investigating 
treatment effects. For example, from a patient perspective, social functioning might be 
an important treatment outcome that is currently not included in definitions of 
treatment response or remission (chapter	7). Second, instead of evaluating treatment 
outcomes, a stronger focus on treatment processes that lead to these outcomes is needed. 
To do so, it is necessary to assess treatment outcomes and potential mechanisms that 
lead to these outcomes repeatedly throughout treatment and to evaluate the temporal 
relations between these variables (chapter	10). However, even when a large number of 
repeated assessments is available, such that the temporal relations between potential 
mechanisms and symptoms can be established, other issues, such as the exact timing of 
assessments or the measurement and operationalization of concepts, complicate the 
study of treatment processes that lead to outcomes. 
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Methodological	considerations	
Methodological shortcomings 
A number of important methodological shortcomings that apply to the studies in this 
dissertation should be mentioned. Since we relied on a variety of research designs in the 
studies presented in this dissertation (experimental neuroimaging, observational 
designs, cohort study, meta-analysis, single case-series) there is no single, overarching, 
methodological issue that applies to all the studies described in this dissertation. In 
general, it can be stated that each study in the current dissertation had its own 
methodological strengths and weaknesses that had mainly to do with the research 
design of each individual study. 
 In the neuroimaging studies described in part I of this dissertation (chapters	2	
and	3) we did not include a clinical control group. It therefore remains unclear how 
specific the results are with respect to chronic depression. It is possible that comparable 
results would have been obtained in patients with non-chronic forms of depression or 
related mental disorders. The issue of lack of specificity is a limitation that applies to 
most previous neuroimaging studies in depression on which the studies described in 
part I of this dissertation were based. Thus one general advice would be that 
neuroimaging studies in psychiatric patients with a given mental disorder should move 
beyond demonstrating differences between patients and healthy participants. By 
including patients with comparable psychiatric and treatment history background, yet 
distinct mental disorder the specificity of the underlying neuropathology of a given 
mental disorder could be established. In the context of depression, depending on the 
specific research questions, appropriate clinical control conditions might be patients 
with primary anxiety disorders or patients with cluster-c personality disorders because 
of overlap in some aspects of symptomatology.  
 The studies described in part II of this dissertation each have their specific 
methodological shortcomings that have to do with the different research designs that 
were used in the respective studies. Chapter	4 describes the findings from a naturalistic 
treatment study. In such study designs a number of factors that might impact the results 
of the study are not controlled for, such as the quality and amount of treatment, as well 
as patient characteristics such as co-morbidity. On the other hand, naturalistic treatment 
studies are less affected by problems that have to do with selection-bias and findings 
from these studies might therefore more readily generalize to everyday practice.  
	 Chapter	 5 describes the findings from a cohort study in which patients with 
depression were followed over a period of two years. In this study the stability of 
personality traits in treated and untreated patients were explored. One major 
methodological issue in this study was that patients were not-randomized to treatments 
and the group of patients that received treatment might therefore not be comparable to 
the group of patients that did not receive treatment. The results of this study should 
therefore not be interpreted in terms of effects of treatment on personality traits but 
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rather in terms of the stability of personality traits in people with depression who seek 
treatment compared to people with depression who do not seek treatment. 
 The study in chapter	6 evaluated the effects of cognitive therapy for depression on 
interpersonal problems. The conclusions that can be drawn from this study are limited 
by the fact that the acute-phase of this multi-phase study only included a single 
treatment condition (cognitive therapy) and no control condition. It therefore remains 
unclear how specific the findings are with respect to cognitive therapy. It is possible, for 
example, that psychotherapy with a stronger focus on interpersonal functioning (e.g. 
interpersonal psychotherapy) has stronger effects on interpersonal problems in 
depression. 
	 Chapter	 7	 describes the results of a meta-analysis that quantifies the effect of 
psychotherapy for depression on social functioning. Meta-analyses in general are a 
rather crude way of exploring treatment effects and are not always well suited to 
answer specific questions about predictors, mediators or moderators of treatment 
effects. Although we were able to include various potential predictors in multivariate 
meta-regression analyses it is difficult to disentangle the relation between study 
characteristics and the effect-size of interest. For example, we found no differences 
between different types of psychotherapy on the effect size of social functioning. 
However this finding is based on different sets of comparisons rather than direct 
comparison between different types of psychotherapy within the same study, which 
limits the conclusions that can be drawn from such findings. Methodologically, meta-
analyses could be improved by obtaining study-level data and basing the analyses on the 
original study-level data rather than group statistics reported in publications. 
 In chapter	8 the theoretical application of schema therapy to chronic depression is 
described. The aim of this chapter was to describe the rationale of applying schema 
therapy to chronic depression. In doing so we did not conduct a formal systematic 
literature review and therefore only describe a selected number of studies to support 
our central claims. Moreover, the model that we describe in chapter	 8 should be 
regarded as a working model with a limited scope on psychological factors. Chronic 
depression is a complex disorder and other psychological factors (e.g. attachment) and 
biological factors (e.g. genes, neurotransmitters, hormones) are also important to 
consider when describing underlying vulnerability to chronic depression. However, in 
our model we aimed to focus on specific psychological factors that can be addressed in 
schema therapy for chronic depression. 
 In chapter	9 we describe the results of a single case-series testing the effects of 
schema therapy for chronic depression. The single case-series design does by definition 
not include a control group which limits the conclusions that can be drawn from the 
study. Although we found positive effects of schema therapy on depressive symptom 
severity, it remains unclear how schema therapy would have performed relative to 
another active treatment condition. We relied on comparing treatment effects with 
symptom changes during a baseline period, however, symptoms also changed during the 
baseline period which complicated the interpretation of the data in this study 
substantially. More specifically, it is unclear what have caused the change in symptoms 
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during the baseline period. One possibility would be that patients with chronic 
depression indeed become less symptomatic when repeatedly completing 
questionnaires, possibly because they gain insights into their symptoms. However, given 
that symptoms in chronic depression are by definition chronic and very difficult to 
change, even with extensive treatments, it is unlikely that change in symptoms during 
the baseline represented real symptomatic improvements. A more likely explanation 
would be that repeated assessments of symptoms with the same questionnaires 
introduces a measurement artifact, as has previously been shown in healthy individuals 
(Longwell & Truax, 2005), an issue that my co-authors and I are currently investigating 
in a separate study. 
 In chapter	10 we investigated temporal relations between changes in depressive 
symptom severity during schema therapy for chronic depression and two potential 
mechanisms of change, the therapeutic alliance and core-beliefs. Results from these 
analyses are limited because we focused on only two potential mechanisms of change in 
schema therapy. Other specific and non-specific factors might also account for change in 
depressive symptoms during schema therapy for chronic depression and should be 
investigated in future studies. Moreover, due to the limited sample size and the lack of a 
control group, we were not able to test more complex models of how potential 
mechanisms might be related to changes in symptoms and we were not able to conduct 
formal mediation analyses to test, for example if the effects of schema therapy on 
depressive symptoms are mediated by change in core-beliefs. Moreover, we assessed 
explicit ratings of core-beliefs and this might not adequately tap the schema change 
processes underlying schema therapy. The appropriate timing of assessments and 
specific types of assessments (implicit vs explicit) of schemas therefore remains a 
challenge for future research. 
Clinical and research implications 
A number of relevant clinical and research implications can be drawn from the findings 
of the studies presented in this dissertation. When confronted with personal relevant 
emotional information, on a neural level, patients with chronic depression show blunted 
emotional responses (chapter	 2). Clinically, this suggests that patients with chronic 
depression might benefit from treatments for depression that focus on increasing 
emotional processing such as emotion focused therapy (Greenberg & Watson, 2006) or 
schema therapy (Young, Klosko, & Weishaar, 2003). Future neuroimaging studies should 
test the effects of these treatments on emotionally blunted neural responses in patients 
with chronic depression. Findings from chapter	3 suggest that following a sad mood-
induction, patients with chronic major depressive disorder show increased functional 
connectivity of resting state networks associated with schematic processing and 
rumination. Clinically, this suggests that patients with chronic depression might benefit 
from treatments that aim to decrease activation of negative schemas that might be 
triggered by negative mood. The degree to which connectivity within these networks 
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following a sad mood induction remains stable following treatment remains to be 
investigated. 
 
Our findings in part II of this dissertation point towards potentially important 
underlying vulnerability factors to depression and the stability of these factors following 
treatment. Patients with depression in chapter	4 were characterized by a distinct set of 
early maladaptive schemas. In chapter	9 we were able to shown that treatment for 
chronic depression focusing on these schemas (schema therapy) has positive effect on 
depressive symptoms. Future research should aim to further determine which early 
maladaptive schemas are specific for patients with chronic depression and whether 
addressing these schemas in treatment results in positive effects. The focus in schema 
therapy in recent years has shifted from a focus on early maladaptive schemas towards a 
focus on schema modes. Schema modes, defined as the moment to moment emotional 
states of patients have not been studied substantially in depression. As we have argued 
in chapter	8 of this dissertation, future research should identify which specific schema 
modes are predominantly activated in patients with (chronic) depression. Our results 
suggest that patients with depression might benefit from a stronger focus on early 
maladaptive schemas (chapter	4), interpersonal problems (chapter	6) or psychosocial 
functioning (chapter	 7). Although current treatments for depression seem to have 
positive effects on each of these underlying vulnerability factors, findings of this 
dissertation indicate that these effects were weaker than the effects on depressive 
symptoms (e.g. chapter	4, chapter	6), suggesting that the underlying vulnerability to 
depression, in terms of these factors, remains at least partly intact following current 
treatments for depression. Addressing these vulnerability factors using an integrative 
treatment approaches such as schema therapy for chronic depression might be fruitful. 
 Our findings from chapter	 7 suggest that more treatment sessions might be 
necessary to repair impaired psychosocial functioning in depression. These findings are 
in line with findings of a meta-analysis suggesting that patients with chronic depression 
might benefit from additional treatment sessions (Cuijpers et al., 2010). Clinically, such 
findings suggest that it might be necessary to provide long term psychotherapeutic 
treatments to patients with chronic depression. Future research should further aim to 
determine the optimal dose and frequency of psychotherapy for chronic depression. Our 
findings from chapter	9 suggest that schema therapy might be an effective treatment for 
patients with chronic depression. These findings add to the accumulating evidence that 
schema therapy is an effective treatment for patients with (chronic) depression (Carter 
et al., 2013; Malogiannis et al., 2014). Future research needs to determine the effects of 
schema therapy for chronic depression in larger samples and more controlled settings. 
Moreover, comparative efficacy studies in which schema therapy is compared to other 
treatment options for chronic depression are needed.  
CHAPTER 11 
 240 
Implications for current definitions of treatment effects 
Studies in part II of this dissertation have investigated the effect of different treatments 
for depression on various presumably underlying vulnerability factors to depression. 
Currently treatment effects in treatment outcome studies of depression are usually 
defined in terms of relative decrease in depressive symptom severity (response) 
absolute decrease in depressive symptom severity (remission) or absence of diagnostic 
criteria (recovery). Thus current definitions on treatment effects exclusively rely on 
treatment effects on depressive symptoms. According to the world health organization, 
health is defined as “…a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity” (World Health Organization, 1948). Thus, in 
order to come to a more complete definition of psychological health, it might be valuable 
to broaden current definitions, for example, by including improvements in psychosocial 
functioning rather than purely relying on symptomatic improvements when evaluating 
treatment effects. 
 Chronic depression, like other chronic mental disorders, is complex and 
multifaceted. Treatment effects might therefore not be adequately covered by only 
assessing symptomatic improvement. It might be valuable to reconsider symptomatic 
improvements as main treatment outcome in chronic depression and rather focus on the 
effects of treatments in terms of how patients learned to cope with depressed mood 
following treatment. For example, it might be more important from a patient and 
economical/societal perspective that chronically depressed patients are able to engage 
in recreational or work related activities despite depressed mood rather than focus on 
the mood itself. As an analogy, in the field of chronic pain research the relevant outcome 
is often how much patients engage in physical activities, despite their pain, rather than 
the pain intensity itself. A similar approach might prove useful in the field of chronic 
depression. 
Future directions 
The studies described in part I of this dissertation provide the first evidence of the 
underlying neuropathology related to self-referential processing and modulation of 
default mode network connectivity by sad mood in patient with chronic depression. In 
addition to the general implications of these studies for future research, our personal 
research agenda includes a follow-up study of the same participants described in part I, 
to assess the effects of schema therapy on the emotional blunted neural responses 
(chapter	2) and increased default mode network connectivity following the sad mood 
challenge (chapter	3). Due to time constrains this follow-up study could not be included 
in this dissertation. The single case series study described in chapter	 9 of this 
dissertation is among the pioneering studies investigating the effects of schema therapy 
for chronic depression and chapter	 10 is the first extensive analyses of potential 
mechanisms of change in schema therapy for chronic depression. In addition to the 
general research implications of these studies, our personal research agenda includes a 
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follow-up evaluation to test the long term effects of schema therapy for chronic 
depression and the investigation of other pathways of change within that context, which 
could also not be included in the current dissertation due to time constrains. Finally, 
with regard to the unexpected decrease in symptoms during the baseline period of the 
single case series, my co-authors and I have started a study in patients with depression 
who are on a waitlist to start with treatment. In this study patients are randomly 
assigned to a condition in which they are asked to complete questionnaires of 
depressive symptom severity once a month or once a week in order to test whether 
assessment frequency introduces a measurement artifact. The results of this study will 
shed more light onto the “baseline effect” observed in chapter	9. 
Overall	conclusion	
Depression is a common mental disorder that often takes a chronic course. Chronic 
depression has substantial negative consequences for the individual and the society. In 
addition to depressive symptoms, patients with depression are characterized by distinct 
maladaptive schemas, high levels of dysfunctional personality traits, interpersonal 
problems and impairments in psychosocial functioning. Although treatment for 
depression seems to have positive effects on these underlying vulnerability factors, the 
improvements are often not as strong as improvements in depressive symptom severity. 
This suggests that the underlying vulnerability to depression, in terms of these factors, 
remains at least in part intact after treatment, which might explain relapse, recurrences 
and chronicity to some extent. Treatment for depression might benefit from an 
additional focus on these underlying vulnerability factors, especially in patients who 
report stronger levels of these vulnerability factors, such as patients with chronic 
depression. In this regard, it might be particularly valuable to take an integrative 
treatment approach, such as schema therapy, to target these distinct vulnerability 
factors. In the current dissertation it was shown that schema therapy had positive 
effects on relevant outcomes in patients with chronic depression. Future studies should 
replicate these findings in larger samples, comparing schema therapy to other treatment 
options for chronic depression. 
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Major depressive disorder is a common and highly disabling mental disorder that often 
takes a chronic course. A depressive disorder is assumed to be chronic when the 
symptoms of depression persist for two years or longer. Previous research has shown 
that compared to non-chronic depression, chronic depression is associated with more 
negative health and economic outcomes, highlighting the importance of effective 
treatments for chronic depression. Current treatments for chronic depression are 
available but are often less effective than treatment for episodic forms of depression. 
Possible reasons for the lack of effectiveness of current treatment approaches might be 
that current treatment options are too time-limited and too symptom focused. The 
central question of the current dissertation was if better treatment outcomes could be 
achieved in long-term psychotherapy for chronic depression that focusses on the 
underlying vulnerability to chronic depression. 
 
The primary aim of the current dissertation was to test the effects and explore the 
underlying mechanisms of a long-term integrative treatment approach (schema therapy) 
for patients with chronic depression. The secondary aim was to further examine 
underlying neurological and psychological vulnerability factors to (chronic) depression 
and to determine the stability of psychological vulnerability factors during treatment for 
depression.  
 
Chapter	1 of this dissertation provides an overview of the diagnostic criteria of a major 
depressive disorder, the conceptualization of different forms of chronic depression, the 
prevalence and consequences of chronic depression and a definition and overview of 
treatment effects of current common treatment approaches to chronic depression. 
Developmental, psychological and neurological vulnerability factors to (chronic) 
depression are described. The chapter ends with an outline of the goals of the current 
dissertation. 
 
In chapter	2, the neural correlates of self-referential processing in patients with chronic 
major depressive disorder were examined. We used functional magnetic resonance 
imaging (fMRI) during a passive self-referential processing paradigm in patients with 
chronic major depressive disorder (n = 17) and matched healthy controls (n = 18). We 
found that patients with chronic depression had decreased BOLD signal during 
processing of negative depression related personality traits vs. neutral words in the 
medial prefrontal cortex. Compared to patients, controls had increased BOLD signal in 
the dorsolateral prefrontal cortex during processing of positive vs. neutral personality 
trait words. These findings suggest that chronic depression is characterized by distinct 
neural processing of emotional self-relevant stimuli in these brain areas. We interpreted 
these findings in terms of a blunted emotional response in patients with chronic 
depression. 
 
In chapter	3, the default mode network functional connectivity during rest in patients 
with chronic depression and matched controls before and after a sad mood-induction 
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was investigated. The mood induction procedure resulted in decreased mood ratings in 
patients with chronic depression and in non-patient controls. Posterior cingulate cortex 
(PCC) connectivity with the left parahippocampal gyrus, the left superior temporal gyrus 
and the left anterior inferior temporal cortex increased in patients with chronic 
depression, relative to controls, following the sad mood induction. In contrast, PCC 
connectivity with the left anterior prefrontal cortex and the right precuneus decreased 
in patients with chronic depression and increased in controls following the sad mood 
induction. We interpreted these findings in terms of activation of negative latent 
schemas or rumination of negative thoughts in patients with chronic depression, 
triggered by the mood induction. Connectivity in non-patient controls following the 
mood induction was interpreted as indicative of a cognitive control (coping) mechanism 
possibly preventing non-patient controls from retrieving negative memories and 
engaging in ruminative thinking.  
 
Next to neurological disturbances underlying chronic depression, we also tested the 
stability of psychological vulnerability factors during treatment for depression. The 
study described in chapter	4 tested the stability of early maladaptive schemas over a 
course of outpatient treatment for depression as well as the relation of schemas with 
depressive symptoms in 132 patients with a major depressive disorder. Specific 
schemas (failure, emotional deprivation, abandonment/instability) were found to be 
related to depressive symptom severity. These schemas, as well as other schemas that 
were unrelated to depressive symptoms, remained relatively stable over the course of 
treatment. Our interpretation of these findings was that the underlying vulnerability to 
depression, in terms of early maladaptive schemas, remains intact following outpatient 
treatment for depression, highlighting the potential value of addressing these schemas 
in schema therapy. 
	
Chapter	5 is based on data of a longitudinal cohort study, the Netherlands Study for 
Depression and Anxiety. Based on the data of this study, we investigated the two-year 
stability of the personality traits neuroticism and extraversion in treated and untreated 
patients with depression. We found that neuroticism and depressive symptoms 
decreased in treated and untreated people with depression whereas extraversion did 
not change significantly. We discuss these findings in terms of the mood-state 
dependency of neuroticism and concluded that assessment of personality traits in 
depression is clouded by the current mood state. 
 
The relation between interpersonal problems, the therapeutic alliance and depressive 
symptoms during cognitive therapy for depression was examined in chapter	 6. 
Following a 16 to 20 session course of cognitive therapy, interpersonal distress 
improved whereas the interpersonal style of depressed patients remained largely stable. 
Patients who scored high on agency/dominance prior to treatment reported lower 
quality therapeutic alliance whereas patients who scored high on communion/affection 
prior to treatment reported higher quality alliance. Patients experiencing higher 
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interpersonal distress prior to treatment reported higher symptom severity throughout 
treatment. These findings suggest that interpersonal problems of patients with 
depression have some predictive validity with respect to the therapeutic alliance and 
treatment outcomes. 
	
Chapter	 7 describes the findings of a meta-analysis quantifying the effects of 
psychotherapy for depression on improvements in psychosocial functioning. We 
identified 31 randomized controlled trials comparing the effects of psychotherapy to a 
control group that also included a measure of psychosocial functioning at post treatment. 
Psychotherapy resulted in significant improvements in psychosocial functioning at post-
treatment with moderate effect sizes. In multivariate meta-regression analyses, the 
effect size of depressive symptoms, the number of treatment sessions and the treatment 
format (individual versus group) remained as significant predictors of the effect size for 
psychosocial functioning. We concluded that psychotherapy has positive effects on 
psychosocial functioning in depression and that these effects are highly related to, but 
partly independent from the effects of psychotherapy on depressive symptom severity. 
 
In chapter	8 the theoretical application of schema therapy for chronic depression is 
described. Based on our own research and similar studies we argue that chronic 
depression is characterized by a number of psychological and developmental 
vulnerability factors (adverse childhood events, personality pathology, cognitive factors, 
interpersonal factors) and that current treatments for depression might not adequately 
address these factors. We provide examples of how these factors might be addressed in 
schema therapy for chronic depression and provide a treatment manual of schema 
therapy for chronic depression. 
 
The results of a single case-series study of schema therapy for chronic depression are 
described in chapter	 9. In this study 25 patients with a chronic major depressive 
disorder were first assessed during a 6 to 24 weeks baseline period. Following this, 
patients entered a 12 weeks exploration phase of the study during which schemas were 
explored, the case-conceptualization was done and treatment goals were set. After the 
exploration phase, patients received up to 65 sessions individual schema therapy. Of the 
25 patients who started with the study, five dropped out during the baseline phase. Of 
the remaining 20 patients who started with treatment, no one dropped out, 40% 
responded and 35% remitted. Of the 12 patients who were followed until treatment 
completion, 58% recovered at the end of the intervention. Mixed model regression 
analyses contrasting exploration phase and intervention phase effects with the baseline 
phase yielded significant effects of the intervention on depressive symptom severity, 
global symptomatic distress and overall wellbeing. These findings provide preliminary 
evidence for the effectiveness of schema therapy for chronic depression.  
 
In chapter	 10 the underlying mechanisms of change in schema therapy for chronic 
depression were explored. In particular, we investigated temporal relations between 
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change in depressive symptoms during schema therapy for chronic depression and 
change in negative core-beliefs as well as the relation between change in symptoms and 
the therapeutic alliance. Our findings have shown that there are no temporal relations 
between changes in negative core-beliefs and change in depressive symptoms during 
schema therapy for chronic depression. Instead, changes in negative core-beliefs are 
concurrently associated with changes in depressive symptoms. Moreover, change in 
depressive symptoms was unrelated to ratings of the therapeutic alliance but alliance 
ratings were at least to some degree colored by the current mood state. 
 
In chapter	 11, the findings of this dissertation are discussed. A number of 
methodological weaknesses as well as clinical and research implications are discussed. 
It is argued that depression is characterized by a number of underlying vulnerability 
factors and that patients with depression might benefit from a focus on these factors. 
Our findings indicate that schema therapy might be a valuable treatment option for 
patients with chronic depression and shed some light on the underlying mechanisms of 
change. The overall conclusion that can be drawn at this point is that schema therapy is 
a promising treatment for chronic depression but that randomized clinical trials are 
needed to demonstrate the effectiveness. 
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This dissertation describes the results of a number of studies on the underlying 
vulnerability to (chronic) depression and on the psychological treatment of chronic 
depression with schema therapy. In describing the knowledge valorization of the results 
of the current dissertation, the focus is on the societal and economic relevance of the 
findings, potential target groups, possible activities and/or products and on the innovative 
aspects of the studies conducted for this dissertation. Examples of how knowledge 
valorization has been achieved and ideas for how knowledge valorization can further be 
realized are described at the end of the addendum. 
Societal	and	Economic	Relevance	
Depression is a common mental disorder that is associated with negative consequences 
from a clinical, societal and economic point of view (World Health Organization, 2004). 
The economic burden of depression is due to the direct costs of the disorder (i.e. costs of 
treatment) as well as indirect costs (e.g. work absence). According to the Dutch National 
Institute for Public Health and the Environment (Rijksinstitut voor Volksgezondheid en 
Milieu; RIVM), depression is one of the most expensive illnesses with annual costs of 
approximately 1.6 billion euro in the Netherlands (RIVM, 2013). The UK office for 
national statistics (ONS) has estimated that 13.3 million work days were lost in 2011 
due to depression (ONS, 2012). Especially chronic forms of depression seem to be 
associated with these negative consequences. The costs of depression can be explained 
by the duration of symptoms, thus by the chronicity of the disorder (Fostick, Silberman, 
Beckman, Spivak, & Amital, 2010). This situation calls for effective treatments for 
patients with (chronic) depression. Although effective treatments for depression exist, 
about half of the patients with depression do not respond to treatment (Cuijpers et al., 
2014), an unacceptably low rate of response.  
 Given these numbers, research into the underlying vulnerability factors of (chronic) 
depression and research exploring new treatment options for patients with chronic 
depression is of great relevance on a clinical, societal as well as economic level. Although 
the findings of the studies described in this dissertation do not directly contribute to 
decreased health care costs, they point towards new treatment targets that might 
ultimately decrease treatment costs. The cost-effectiveness of schema therapy has been 
demonstrated previously, in patients with personality disorders (e.g. Bamelis et al, in 
prep; van Asselt et al., 2008). Although in the current dissertation, my co-authors and I 
did not formally assess the cost-effectiveness of schema therapy, the studies described 
in the current dissertation set the stage for future studies that might inform on the cost-
effectiveness of schema therapy for chronic depression which, when implemented might 
have direct relevance on economic costs. 
Target	groups	
The findings of this dissertation are relevant for psychotherapy researchers, for 
professionals working in clinical settings, patients suffering from chronic depression 
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and stakeholders from the industry and technology sector. The results of the studies of 
this dissertation show that current treatments for depression do not adequately touch 
the underlying vulnerability to depression and that a new psychological treatment 
approach, schema therapy, has positive effects on depressive symptoms in patients with 
chronic depression. Although it is too premature to implement schema therapy for 
chronic depression in the mental health care system, professionals, working in mental 
health care might use specific therapeutic techniques that are described in this 
dissertation. The studies described in this dissertation provide the underlying rationale 
of using these techniques in the psychological treatment of patients with chronic 
depression. The industry and technology sector has started to translate psychosocial 
interventions for mental disorders into (online) computerized mental health 
interventions and/or smartphone applications. As the evidence of schema therapy for 
patients with chronic mental health problems is increasing, the interest of third parties 
in such applications might grow and similar applications might be developed based on 
the principles and techniques used in schema therapy. Thereby, the findings from the 
studies described in this dissertation are indirectly contributing to the knowledge 
utilization outside the academic sector. Specifically, the results of the study described in 
chapter 9 of this dissertation contribute to the emerging evidence of schema therapy for 
chronic depression and thereby promotes interest in schema therapy by stakeholders 
within and outside the academic community. 
Activities	and	Products	
The findings of the studies described in the current dissertation point towards 
possibilities for activities and/or products. While it is too premature to implement 
schema therapy for chronic depression as a standard treatment in the mental health 
care sector, workshops and training programs can be organized by schema therapists to 
teach health care professionals specific schema therapy techniques. Findings from the 
studies of the current dissertation provide the rationale for using these techniques in the 
treatment of patients with chronic depression. For example, health care professionals 
might organize workshops in the context of scientific conferences during which schema 
therapy techniques that can be used in the treatment of patients with chronic 
depression are taught to other health care professionals. Moreover, specific therapeutic 
techniques used in schema therapy might be integrated into formal psychotherapy 
training modules. Schema therapists might also produce formal training videos or other 
educational material to promote training in schema therapy. The findings from chapter 
8 and chapter 9 provide a rationale and preliminary evidence of applying schema 
therapy to chronic depression and thus for these activities/products. 
Innovation	
The studies conducted in this dissertation are innovative as they adress novel research 
questions, many of which have not previously been explored. The study described in 
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chapter 3 of this dissertation, for example, adapted procedures used in experimental 
psychology (sad mood induction) during neuroimaging of patients with a current 
chronic depression. This allowed for studying neural reactions to a sad mood challenge 
in currently depressed individuals, which has not been studied before.  
 One major innovation of the single case series study described in chapter 9 of this 
dissertation is the large number of repeated assessments throughout the study period. 
This allowed for a more dynamic modeling of change in depressive symptoms 
throughout the different study phases. Based on this innovative study design we could 
show, for example, that durign a period in which no treatment was provided, depressive 
symptoms improved initally, before returning to a baseline again. 
 The findings described in chapter 10 of this dissertation are based on a novel, 
innovative approach of studying underlying mechanisms of change in psychotherapy 
research. Whereas traditional treatment studies have focussed on between-person 
differences, the study described in chapter 10 has focussed on changes within-
individuals over time. This allowed for studying potential mechanisms of change in 
schema therapy for chronic depresison in a realtively small sample and to disentagle the 
temporal relations between study variables, an often neglected prerequisite in process-
outcome research. 
Schedule	and	Implementation	
Some of the studies described in this dissertation have already evoked interest outside 
of the scientific community which has resulted in traditional and social media 
apperances. Due to these media apperances, some of the resutls of the studies of this 
dissertation have been communicated to a broader audience, fostering public 
engagement. For example, the study described in chapter 7 of this dissertation has been 
featured on “The Mental Elf” website (04/2014), a mental health blog reaching more 
thant 30.000 followers/subscribers at various professional levels. Public engagement in 
study results was also promoted by presenting the rationale of chapter 9 during a 
newspaper and during a TV live interview. In addition to this, studies from this 
dissertation have been translated into Dutch and German and published in clinical 
journals that are more likely to reach health care professionals who are not working in a 
research setting. Moreover, therapists who were involved in studies described in this 
dissertation have organized workshops of schema therapy for chronic depression for 
health care professionals thereby uitilizing knowlwedge derived from studies of this 
dissertation. Knowledge valorization will further be stimulated by communicating 
findings of this dissertation not only within the scientific community (journal 
publications, conference presentations) but also outside the scientific community (for 
example via press releases).	
  
VALORIZATION 
 256 
References	
Bamelis, LLM, Arntz, A, Wetzelaer, P, Verdoorn, R, Evers, SMAA. Economic evaluation for personality 
disorders: a multicenterd randomized trial. Submitted manuscript. 
Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. (2014) The effects of 
psychotherapies for major depression in adults on remission, recovery and improvement: A meta-
analysis. J Affect Disord, 159, 118-126. 
Fostick, L., Silberman, A., Beckman, M., Spivak, B., & Amital, D. (2010). The economic impact of depression: 
Resistance or severity? European Neuropsychopharmacology, 20(10), 671-675. 
Office of National Statistics (2012). Sickness Absence in the Labour Market, April 2012. 
RIVM. Kosten van Ziekten in Nederland. Bilthoven: RIVM, http://www.kostenvanziekten.nl;, versie 1.3, 26 
november 2013.  
van Asselt, A. D., Dirksen, C. D., Arntz, A., Giesen-Bloo, J. H., van Dyck, R., Spinhoven, P., . . . Severens, J. L. 
(2008). Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of 
schema-focused therapy v. transference-focused psychotherapy. British Journal of Psychiatry, 
192(6), 450-457. 
World Health Organization. The global burden of disease: 2004 update. 2008, Geneva, Switzerland: World 
Health Organization. 
 
 
 
 
  
 257
 
Acknowledgements	
  
ACKNOWLEDGEMENTS 
 258 
  
ACKNOWLEDGEMENTS 
 259
I would like to thank everybody who has supported me during the last five years and 
who has contributed to this dissertation. You all made my PhD years a great experience. 
 
First of all I would like to thank my promotors, Prof. Marcus Huibers and Prof. Arnoud 
Arntz and my co-promotor, Prof. Frenk Peeters. 
 
Marcus, you have been a fantastic supervisor who always supported me. We met during 
the research master program and when you told me that you have a job opening for a 
PhD position I immediately knew that this position would be the perfect match. I want to 
thank you for your trust and confidence in me that I would make this PhD project a 
success and for pushing me during these years. In the first week of my work as a PhD 
student you told me that “the goal is to become world famous” and that “the sky is the 
limit”. I’m afraid that I did not succeed in this but you always took good care of me and 
provided me with all the opportunities to develop and grow as a researcher and I’m very 
thankful for that. You have taught me that the key fundament for a successful research 
project is a good method and I hope that this dissertation can be regarded as proof that 
we succeeded in implementing this. You also have been very generous in offering an 
extension, when things were going slower than we had hoped for and in supporting 
extended work visits abroad (Leuven, Philadelphia). I have learned a lot from you, not 
only research-wise but also life-wise. We also had great fun at conferences (Boston, New 
York, Reykjavík, Marrakesh, Den Haag) and I learned another important lesson from you 
during these trips: “work hard play hard”. Marcus, thank you for everything and I really 
hope we will continue to work together. 
 
Arnoud, you have been a great supervisor and a great mentor for me. You have 
supported me already during the research master when you involved me in a study that 
resulted in my first co-authored publication and I am very grateful for this. You always 
had an open door when I had more or less urgent questions about multi-level analyses, 
the correct covariance structures and so on. The time and efforts you took for this was 
not only very helpful for working towards getting the studies published but also a great 
learning experience for me. I could always count on your support and it was a great 
privilege to work with you and I hope that this will be continued. 
 
Frenk, thank you for all your support before and during my PhD project. During the 
research master program you helped me to arrange my research internship at the 
Psychiatry Department at the University of Pennsylvania. This research experience 
made me realize that I wanted to pursue a career in research. You also always supported 
me at all stages of the PhD project, for example when we struggled with a slow intake of 
new participants. Many thanks for everything. 
 
Although not officially co-promotor, I would also like to thank Jill Lobbestael for being a 
great mentor. Jill, thank you for all your input in the schema therapy project from the 
ACKNOWLEDGEMENTS 
 260 
beginning to the end and for giving me the opportunity to extent my contract and 
working together with you on one of your Veni studies. 
 
I would like to thank all patients who participated in the schema therapy study for all 
their efforts and for bringing up the motivation and energy of completing all the 
questionnaires every week. Obviously there would be no dissertation without your 
commitment. Thank you. 
 
I want to thank the therapists at the Riagg Maastricht who have provided schema 
therapy in the case series study: Ina Leeuw, Christel Achterberg, Claudia Mordang and 
Annemiek Dobbelaar. Thank you for your commitment to the study and for taking on the 
extra workload associated with the study. Ina, I want to thank you in particular for your 
special commitment in supporting the study from the beginning to the end and for all 
the efforts that you took to help making the schema therapy for chronic depression 
project a success. 
 
Thanks are also due to all intakers of team 1 at the Riagg Maastricht for screening 
patients for the study and for taking on the extra work load that was associated with this: 
Claudia Mordang, Josien Schneiders, Danielle Ummels, Elisa Wensink, Marionne Wolfis, 
Andrea Smits, Iris Tan, Eline Mollema. 
 
I would also like to thank the former team-manager of the mood disorder treatment 
section at the Riagg, Anja Kaarst, for her support and commitment of conducting this 
study at the Riagg Maastricht. Anja, thank you very much for supporting me when 
setting up the study and for your help with keeping the study running. 
 
Thanks are also due to Hannie van Genderen for giving me the opportunity to work as a 
statistical analyst for the Riagg Maastricht. 
 
I want to thank the management of the Riagg Maastricht for the financial support of my 
position and the clinical study. 
 
I would like to thank everybody who has supported me in setting up and conducting the 
fMRI studies of my dissertation. Nicolette, thank you so much for all the efforts and for 
your patience when teaching me how to use the MRI scanner and in explaining and 
helping with the data-analysis. Obviously without your help I would not have succeeded 
in getting the two fMRI papers in my dissertation. Conny, thank you so much for 
spending all the hours with me on the resting state analyses. Linda, thank you for your 
many backup hours when scanning the last participants on the good old Allegra.  
 
Thanks are due to all collaborators and co-authors from the studies for my dissertation: 
Lotte Bamelis, thank you for letting me use your data set for one of our studies. Michael 
Thase, thank you for hosting me in Philadelphia and for giving me the opportunity to 
ACKNOWLEDGEMENTS 
 261
publish my master thesis research together with you. Robin Jarrett, Lee Anna Clark and 
Jeffrey Vittengl, the conference calls and informal discussions were a great learning 
experience for me. Robert DeRubeis, dear Rob thank you for your hospitality when 
hosting me in Philadelphia. I very much appreciated our discussions and exchange of 
ideas on the mechanisms paper and the welcoming atmosphere at the DeRubeis lab in 
Philadelphia.  
 
Thanks are due to the research coordinators, research assistants and support staff at 
Maastricht University who supported the studies described in my dissertation: Annie 
Hendriks and Annie Raven you were always very helpful with all the practical and 
organizational aspects of the studies and this contributed to the fact that the studies 
were running smoothly: As I learned, a phenomenon known as the “Annie effect”. Annie 
H, thank you so much for all your support and help in recruiting participants for my 
studies and for helping with keeping participants in the study. Annie R, finding matched 
control participants for the fMRI study was a big challenge. Thank you for your help with 
this. Rosanne, I would like to thank you for providing the infrastructure for online data 
collection and helping with the logistics of the studies. Over the years I have become an 
EMIUM expert and I would like to thank Rosanne and Sita for their time and patience in 
explaining everything and helping out quickly when necessary. I would also like to thank 
Michelle Houben and Elly Niesten for helping out with the SCID interviews. Thanks are 
also due to Michiel Vestjens for programming an online flash version of the implicit 
measures used in my studies and for Anne Roefs who developed this implicit measure 
and generously shared it for use in our studies.  
 
I also want to thank all local research coordinators at the Riagg Maastricht for their 
support in patient recruitment and their help with the logistics of the study: Brigit Lok, 
Nicole van Loo, Christel Harisma and Marga Schnitzler. 
 
I would like to thank Angela Verweij and Lindy Dullens for all their organizational help 
throughout the years. 
 
Thanks are due to all students who have supported recruitment of participants and 
collected data, Patrick Schwarz, Danielle Jongen, Michiel van den Goor, Nora Krott, Lana 
Pulmanns.  
 
I would like to thank the members of my evaluation committee: Prof. Peter Muris, Prof. 
David Bernstein, Prof. Claudi Bockting, Prof. Jan Spijker and Dr Jeffrey Roelofs for taking 
the time to read and to evaluate my dissertation manuscript. 
 
Peter, I would also like to thank you for supporting the depression symposium that Lotte 
and I have organized. 
 
ACKNOWLEDGEMENTS 
 262 
Lotte and Thomas, dear paranimfen: thank you for your support in the preparation of 
my defense. Dear Lotte you were my research sister and roomie from the beginning of 
the PhD and we went through all the phases of the PhD together: From the happy 
moments (last participant included party) to the “stupid-ass” moments (rejected 
papers). Thank you for the good time and keep up the “Lemmens & Renner depression 
lab” here in Maastricht. Thomas, we know each other since we started studying in 2004. 
I always enjoyed chatting with you when you walked by the office with your coffee mug 
and I have good memories of EPP symposia, biertjes and billiard matches. 
 
I also would like to thank all other PhD students at CPS for making me feel at home and 
all the fun we had at conferences, dinners, EPP symposia, retreats and previous defense 
parties. 
 
Last but not least I would like to thank my family and friends from outside the UM for 
always being there for me and for supporting me when needed during these busy last 
five years. Elisabeth, vielen Dank für deine großzügige Unterstützung mein Leben lang. 
Du hast mich nie mit irgendwelchen Erwartungen unter Druck gesetzt und hast mich auf 
meinen Weg immer bedingungslos unterstützt. Dafür bin ich dir sehr dankbar. Klaus, 
auch dir danke ich für deine Unterstützung und Verständnis dafür, dass in den letzten 
Jahren oft die Zeit fehlte, um einen intensiveren Kontakt zu haben. Auch dir bin ich sehr 
dankbar für deine bedingungslose Unterstützung während meines Studiums und in der 
Zeit danach. Liebe Oma Rosa, auch dir möchte ich recht herzlich danken für deine 
Unterstützung während meines Studiums. Außerdem möchte ich mich beim Rest der 
Familie bedanken für euer Interesse an meiner Arbeit und euer Verständnis, wenn die 
Arbeit Vorrang hatte. Mein Dank gilt auch Jessicas Familie, insbesondere Annette und 
Dietrich, für die tolle Unterstützung in den letzten Jahren. Wir konnten uns immer auf 
euch verlassen in stressigen Zeiten und dafür bin ich euch sehr dankbar. 
 
Dank geht auch an meine Freunde in Köln, dafür, dass ihr zu mir gehalten habt, auch 
wenn ich in den letzten Monaten abgetaucht bin und alles abgesagt habe, weil die Arbeit 
vorging. 
 
Jessi, du warst die wichtigste Person für mich in all den Jahren. Du hast mir den Raum 
gegeben um meine Arbeit abzurunden und mich bedingungslos unterstützt. Du hast 
mich in den stressigen Wochen aufgemuntert und mir gezeigt, dass die Arbeit nicht alles 
ist und dafür liebe ich Dich. Die letzten Jahre waren eine spannende und aufregende Zeit.  
Auf ins nächste Abenteuer! 
 
 
 
  
 263
 
Curriculum	Vitae	
  
CURRICULUM VITAE 
 264 
  
CURRICULUM VITAE 
 265
Fritz Renner was born in Cologne (Germany) on July 30th 1982. He graduated from high 
school and obtained the German Abitur degree in Cologne in 2002. After this he 
conducted alternative Civilian Service (“Zivildienst”) for 10 months at an urban geriatric 
psychiatric nursing home in Cologne. In 2004 he started to study Psychology, with a 
specialization in Cognitive Psychology, at Maastricht University (The Netherlands). 
During the bachelor program he spent six months at Lund University (Sweden). After 
obtaining his Bachelor of Science degree in 2004, he joined the Research Master 
program in Cognitive Neuroscience, Neuropsychology and Psychopathology with a 
specialization in Psychopathology at Maastricht University. In the research master he 
received the prestigious Huygens fellowship by the Dutch Ministry of Education, Culture 
and Science. During the research master program he conducted a three months clinical 
internship at the Cologne Early Recognition and Intervention Centre for Mental Crises, 
University Hospital Cologne (Germany) and a six months research internship at the 
Mood and Anxiety Disorders Research Unit, Department of Psychiatry, University of 
Pennsylvania (USA). During the research master he worked as a student assistant at the 
Department of Psychiatry at Maastricht University. In September 2009 he graduated 
cum-laude from the research master program and started his PhD project at the 
Department of Clinical Psychological Science at Maastricht University. During the PhD 
project he worked at the community mental health center (RIAGG Maastricht) as a 
clinical psychologist one day per week for five months. During the PhD he received two 
micro grants for the development and evaluation of an online peer-review system for 
students. As part of his PhD project he visited the Methodology and Statistics of 
Educational Sciences Research Group at the University of Leuven (Belgium) for one 
month and the Department of Psychology, University of Pennsylvania (USA) for one 
month. 
  
CURRICULUM VITAE 
 266 
  
CURRICULUM VITAE 
 267
Publications	
Journal Articles 
Renner, F., Bamelis, L. L. M., Huibers, M. J. H., Speckens, A., & Arntz, A. (in press). The 
impact of comorbid depression on treatment outcomes in personality disorders: Results 
of a randomized controlled trial. Behavioral Research and Therapy.  
 
Dinger, U., Barrett, M. S., Zimmermann, J., Zilcha-Mano, S., Schauenburg, H., Wright, A. G. 
C., Renner, F., & Barber, J. P. (in press). Depressive Experiences: Dependency, Self-
Criticism and Interpersonal Problems in Major Depression. Journal of Clinical Psychology. 
 
Renner, F., Cuijpers, P., & Huibers, M. J. H. (2014). The effect of psychotherapy for 
depression on improvements in social functioning: a meta-analysis. Psychological 
Medicine, 44 (14), 2913-2926. 
 
Werthmann, J., Renner, F., Roefs, A., Huibers, M. J. H., Plumanns, L., Krott, N., & Jansen, A. 
(2014). Looking at food in sad mood: Do attention biases lead emotional eaters into 
overeating after a negative mood induction? Eating Behaviors, 15 (2), 230-236. 
 
Renner, F., Arntz, A., Leeuw, I., & Huibers, M. J. H. (2014). Schematherapie für chronische 
Depressionen [Treatment for chronic depression using schema therapy]. 
Verhaltenstherapie, 24, 169-181. 
 
Renner, F., Arntz, A., Leeuw, I. & Huibers, M. J. H. (2014). Behandeling van chronische 
depressie met schema therapie [Treatment for chronic depression using schema 
therapy]. Tijdschrift voor Psychotherapie, 40 (4), 256-272. 
 
Renner, F., Schwarz, P., Peters, M. L., & Huibers, M. J. H. (2014). Effects of a best-possible-
self mental imagery exercise on mood and dysfunctional attitudes. Psychiatry Research, 
215 (1), 105-110. 
 
Moradveisi, L., Huibers, M. J. H., Renner, F. & Arntz, A. (2014). The influence of patients' 
preference/attitude towards psychotherapy and antidepressant medication on the 
treatment of major depressive disorder. Journal of Behavior Therapy and Experimental 
Psychiatry, 45, 170-177. 
 
Renner, F., Van Goor, M., Huibers, M. J. H., Arntz, A., Butz, B., & Bernstein, D. P. (2014). 
Effecten van schemagroepstherapie bij jongvolwassenen [Effects of group 
schematherapy for adolescents]. Gedragstherapie, 47 (1), 20-36. 
  
CURRICULUM VITAE 
 268 
Renner, F., Van Goor, M., Huibers, M. J. H., Arntz, A., Butz, B., & Bernstein, D. P. (2013). 
Short-term group schema cognitive-behavioral therapy for young adults with 
personality disorders and personality disorder features: Associations with changes in 
symptomatic distress, schemas, schema modes and coping styles. Behavioral Research 
and Therapy, 51, 487-492. 
 
Schultze-Lutter, F., Renner, F., Paruch, J., Julkowski, D., Klosterkotter, J., & Ruhrmann, S. 
(2013). Self-Reported Psychotic-Like Experiences Are a Poor Estimate of Clinician-Rated 
Attenuated and Frank Delusions and Hallucinations. Psychopathology, 47 (3), 194-201. 
 
Renner, F., Arntz, A., Leeuw, I. & Huibers, M. J. H. (2013). Treatment for chronic 
depression using schema therapy. Clinical Psychology Science and Practice, 20, 166-180. 
 
Moradveisi, L., Huibers, M., Renner, F., Arasteh, M., & Arntz, A. (2013). The influence of 
comorbid personality disorder on the effects of behavioural activation vs. 
antidepressant medication for major depressive disorder: Results from a randomized 
trial in Iran. Behaviour Research and Therapy, 51, 499-506. 
 
Renner, F., Penninx, B. W. J. H., Peeters, F., Cuijpers, P., & Huibers, M. J. H. (2013). Two-
year stability and change of neuroticism and extraversion in treated and untreated 
persons with depression: Findings from the Netherlands Study of Depression and 
Anxiety (NESDA). Journal of Affective Disorders, 150 (2), 201-208. 
 
Moradveisi, L., Huibers, M. J. H., Renner, F., Arasteh, M., & Arntz, A. (2013). 'Results for 
behavioural activation are overstated': Reply. The British Journal of Psychiatry, 202 (6), 
466-467. 
 
Moradveisi, L., Huibers, M. J. H., Renner, F., Arasteh, M., & Arntz, A. (2013). Behavioural 
activation v. antidepressant medication for treating depression in Iran: randomised trial. 
The British Journal of Psychiatry, 202, 204-211. 
 
Renner, F., Jarrett, R. B., Vittengl, J. R., Barrett, M. S., Clark, L. A., & Thase, M. E. (2012). 
Interpersonal problems as predictors of therapeutic alliance and symptom improvement 
in cognitive therapy for depression. Journal of Affective Disorders, 138 (3), 458-467.  
 
Renner, F., Lobbestael, J., Peeters, F., Arntz, A., & Huibers, M. J. H. (2012). Early 
maladaptive schemas in depressed patients: Stability and relation with depressive 
symptoms over the course of treatment. Journal of Affective Disorders, 136 (3), 581-590.  
 
Bamelis, L. L. M., Renner, F., Heidkamp, D., & Arntz, A. (2011). Extended schema mode 
conceptualizations for specific personality disorders: an empirical study. Journal of 
Personality Disorders, 25 (1), 41-58.  
CURRICULUM VITAE 
 269
Submitted manuscripts 
Renner, F., Siep, N., Lobbestael, J., Arntz, A., Peeters, F., & Huibers, M. J. H. (2014). Neural 
correlates of self-referential processing and implicit self-associations in chronic 
depression. Submitted for publication. 
 
Renner, F., Arntz, A., Peeters, F., Lobbestael, J., & Huibers, M. J. H. (2014). Schema therapy 
for chronic depression: Results of a multiple single case series study. Submitted for 
publication. 
 
Renner, F., Siep, N., Arntz, A., van de Ven, V., Peeters, F., Quaedflieg, C., & Huibers, M. J. H. 
(2014). Sad mood induction modulates default mode network resting-state functional 
connectivity in chronic depression. Submitted for publication. 
 
Lemmens, L. H. J. M., Renner, F., & Peeters, F. (2014). Persisterende Depressieve Stoornis 
[Persistent Depressive Disorder]. In I. Franken, P. Muris & D. Denys (Eds.), Basisboek 
Psychopathologie. Utrecht: de Tijdstroom. Book chapter submitted for publication. 
Conference	Presentations	
Schema therapy for chronic depression: Testing potential mechanisms of change. 
Symposium presentation at the Congress of the European Association of Behavioral and 
Cognitive Therapies (EABCT) 2014. The Hague, the Netherlands. 
 
Schema therapy for (chronic) depression. Symposium presentation at the world 
congress of the International Society of Schema Therapy (ISST) 2014. Istanbul, Turkey. 
 
Schema therapy for chronic depression. Symposium presentation at the Congress of the 
European Association of Behavioral and Cognitive Therapies (EABCT) 2013. Marrakesh, 
Morocco. 
 
Self-referential processing in depressed patients and matched non-clinical controls: An 
fMRI study. Open paper presentation at the “Tagung experimentell arbeitender 
Psychologen” (TeaP) [Conference of Experimental Psychologists] 2013. Vienna, Austria. 
 
Schemagerichte therapie voor chronische depressie [Schema therapy for chronic 
depression]. Invited talk at the “Psychiaterconferentie GGZ Noord-Holland-Noord” 2013. 
Heiloo, the Netherlands. 
 
Single case series of schema-focused therapy for chronic depression: Preliminary 
findings. Symposium presentation at the world congress of the International Society of 
Schema Therapy (ISST) 2012. New York City, USA. 
 
CURRICULUM VITAE 
 270 
Schemagerichte therapie voor chronische depressie [Schema therapy for chronic 
depression]. Symposium presentation at the Dutch Association for Cognitive Behavioral 
Treatments (VGCT) 2012. Veldhoven, the Netherlands. 
  
Early maladaptive schemas in depressed patients: Structure, stability and relation with 
depressive symptoms. Open paper presentation at the Congress of the European 
Association of Behavioral and Cognitive Therapies (EABCT) 2011. Reykjavik, Iceland.  
 
Interpersonal problems as predictors of therapeutic alliance and symptom improvement 
in cognitive therapy for depression. Open paper presentation at the Congress of the 
European Association of Behavioral and Cognitive Therapies (EABCT) 2011. Reykjavik, 
Iceland. 
 
Early maladaptive schemas in depressed patients: Structure, stability and relation with 
depressive symptoms. Poster presented at the World Congress of Cognitive Behavioral 
Therapies (WCBCT) 2010. Boston, USA. 
 
Interpersonal problems as predictors of therapeutic alliance and symptom improvement 
in cognitive therapy for depression. Poster presented at the World Congress of Cognitive 
Behavioral Therapies (WCBCT) 2010. Boston, USA. 
 
Early maladaptive schemas in depressed patients: Structure, stability and relation with 
depressive symptoms. Open paper presentation at the International Society of Schema 
Therapy (ISST) Conference, 2010. Berlin, Germany. 
 
